page	event	quadrant	sample_name	position	oscillating_cn_2&3_states	cn_segments	event_region	full_text
1	1	Upper_Left	BTCA_donor_A096	1:120690998−248630158	21, 25	291	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	BTCA_donor_A096 Biliary−AdenoCA Cancer type 1:120690998−248630158 Position With other complex events Type 214 Interleaved intrachr. SVs 215 Total SVs (intrachr. + transl.) DEL: 47; DUP: 56; h2hINV: 62; SV types t2tINV: 49; TRA: 1 292 SVs in sample 21, 25 Oscillating CN (2 and 3 states) 291 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
1	2	Upper_Right	BTCA_donor_B070	19:8183835−57827516	8, 15	67	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	BTCA_donor_B070 Biliary−AdenoCA Cancer type 19:8183835−57827516 Position With other complex events Type 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 9; SV types t2tINV: 7; TRA: 0 166 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 67 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
1	3	Lower_Left	BTCA_donor_C080	6:67710168−124238025	7, 11	19	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	75 MB 100 MB 125 MB BTCA_donor_C080 Biliary−AdenoCA Cancer type 6:67710168−124238025 Position With other complex events Type 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 7 142 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 19 CN segments
1	4	Lower_Right	BTCA_donor_C080	12:15005593−128406118	7, 18	18	{'min_x': 327.82000732421875, 'min_y': 705.2749633789062, 'max_x': 553.47216796875, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB BTCA_donor_C080 Biliary−AdenoCA Cancer type 12:15005593−128406118 Position With other complex events Type 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 8 142 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 18 CN segments
2	1	Upper_Left	RK142	1:1138581−66347938	14, 26	26	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.54379272460938, 'max_y': 416.3340148925781}	RK142 Biliary−AdenoCA Cancer type 1:1138581−66347938 Position With other complex events Type 34 Interleaved intrachr. SVs 86 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 11; SV types t2tINV: 6; TRA: 52 168 SVs in sample 14, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
2	2	Upper_Right	RK142	14:21707781−107204434	41, 41	41	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	RK142 Biliary−AdenoCA Cancer type 14:21707781−107204434 Position Canonical without polyploidization Type 30 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 8; SV types t2tINV: 9; TRA: 49 168 SVs in sample 41, 41 Oscillating CN (2 and 3 states) 41 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 1:1138581−66347937; Linked to chrs
2	3	Lower_Left	RK208	10:24963425−133800853	11, 21	89	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 252.2521209716797, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB RK208 Biliary−AdenoCA Cancer type 10:24963425−133800853 Position With other complex events Type 50 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 15; DUP: 15; h2hINV: 11; SV types t2tINV: 9; TRA: 5 294 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 89 CN segments
2	4	Lower_Right	RK307	8:47769789−143083576	9, 13	45	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB RK307 Biliary−AdenoCA Cancer type 8:47769789−143083576 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 4; SV types t2tINV: 5; TRA: 0 89 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 45 CN segments
3	1	Upper_Left	RK307	14:56412147−79304555	7, 8	11	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	RK307 Biliary−AdenoCA Cancer type 14:56412147−79304555 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 0 89 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 11 CN segments 0.59 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
3	2	Upper_Right	RK308	13:20391473−54701210	42, 65	65	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	RK308 Biliary−AdenoCA Cancer type 3:999520−181068319 Position Canonical without polyploidization Type 35 Interleaved intrachr. SVs 127 Total SVs (intrachr. + transl.) DEL: 12; DUP: 6; h2hINV: 12; SV types t2tINV: 5; TRA: 92 290 SVs in sample 42, 65 Oscillating CN (2 and 3 states) 65 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 13:20391473−54701210;6:4291463−102377482 Linked to chrs
3	3	Lower_Left	RK308	6:4291463−102377483	21, 35	54	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 266.6219787597656, 'max_y': 838.7838134765625}	40 MB 80 MB 120 MB 160 MB RK308 Biliary−AdenoCA Cancer type 6:4291463−102377483 Position With other complex events Type 27 Interleaved intrachr. SVs 131 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 6; SV types t2tINV: 8; TRA: 104 290 SVs in sample 21, 35 Oscillating CN (2 and 3 states) 54 CN segments 0.84 FDR fragment joints
3	4	Lower_Right	RK308	13:20391473−54701211	38, 38	38	{'min_x': 306.6300048828125, 'min_y': 705.2749633789062, 'max_x': 530.3822021484375, 'max_y': 838.7838134765625}	20 MB 40 MB 60 MB 80 MB 100 MB RK308 Biliary−AdenoCA Cancer type 13:20391473−54701211 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 3; SV types t2tINV: 4; TRA: 72 290 SVs in sample 38, 38 Oscillating CN (2 and 3 states) 38 CN segments 0.92 FDR fragment joints
4	1	Upper_Left	RK308	19:32501825−58859068	17, 30	30	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK308 Biliary−AdenoCA Cancer type 19:32501825−58859068 Position With other complex events Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 5; SV types t2tINV: 3; TRA: 0 290 SVs in sample 17, 30 Oscillating CN (2 and 3 states) 30 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
4	2	Upper_Right	RK316	6:108425970−158281848	7, 10	50	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.42401123046875}	RK316 Biliary−AdenoCA Cancer type 9:5597836−123851444 Position With other complex events Type 79 Interleaved intrachr. SVs 102 Total SVs (intrachr. + transl.) DEL: 13; DUP: 20; h2hINV: 23; SV types t2tINV: 23; TRA: 23 128 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 50 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 6:108425970−158281848; Linked to chrs
4	3	Lower_Left	096b4f32-10c1-4737-a0dd-cae04c54ee33	3:31044413−84685234	12, 12	12	{'min_x': 39.56990051269531, 'min_y': 705.2749633789062, 'max_x': 248.15975952148438, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 096b4f32−10c1−4737−a0dd−cae04c54ee33 Bladder−TCC Cancer type 3:31044413−84685234 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 136 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
4	4	Lower_Right	096b4f32-10c1-4737-a0dd-cae04c54ee33	5:67743249−176695147	14, 20	20	{'min_x': 312.2900085449219, 'min_y': 705.2749633789062, 'max_x': 537.65966796875, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 096b4f32−10c1−4737−a0dd−cae04c54ee33 Bladder−TCC Cancer type 5:67743249−176695147 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 5; SV types t2tINV: 3; TRA: 0 136 SVs in sample 14, 20 Oscillating CN (2 and 3 states) 20 CN segments
5	1	Upper_Left	3ed614e7-f356-4d87-985b-d3bbbae3bb40	11:8965507−99216922	8, 22	22	{'min_x': 38.360198974609375, 'min_y': 282.3299865722656, 'max_x': 249.36595153808594, 'max_y': 416.3340148925781}	3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 16:6669849−31591597 Position With other complex events Type 5 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 8 449 SVs in sample 8, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.92 FDR fragment joints 0.27 FDR chr. breakp. enrich. 11:8965507−99216922;X:3858348−76848684 Linked to chrs
5	2	Upper_Right	3ed614e7-f356-4d87-985b-d3bbbae3bb40	16:6669849−31591596	7, 7	7	{'min_x': 328.04998779296875, 'min_y': 286.6499938964844, 'max_x': 538.6798706054688, 'max_y': 416.42401123046875}	3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type X:3858348−76848685 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 4 449 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.64 FDR fragment joints 0.28 FDR chr. breakp. enrich. 16:6669849−31591596; Linked to chrs
5	3	Lower_Left	493a4ff2-37a5-4b79-928d-83dbfe534556	4:144150885−190874076	9, 16	29	{'min_x': 35.71989822387695, 'min_y': 705.2749633789062, 'max_x': 246.98406982421875, 'max_y': 833.6940307617188}	100 MB 125 MB 150 MB 175 MB 493a4ff2−37a5−4b79−928d−83dbfe534556 Bladder−TCC Cancer type 4:144150885−190874076 Position With other complex events Type 24 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 7; SV types t2tINV: 8; TRA: 3 117 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 29 CN segments
5	4	Lower_Right	5d54c742-5a8e-4c40-8d62-95e75e210ab8	4:72403638−190385402	9, 10	37	{'min_x': 313.4200134277344, 'min_y': 705.2749633789062, 'max_x': 538.3579711914062, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 5d54c742−5a8e−4c40−8d62−95e75e210ab8 Bladder−TCC Cancer type 4:72403638−190385402 Position With other complex events Type 20 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 6; SV types t2tINV: 6; TRA: 9 175 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 37 CN segments
6	1	Upper_Left	5d54c742-5a8e-4c40-8d62-95e75e210ab8	12:15725603−31961309	7, 13	13	{'min_x': 38.86989974975586, 'min_y': 286.6499938964844, 'max_x': 248.8579559326172, 'max_y': 416.3340148925781}	5d54c742−5a8e−4c40−8d62−95e75e210ab8 Bladder−TCC Cancer type 12:15725603−31961309 Position With other complex events Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 3 175 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.64 FDR fragment joints 0.05 FDR chr. breakp. enrich. Linked to chrs
6	2	Upper_Right	797a71ee-372d-41e5-aeee-5ab3c4661110	13:21033268−104354353	10, 27	41	{'min_x': 328.5299987792969, 'min_y': 286.6499938964844, 'max_x': 538.1979370117188, 'max_y': 416.42401123046875}	797a71ee−372d−41e5−aeee−5ab3c4661110 Bladder−TCC Cancer type 13:21033268−104354353 Position With other complex events Type 14 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 15 145 SVs in sample 10, 27 Oscillating CN (2 and 3 states) 41 CN segments 0.78 FDR fragment joints 0 FDR chr. breakp. enrich. 20:24187366−56783858; Linked to chrs
6	3	Lower_Left	797a71ee-372d-41e5-aeee-5ab3c4661110	20:24187366−56783859	16, 16	16	{'min_x': 39.03010177612305, 'min_y': 705.2749633789062, 'max_x': 248.6979522705078, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 797a71ee−372d−41e5−aeee−5ab3c4661110 Bladder−TCC Cancer type 20:24187366−56783859 Position After polyploidization Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 8 145 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
6	4	Lower_Right	904a8757-e0c5-41ef-b583-c8f170caaac1	8:5291228−33089595	11, 14	14	{'min_x': 330.0400085449219, 'min_y': 705.2749633789062, 'max_x': 536.69189453125, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 904a8757−e0c5−41ef−b583−c8f170caaac1 Bladder−TCC Cancer type 8:5291228−33089595 Position Before polyploidization Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 1 274 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments
7	1	Upper_Left	904a8757-e0c5-41ef-b583-c8f170caaac1	21:14511470−48074038	14, 16	43	{'min_x': 40.539798736572266, 'min_y': 286.6499938964844, 'max_x': 247.19195556640625, 'max_y': 416.3340148925781}	904a8757−e0c5−41ef−b583−c8f170caaac1 Bladder−TCC Cancer type 21:14511470−48074038 Position With other complex events Type 39 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 12; DUP: 11; h2hINV: 8; SV types t2tINV: 8; TRA: 1 274 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 43 CN segments 0.81 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
7	2	Upper_Right	f48937ed-e294-41f0-8872-7010391167a9	2:82560680−181154512	9, 9	9	{'min_x': 330.0400085449219, 'min_y': 286.6499938964844, 'max_x': 536.69189453125, 'max_y': 416.3340148925781}	f48937ed−e294−41f0−8872−7010391167a9 Bladder−TCC Cancer type 2:82560680−181154512 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 5 78 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
7	3	Lower_Left	CGP_donor_1437410	6:70986165−164827209	17, 17	17	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 234.45211791992188, 'max_y': 833.6940307617188}	100 MB 125 MB 150 MB CGP_donor_1437410 Bone−Benign Cancer type 6:70986165−164827209 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 3; SV types t2tINV: 5; TRA: 9 33 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
7	4	Lower_Right	CGP_donor_1437411	1:51871319−244912139	18, 18	18	{'min_x': 305.239990234375, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1437411 Bone−Benign Cancer type 1:51871319−244912139 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 130 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 118 513 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments 1 FDR fragment joints
8	1	Upper_Left	CGP_donor_1437411	1:51871319−244912138	37, 37	37	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 420.74383544921875}	CGP_donor_1437411 Bone−Benign Cancer type 2:8888556−242818178 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 134 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 6; TRA: 121 513 SVs in sample 37, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 1:51871319−244912138;4:3484005−186431923 Linked to chrs 5:67575508−163331316;
8	2	Upper_Right	CGP_donor_1437411	1:51871319−244912138	37, 37	37	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	CGP_donor_1437411 Bone−Benign Cancer type 4:3484005−186431924 Position Canonical without polyploidization Type 30 Interleaved intrachr. SVs 195 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 6; SV types t2tINV: 7; TRA: 165 513 SVs in sample 37, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 1:51871319−244912138;2:8888556−242818177 Linked to chrs
8	3	Lower_Left	CGP_donor_1437411	5:67575508−163331317	11, 11	20	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 233.12196350097656, 'max_y': 838.7838134765625}	75 MB 100 MB 125 MB 150 MB CGP_donor_1437411 Bone−Benign Cancer type 5:67575508−163331317 Position With other complex events Type 3 Interleaved intrachr. SVs 93 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 90 513 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 20 CN segments 0.59 FDR fragment joints
8	4	Lower_Right	CGP_donor_1437411	6:1694508−170873562	57, 57	57	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 545.572021484375, 'max_y': 838.7838134765625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1437411 Bone−Benign Cancer type 6:1694508−170873562 Position Canonical without polyploidization Type 65 Interleaved intrachr. SVs 284 Total SVs (intrachr. + transl.) DEL: 16; DUP: 15; h2hINV: 16; SV types t2tINV: 18; TRA: 219 513 SVs in sample 57, 57 Oscillating CN (2 and 3 states) 57 CN segments 0.98 FDR fragment joints
9	1	Upper_Left	CGP_donor_1602529	4:35358971−48132846	11, 15	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1602529 Bone−Epith Cancer type 4:35358971−48132846 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 5; TRA: 13 71 SVs in sample 11, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
9	2	Upper_Right	CGP_donor_1691150	15:33454042−35471243	15, 15	15	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CGP_donor_1691150 Bone−Epith Cancer type 1:2737096−33713570 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 6 103 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0.07 FDR chr. breakp. enrich. 15:33454042−35471243; Linked to chrs
9	3	Lower_Left	CGP_donor_1691150	18:19084928−61967083	16, 27	27	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 258.3800354003906, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB CGP_donor_1691150 Bone−Epith Cancer type 18:19084928−61967083 Position With other complex events Type 16 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 2; SV types t2tINV: 7; TRA: 16 103 SVs in sample 16, 27 Oscillating CN (2 and 3 states) 27 CN segments
9	4	Lower_Right	CGP_donor_1841267	16:46689644−89652038	24, 24	24	{'min_x': 325.260009765625, 'min_y': 705.2749633789062, 'max_x': 560.3299560546875, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB CGP_donor_1841267 Bone−Epith Cancer type 16:46689644−89652038 Position Canonical without polyploidization Type 32 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 9; SV types t2tINV: 12; TRA: 1 59 SVs in sample 24, 24 Oscillating CN (2 and 3 states) 24 CN segments
10	1	Upper_Left	CGP_donor_1397077	20:14754035−59064330	9, 13	40	{'min_x': 38.70000076293945, 'min_y': 282.3299865722656, 'max_x': 249.0299530029297, 'max_y': 416.3340148925781}	CGP_donor_1397077 Bone−Osteosarc Cancer type 6:88458092−155828131 Position With other complex events Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 13 379 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 40 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 20:14754035−59064330;5:759551−44322946 Linked to chrs
10	2	Upper_Right	CGP_donor_1397083	16:32468669−82206220	7, 10	19	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1397083 Bone−Osteosarc Cancer type 16:32468669−82206220 Position With other complex events Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 0; SV types t2tINV: 3; TRA: 4 142 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 19 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
10	3	Lower_Left	CGP_donor_1397084	1:213162214−247806789	13, 14	30	{'min_x': 53.360198974609375, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB CGP_donor_1397084 Bone−Osteosarc Cancer type 1:213162214−247806789 Position With other complex events Type 21 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 5; SV types t2tINV: 6; TRA: 3 195 SVs in sample 13, 14 Oscillating CN (2 and 3 states) 30 CN segments
10	4	Lower_Right	CGP_donor_1397084	8:155450−145113709	8, 20	90	{'min_x': 309.17999267578125, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB CGP_donor_1397084 Bone−Osteosarc Cancer type 8:155450−145113709 Position With other complex events Type 83 Interleaved intrachr. SVs 83 Total SVs (intrachr. + transl.) DEL: 21; DUP: 16; h2hINV: 24; SV types t2tINV: 22; TRA: 0 195 SVs in sample 8, 20 Oscillating CN (2 and 3 states) 90 CN segments
11	1	Upper_Left	CGP_donor_1437403	3:137693454−187956215	11, 22	30	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1437403 Bone−Osteosarc Cancer type 3:137693454−187956215 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 1; SV types t2tINV: 2; TRA: 1 445 SVs in sample 11, 22 Oscillating CN (2 and 3 states) 30 CN segments 0.59 FDR fragment joints 0.16 FDR chr. breakp. enrich. Linked to chrs
11	2	Upper_Right	CGP_donor_1437403	10:757620−15159495	9, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CGP_donor_1437403 Bone−Osteosarc Cancer type 10:757620−15159495 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 445 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
11	3	Lower_Left	CGP_donor_1437403	14:48802183−106839331	15, 19	19	{'min_x': 55.18009948730469, 'min_y': 705.2749633789062, 'max_x': 251.10205078125, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB CGP_donor_1437403 Bone−Osteosarc Cancer type 14:48802183−106839331 Position After polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 1 445 SVs in sample 15, 19 Oscillating CN (2 and 3 states) 19 CN segments
11	4	Lower_Right	CGP_donor_1437404	3:5273444−86230794	19, 25	55	{'min_x': 309.3500061035156, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB CGP_donor_1437404 Bone−Osteosarc Cancer type 3:5273444−86230794 Position With other complex events Type 25 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 9; DUP: 9; h2hINV: 3; SV types t2tINV: 4; TRA: 43 597 SVs in sample 19, 25 Oscillating CN (2 and 3 states) 55 CN segments
12	1	Upper_Left	CGP_donor_1437404	4:121261720−181140074	36, 50	57	{'min_x': 61.849998474121094, 'min_y': 286.6499938964844, 'max_x': 225.87779235839844, 'max_y': 416.42401123046875}	CGP_donor_1437404 Bone−Osteosarc Cancer type 4:121261720−181140074 Position After polyploidization Type 36 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 7; SV types t2tINV: 9; TRA: 13 597 SVs in sample 36, 50 Oscillating CN (2 and 3 states) 57 CN segments 0.87 FDR fragment joints 0 FDR chr. breakp. enrich. 6:40585455−137670951; Linked to chrs
12	2	Upper_Right	CGP_donor_1437404	16:956773−33610119	14, 16	33	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	CGP_donor_1437404 Bone−Osteosarc Cancer type 5:18472606−43606863 Position With other complex events Type 19 Interleaved intrachr. SVs 59 Total SVs (intrachr. + transl.) DEL: 3; DUP: 9; h2hINV: 3; SV types t2tINV: 4; TRA: 40 597 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 33 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 16:956773−33610119;6:40585455−137670951 Linked to chrs
12	3	Lower_Left	CGP_donor_1437404	12:54388545−79574150	3, 4	127	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 263.2521057128906, 'max_y': 838.7838134765625}	50 MB 75 MB 100 MB 125 MB CGP_donor_1437404 Bone−Osteosarc Cancer type 12:54388545−79574150 Position With other complex events Type 58 Interleaved intrachr. SVs 85 Total SVs (intrachr. + transl.) DEL: 16; DUP: 12; h2hINV: 16; SV types t2tINV: 14; TRA: 27 597 SVs in sample 3, 4 Oscillating CN (2 and 3 states) 127 CN segments 0.9 FDR fragment joints
12	4	Lower_Right	CGP_donor_1437404	19:29326898−57862516	14, 14	19	{'min_x': 312.9200134277344, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB CGP_donor_1437404 Bone−Osteosarc Cancer type 19:29326898−57862516 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 0; SV types t2tINV: 3; TRA: 14 597 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 19 CN segments
13	1	Upper_Left	CGP_donor_1437406	3:8793061−39393867	11, 11	11	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1437406 Bone−Osteosarc Cancer type 3:8793061−39393867 Position After polyploidization Type 7 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 16 871 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 5:55072−32110729; Linked to chrs
13	2	Upper_Right	CGP_donor_1437406	3:8793061−39393866	6, 6	99	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.42401123046875}	CGP_donor_1437406 Bone−Osteosarc Cancer type 5:55072−32110730 Position With other complex events Type 55 Interleaved intrachr. SVs 130 Total SVs (intrachr. + transl.) DEL: 12; DUP: 17; h2hINV: 16; SV types t2tINV: 10; TRA: 75 871 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 99 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:8793061−39393866; Linked to chrs
13	3	Lower_Left	CGP_donor_1437406	12:4757456−129380238	4, 5	551	{'min_x': 55.460201263427734, 'min_y': 705.2749633789062, 'max_x': 262.79193115234375, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_1437406 Bone−Osteosarc Cancer type 12:4757456−129380238 Position With other complex events Type 340 Interleaved intrachr. SVs 560 Total SVs (intrachr. + transl.) DEL: 90; DUP: 99; h2hINV: 72; SV types t2tINV: 79; TRA: 220 871 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 551 CN segments
13	4	Lower_Right	CGP_donor_1437407	11:86917622−100968022	14, 14	14	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 544.5123291015625, 'max_y': 833.6940307617188}	90 MB 95 MB 100 MB CGP_donor_1437407 Bone−Osteosarc Cancer type 11:86917622−100968022 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 92 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
14	1	Upper_Left	CGP_donor_1437407	20:50980028−62689311	13, 29	46	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.54379272460938, 'max_y': 416.3340148925781}	CGP_donor_1437407 Bone−Osteosarc Cancer type 20:50980028−62689311 Position With other complex events Type 45 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 13; DUP: 8; h2hINV: 12; SV types t2tINV: 12; TRA: 6 92 SVs in sample 13, 29 Oscillating CN (2 and 3 states) 46 CN segments 0.8 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
14	2	Upper_Right	CGP_donor_1437409	2:189048530−203590444	13, 13	13	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1437409 Bone−Osteosarc Cancer type 2:189048530−203590444 Position Before polyploidization Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 5; TRA: 1 118 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.59 FDR fragment joints 0.05 FDR chr. breakp. enrich. Linked to chrs
14	3	Lower_Left	CGP_donor_1437409	12:22931670−39481564	14, 17	34	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 270.6520690917969, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB CGP_donor_1437409 Bone−Osteosarc Cancer type 12:22931670−39481564 Position With other complex events Type 14 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 5; TRA: 3 118 SVs in sample 14, 17 Oscillating CN (2 and 3 states) 34 CN segments
14	4	Lower_Right	CGP_donor_1437409	16:2570177−12331926	8, 8	8	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 521.1299438476562, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB CGP_donor_1437409 Bone−Osteosarc Cancer type 16:2570177−12331926 Position Before polyploidization Type 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 3 118 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
15	1	Upper_Left	CGP_donor_1490908	14:60585562−102848228	12, 21	52	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1490908 Bone−Osteosarc Cancer type 1:5777564−248793247 Position With other complex events Type 23 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 23 216 SVs in sample 12, 21 Oscillating CN (2 and 3 states) 52 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 14:60585562−102848228; Linked to chrs
15	2	Upper_Right	CGP_donor_1490908	6:64603046−167895820	11, 13	130	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	CGP_donor_1490908 Bone−Osteosarc Cancer type 6:64603046−167895820 Position With other complex events Type 58 Interleaved intrachr. SVs 75 Total SVs (intrachr. + transl.) DEL: 10; DUP: 15; h2hINV: 15; SV types t2tINV: 18; TRA: 17 216 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 130 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
15	3	Lower_Left	CGP_donor_1490914	6:76106264−166727720	6, 9	65	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 229.22010803222656, 'max_y': 833.6940307617188}	100 MB 125 MB 150 MB CGP_donor_1490914 Bone−Osteosarc Cancer type 6:76106264−166727720 Position With other complex events Type 61 Interleaved intrachr. SVs 91 Total SVs (intrachr. + transl.) DEL: 20; DUP: 16; h2hINV: 12; SV types t2tINV: 13; TRA: 30 462 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 65 CN segments
15	4	Lower_Right	CGP_donor_1490914	10:50348934−97731679	9, 13	15	{'min_x': 305.7799987792969, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB CGP_donor_1490914 Bone−Osteosarc Cancer type 10:50348934−97731679 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 5 462 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 15 CN segments
16	1	Upper_Left	CGP_donor_1490914	X:97627888−151461839	7, 13	78	{'min_x': 61.849998474121094, 'min_y': 286.6499938964844, 'max_x': 225.87783813476562, 'max_y': 416.42401123046875}	CGP_donor_1490914 Bone−Osteosarc Cancer type 19:16843361−54772913 Position With other complex events Type 31 Interleaved intrachr. SVs 100 Total SVs (intrachr. + transl.) DEL: 8; DUP: 4; h2hINV: 10; SV types t2tINV: 9; TRA: 69 462 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 78 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. X:97627888−151461839; Linked to chrs
16	2	Upper_Right	CGP_donor_1528364	18:63082505−77710469	10, 16	81	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5380249023438, 'max_y': 416.4242248535156}	CGP_donor_1528364 Bone−Osteosarc Cancer type 2:98265301−240710956 Position With other complex events Type 30 Interleaved intrachr. SVs 95 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 8; SV types t2tINV: 9; TRA: 65 927 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 81 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. 1:2249362−182869103;10:44478896−86379720 18:63082505−77710469;3:39705096−116872806 Linked to chrs
16	3	Lower_Left	CGP_donor_1528364	4:161515724−190840263	11, 12	65	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.4639282226562}	50 MB 100 MB 150 MB CGP_donor_1528364 Bone−Osteosarc Cancer type 4:161515724−190840263 Position With other complex events Type 17 Interleaved intrachr. SVs 84 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 2; SV types t2tINV: 4; TRA: 67 927 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 65 CN segments 0.59 FDR fragment joints
16	4	Lower_Right	CGP_donor_1528364	5:878141−41078797	12, 12	126	{'min_x': 309.3900146484375, 'min_y': 705.2749633789062, 'max_x': 526.39208984375, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB 150 MB CGP_donor_1528364 Bone−Osteosarc Cancer type 5:878141−41078797 Position With other complex events Type 57 Interleaved intrachr. SVs 143 Total SVs (intrachr. + transl.) DEL: 16; DUP: 14; h2hINV: 16; SV types t2tINV: 11; TRA: 86 927 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 126 CN segments 0.84 FDR fragment joints
17	1	Upper_Left	CGP_donor_1528364	2:98265301−240710955	8, 15	274	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.42401123046875}	CGP_donor_1528364 Bone−Osteosarc Cancer type 7:62514967−158846143 Position With other complex events Type 233 Interleaved intrachr. SVs 257 Total SVs (intrachr. + transl.) DEL: 56; DUP: 62; h2hINV: 56; SV types t2tINV: 59; TRA: 24 927 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 274 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 2:98265301−240710955; Linked to chrs
17	2	Upper_Right	CGP_donor_1528364	8:71431403−119090655	9, 22	22	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1528364 Bone−Osteosarc Cancer type 8:71431403−119090655 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 927 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
17	3	Lower_Left	CGP_donor_1528364	10:44478896−86379721	15, 30	70	{'min_x': 38.70000076293945, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	50 MB 100 MB CGP_donor_1528364 Bone−Osteosarc Cancer type 10:44478896−86379721 Position With other complex events Type 13 Interleaved intrachr. SVs 85 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 72 927 SVs in sample 15, 30 Oscillating CN (2 and 3 states) 70 CN segments 0.59 FDR fragment joints
17	4	Lower_Right	CGP_donor_1528364	18:63082505−77710470	7, 17	83	{'min_x': 328.20001220703125, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 838.7838134765625}	20 MB 40 MB 60 MB CGP_donor_1528364 Bone−Osteosarc Cancer type 18:63082505−77710470 Position With other complex events Type 16 Interleaved intrachr. SVs 120 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 1; SV types t2tINV: 5; TRA: 104 927 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 83 CN segments 0.59 FDR fragment joints
18	1	Upper_Left	CGP_donor_1528371	12:70291799−112943997	9, 18	23	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1528371 Bone−Osteosarc Cancer type 12:70291799−112943997 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 4 349 SVs in sample 9, 18 Oscillating CN (2 and 3 states) 23 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
18	2	Upper_Right	CGP_donor_1528371	13:103350092−106906740	7, 7	12	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1528371 Bone−Osteosarc Cancer type 13:103350092−106906740 Position With other complex events Type 11 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 0; SV types t2tINV: 3; TRA: 28 349 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
18	3	Lower_Left	CGP_donor_1528381	2:143820724−160979294	7, 7	13	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	160 MB 180 MB 200 MB CGP_donor_1528381 Bone−Osteosarc Cancer type 2:143820724−160979294 Position With other complex events Type 5 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 0; SV types t2tINV: 1; TRA: 13 247 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.36 FDR fragment joints
18	4	Lower_Right	CGP_donor_1528381	6:494867−75444947	20, 24	43	{'min_x': 308.739990234375, 'min_y': 705.2749633789062, 'max_x': 550.822265625, 'max_y': 833.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB CGP_donor_1528381 Bone−Osteosarc Cancer type 6:494867−75444947 Position With other complex events Type 21 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 4; SV types t2tINV: 6; TRA: 8 247 SVs in sample 20, 24 Oscillating CN (2 and 3 states) 43 CN segments
19	1	Upper_Left	CGP_donor_1528381	17:7586844−41815158	8, 9	18	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 416.3340148925781}	CGP_donor_1528381 Bone−Osteosarc Cancer type 19:5000187−56724969 Position With other complex events Type 3 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 15 247 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 18 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 17:7586844−41815158;2:143820724−160979293 Linked to chrs
19	2	Upper_Right	CGP_donor_1691133	2:184287853−237379430	11, 12	27	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	CGP_donor_1691133 Bone−Osteosarc Cancer type 2:184287853−237379430 Position With other complex events Type 22 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 4; SV types t2tINV: 5; TRA: 22 325 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 27 CN segments 0.73 FDR fragment joints 0 FDR chr. breakp. enrich. 18:20691527−64759311; Linked to chrs
19	3	Lower_Left	CGP_donor_1691133	5:49680325−176939873	8, 12	20	{'min_x': 62.480098724365234, 'min_y': 705.2749633789062, 'max_x': 226.8821563720703, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB 150 MB CGP_donor_1691133 Bone−Osteosarc Cancer type 5:49680325−176939873 Position With other complex events Type 24 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 9; SV types t2tINV: 6; TRA: 5 325 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 20 CN segments
19	4	Lower_Right	CGP_donor_1691133	8:54201065−139568174	8, 19	23	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB CGP_donor_1691133 Bone−Osteosarc Cancer type 8:54201065−139568174 Position With other complex events Type 12 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 2 325 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 23 CN segments
20	1	Upper_Left	CGP_donor_1691133	2:184287853−237379429	7, 9	43	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1691133 Bone−Osteosarc Cancer type 18:20691527−64759312 Position With other complex events Type 22 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 7; SV types t2tINV: 8; TRA: 9 325 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 43 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 2:184287853−237379429; Linked to chrs
20	2	Upper_Right	CGP_donor_1691135	9:1002337−47212849	9, 24	54	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1691135 Bone−Osteosarc Cancer type 9:1002337−47212849 Position With other complex events Type 32 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 9; SV types t2tINV: 9; TRA: 11 136 SVs in sample 9, 24 Oscillating CN (2 and 3 states) 54 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
20	3	Lower_Left	CGP_donor_1691135	21:33576946−40152008	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 267.59014892578125, 'max_y': 833.6940307617188}	20 MB 25 MB 30 MB 35 MB 40 MB CGP_donor_1691135 Bone−Osteosarc Cancer type 21:33576946−40152008 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 2; SV types t2tINV: 0; TRA: 0 136 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
20	4	Lower_Right	CGP_donor_1691147	1:146691688−249090423	13, 67	79	{'min_x': 341.9700012207031, 'min_y': 705.2749633789062, 'max_x': 561.5921020507812, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB 250 MB CGP_donor_1691147 Bone−Osteosarc Cancer type 1:146691688−249090423 Position With other complex events Type 35 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 12; DUP: 10; h2hINV: 8; SV types t2tINV: 5; TRA: 0 279 SVs in sample 13, 67 Oscillating CN (2 and 3 states) 79 CN segments
21	1	Upper_Left	CGP_donor_1691147	2:4339643−84633644	8, 22	22	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1691147 Bone−Osteosarc Cancer type 2:4339643−84633644 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 0 279 SVs in sample 8, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.84 FDR fragment joints 0.76 FDR chr. breakp. enrich. Linked to chrs
21	2	Upper_Right	CGP_donor_1691147	8:121801782−134076197	9, 9	9	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1691147 Bone−Osteosarc Cancer type 8:121801782−134076197 Position After polyploidization Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 1; TRA: 1 279 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0.32 FDR chr. breakp. enrich. Linked to chrs
21	3	Lower_Left	CGP_donor_1691147	15:33299268−98372536	8, 9	29	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB CGP_donor_1691147 Bone−Osteosarc Cancer type 15:33299268−98372536 Position With other complex events Type 23 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 6; SV types t2tINV: 8; TRA: 3 279 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 29 CN segments
21	4	Lower_Right	CGP_donor_1691147	18:2636202−13923208	9, 11	13	{'min_x': 308.3399963378906, 'min_y': 705.2749633789062, 'max_x': 532.8580932617188, 'max_y': 833.6940307617188}	2.5 MB 5 MB 7.5 MB 10 MB 12.5 MB CGP_donor_1691147 Bone−Osteosarc Cancer type 18:2636202−13923208 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 0 279 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 13 CN segments
22	1	Upper_Left	CGP_donor_1691147	19:2553855−32893078	5, 7	72	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.54379272460938, 'max_y': 416.3340148925781}	CGP_donor_1691147 Bone−Osteosarc Cancer type 19:2553855−32893078 Position With other complex events Type 41 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 12; DUP: 4; h2hINV: 15; SV types t2tINV: 10; TRA: 6 279 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 72 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
22	2	Upper_Right	CGP_donor_1691149	2:95756719−226666706	10, 10	32	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1691149 Bone−Osteosarc Cancer type 2:95756719−226666706 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 93 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 32 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
22	3	Lower_Left	CGP_donor_1691149	12:39356696−73985137	4, 5	77	{'min_x': 60.18009948730469, 'min_y': 705.2749633789062, 'max_x': 242.41001892089844, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB CGP_donor_1691149 Bone−Osteosarc Cancer type 12:39356696−73985137 Position With other complex events Type 53 Interleaved intrachr. SVs 56 Total SVs (intrachr. + transl.) DEL: 17; DUP: 16; h2hINV: 8; SV types t2tINV: 12; TRA: 3 93 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 77 CN segments
22	4	Lower_Right	CGP_donor_1691207	5:4320966−44667330	14, 43	112	{'min_x': 339.9599914550781, 'min_y': 705.2749633789062, 'max_x': 531.769775390625, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB CGP_donor_1691207 Bone−Osteosarc Cancer type 5:4320966−44667330 Position With other complex events Type 63 Interleaved intrachr. SVs 92 Total SVs (intrachr. + transl.) DEL: 12; DUP: 21; h2hINV: 16; SV types t2tINV: 14; TRA: 29 415 SVs in sample 14, 43 Oscillating CN (2 and 3 states) 112 CN segments
23	1	Upper_Left	CGP_donor_1691207	5:4320966−44667329	16, 16	30	{'min_x': 38.70000076293945, 'min_y': 282.3299865722656, 'max_x': 249.0299530029297, 'max_y': 416.3340148925781}	CGP_donor_1691207 Bone−Osteosarc Cancer type 8:50128153−138434525 Position With other complex events Type 31 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 4; DUP: 9; h2hINV: 9; SV types t2tINV: 9; TRA: 14 415 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 30 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 5:4320966−44667329;7:3613250−157967148 Linked to chrs
23	2	Upper_Right	CGP_donor_1691208	18:329522−9437571	6, 7	47	{'min_x': 329.8599853515625, 'min_y': 282.3299865722656, 'max_x': 536.8639526367188, 'max_y': 416.3340148925781}	CGP_donor_1691208 Bone−Osteosarc Cancer type 11:59962284−134707313 Position With other complex events Type 51 Interleaved intrachr. SVs 61 Total SVs (intrachr. + transl.) DEL: 11; DUP: 12; h2hINV: 15; SV types t2tINV: 13; TRA: 10 124 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 47 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 18:329522−9437571;4:27990522−39404507 Linked to chrs
23	3	Lower_Left	CGP_donor_1691209	1:151613490−246812975	8, 11	14	{'min_x': 52.730098724365234, 'min_y': 705.2749633789062, 'max_x': 224.29197692871094, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CGP_donor_1691209 Bone−Osteosarc Cancer type 1:151613490−246812975 Position With other complex events Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 66 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 14 CN segments
23	4	Lower_Right	CGP_donor_1691210	9:90338614−98608467	10, 18	28	{'min_x': 327.3399963378906, 'min_y': 705.2749633789062, 'max_x': 548.8523559570312, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB CGP_donor_1691210 Bone−Osteosarc Cancer type 9:90338614−98608467 Position With other complex events Type 6 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 20 183 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 28 CN segments
24	1	Upper_Left	CGP_donor_1691210	12:66698784−98376745	11, 21	55	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1691210 Bone−Osteosarc Cancer type 12:66698784−98376745 Position With other complex events Type 32 Interleaved intrachr. SVs 56 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 9; SV types t2tINV: 12; TRA: 24 183 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 55 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 9:90338614−98608466; Linked to chrs
24	2	Upper_Right	CGP_donor_1691211	17:996864−13569640	15, 42	76	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	CGP_donor_1691211 Bone−Osteosarc Cancer type 2:9233757−238199400 Position With other complex events Type 15 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 37 606 SVs in sample 15, 42 Oscillating CN (2 and 3 states) 76 CN segments 0.62 FDR fragment joints 0.04 FDR chr. breakp. enrich. 17:996864−13569640;9:72321762−137935608 Linked to chrs
24	3	Lower_Left	CGP_donor_1691211	9:72321762−137935609	9, 10	86	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 225.87779235839844, 'max_y': 838.7838134765625}	50 MB 100 MB CGP_donor_1691211 Bone−Osteosarc Cancer type 9:72321762−137935609 Position With other complex events Type 28 Interleaved intrachr. SVs 91 Total SVs (intrachr. + transl.) DEL: 11; DUP: 8; h2hINV: 4; SV types t2tINV: 5; TRA: 63 606 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 86 CN segments 0.59 FDR fragment joints
24	4	Lower_Right	CGP_donor_1691211	16:6326850−23636186	9, 10	28	{'min_x': 308.6700134277344, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	0 MB 20 MB 40 MB 60 MB CGP_donor_1691211 Bone−Osteosarc Cancer type 16:6326850−23636186 Position With other complex events Type 9 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 17 606 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 28 CN segments
25	1	Upper_Left	CGP_donor_1691211	2:9233757−238199399	8, 11	23	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1691211 Bone−Osteosarc Cancer type 17:996864−13569641 Position With other complex events Type 4 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 15 606 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 23 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 2:9233757−238199399; Linked to chrs
25	2	Upper_Right	CGP_donor_1691213	12:38831735−119704558	9, 13	25	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 420.74383544921875}	CGP_donor_1691213 Bone−Osteosarc Cancer type 11:25558833−42430376 Position With other complex events Type 4 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 22 596 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 25 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 12:38831735−119704558;19:7659219−23705866 Linked to chrs 8:98131760−131862130;
25	3	Lower_Left	CGP_donor_1691213	12:38831735−119704559	5, 8	232	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 271.7522277832031, 'max_y': 834.4639282226562}	60 MB 80 MB 100 MB 120 MB CGP_donor_1691213 Bone−Osteosarc Cancer type 12:38831735−119704559 Position With other complex events Type 111 Interleaved intrachr. SVs 234 Total SVs (intrachr. + transl.) DEL: 22; DUP: 26; h2hINV: 34; SV types t2tINV: 29; TRA: 123 596 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 232 CN segments 0.64 FDR fragment joints
25	4	Lower_Right	CGP_donor_1691214	3:29117586−189128945	7, 17	82	{'min_x': 319.8599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 834.4639282226562}	50 MB 100 MB 150 MB CGP_donor_1691214 Bone−Osteosarc Cancer type 3:29117586−189128945 Position With other complex events Type 10 Interleaved intrachr. SVs 84 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 74 652 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 82 CN segments 0.96 FDR fragment joints
26	1	Upper_Left	CGP_donor_1691214	14:41964680−78837997	7, 8	166	{'min_x': 35.360198974609375, 'min_y': 278.0099792480469, 'max_x': 252.3719482421875, 'max_y': 416.4242248535156}	CGP_donor_1691214 Bone−Osteosarc Cancer type X:48348455−150018347 Position With other complex events Type 98 Interleaved intrachr. SVs 229 Total SVs (intrachr. + transl.) DEL: 24; DUP: 27; h2hINV: 19; SV types t2tINV: 28; TRA: 131 652 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 166 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 14:41964680−78837997;18:5480934−11055616 2:11400−232123608;3:29117586−189128944 Linked to chrs
26	2	Upper_Right	CGP_donor_1691215	17:54416−80744029	37, 73	73	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	CGP_donor_1691215 Bone−Osteosarc Cancer type 17:54416−80744029 Position With other complex events Type 158 Interleaved intrachr. SVs 158 Total SVs (intrachr. + transl.) DEL: 40; DUP: 44; h2hINV: 34; SV types t2tINV: 40; TRA: 0 166 SVs in sample 37, 73 Oscillating CN (2 and 3 states) 73 CN segments 0.81 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
26	3	Lower_Left	CGP_donor_1691217	13:20312035−47194343	12, 18	56	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 225.87783813476562, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB CGP_donor_1691217 Bone−Osteosarc Cancer type 13:20312035−47194343 Position With other complex events Type 32 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 10; SV types t2tINV: 9; TRA: 7 380 SVs in sample 12, 18 Oscillating CN (2 and 3 states) 56 CN segments 0.82 FDR fragment joints
26	4	Lower_Right	CGP_donor_1691217	X:88486379−153095441	9, 11	29	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 555.6618041992188, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB CGP_donor_1691217 Bone−Osteosarc Cancer type X:88486379−153095441 Position With other complex events Type 28 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 6; SV types t2tINV: 8; TRA: 10 380 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 29 CN segments 0.98 FDR fragment joints
27	1	Upper_Left	CGP_donor_1230755	1:16076342−181848575	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	CGP_donor_1230755 Breast−AdenoCA Cancer type 5:31942233−93707021 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 6 54 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 1:16076342−181848575; Linked to chrs
27	2	Upper_Right	CGP_donor_1230755	1:16076342−181848575	7, 12	12	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	CGP_donor_1230755 Breast−AdenoCA Cancer type 8:17274088−43561752 Position With other complex events Type 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 10 54 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 1:16076342−181848575;6:21024781−109641657 Linked to chrs
27	3	Lower_Left	CGP_donor_1232859	6:56201574−162603780	9, 12	31	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 265.2519836425781, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB 140 MB 160 MB CGP_donor_1232859 Breast−AdenoCA Cancer type 6:56201574−162603780 Position With other complex events Type 22 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 4; SV types t2tINV: 4; TRA: 16 316 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 31 CN segments
27	4	Lower_Right	CGP_donor_1234121	18:19776092−47210113	7, 8	15	{'min_x': 336.82000732421875, 'min_y': 705.2749633789062, 'max_x': 559.3904418945312, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1234121 Breast−AdenoCA Cancer type 18:19776092−47210113 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 4; TRA: 2 149 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 15 CN segments
28	1	Upper_Left	CGP_donor_1234122	2:3892443−238924020	26, 26	26	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1234122 Breast−AdenoCA Cancer type 2:3892443−238924020 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 6 83 SVs in sample 26, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
28	2	Upper_Right	CGP_donor_1234123	1:101766772−111649270	10, 13	15	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1234123 Breast−AdenoCA Cancer type 1:101766772−111649270 Position Before polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 4 29 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
28	3	Lower_Left	CGP_donor_1234124	1:16353677−153794553	7, 13	24	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 264.53216552734375, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CGP_donor_1234124 Breast−AdenoCA Cancer type 1:16353677−153794553 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 7; SV types t2tINV: 6; TRA: 0 95 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 24 CN segments
28	4	Lower_Right	CGP_donor_1234124	2:23018733−86416994	7, 9	9	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 535.1102905273438, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB CGP_donor_1234124 Breast−AdenoCA Cancer type 2:23018733−86416994 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 5; TRA: 0 95 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments
29	1	Upper_Left	CGP_donor_1234124	20:14054448−51465273	7, 7	7	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1234124 Breast−AdenoCA Cancer type 20:14054448−51465273 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 95 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.84 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
29	2	Upper_Right	CGP_donor_1333047	4:57932328−158974416	7, 7	9	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CGP_donor_1333047 Breast−AdenoCA Cancer type 18:47340927−64019671 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 17 249 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 9 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 4:57932328−158974416; Linked to chrs
29	3	Lower_Left	CGP_donor_1333048	13:41489453−67817353	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 263.8800048828125, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB CGP_donor_1333048 Breast−AdenoCA Cancer type 13:41489453−67817353 Position Canonical without polyploidization Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 0 178 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
29	4	Lower_Right	CGP_donor_1337214	2:167215273−179453980	9, 10	11	{'min_x': 327.3299865722656, 'min_y': 705.2749633789062, 'max_x': 538.811767578125, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CGP_donor_1337214 Breast−AdenoCA Cancer type 2:167215273−179453980 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 161 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 11 CN segments
30	1	Upper_Left	CGP_donor_1337222	19:5982144−53477754	19, 22	22	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1337222 Breast−AdenoCA Cancer type 19:5982144−53477754 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 1 23 SVs in sample 19, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.77 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
30	2	Upper_Right	CGP_donor_1337225	1:147121037−226598450	7, 9	31	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1337225 Breast−AdenoCA Cancer type 1:147121037−226598450 Position With other complex events Type 26 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 8; SV types t2tINV: 6; TRA: 0 53 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 31 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
30	3	Lower_Left	CGP_donor_1337226	1:41613153−240778773	21, 24	59	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	100 MB 150 MB 200 MB CGP_donor_1337226 Breast−AdenoCA Cancer type 1:41613153−240778773 Position With other complex events Type 23 Interleaved intrachr. SVs 128 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 2; SV types t2tINV: 8; TRA: 105 473 SVs in sample 21, 24 Oscillating CN (2 and 3 states) 59 CN segments 0.59 FDR fragment joints
30	4	Lower_Right	CGP_donor_1337226	2:26938396−230264706	12, 20	86	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 526.0618286132812, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1337226 Breast−AdenoCA Cancer type 2:26938396−230264706 Position With other complex events Type 40 Interleaved intrachr. SVs 150 Total SVs (intrachr. + transl.) DEL: 6; DUP: 13; h2hINV: 12; SV types t2tINV: 9; TRA: 110 473 SVs in sample 12, 20 Oscillating CN (2 and 3 states) 86 CN segments 0.59 FDR fragment joints
31	1	Upper_Left	CGP_donor_1337226	1:41613153−240778772	12, 46	89	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 420.74383544921875}	CGP_donor_1337226 Breast−AdenoCA Cancer type 6:35204768−167887451 Position With other complex events Type 31 Interleaved intrachr. SVs 157 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 9; SV types t2tINV: 8; TRA: 126 473 SVs in sample 12, 46 Oscillating CN (2 and 3 states) 89 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. 1:41613153−240778772;2:26938396−230264705 Linked to chrs 3:88027440−192058994;
31	2	Upper_Right	CGP_donor_1337226	10:42502102−123920853	8, 10	15	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1337226 Breast−AdenoCA Cancer type 10:42502102−123920853 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 0; TRA: 1 473 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 15 CN segments 0.59 FDR fragment joints 0.19 FDR chr. breakp. enrich. Linked to chrs
31	3	Lower_Left	CGP_donor_1337231	1:227864992−247779692	7, 14	24	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	175 MB 200 MB 225 MB CGP_donor_1337231 Breast−AdenoCA Cancer type 1:227864992−247779692 Position With other complex events Type 16 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 10 213 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 24 CN segments
31	4	Lower_Right	CGP_donor_1337231	9:73011782−140301664	7, 9	20	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB CGP_donor_1337231 Breast−AdenoCA Cancer type 9:73011782−140301664 Position With other complex events Type 11 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 6 213 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 20 CN segments
32	1	Upper_Left	CGP_donor_1337231	11:2020871−105572582	8, 8	67	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	CGP_donor_1337231 Breast−AdenoCA Cancer type 11:2020871−105572582 Position With other complex events Type 48 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 14; DUP: 10; h2hINV: 10; SV types t2tINV: 14; TRA: 4 213 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 67 CN segments 0.8 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
32	2	Upper_Right	CGP_donor_1337231	12:34572727−133356868	10, 17	17	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1337231 Breast−AdenoCA Cancer type 12:34572727−133356868 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 1 213 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.78 FDR fragment joints 0.21 FDR chr. breakp. enrich. Linked to chrs
32	3	Lower_Left	CGP_donor_1347731	7:1295015−158613922	43, 62	62	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 272.9420471191406, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CGP_donor_1347731 Breast−AdenoCA Cancer type 7:1295015−158613922 Position Canonical without polyploidization Type 112 Interleaved intrachr. SVs 130 Total SVs (intrachr. + transl.) DEL: 28; DUP: 25; h2hINV: 29; SV types t2tINV: 30; TRA: 18 155 SVs in sample 43, 62 Oscillating CN (2 and 3 states) 62 CN segments
32	4	Lower_Right	CGP_donor_1347742	15:66537420−102369380	7, 7	110	{'min_x': 347.4100036621094, 'min_y': 705.2749633789062, 'max_x': 553.161865234375, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB CGP_donor_1347742 Breast−AdenoCA Cancer type 15:66537420−102369380 Position With other complex events Type 54 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 14; DUP: 12; h2hINV: 13; SV types t2tINV: 15; TRA: 12 230 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 110 CN segments
33	1	Upper_Left	CGP_donor_1347751	8:30557729−121251839	11, 20	41	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1347751 Breast−AdenoCA Cancer type 8:30557729−121251839 Position With other complex events Type 28 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 8; SV types t2tINV: 6; TRA: 3 828 SVs in sample 11, 20 Oscillating CN (2 and 3 states) 41 CN segments 0.93 FDR fragment joints 0.12 FDR chr. breakp. enrich. Linked to chrs
33	2	Upper_Right	CGP_donor_1347751	18:20621968−77903677	18, 38	175	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	CGP_donor_1347751 Breast−AdenoCA Cancer type 11:67012799−101615430 Position With other complex events Type 204 Interleaved intrachr. SVs 212 Total SVs (intrachr. + transl.) DEL: 45; DUP: 64; h2hINV: 47; SV types t2tINV: 48; TRA: 8 828 SVs in sample 18, 38 Oscillating CN (2 and 3 states) 175 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 18:20621968−77903677;9:1126285−125671727 Linked to chrs
33	3	Lower_Left	CGP_donor_1347751	18:20621968−77903678	11, 16	16	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB CGP_donor_1347751 Breast−AdenoCA Cancer type 18:20621968−77903678 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 6; TRA: 1 828 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 16 CN segments
33	4	Lower_Right	CGP_donor_1353427	4:20249209−76099019	12, 21	28	{'min_x': 337.8800048828125, 'min_y': 705.2749633789062, 'max_x': 544.7122802734375, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CGP_donor_1353427 Breast−AdenoCA Cancer type 4:20249209−76099019 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 0 267 SVs in sample 12, 21 Oscillating CN (2 and 3 states) 28 CN segments
34	1	Upper_Left	CGP_donor_1353427	14:41756381−106200524	19, 23	47	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1353427 Breast−AdenoCA Cancer type 5:112844490−180014178 Position With other complex events Type 16 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 3; SV types t2tINV: 4; TRA: 27 267 SVs in sample 19, 23 Oscillating CN (2 and 3 states) 47 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. 14:41756381−106200524; Linked to chrs
34	2	Upper_Right	CGP_donor_1353427	5:112844490−180014177	26, 37	39	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CGP_donor_1353427 Breast−AdenoCA Cancer type 14:41756381−106200525 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 25 267 SVs in sample 26, 37 Oscillating CN (2 and 3 states) 39 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 5:112844490−180014177; Linked to chrs
34	3	Lower_Left	CGP_donor_1353434	4:60055635−137193613	9, 9	42	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 235.72206115722656, 'max_y': 833.6940307617188}	80 MB 120 MB 160 MB CGP_donor_1353434 Breast−AdenoCA Cancer type 4:60055635−137193613 Position With other complex events Type 18 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 7 291 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 42 CN segments
34	4	Lower_Right	CGP_donor_1364028	2:143479926−239003903	7, 7	7	{'min_x': 320.7200012207031, 'min_y': 705.2749633789062, 'max_x': 562.5721435546875, 'max_y': 833.6940307617188}	140 MB 160 MB 180 MB 200 MB 220 MB 240 MB CGP_donor_1364028 Breast−AdenoCA Cancer type 2:143479926−239003903 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 9; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 26 203 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
35	1	Upper_Left	CGP_donor_1364028	2:143479926−239003902	9, 22	22	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1364028 Breast−AdenoCA Cancer type 3:11137338−196396672 Position With other complex events Type 22 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 8; TRA: 20 203 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.73 FDR fragment joints 0 FDR chr. breakp. enrich. 2:143479926−239003902; Linked to chrs
35	2	Upper_Right	CGP_donor_1364028	20:13487327−62399710	7, 7	7	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	CGP_donor_1364028 Breast−AdenoCA Cancer type 14:84761805−88311296 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 5 203 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0.01 FDR chr. breakp. enrich. 20:13487327−62399710;6:2192497−33282946 Linked to chrs
35	3	Lower_Left	CGP_donor_1364028	20:13487327−62399711	9, 10	59	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 257.6401672363281, 'max_y': 838.7838134765625}	20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1364028 Breast−AdenoCA Cancer type 20:13487327−62399711 Position With other complex events Type 27 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 8; SV types t2tINV: 8; TRA: 36 203 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 59 CN segments 0.84 FDR fragment joints
35	4	Lower_Right	CGP_donor_1364033	6:57399664−170784376	7, 14	94	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 543.72216796875, 'max_y': 838.7838134765625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 6:57399664−170784376 Position With other complex events Type 47 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 13; DUP: 13; h2hINV: 10; SV types t2tINV: 11; TRA: 33 529 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 94 CN segments 0.92 FDR fragment joints
36	1	Upper_Left	CGP_donor_1364033	13:69277093−114427555	12, 12	12	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1364033 Breast−AdenoCA Cancer type 13:69277093−114427555 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 529 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.64 FDR fragment joints 0.65 FDR chr. breakp. enrich. Linked to chrs
36	2	Upper_Right	CGP_donor_1374616	3:149533512−196009872	11, 39	39	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	CGP_donor_1374616 Breast−AdenoCA Cancer type 3:149533512−196009872 Position With other complex events Type 20 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 5; SV types t2tINV: 4; TRA: 9 144 SVs in sample 11, 39 Oscillating CN (2 and 3 states) 39 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. X:3867520−67168966; Linked to chrs
36	3	Lower_Left	CGP_donor_1374616	8:41958285−66532612	19, 19	19	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 265.57196044921875, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB 140 MB CGP_donor_1374616 Breast−AdenoCA Cancer type 8:41958285−66532612 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 4 144 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments
36	4	Lower_Right	CGP_donor_1374616	X:3867520−67168967	10, 10	26	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 521.860107421875, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB CGP_donor_1374616 Breast−AdenoCA Cancer type X:3867520−67168967 Position With other complex events Type 4 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 16 144 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 26 CN segments
37	1	Upper_Left	CGP_donor_1374617	3:160434199−161100668	10, 22	44	{'min_x': 37.03010177612305, 'min_y': 282.3299865722656, 'max_x': 250.69595336914062, 'max_y': 416.3340148925781}	CGP_donor_1374617 Breast−AdenoCA Cancer type 1:112053543−248836624 Position With other complex events Type 18 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 6; SV types t2tINV: 6; TRA: 6 85 SVs in sample 10, 22 Oscillating CN (2 and 3 states) 44 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:160434199−161100668;8:809654−92053761 Linked to chrs
37	2	Upper_Right	CGP_donor_1374617	3:160434199−161100668	11, 23	23	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	CGP_donor_1374617 Breast−AdenoCA Cancer type 8:809654−92053762 Position With other complex events Type 8 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 22 85 SVs in sample 11, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:160434199−161100668; Linked to chrs
37	3	Lower_Left	CGP_donor_1374618	11:26862299−100822979	36, 39	39	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 268.3419189453125, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB CGP_donor_1374618 Breast−AdenoCA Cancer type 11:26862299−100822979 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 5; DUP: 10; h2hINV: 4; SV types t2tINV: 4; TRA: 5 51 SVs in sample 36, 39 Oscillating CN (2 and 3 states) 39 CN segments
37	4	Lower_Right	CGP_donor_1374618	14:28112043−76435431	8, 17	17	{'min_x': 316.5, 'min_y': 705.2749633789062, 'max_x': 527.7301025390625, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB CGP_donor_1374618 Breast−AdenoCA Cancer type 14:28112043−76435431 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 0 51 SVs in sample 8, 17 Oscillating CN (2 and 3 states) 17 CN segments
38	1	Upper_Left	CGP_donor_1397088	5:56141249−179216352	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1397088 Breast−AdenoCA Cancer type 5:56141249−179216352 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 16 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
38	2	Upper_Right	CGP_donor_1397260	6:38510448−42541218	11, 14	56	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.42401123046875}	CGP_donor_1397260 Breast−AdenoCA Cancer type 3:4365807−88334064 Position With other complex events Type 31 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 10; DUP: 4; h2hINV: 10; SV types t2tINV: 7; TRA: 3 160 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 56 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 6:38510448−42541218; Linked to chrs
38	3	Lower_Left	CGP_donor_1397282	3:763757−27175998	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 252.61180114746094, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB CGP_donor_1397282 Breast−AdenoCA Cancer type 3:763757−27175998 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 91 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
38	4	Lower_Right	CGP_donor_1397282	17:6803218−63783380	8, 14	48	{'min_x': 351.3500061035156, 'min_y': 705.2749633789062, 'max_x': 541.3401489257812, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB CGP_donor_1397282 Breast−AdenoCA Cancer type 17:6803218−63783380 Position With other complex events Type 31 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 4; SV types t2tINV: 10; TRA: 2 91 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 48 CN segments
39	1	Upper_Left	CGP_donor_1475202	1:80341830−241765599	14, 18	27	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1475202 Breast−AdenoCA Cancer type 1:80341830−241765599 Position With other complex events Type 10 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 6; SV types t2tINV: 1; TRA: 21 217 SVs in sample 14, 18 Oscillating CN (2 and 3 states) 27 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
39	2	Upper_Right	CGP_donor_1475202	19:4796337−21735945	7, 21	48	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3778686523438, 'max_y': 416.42401123046875}	CGP_donor_1475202 Breast−AdenoCA Cancer type 3:4105086−194006757 Position With other complex events Type 31 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 15; DUP: 7; h2hINV: 6; SV types t2tINV: 3; TRA: 27 217 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 48 CN segments 0.31 FDR fragment joints 0 FDR chr. breakp. enrich. 19:4796337−21735945; Linked to chrs
39	3	Lower_Left	CGP_donor_1475202	7:8316244−16409139	9, 13	13	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 272.7720031738281, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CGP_donor_1475202 Breast−AdenoCA Cancer type 7:8316244−16409139 Position After polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 0 217 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 13 CN segments
39	4	Lower_Right	CGP_donor_1503014	3:24341426−76090407	7, 7	13	{'min_x': 341.75, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CGP_donor_1503014 Breast−AdenoCA Cancer type 3:24341426−76090407 Position With other complex events Type 19 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 10 161 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments
40	1	Upper_Left	CGP_donor_1503014	14:37444009−62292108	12, 12	12	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1503014 Breast−AdenoCA Cancer type 14:37444009−62292108 Position After polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 0; TRA: 1 161 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints 0.03 FDR chr. breakp. enrich. Linked to chrs
40	2	Upper_Right	CGP_donor_1503014	20:7490391−60291793	8, 8	31	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1503014 Breast−AdenoCA Cancer type 20:7490391−60291793 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 1 161 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 31 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
40	3	Lower_Left	CGP_donor_1503016	6:70321603−92182155	13, 13	13	{'min_x': 43.26020050048828, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB 140 MB CGP_donor_1503016 Breast−AdenoCA Cancer type 6:70321603−92182155 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 1 72 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
40	4	Lower_Right	CGP_donor_1503020	7:23638008−149260298	13, 17	34	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 561.7623291015625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CGP_donor_1503020 Breast−AdenoCA Cancer type 7:23638008−149260298 Position With other complex events Type 25 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 8; SV types t2tINV: 9; TRA: 8 45 SVs in sample 13, 17 Oscillating CN (2 and 3 states) 34 CN segments
41	1	Upper_Left	CGP_donor_1503150	4:31802737−183234503	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CGP_donor_1503150 Breast−AdenoCA Cancer type 4:31802737−183234503 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 3 180 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.64 FDR fragment joints 0.93 FDR chr. breakp. enrich. Linked to chrs
41	2	Upper_Right	CGP_donor_1503150	13:57920742−114632856	11, 12	12	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CGP_donor_1503150 Breast−AdenoCA Cancer type 13:57920742−114632856 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 1 180 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
41	3	Lower_Left	CGP_donor_1503150	19:6471749−14092495	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	5 MB 10 MB 15 MB CGP_donor_1503150 Breast−AdenoCA Cancer type 19:6471749−14092495 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 10 180 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
41	4	Lower_Right	CGP_donor_1503156	15:23149223−92319473	14, 16	40	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 517.360107421875, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB CGP_donor_1503156 Breast−AdenoCA Cancer type 15:23149223−92319473 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 9; h2hINV: 5; SV types t2tINV: 3; TRA: 0 66 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 40 CN segments
42	1	Upper_Left	CGP_donor_1187030	1:63616590−107970984	7, 20	63	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.42401123046875}	CGP_donor_1187030 Breast−AdenoCA Cancer type 5:81925457−135300603 Position With other complex events Type 40 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 13; DUP: 10; h2hINV: 10; SV types t2tINV: 7; TRA: 2 98 SVs in sample 7, 20 Oscillating CN (2 and 3 states) 63 CN segments 0.69 FDR fragment joints 0 FDR chr. breakp. enrich. 1:63616590−107970984; Linked to chrs
42	2	Upper_Right	CGP_donor_1187031	7:99895066−127463712	13, 18	18	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1187031 Breast−AdenoCA Cancer type 7:99895066−127463712 Position Before polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 3; TRA: 0 89 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
42	3	Lower_Left	CGP_donor_1187033	9:17517806−130978055	13, 13	13	{'min_x': 48.389801025390625, 'min_y': 705.2749633789062, 'max_x': 259.6019592285156, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_1187033 Breast−AdenoCA Cancer type 9:17517806−130978055 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 1 228 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
42	4	Lower_Right	CGP_donor_1187033	21:18531210−42344561	10, 10	10	{'min_x': 321.7099914550781, 'min_y': 705.2749633789062, 'max_x': 535.7401123046875, 'max_y': 833.6940307617188}	20 MB 25 MB 30 MB 35 MB 40 MB CGP_donor_1187033 Breast−AdenoCA Cancer type 21:18531210−42344561 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 1 228 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
43	1	Upper_Left	CGP_donor_1199104	4:53118926−163564695	7, 12	25	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_1199104 Breast−AdenoCA Cancer type X:30692107−137148702 Position With other complex events Type 3 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 9 803 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 25 CN segments 0.91 FDR fragment joints 0.28 FDR chr. breakp. enrich. 4:53118926−163564695; Linked to chrs
43	2	Upper_Right	CGP_donor_1199129	6:124809960−139777060	9, 10	80	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.42401123046875}	CGP_donor_1199129 Breast−AdenoCA Cancer type 6:124809960−139777060 Position With other complex events Type 80 Interleaved intrachr. SVs 91 Total SVs (intrachr. + transl.) DEL: 14; DUP: 25; h2hINV: 21; SV types t2tINV: 20; TRA: 11 416 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 80 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 1:7883677−218951308; Linked to chrs
43	3	Lower_Left	CGP_donor_1199137	8:53301916−73691310	15, 15	15	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	50 MB 100 MB CGP_donor_1199137 Breast−AdenoCA Cancer type 8:53301916−73691310 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 249 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments
43	4	Lower_Right	CGP_donor_1199138	3:44425923−90280177	14, 17	23	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	80 MB 120 MB 160 MB CGP_donor_1199138 Breast−AdenoCA Cancer type 3:44425923−90280177 Position Canonical without polyploidization Type 36 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 14; DUP: 8; h2hINV: 8; SV types t2tINV: 6; TRA: 0 426 SVs in sample 14, 17 Oscillating CN (2 and 3 states) 23 CN segments
44	1	Upper_Left	CGP_donor_1230728	16:2388599−19726671	8, 11	37	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1230728 Breast−AdenoCA Cancer type 16:2388599−19726671 Position With other complex events Type 21 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 3; SV types t2tINV: 6; TRA: 1 329 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 37 CN segments 0.72 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
44	2	Upper_Right	CGP_donor_1230728	17:37232274−80621815	8, 8	116	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.42401123046875}	CGP_donor_1230728 Breast−AdenoCA Cancer type 17:37232274−80621815 Position With other complex events Type 55 Interleaved intrachr. SVs 78 Total SVs (intrachr. + transl.) DEL: 15; DUP: 13; h2hINV: 14; SV types t2tINV: 13; TRA: 23 329 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 116 CN segments 0.99 FDR fragment joints 0 FDR chr. breakp. enrich. 18:2681027−74577800; Linked to chrs
44	3	Lower_Left	CGP_donor_1230729	X:108395802−120251740	7, 7	7	{'min_x': 35.25, 'min_y': 705.2749633789062, 'max_x': 269.5719909667969, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB 120 MB CGP_donor_1230729 Breast−AdenoCA Cancer type X:108395802−120251740 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 0 107 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
44	4	Lower_Right	CGP_donor_1230778	6:5750165−170904138	12, 13	54	{'min_x': 348.010009765625, 'min_y': 705.2749633789062, 'max_x': 545.1719970703125, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CGP_donor_1230778 Breast−AdenoCA Cancer type 6:5750165−170904138 Position With other complex events Type 54 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 11; DUP: 13; h2hINV: 15; SV types t2tINV: 15; TRA: 3 182 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 54 CN segments
45	1	Upper_Left	CGP_donor_1337235	11:17489408−47547069	8, 20	20	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1337235 Breast−AdenoCA Cancer type 11:17489408−47547069 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 2; SV types t2tINV: 3; TRA: 0 116 SVs in sample 8, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.77 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
45	2	Upper_Right	CGP_donor_1347739	3:103694800−184410665	8, 8	18	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1347739 Breast−AdenoCA Cancer type 3:103694800−184410665 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 36 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
45	3	Lower_Left	CGP_donor_1353431	11:65669076−121347315	34, 40	59	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 227.54379272460938, 'max_y': 838.7838134765625}	50 MB 75 MB 100 MB CGP_donor_1353431 Breast−AdenoCA Cancer type 11:65669076−121347315 Position With other complex events Type 42 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 11; DUP: 8; h2hINV: 13; SV types t2tINV: 10; TRA: 7 276 SVs in sample 34, 40 Oscillating CN (2 and 3 states) 59 CN segments 0.82 FDR fragment joints
45	4	Lower_Right	CGP_donor_1353431	15:30027396−46766066	10, 10	10	{'min_x': 307.1499938964844, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	30 MB 35 MB 40 MB 45 MB CGP_donor_1353431 Breast−AdenoCA Cancer type 15:30027396−46766066 Position After polyploidization Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 6 276 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
46	1	Upper_Left	CGP_donor_1363969	21:10785441−47214482	12, 18	36	{'min_x': 61.849998474121094, 'min_y': 286.6499938964844, 'max_x': 225.87779235839844, 'max_y': 416.3340148925781}	CGP_donor_1363969 Breast−AdenoCA Cancer type 21:10785441−47214482 Position With other complex events Type 30 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 12; DUP: 9; h2hINV: 4; SV types t2tINV: 5; TRA: 3 680 SVs in sample 12, 18 Oscillating CN (2 and 3 states) 36 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
46	2	Upper_Right	CGP_donor_1410205	8:28416833−125849825	7, 7	15	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1410205 Breast−AdenoCA Cancer type 8:28416833−125849825 Position With other complex events Type 3 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 5 341 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 15 CN segments 0.91 FDR fragment joints 0.06 FDR chr. breakp. enrich. Linked to chrs
46	3	Lower_Left	CGP_donor_1472395	10:38453757−89733903	15, 17	27	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 267.1617736816406, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB CGP_donor_1472395 Breast−AdenoCA Cancer type 10:38453757−89733903 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 0 132 SVs in sample 15, 17 Oscillating CN (2 and 3 states) 27 CN segments
46	4	Lower_Right	CGP_donor_1606179	6:947294−169801583	14, 19	224	{'min_x': 308.1300048828125, 'min_y': 705.2749633789062, 'max_x': 547.01220703125, 'max_y': 833.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB CGP_donor_1606179 Breast−AdenoCA Cancer type 6:947294−169801583 Position With other complex events Type 171 Interleaved intrachr. SVs 190 Total SVs (intrachr. + transl.) DEL: 49; DUP: 42; h2hINV: 40; SV types t2tINV: 40; TRA: 19 372 SVs in sample 14, 19 Oscillating CN (2 and 3 states) 224 CN segments
47	1	Upper_Left	CGP_donor_1654385	21:10701912−45821258	7, 7	112	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	CGP_donor_1654385 Breast−AdenoCA Cancer type 21:10701912−45821258 Position With other complex events Type 55 Interleaved intrachr. SVs 147 Total SVs (intrachr. + transl.) DEL: 15; DUP: 13; h2hINV: 18; SV types t2tINV: 9; TRA: 92 372 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 112 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
47	2	Upper_Right	CGP_donor_1701345	12:52240971−107248205	8, 12	22	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1701345 Breast−AdenoCA Cancer type 12:52240971−107248205 Position With other complex events Type 20 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 6; SV types t2tINV: 6; TRA: 1 368 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 22 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
47	3	Lower_Left	CGP_donor_1701345	17:424593−20104085	11, 25	25	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 269.440185546875, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB CGP_donor_1701345 Breast−AdenoCA Cancer type 17:424593−20104085 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 2; TRA: 0 368 SVs in sample 11, 25 Oscillating CN (2 and 3 states) 25 CN segments
47	4	Lower_Right	05506f4c-e701-4a9d-ae06-97f066aade43	1:37390229−190370478	12, 23	35	{'min_x': 308.30999755859375, 'min_y': 705.2749633789062, 'max_x': 536.8619384765625, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB 150 MB 200 MB 05506f4c−e701−4a9d−ae06−97f066aade43 Breast−AdenoCA Cancer type 1:37390229−190370478 Position With other complex events Type 8 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 1; TRA: 15 742 SVs in sample 12, 23 Oscillating CN (2 and 3 states) 35 CN segments 0.64 FDR fragment joints
48	1	Upper_Left	084c6aec-94f7-4090-8f3f-59fa9e89721a	18:11570704−36396525	37, 37	37	{'min_x': 42.039798736572266, 'min_y': 286.6499938964844, 'max_x': 245.6859588623047, 'max_y': 416.42401123046875}	084c6aec−94f7−4090−8f3f−59fa9e89721a Breast−AdenoCA Cancer type 3:36209435−190323857 Position Canonical without polyploidization Type 36 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 10; SV types t2tINV: 9; TRA: 7 257 SVs in sample 37, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 18:11570704−36396525; Linked to chrs
48	2	Upper_Right	084c6aec-94f7-4090-8f3f-59fa9e89721a	8:33053387−75087726	9, 13	42	{'min_x': 331.5400085449219, 'min_y': 286.6499938964844, 'max_x': 535.1859130859375, 'max_y': 416.42401123046875}	084c6aec−94f7−4090−8f3f−59fa9e89721a Breast−AdenoCA Cancer type 7:6161338−57778540 Position With other complex events Type 19 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 29 257 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 42 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 8:33053387−75087726; Linked to chrs
48	3	Lower_Left	084c6aec-94f7-4090-8f3f-59fa9e89721a	8:33053387−75087727	9, 9	36	{'min_x': 42.039798736572266, 'min_y': 705.2749633789062, 'max_x': 245.6859588623047, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 084c6aec−94f7−4090−8f3f−59fa9e89721a Breast−AdenoCA Cancer type 8:33053387−75087727 Position With other complex events Type 25 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 5; SV types t2tINV: 8; TRA: 28 257 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 36 CN segments
48	4	Lower_Right	084c6aec-94f7-4090-8f3f-59fa9e89721a	12:22079238−133021689	13, 28	28	{'min_x': 313.55999755859375, 'min_y': 705.2749633789062, 'max_x': 543.721923828125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 084c6aec−94f7−4090−8f3f−59fa9e89721a Breast−AdenoCA Cancer type 12:22079238−133021689 Position With other complex events Type 23 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 9; SV types t2tINV: 8; TRA: 9 257 SVs in sample 13, 28 Oscillating CN (2 and 3 states) 28 CN segments
49	1	Upper_Left	0bc5744c-5fa3-45bb-87d0-70a02068b392	12:6603538−25009802	9, 13	14	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 12:6603538−25009802 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 6; TRA: 11 487 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 0.14 FDR chr. breakp. enrich. Linked to chrs
49	2	Upper_Right	0bc5744c-5fa3-45bb-87d0-70a02068b392	X:15557457−38830595	8, 18	40	{'min_x': 328.7099914550781, 'min_y': 286.6499938964844, 'max_x': 538.0198974609375, 'max_y': 416.3340148925781}	0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type X:15557457−38830595 Position With other complex events Type 31 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 10; SV types t2tINV: 12; TRA: 1 487 SVs in sample 8, 18 Oscillating CN (2 and 3 states) 40 CN segments 0.53 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
49	3	Lower_Left	0dca98b0-f43e-45b6-9a02-00092c78678c	X:96927939−148453406	23, 37	37	{'min_x': 39.539798736572266, 'min_y': 705.2749633789062, 'max_x': 262.7220153808594, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB 150 MB 0dca98b0−f43e−45b6−9a02−00092c78678c Breast−AdenoCA Cancer type X:96927939−148453406 Position Canonical without polyploidization Type 22 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 7; SV types t2tINV: 6; TRA: 3 552 SVs in sample 23, 37 Oscillating CN (2 and 3 states) 37 CN segments
49	4	Lower_Right	1174f6e4-ffbe-4e59-a000-8d861c968369	20:2418957−62264410	10, 12	51	{'min_x': 330.5400085449219, 'min_y': 705.2749633789062, 'max_x': 549.7301635742188, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 1174f6e4−ffbe−4e59−a000−8d861c968369 Breast−AdenoCA Cancer type 20:2418957−62264410 Position With other complex events Type 16 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 2; SV types t2tINV: 4; TRA: 38 357 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 51 CN segments
50	1	Upper_Left	17c1d42c-cb84-4655-a4cd-b54bae17ecaf	8:2456699−67762073	12, 22	24	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	17c1d42c−cb84−4655−a4cd−b54bae17ecaf Breast−AdenoCA Cancer type 8:2456699−67762073 Position With other complex events Type 11 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 5; TRA: 4 44 SVs in sample 12, 22 Oscillating CN (2 and 3 states) 24 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
50	2	Upper_Right	1d27253f-b036-44e7-a04d-8da5bbf57419	1:214161940−231274267	11, 13	62	{'min_x': 329.2099914550781, 'min_y': 286.6499938964844, 'max_x': 537.5219116210938, 'max_y': 416.3340148925781}	1d27253f−b036−44e7−a04d−8da5bbf57419 Breast−AdenoCA Cancer type 1:214161940−231274267 Position With other complex events Type 71 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 18; DUP: 20; h2hINV: 16; SV types t2tINV: 17; TRA: 3 256 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 62 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
50	3	Lower_Left	1d27253f-b036-44e7-a04d-8da5bbf57419	6:124419945−169580563	9, 14	14	{'min_x': 39.710201263427734, 'min_y': 705.2749633789062, 'max_x': 256.0821533203125, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 1d27253f−b036−44e7−a04d−8da5bbf57419 Breast−AdenoCA Cancer type 6:124419945−169580563 Position Before polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 256 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 14 CN segments
50	4	Lower_Right	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	3:49458810−79003885	7, 13	48	{'min_x': 310.3800048828125, 'min_y': 705.2749633789062, 'max_x': 537.5219116210938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 3:49458810−79003885 Position With other complex events Type 51 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 13; DUP: 10; h2hINV: 17; SV types t2tINV: 11; TRA: 4 618 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 48 CN segments
51	1	Upper_Left	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	4:103236038−155236187	7, 12	62	{'min_x': 39.710201263427734, 'min_y': 286.6499938964844, 'max_x': 248.02195739746094, 'max_y': 416.42401123046875}	233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 6:12923765−104967173 Position With other complex events Type 40 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 10; DUP: 11; h2hINV: 10; SV types t2tINV: 9; TRA: 4 618 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 62 CN segments 0.99 FDR fragment joints 0.09 FDR chr. breakp. enrich. 4:103236038−155236187; Linked to chrs
51	2	Upper_Right	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	2:181721293−233322093	12, 18	77	{'min_x': 319.8599853515625, 'min_y': 278.0099792480469, 'max_x': 546.8699951171875, 'max_y': 416.4242248535156}	233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 17:29900854−72983271 Position With other complex events Type 24 Interleaved intrachr. SVs 59 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 3; SV types t2tINV: 5; TRA: 35 618 SVs in sample 12, 18 Oscillating CN (2 and 3 states) 77 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 2:181721293−233322093;4:103236038−155236187 8:63956033−143798716;X:3683303−142419843 Linked to chrs
51	3	Lower_Left	2a84997d-ccee-4f46-bea2-752534f26416	1:153229764−225437151	9, 12	49	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 247.36195373535156, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 1:153229764−225437151 Position With other complex events Type 16 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 6; SV types t2tINV: 5; TRA: 33 596 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 49 CN segments 0.59 FDR fragment joints
51	4	Lower_Right	2a84997d-ccee-4f46-bea2-752534f26416	9:38002140−140385138	21, 29	73	{'min_x': 308.6499938964844, 'min_y': 705.2749633789062, 'max_x': 536.8618774414062, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 9:38002140−140385138 Position With other complex events Type 24 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 4; DUP: 9; h2hINV: 6; SV types t2tINV: 5; TRA: 1 596 SVs in sample 21, 29 Oscillating CN (2 and 3 states) 73 CN segments
52	1	Upper_Left	2a84997d-ccee-4f46-bea2-752534f26416	10:23170902−117935906	7, 11	161	{'min_x': 40.36989974975586, 'min_y': 286.6499938964844, 'max_x': 247.36195373535156, 'max_y': 416.42401123046875}	2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 12:677748−48135242 Position With other complex events Type 80 Interleaved intrachr. SVs 84 Total SVs (intrachr. + transl.) DEL: 17; DUP: 16; h2hINV: 29; SV types t2tINV: 18; TRA: 4 596 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 161 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 10:23170902−117935906; Linked to chrs
52	2	Upper_Right	2a84997d-ccee-4f46-bea2-752534f26416	1:153229764−225437150	8, 19	32	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 416.3340148925781}	2a84997d−ccee−4f46−bea2−752534f26416 Breast−AdenoCA Cancer type 14:56204105−67427196 Position With other complex events Type 5 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 27 596 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 32 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 1:153229764−225437150;22:17885241−46307015 Linked to chrs
52	3	Lower_Left	324bcba2-f6a4-45a6-807c-215bdffcca21	1:150164066−242610593	7, 7	61	{'min_x': 40.710201263427734, 'min_y': 705.2749633789062, 'max_x': 247.0139617919922, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 324bcba2−f6a4−45a6−807c−215bdffcca21 Breast−AdenoCA Cancer type 1:150164066−242610593 Position With other complex events Type 11 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 2; SV types t2tINV: 2; TRA: 15 429 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 61 CN segments
52	4	Lower_Right	324bcba2-f6a4-45a6-807c-215bdffcca21	12:27880056−131551013	8, 33	48	{'min_x': 308.3900146484375, 'min_y': 705.2749633789062, 'max_x': 536.513916015625, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 324bcba2−f6a4−45a6−807c−215bdffcca21 Breast−AdenoCA Cancer type 12:27880056−131551013 Position With other complex events Type 16 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 5; SV types t2tINV: 3; TRA: 8 429 SVs in sample 8, 33 Oscillating CN (2 and 3 states) 48 CN segments
53	1	Upper_Left	359f12f9-5c41-48a4-85bc-fd7e307bf7d8	1:150066880−242290225	7, 7	21	{'min_x': 41.38010025024414, 'min_y': 286.6499938964844, 'max_x': 246.34596252441406, 'max_y': 416.3340148925781}	359f12f9−5c41−48a4−85bc−fd7e307bf7d8 Breast−AdenoCA Cancer type 1:150066880−242290225 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 6; TRA: 0 83 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
53	2	Upper_Right	3fc3755d-a3f8-4e2c-813f-ff124f2a75c1	17:5222718−62920805	7, 13	25	{'min_x': 332.7099914550781, 'min_y': 286.6499938964844, 'max_x': 534.0198974609375, 'max_y': 416.3340148925781}	3fc3755d−a3f8−4e2c−813f−ff124f2a75c1 Breast−AdenoCA Cancer type 17:5222718−62920805 Position With other complex events Type 10 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 5 35 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 25 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
53	3	Lower_Left	44bec761-b603-49c0-8634-f6bfe0319bb1	3:79667212−191335908	8, 8	189	{'min_x': 39.91019821166992, 'min_y': 705.2749633789062, 'max_x': 247.8219451904297, 'max_y': 833.6940307617188}	100 MB 125 MB 150 MB 175 MB 44bec761−b603−49c0−8634−f6bfe0319bb1 Breast−AdenoCA Cancer type 3:79667212−191335908 Position With other complex events Type 103 Interleaved intrachr. SVs 158 Total SVs (intrachr. + transl.) DEL: 18; DUP: 22; h2hINV: 35; SV types t2tINV: 28; TRA: 55 320 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 189 CN segments
53	4	Lower_Right	44bec761-b603-49c0-8634-f6bfe0319bb1	8:13658370−76896511	7, 13	54	{'min_x': 329.4100036621094, 'min_y': 705.2749633789062, 'max_x': 537.3219604492188, 'max_y': 833.6940307617188}	50 MB 100 MB 44bec761−b603−49c0−8634−f6bfe0319bb1 Breast−AdenoCA Cancer type 8:13658370−76896511 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 10; DUP: 8; h2hINV: 5; SV types t2tINV: 6; TRA: 0 320 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 54 CN segments
54	1	Upper_Left	53886143-c1c6-40e9-88e6-e4e5e0271fc8	6:6520338−168564355	20, 27	78	{'min_x': 40.03010177612305, 'min_y': 286.6499938964844, 'max_x': 247.699951171875, 'max_y': 416.3340148925781}	53886143−c1c6−40e9−88e6−e4e5e0271fc8 Breast−AdenoCA Cancer type 6:6520338−168564355 Position With other complex events Type 40 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 8; DUP: 12; h2hINV: 11; SV types t2tINV: 9; TRA: 0 113 SVs in sample 20, 27 Oscillating CN (2 and 3 states) 78 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
54	2	Upper_Right	5580b21a-2cdb-4777-ad79-6e06654144f5	8:47141968−146282239	17, 54	129	{'min_x': 328.8699951171875, 'min_y': 286.6499938964844, 'max_x': 537.85986328125, 'max_y': 416.3340148925781}	5580b21a−2cdb−4777−ad79−6e06654144f5 Breast−AdenoCA Cancer type 8:47141968−146282239 Position With other complex events Type 72 Interleaved intrachr. SVs 72 Total SVs (intrachr. + transl.) DEL: 17; DUP: 23; h2hINV: 16; SV types t2tINV: 16; TRA: 0 252 SVs in sample 17, 54 Oscillating CN (2 and 3 states) 129 CN segments 0.67 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
54	3	Lower_Left	566792ae-f853-4a47-856d-f02cdcfcb18a	10:109264246−123915303	8, 14	16	{'min_x': 40.86989974975586, 'min_y': 705.2749633789062, 'max_x': 268.4320983886719, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB 566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 10:109264246−123915303 Position With other complex events Type 17 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 5; SV types t2tINV: 7; TRA: 5 579 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 16 CN segments
54	4	Lower_Right	566792ae-f853-4a47-856d-f02cdcfcb18a	22:22420637−33518317	8, 10	10	{'min_x': 306.2099914550781, 'min_y': 705.2749633789062, 'max_x': 540.208251953125, 'max_y': 833.6940307617188}	22.5 MB 25 MB 27.5 MB 30 MB 32.5 MB 566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 22:22420637−33518317 Position Before polyploidization Type 6 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 14 579 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 10 CN segments
55	1	Upper_Left	5dd423e8-feaa-4568-a750-500948c41d6c	X:133728817−149525449	10, 17	17	{'min_x': 39.599998474121094, 'min_y': 286.6499938964844, 'max_x': 248.13003540039062, 'max_y': 416.3340148925781}	5dd423e8−feaa−4568−a750−500948c41d6c Breast−AdenoCA Cancer type X:133728817−149525449 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 255 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
55	2	Upper_Right	5fd9552a-c742-4388-940d-295d1107ae00	6:27642577−84092516	17, 19	22	{'min_x': 329.0400085449219, 'min_y': 286.6499938964844, 'max_x': 537.6898803710938, 'max_y': 416.3340148925781}	5fd9552a−c742−4388−940d−295d1107ae00 Breast−AdenoCA Cancer type 6:27642577−84092516 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 1; TRA: 1 97 SVs in sample 17, 19 Oscillating CN (2 and 3 states) 22 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
55	3	Lower_Left	65cac997-4d39-4501-85ec-4fcb328a8eb5	3:39702805−190330615	7, 10	40	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 248.18995666503906, 'max_y': 834.4639282226562}	50 MB 100 MB 150 MB 65cac997−4d39−4501−85ec−4fcb328a8eb5 Breast−AdenoCA Cancer type 3:39702805−190330615 Position With other complex events Type 7 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 35 909 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 40 CN segments 0.74 FDR fragment joints
55	4	Lower_Right	6fa2a667-9c36-4526-8a58-1975e863a806	19:7866667−39524085	11, 14	34	{'min_x': 328.4100036621094, 'min_y': 705.2749633789062, 'max_x': 537.199951171875, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 6fa2a667−9c36−4526−8a58−1975e863a806 Breast−AdenoCA Cancer type 19:7866667−39524085 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 0 259 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 34 CN segments
56	1	Upper_Left	733a2a0f-b37a-4b81-b49e-3c0f30d1eb37	17:34384789−59566710	10, 10	57	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 416.3340148925781}	733a2a0f−b37a−4b81−b49e−3c0f30d1eb37 Breast−AdenoCA Cancer type 1:145117775−243098983 Position With other complex events Type 22 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 6; SV types t2tINV: 5; TRA: 32 403 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 57 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. 17:34384789−59566710;8:31896789−139505358 Linked to chrs
56	2	Upper_Right	733a2a0f-b37a-4b81-b49e-3c0f30d1eb37	1:145117775−243098982	36, 36	58	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 416.3340148925781}	733a2a0f−b37a−4b81−b49e−3c0f30d1eb37 Breast−AdenoCA Cancer type 8:31896789−139505359 Position Canonical without polyploidization Type 58 Interleaved intrachr. SVs 139 Total SVs (intrachr. + transl.) DEL: 23; DUP: 11; h2hINV: 13; SV types t2tINV: 11; TRA: 81 403 SVs in sample 36, 36 Oscillating CN (2 and 3 states) 58 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145117775−243098982;17:34384789−59566710 Linked to chrs
56	3	Lower_Left	784de7ac-8424-42eb-83d4-a1bebaa42b97	17:25428583−38145015	7, 7	48	{'min_x': 38.36989974975586, 'min_y': 705.2749633789062, 'max_x': 250.31019592285156, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 784de7ac−8424−42eb−83d4−a1bebaa42b97 Breast−AdenoCA Cancer type 17:25428583−38145015 Position With other complex events Type 12 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 5; SV types t2tINV: 2; TRA: 30 106 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 48 CN segments
56	4	Lower_Right	8bd68696-5eeb-46d7-9dc6-c39c849029a4	6:43335892−113274184	11, 11	21	{'min_x': 328.0400085449219, 'min_y': 705.2749633789062, 'max_x': 552.7222290039062, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 8bd68696−5eeb−46d7−9dc6−c39c849029a4 Breast−AdenoCA Cancer type 6:43335892−113274184 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 2 343 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 21 CN segments
57	1	Upper_Left	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	6:66019356−135278032	9, 10	88	{'min_x': 39.73979949951172, 'min_y': 286.6499938964844, 'max_x': 247.99179077148438, 'max_y': 416.42401123046875}	8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 12:2943203−96943878 Position With other complex events Type 29 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 10; SV types t2tINV: 9; TRA: 25 500 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 88 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 6:66019356−135278032; Linked to chrs
57	2	Upper_Right	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	21:35999819−47786447	9, 11	29	{'min_x': 329.239990234375, 'min_y': 286.6499938964844, 'max_x': 537.4917602539062, 'max_y': 416.42401123046875}	8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 20:11131846−59577547 Position With other complex events Type 7 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 8 500 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 29 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 21:35999819−47786447; Linked to chrs
57	3	Lower_Left	9435447e-d65f-408b-863b-6576b1d652dd	10:87322920−113509134	7, 21	26	{'min_x': 38.91019821166992, 'min_y': 705.2749633789062, 'max_x': 272.1821594238281, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB 9435447e−d65f−408b−863b−6576b1d652dd Breast−AdenoCA Cancer type 10:87322920−113509134 Position With other complex events Type 28 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 5; SV types t2tINV: 5; TRA: 2 137 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 26 CN segments
57	4	Lower_Right	993103b1-e5a1-4c33-8629-be53ebc41d64	2:159664646−172537729	11, 13	17	{'min_x': 309.3999938964844, 'min_y': 705.2749633789062, 'max_x': 560.6322631835938, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB 200 MB 993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type 2:159664646−172537729 Position After polyploidization Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 5; TRA: 1 202 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 17 CN segments
58	1	Upper_Left	993103b1-e5a1-4c33-8629-be53ebc41d64	11:16582735−78899878	12, 14	41	{'min_x': 38.70000076293945, 'min_y': 286.6499938964844, 'max_x': 249.0279541015625, 'max_y': 416.42401123046875}	993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type 4:36303099−108458117 Position With other complex events Type 16 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 6; TRA: 11 202 SVs in sample 12, 14 Oscillating CN (2 and 3 states) 41 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:16582735−78899878; Linked to chrs
58	2	Upper_Right	993103b1-e5a1-4c33-8629-be53ebc41d64	4:36303099−108458116	10, 13	33	{'min_x': 328.20001220703125, 'min_y': 286.6499938964844, 'max_x': 538.5279541015625, 'max_y': 416.42401123046875}	993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type 11:16582735−78899879 Position With other complex events Type 15 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 11 202 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 33 CN segments 0.99 FDR fragment joints 0 FDR chr. breakp. enrich. 4:36303099−108458116; Linked to chrs
58	3	Lower_Left	993103b1-e5a1-4c33-8629-be53ebc41d64	20:35943756−60123567	7, 9	24	{'min_x': 38.70000076293945, 'min_y': 705.2749633789062, 'max_x': 267.77996826171875, 'max_y': 833.6940307617188}	40 MB 45 MB 50 MB 55 MB 60 MB 993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type 20:35943756−60123567 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 4; SV types t2tINV: 6; TRA: 0 202 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 24 CN segments
58	4	Lower_Right	9d95a65b-e41d-4f93-92d4-99dce29ff40d	3:118944666−165998674	8, 11	11	{'min_x': 309.05999755859375, 'min_y': 705.2749633789062, 'max_x': 536.8438720703125, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 9d95a65b−e41d−4f93−92d4−99dce29ff40d Breast−AdenoCA Cancer type 3:118944666−165998674 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 0 143 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments
59	1	Upper_Left	9d95a65b-e41d-4f93-92d4-99dce29ff40d	13:22617012−47972350	8, 13	23	{'min_x': 40.38010025024414, 'min_y': 286.6499938964844, 'max_x': 247.34396362304688, 'max_y': 416.3340148925781}	9d95a65b−e41d−4f93−92d4−99dce29ff40d Breast−AdenoCA Cancer type 13:22617012−47972350 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 2 143 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 23 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
59	2	Upper_Right	9fefbe7c-f66a-4940-843e-285cb7b392c1	1:31254630−243789937	16, 19	345	{'min_x': 330.3999938964844, 'min_y': 286.6499938964844, 'max_x': 536.3237915039062, 'max_y': 416.42401123046875}	9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 1:31254630−243789937 Position With other complex events Type 254 Interleaved intrachr. SVs 351 Total SVs (intrachr. + transl.) DEL: 64; DUP: 65; h2hINV: 60; SV types t2tINV: 65; TRA: 97 740 SVs in sample 16, 19 Oscillating CN (2 and 3 states) 345 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. 6:5413201−164420805; Linked to chrs
59	3	Lower_Left	9fefbe7c-f66a-4940-843e-285cb7b392c1	11:77294848−126487192	10, 14	20	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 246.82379150390625, 'max_y': 838.7838134765625}	60 MB 80 MB 100 MB 120 MB 9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 11:77294848−126487192 Position With other complex events Type 12 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 29 740 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 20 CN segments 0.8 FDR fragment joints
59	4	Lower_Right	a8015490-9740-45c9-8bd2-eb6d1beefc2e	11:28062319−128514909	7, 8	20	{'min_x': 328.7099914550781, 'min_y': 705.2749633789062, 'max_x': 552.3323364257812, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB a8015490−9740−45c9−8bd2−eb6d1beefc2e Breast−AdenoCA Cancer type 11:28062319−128514909 Position With other complex events Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 10 76 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 20 CN segments
60	1	Upper_Left	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	9:71455580−141089210	11, 21	21	{'min_x': 40.539798736572266, 'min_y': 286.6499938964844, 'max_x': 247.1839599609375, 'max_y': 416.3340148925781}	a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 9:71455580−141089210 Position With other complex events Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 1 463 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.64 FDR fragment joints 0.72 FDR chr. breakp. enrich. Linked to chrs
60	2	Upper_Right	aeb6a3a6-b57a-4c53-90e6-e833777dd2a1	18:23409571−39483311	13, 13	13	{'min_x': 328.2300109863281, 'min_y': 286.6499938964844, 'max_x': 538.4978637695312, 'max_y': 416.3340148925781}	aeb6a3a6−b57a−4c53−90e6−e833777dd2a1 Breast−AdenoCA Cancer type 18:23409571−39483311 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 2 117 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
60	3	Lower_Left	b43e41af-1d82-4b5f-b8f1-add0510e6b86	9:86410803−134980826	7, 10	15	{'min_x': 35.03010177612305, 'min_y': 705.2749633789062, 'max_x': 247.48394775390625, 'max_y': 833.6940307617188}	90 MB 100 MB 110 MB 120 MB 130 MB b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 9:86410803−134980826 Position With other complex events Type 5 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 0; TRA: 12 296 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 15 CN segments
60	4	Lower_Right	b43e41af-1d82-4b5f-b8f1-add0510e6b86	10:6867995−30890977	13, 19	27	{'min_x': 329.739990234375, 'min_y': 705.2749633789062, 'max_x': 549.9000854492188, 'max_y': 833.6940307617188}	10 MB 15 MB 20 MB 25 MB 30 MB b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 10:6867995−30890977 Position With other complex events Type 15 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 4 296 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 27 CN segments
61	1	Upper_Left	b43e41af-1d82-4b5f-b8f1-add0510e6b86	19:48961354−58347531	8, 8	15	{'min_x': 40.23979949951172, 'min_y': 286.6499938964844, 'max_x': 247.48394775390625, 'max_y': 416.3340148925781}	b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 19:48961354−58347531 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 2 296 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
61	2	Upper_Right	b43e41af-1d82-4b5f-b8f1-add0510e6b86	22:24093006−30283046	7, 7	13	{'min_x': 329.739990234375, 'min_y': 286.6499938964844, 'max_x': 536.98388671875, 'max_y': 416.42401123046875}	b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 22:24093006−30283046 Position With other complex events Type 3 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 12 296 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 20:4186490−34159089; Linked to chrs
61	3	Lower_Left	b97bf89a-7a85-4eef-ae7e-f787aead1f0a	1:2468572−121208979	8, 13	99	{'min_x': 41.539798736572266, 'min_y': 705.2749633789062, 'max_x': 246.1859588623047, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB b97bf89a−7a85−4eef−ae7e−f787aead1f0a Breast−AdenoCA Cancer type 1:2468572−121208979 Position With other complex events Type 54 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 19; DUP: 12; h2hINV: 14; SV types t2tINV: 9; TRA: 0 194 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 99 CN segments
61	4	Lower_Right	c0892598-1f7b-4f23-9cd8-731f797753d5	1:150239597−180719223	9, 9	59	{'min_x': 330.3699951171875, 'min_y': 705.2749633789062, 'max_x': 536.3538818359375, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 1:150239597−180719223 Position With other complex events Type 38 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 11; DUP: 12; h2hINV: 8; SV types t2tINV: 7; TRA: 3 358 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 59 CN segments
62	1	Upper_Left	c0892598-1f7b-4f23-9cd8-731f797753d5	19:12064068−51987941	90, 90	90	{'min_x': 32.019901275634766, 'min_y': 282.3299865722656, 'max_x': 255.70394897460938, 'max_y': 416.3340148925781}	c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 2:4509988−88587826 Position After polyploidization Type 39 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 12; DUP: 8; h2hINV: 12; SV types t2tINV: 7; TRA: 50 358 SVs in sample 90, 90 Oscillating CN (2 and 3 states) 90 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 19:12064068−51987941;6:107014877−166856041 Linked to chrs
62	2	Upper_Right	c0892598-1f7b-4f23-9cd8-731f797753d5	6:107014877−166856042	37, 41	57	{'min_x': 330.3699951171875, 'min_y': 286.6499938964844, 'max_x': 536.3538818359375, 'max_y': 416.42401123046875}	c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 6:107014877−166856042 Position After polyploidization Type 23 Interleaved intrachr. SVs 72 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 6; SV types t2tINV: 10; TRA: 49 358 SVs in sample 37, 41 Oscillating CN (2 and 3 states) 57 CN segments 0.54 FDR fragment joints 0 FDR chr. breakp. enrich. 2:4509988−88587825; Linked to chrs
62	3	Lower_Left	c364e81c-eb1e-4870-ab37-9c661f5f2e3d	16:5415371−33325043	7, 13	38	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 247.52195739746094, 'max_y': 838.7838134765625}	10 MB 15 MB 20 MB 25 MB 30 MB c364e81c−eb1e−4870−ab37−9c661f5f2e3d Breast−AdenoCA Cancer type 16:5415371−33325043 Position With other complex events Type 25 Interleaved intrachr. SVs 50 Total SVs (intrachr. + transl.) DEL: 3; DUP: 9; h2hINV: 6; SV types t2tINV: 7; TRA: 25 397 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 38 CN segments 0.59 FDR fragment joints
62	4	Lower_Right	d67cd793-2931-429a-9084-2f3c4c8be7ad	12:33908610−132258021	8, 14	14	{'min_x': 328.8699951171875, 'min_y': 705.2749633789062, 'max_x': 546.7919921875, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB d67cd793−2931−429a−9084−2f3c4c8be7ad Breast−AdenoCA Cancer type 12:33908610−132258021 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 3 427 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments
63	1	Upper_Left	d6f7afc0-1558-43ad-acb1-2b5311ed2264	6:105302877−111874189	7, 7	39	{'min_x': 39.88010025024414, 'min_y': 286.6499938964844, 'max_x': 247.85195922851562, 'max_y': 416.42401123046875}	d6f7afc0−1558−43ad−acb1−2b5311ed2264 Breast−AdenoCA Cancer type 12:66502753−130003739 Position With other complex events Type 11 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 21 304 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 39 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 6:105302877−111874189; Linked to chrs
63	2	Upper_Right	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	3:83571470−194744513	10, 15	139	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 416.3340148925781}	d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 11:1073009−116625595 Position With other complex events Type 159 Interleaved intrachr. SVs 176 Total SVs (intrachr. + transl.) DEL: 38; DUP: 51; h2hINV: 33; SV types t2tINV: 37; TRA: 17 1222 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 139 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 3:83571470−194744513;9:100142774−123611054 Linked to chrs
63	3	Lower_Left	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	2:8912100−170495188	11, 21	46	{'min_x': 39.88010025024414, 'min_y': 705.2749633789062, 'max_x': 247.85195922851562, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 2:8912100−170495188 Position With other complex events Type 9 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 24 662 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 46 CN segments
63	4	Lower_Right	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	3:143115106−168498933	8, 19	43	{'min_x': 308.6400146484375, 'min_y': 705.2749633789062, 'max_x': 537.3518676757812, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 3:143115106−168498933 Position With other complex events Type 17 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 6; SV types t2tINV: 3; TRA: 10 662 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 43 CN segments
64	1	Upper_Left	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	13:37775397−48509222	8, 11	107	{'min_x': 33.68980026245117, 'min_y': 278.0099792480469, 'max_x': 254.03794860839844, 'max_y': 416.4242248535156}	eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 15:39425396−101227081 Position With other complex events Type 37 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 10; SV types t2tINV: 7; TRA: 18 662 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 107 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. 13:37775397−48509222;14:20532445−36857209 17:46099635−77801969;20:2682796−61152781 Linked to chrs
64	2	Upper_Right	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	13:37775397−48509222	8, 8	91	{'min_x': 321.5199890136719, 'min_y': 278.0099792480469, 'max_x': 545.2039794921875, 'max_y': 416.4242248535156}	eadf8482−e60e−4307−adb7−d5c3b9fa6cae Breast−AdenoCA Cancer type 17:46099635−77801970 Position With other complex events Type 47 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 7; DUP: 15; h2hINV: 14; SV types t2tINV: 11; TRA: 18 662 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 91 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 13:37775397−48509222;15:39425396−101227080 2:8912100−170495187;3:143115106−168498932 Linked to chrs
64	3	Lower_Left	f0787165-6f58-4d67-b510-928eea2c4882	1:146473725−244991894	9, 10	70	{'min_x': 40.36989974975586, 'min_y': 705.2749633789062, 'max_x': 247.36195373535156, 'max_y': 833.6940307617188}	175 MB 200 MB 225 MB f0787165−6f58−4d67−b510−928eea2c4882 Breast−AdenoCA Cancer type 1:146473725−244991894 Position With other complex events Type 38 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 10; SV types t2tINV: 9; TRA: 7 421 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 70 CN segments
64	4	Lower_Right	f0787165-6f58-4d67-b510-928eea2c4882	17:22038970−67294772	7, 10	52	{'min_x': 329.8699951171875, 'min_y': 705.2749633789062, 'max_x': 557.5499877929688, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB f0787165−6f58−4d67−b510−928eea2c4882 Breast−AdenoCA Cancer type 17:22038970−67294772 Position With other complex events Type 20 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 2; SV types t2tINV: 7; TRA: 19 421 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 52 CN segments
65	1	Upper_Left	f45210d3-9e66-4f5e-bef1-5ee5547cc893	2:16757311−150416613	13, 13	31	{'min_x': 41.039798736572266, 'min_y': 286.6499938964844, 'max_x': 246.6839599609375, 'max_y': 416.3340148925781}	f45210d3−9e66−4f5e−bef1−5ee5547cc893 Breast−AdenoCA Cancer type 2:16757311−150416613 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 4; SV types t2tINV: 4; TRA: 1 179 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 31 CN segments 0.46 FDR fragment joints 0.39 FDR chr. breakp. enrich. Linked to chrs
65	2	Upper_Right	f45210d3-9e66-4f5e-bef1-5ee5547cc893	7:62474285−101131925	18, 19	30	{'min_x': 330.5400085449219, 'min_y': 286.6499938964844, 'max_x': 536.1838989257812, 'max_y': 416.3340148925781}	f45210d3−9e66−4f5e−bef1−5ee5547cc893 Breast−AdenoCA Cancer type 7:62474285−101131925 Position After polyploidization Type 11 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 6 179 SVs in sample 18, 19 Oscillating CN (2 and 3 states) 30 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
65	3	Lower_Left	f6e1ec78-5ad9-4879-9b7e-262d17b166ad	4:140599465−173380457	8, 13	13	{'min_x': 39.210201263427734, 'min_y': 705.2749633789062, 'max_x': 248.51995849609375, 'max_y': 833.6940307617188}	150 MB 160 MB 170 MB f6e1ec78−5ad9−4879−9b7e−262d17b166ad Breast−AdenoCA Cancer type 4:140599465−173380457 Position Before polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 2 320 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 13 CN segments
65	4	Lower_Right	f6e1ec78-5ad9-4879-9b7e-262d17b166ad	6:15272594−170042856	10, 11	41	{'min_x': 328.7099914550781, 'min_y': 705.2749633789062, 'max_x': 545.9220581054688, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB f6e1ec78−5ad9−4879−9b7e−262d17b166ad Breast−AdenoCA Cancer type 6:15272594−170042856 Position With other complex events Type 14 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 5; SV types t2tINV: 3; TRA: 18 320 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 41 CN segments
66	1	Upper_Left	CGP_donor_1234120	4:53312523−80369667	7, 7	29	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_1234120 Breast−LobularCA Cancer type 4:53312523−80369667 Position With other complex events Type 13 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 5 344 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 29 CN segments 0.88 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
66	2	Upper_Right	CGP_donor_1234120	14:24801053−53663407	7, 15	17	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1234120 Breast−LobularCA Cancer type 14:24801053−53663407 Position With other complex events Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 3 344 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints 1 FDR chr. breakp. enrich. Linked to chrs
66	3	Lower_Left	CGP_donor_1347756	2:18030650−144747582	7, 11	17	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	50 MB 100 MB CGP_donor_1347756 Breast−LobularCA Cancer type 2:18030650−144747582 Position With other complex events Type 6 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 13 114 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 17 CN segments 0.91 FDR fragment joints
66	4	Lower_Right	CGP_donor_1347756	6:99814201−149683677	10, 10	10	{'min_x': 309.1000061035156, 'min_y': 705.2749633789062, 'max_x': 561.3119506835938, 'max_y': 838.7838134765625}	70 MB 90 MB 110 MB 130 MB 150 MB CGP_donor_1347756 Breast−LobularCA Cancer type 6:99814201−149683677 Position Before polyploidization Type 3 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 15 114 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.59 FDR fragment joints
67	1	Upper_Left	CGP_donor_1347756	10:47144724−120650613	9, 11	25	{'min_x': 32.019901275634766, 'min_y': 278.0099792480469, 'max_x': 255.7040252685547, 'max_y': 416.4242248535156}	CGP_donor_1347756 Breast−LobularCA Cancer type 8:11620647−85317947 Position With other complex events Type 5 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 22 114 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 25 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 2:18030650−144747581;6:99814201−149683676 10:47144724−120650613;13:72316685−73246808 Linked to chrs
67	2	Upper_Right	CGP_donor_1347756	10:47144724−120650614	12, 21	33	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_1347756 Breast−LobularCA Cancer type 10:47144724−120650614 Position With other complex events Type 22 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 8; SV types t2tINV: 10; TRA: 10 114 SVs in sample 12, 21 Oscillating CN (2 and 3 states) 33 CN segments 0.24 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
67	3	Lower_Left	27b05b15-a44b-45ed-a6e3-e7d1ca488ea9	17:50377400−63525147	9, 13	14	{'min_x': 38.539798736572266, 'min_y': 705.2749633789062, 'max_x': 257.7901916503906, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 60 MB 70 MB 27b05b15−a44b−45ed−a6e3−e7d1ca488ea9 Breast−LobularCA Cancer type 17:50377400−63525147 Position Before polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 116 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 14 CN segments
67	4	Lower_Right	a482fc4c-ff1d-46a0-a968-7df06422cc4b	12:58617819−89640811	9, 9	21	{'min_x': 325.95001220703125, 'min_y': 705.2749633789062, 'max_x': 560.380126953125, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB a482fc4c−ff1d−46a0−a968−7df06422cc4b Breast−LobularCA Cancer type 12:58617819−89640811 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 1 86 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 21 CN segments
68	1	Upper_Left	ef4cbd38-bc79-4d60-a715-647edd2ebe9e	13:19943737−57122358	7, 7	41	{'min_x': 38.91019821166992, 'min_y': 286.6499938964844, 'max_x': 248.81993103027344, 'max_y': 416.42401123046875}	ef4cbd38−bc79−4d60−a715−647edd2ebe9e Breast−LobularCA Cancer type 8:42881572−135695930 Position With other complex events Type 19 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 8; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 13 134 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 41 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 13:19943737−57122358; Linked to chrs
68	2	Upper_Right	ef4cbd38-bc79-4d60-a715-647edd2ebe9e	8:42881572−135695929	7, 8	21	{'min_x': 328.4100036621094, 'min_y': 286.6499938964844, 'max_x': 538.3199462890625, 'max_y': 416.42401123046875}	ef4cbd38−bc79−4d60−a715−647edd2ebe9e Breast−LobularCA Cancer type 13:19943737−57122359 Position With other complex events Type 4 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 19 134 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 21 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 8:42881572−135695929; Linked to chrs
68	3	Lower_Left	7c93642d-7e05-40f8-b1ef-a014edcfba42	6:46659231−58507397	10, 16	16	{'min_x': 40.710201263427734, 'min_y': 705.2749633789062, 'max_x': 264.9718933105469, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 7c93642d−7e05−40f8−b1ef−a014edcfba42 Cervix−SCC Cancer type 6:46659231−58507397 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 1; SV types t2tINV: 6; TRA: 0 138 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 16 CN segments
68	4	Lower_Right	dfd30f94-19e3-4838-95df-14a3763419af	21:15698147−47079851	14, 16	16	{'min_x': 331.0400085449219, 'min_y': 705.2749633789062, 'max_x': 535.6858520507812, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB dfd30f94−19e3−4838−95df−14a3763419af Cervix−SCC Cancer type 21:15698147−47079851 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 5; TRA: 0 48 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
69	1	Upper_Left	0078b0c4-68a9-483b-9aab-61156d263213	17:7417765−57239409	11, 11	11	{'min_x': 38.70000076293945, 'min_y': 286.6499938964844, 'max_x': 249.0279541015625, 'max_y': 416.3340148925781}	0078b0c4−68a9−483b−9aab−61156d263213 CNS−GBM Cancer type 17:7417765−57239409 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 0 78 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
69	2	Upper_Right	01a92062-967a-4900-8dc7-a5ecd3b3f8e2	5:30169917−33114490	10, 17	17	{'min_x': 329.0400085449219, 'min_y': 286.6499938964844, 'max_x': 537.68994140625, 'max_y': 416.42401123046875}	01a92062−967a−4900−8dc7−a5ecd3b3f8e2 CNS−GBM Cancer type 6:5106696−142756791 Position With other complex events Type 15 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 5 98 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.62 FDR fragment joints 0 FDR chr. breakp. enrich. 5:30169917−33114490; Linked to chrs
69	3	Lower_Left	054f472f-98cb-4559-b2e2-b5f800fc8eef	2:176323−23468097	19, 32	49	{'min_x': 42.210201263427734, 'min_y': 705.2749633789062, 'max_x': 245.51795959472656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 054f472f−98cb−4559−b2e2−b5f800fc8eef CNS−GBM Cancer type 2:176323−23468097 Position With other complex events Type 22 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 10; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 3 85 SVs in sample 19, 32 Oscillating CN (2 and 3 states) 49 CN segments
69	4	Lower_Right	054f472f-98cb-4559-b2e2-b5f800fc8eef	13:20289812−114141768	9, 9	9	{'min_x': 306.7699890136719, 'min_y': 705.2749633789062, 'max_x': 535.0178833007812, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 100 MB 054f472f−98cb−4559−b2e2−b5f800fc8eef CNS−GBM Cancer type 13:20289812−114141768 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 0 85 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
70	1	Upper_Left	0798dbe2-1914-427c-a2fe-2a865d0d6eda	10:5388962−135052041	19, 29	59	{'min_x': 39.23979949951172, 'min_y': 286.6499938964844, 'max_x': 248.48976135253906, 'max_y': 416.42401123046875}	0798dbe2−1914−427c−a2fe−2a865d0d6eda CNS−GBM Cancer type 10:5388962−135052041 Position With other complex events Type 68 Interleaved intrachr. SVs 116 Total SVs (intrachr. + transl.) DEL: 20; DUP: 17; h2hINV: 16; SV types t2tINV: 15; TRA: 48 209 SVs in sample 19, 29 Oscillating CN (2 and 3 states) 59 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. 9:17843117−36219342; Linked to chrs
70	2	Upper_Right	12824b2b-9c0a-4dcf-8941-34593a4e93da	1:2695318−36867510	13, 20	27	{'min_x': 328.8699951171875, 'min_y': 286.6499938964844, 'max_x': 537.8599243164062, 'max_y': 416.3340148925781}	12824b2b−9c0a−4dcf−8941−34593a4e93da CNS−GBM Cancer type 1:2695318−36867510 Position With other complex events Type 54 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 16; DUP: 11; h2hINV: 14; SV types t2tINV: 13; TRA: 0 92 SVs in sample 13, 20 Oscillating CN (2 and 3 states) 27 CN segments 0.85 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
70	3	Lower_Left	12824b2b-9c0a-4dcf-8941-34593a4e93da	7:37590136−58035420	11, 12	18	{'min_x': 39.36989974975586, 'min_y': 705.2749633789062, 'max_x': 248.35995483398438, 'max_y': 833.6940307617188}	40 MB 45 MB 50 MB 55 MB 12824b2b−9c0a−4dcf−8941−34593a4e93da CNS−GBM Cancer type 7:37590136−58035420 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 7; DUP: 1; h2hINV: 7; SV types t2tINV: 6; TRA: 0 92 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 18 CN segments
70	4	Lower_Right	2f4a127f-101a-4192-b3e8-f9be2c8648bc	12:57931744−69260398	7, 8	25	{'min_x': 330.3699951171875, 'min_y': 705.2749633789062, 'max_x': 536.3538818359375, 'max_y': 833.6940307617188}	50 MB 60 MB 2f4a127f−101a−4192−b3e8−f9be2c8648bc CNS−GBM Cancer type 12:57931744−69260398 Position With other complex events Type 100 Interleaved intrachr. SVs 138 Total SVs (intrachr. + transl.) DEL: 29; DUP: 25; h2hINV: 22; SV types t2tINV: 24; TRA: 38 212 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 25 CN segments
71	1	Upper_Left	309005a2-93a8-4566-b8d3-6b9310144266	9:17888570−29115473	17, 17	17	{'min_x': 38.86989974975586, 'min_y': 286.6499938964844, 'max_x': 248.8579559326172, 'max_y': 416.42401123046875}	309005a2−93a8−4566−b8d3−6b9310144266 CNS−GBM Cancer type 16:3345948−59322371 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 13 46 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 9:17888570−29115473; Linked to chrs
71	2	Upper_Right	352768f9-3ce1-419c-beef-6515c78f5d7a	4:148584038−166176935	7, 7	7	{'min_x': 330.5400085449219, 'min_y': 286.6499938964844, 'max_x': 536.1838989257812, 'max_y': 416.3340148925781}	352768f9−3ce1−419c−beef−6515c78f5d7a CNS−GBM Cancer type 4:148584038−166176935 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 65 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.83 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
71	3	Lower_Left	386b629e-fab1-4033-b088-45d6eeb4a13e	15:32981635−50483790	8, 8	8	{'min_x': 39.210201263427734, 'min_y': 705.2749633789062, 'max_x': 262.5499572753906, 'max_y': 833.6940307617188}	35 MB 40 MB 45 MB 50 MB 386b629e−fab1−4033−b088−45d6eeb4a13e CNS−GBM Cancer type 15:32981635−50483790 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 3 114 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
71	4	Lower_Right	386b629e-fab1-4033-b088-45d6eeb4a13e	22:22445020−51056576	9, 9	9	{'min_x': 328.7099914550781, 'min_y': 705.2749633789062, 'max_x': 549.9400634765625, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 386b629e−fab1−4033−b088−45d6eeb4a13e CNS−GBM Cancer type 22:22445020−51056576 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 1 114 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
72	1	Upper_Left	6c28f086-6a25-40b6-93eb-bba0014acda6	7:4042990−157318473	8, 13	109	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	6c28f086−6a25−40b6−93eb−bba0014acda6 CNS−GBM Cancer type 7:4042990−157318473 Position With other complex events Type 103 Interleaved intrachr. SVs 106 Total SVs (intrachr. + transl.) DEL: 23; DUP: 26; h2hINV: 27; SV types t2tINV: 27; TRA: 3 143 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 109 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
72	2	Upper_Right	6c5154d2-af36-492f-b520-d925528824e4	3:172994395−174625575	11, 11	11	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 420.74383544921875}	6c5154d2−af36−492f−b520−d925528824e4 CNS−GBM Cancer type 4:129768712−190820043 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 8 351 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.59 FDR fragment joints 0.42 FDR chr. breakp. enrich. 3:172994395−174625575;7:25188974−57134154 Linked to chrs 19:32306219−58943997;
72	3	Lower_Left	6c5154d2-af36-492f-b520-d925528824e4	7:25188974−57134155	12, 15	207	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 261.9198913574219, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 6c5154d2−af36−492f−b520−d925528824e4 CNS−GBM Cancer type 7:25188974−57134155 Position With other complex events Type 152 Interleaved intrachr. SVs 204 Total SVs (intrachr. + transl.) DEL: 38; DUP: 32; h2hINV: 44; SV types t2tINV: 38; TRA: 52 351 SVs in sample 12, 15 Oscillating CN (2 and 3 states) 207 CN segments
72	4	Lower_Right	6c5154d2-af36-492f-b520-d925528824e4	19:32306219−58943998	24, 30	114	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 838.7838134765625}	40 MB 50 MB 6c5154d2−af36−492f−b520−d925528824e4 CNS−GBM Cancer type 19:32306219−58943998 Position With other complex events Type 100 Interleaved intrachr. SVs 150 Total SVs (intrachr. + transl.) DEL: 27; DUP: 21; h2hINV: 26; SV types t2tINV: 26; TRA: 50 351 SVs in sample 24, 30 Oscillating CN (2 and 3 states) 114 CN segments 0.87 FDR fragment joints
73	1	Upper_Left	713190ed-c6c1-4695-814b-85ca9b95e6a0	15:40649203−97539849	7, 7	7	{'min_x': 38.86989974975586, 'min_y': 286.6499938964844, 'max_x': 248.8579559326172, 'max_y': 416.3340148925781}	713190ed−c6c1−4695−814b−85ca9b95e6a0 CNS−GBM Cancer type 15:40649203−97539849 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 5; SV types t2tINV: 5; TRA: 0 147 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
73	2	Upper_Right	713190ed-c6c1-4695-814b-85ca9b95e6a0	19:5516134−55780057	19, 37	37	{'min_x': 328.3699951171875, 'min_y': 286.6499938964844, 'max_x': 538.3579711914062, 'max_y': 416.3340148925781}	713190ed−c6c1−4695−814b−85ca9b95e6a0 CNS−GBM Cancer type 19:5516134−55780057 Position With other complex events Type 39 Interleaved intrachr. SVs 60 Total SVs (intrachr. + transl.) DEL: 9; DUP: 15; h2hINV: 4; SV types t2tINV: 11; TRA: 21 147 SVs in sample 19, 37 Oscillating CN (2 and 3 states) 37 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
73	3	Lower_Left	737b35e1-d668-4fce-9b6e-76946c7952b6	1:209530581−249214157	51, 51	51	{'min_x': 39.36989974975586, 'min_y': 705.2749633789062, 'max_x': 271.7118835449219, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 250 MB 737b35e1−d668−4fce−9b6e−76946c7952b6 CNS−GBM Cancer type 1:209530581−249214157 Position Canonical without polyploidization Type 103 Interleaved intrachr. SVs 103 Total SVs (intrachr. + transl.) DEL: 26; DUP: 30; h2hINV: 24; SV types t2tINV: 23; TRA: 0 173 SVs in sample 51, 51 Oscillating CN (2 and 3 states) 51 CN segments
73	4	Lower_Right	737b35e1-d668-4fce-9b6e-76946c7952b6	10:71615252−125378628	14, 14	14	{'min_x': 328.8699951171875, 'min_y': 705.2749633789062, 'max_x': 537.8599243164062, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB 120 MB 737b35e1−d668−4fce−9b6e−76946c7952b6 CNS−GBM Cancer type 10:71615252−125378628 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 4 173 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
74	1	Upper_Left	74139255-a635-4c87-814d-3dd04ed630a8	4:1163865−190815012	12, 20	90	{'min_x': 38.730098724365234, 'min_y': 286.6499938964844, 'max_x': 248.99777221679688, 'max_y': 416.3340148925781}	74139255−a635−4c87−814d−3dd04ed630a8 CNS−GBM Cancer type 4:1163865−190815012 Position With other complex events Type 94 Interleaved intrachr. SVs 95 Total SVs (intrachr. + transl.) DEL: 21; DUP: 17; h2hINV: 27; SV types t2tINV: 29; TRA: 1 291 SVs in sample 12, 20 Oscillating CN (2 and 3 states) 90 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
74	2	Upper_Right	74139255-a635-4c87-814d-3dd04ed630a8	15:34114739−74116044	8, 11	19	{'min_x': 328.2300109863281, 'min_y': 286.6499938964844, 'max_x': 538.4977416992188, 'max_y': 416.42401123046875}	74139255−a635−4c87−814d−3dd04ed630a8 CNS−GBM Cancer type 15:34114739−74116044 Position With other complex events Type 17 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 3; SV types t2tINV: 2; TRA: 18 291 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 19 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 9:21130542−26979039; Linked to chrs
74	3	Lower_Left	8da3103e-3e6c-4176-a583-d5fe5e60601e	14:98609565−99894680	10, 10	10	{'min_x': 39.730098724365234, 'min_y': 705.2749633789062, 'max_x': 271.23211669921875, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 8da3103e−3e6c−4176−a583−d5fe5e60601e CNS−GBM Cancer type 14:98609565−99894680 Position Canonical without polyploidization Type 36 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 10; SV types t2tINV: 7; TRA: 0 131 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
74	4	Lower_Right	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	11:6033888−105143674	15, 39	39	{'min_x': 328.7099914550781, 'min_y': 705.2749633789062, 'max_x': 548.4325561523438, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 93ed7a2b−b0cb−4a84−871f−5c34a0b6a640 CNS−GBM Cancer type 11:6033888−105143674 Position With other complex events Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 3; SV types t2tINV: 3; TRA: 0 175 SVs in sample 15, 39 Oscillating CN (2 and 3 states) 39 CN segments
75	1	Upper_Left	b37d944c-c65c-46d6-bb8b-3eb37cb85b68	15:71116986−102044792	7, 7	7	{'min_x': 37.88010025024414, 'min_y': 286.6499938964844, 'max_x': 249.84796142578125, 'max_y': 416.3340148925781}	b37d944c−c65c−46d6−bb8b−3eb37cb85b68 CNS−GBM Cancer type 15:71116986−102044792 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 15 130 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
75	2	Upper_Right	b37d944c-c65c-46d6-bb8b-3eb37cb85b68	X:70334273−87509185	9, 12	12	{'min_x': 327.3800048828125, 'min_y': 286.6499938964844, 'max_x': 539.347900390625, 'max_y': 416.3340148925781}	b37d944c−c65c−46d6−bb8b−3eb37cb85b68 CNS−GBM Cancer type X:70334273−87509185 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 2 130 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
75	3	Lower_Left	bf339349-062f-4ea9-a0b2-d87d3a21099e	6:155280936−168158297	42, 43	89	{'min_x': 40.039798736572266, 'min_y': 705.2749633789062, 'max_x': 258.06182861328125, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB bf339349−062f−4ea9−a0b2−d87d3a21099e CNS−GBM Cancer type 6:155280936−168158297 Position With other complex events Type 136 Interleaved intrachr. SVs 186 Total SVs (intrachr. + transl.) DEL: 32; DUP: 34; h2hINV: 35; SV types t2tINV: 35; TRA: 50 338 SVs in sample 42, 43 Oscillating CN (2 and 3 states) 89 CN segments
75	4	Lower_Right	de7b7cac-f094-4d59-8651-e991e34ea093	7:43019383−45110155	7, 7	13	{'min_x': 321.9100036621094, 'min_y': 705.2749633789062, 'max_x': 550.8118286132812, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB 150 MB de7b7cac−f094−4d59−8651−e991e34ea093 CNS−GBM Cancer type 7:43019383−45110155 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 105 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments
76	1	Upper_Left	de7b7cac-f094-4d59-8651-e991e34ea093	16:85956549−89924266	8, 11	11	{'min_x': 39.539798736572266, 'min_y': 286.6499938964844, 'max_x': 248.18994140625, 'max_y': 416.3340148925781}	de7b7cac−f094−4d59−8651−e991e34ea093 CNS−GBM Cancer type 16:85956549−89924266 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 5; SV types t2tINV: 5; TRA: 0 105 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
76	2	Upper_Right	e17a6048-7a72-42c0-ad3f-97cbff02bc9f	12:51821337−88808438	7, 19	20	{'min_x': 331.0400085449219, 'min_y': 286.6499938964844, 'max_x': 535.6859130859375, 'max_y': 416.3340148925781}	e17a6048−7a72−42c0−ad3f−97cbff02bc9f CNS−GBM Cancer type 12:51821337−88808438 Position With other complex events Type 16 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 11 65 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 20 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
76	3	Lower_Left	f45f4a30-6b4c-4f15-9140-959d6a25a45f	9:19934041−27288375	23, 25	25	{'min_x': 41.710201263427734, 'min_y': 705.2749633789062, 'max_x': 246.01596069335938, 'max_y': 833.6940307617188}	22 MB 24 MB 26 MB f45f4a30−6b4c−4f15−9140−959d6a25a45f CNS−GBM Cancer type 9:19934041−27288375 Position Canonical without polyploidization Type 48 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 12; DUP: 11; h2hINV: 13; SV types t2tINV: 12; TRA: 0 119 SVs in sample 23, 25 Oscillating CN (2 and 3 states) 25 CN segments
76	4	Lower_Right	ICGC_MB110	16:275259−87888760	9, 16	18	{'min_x': 308.70001220703125, 'min_y': 705.2749633789062, 'max_x': 537.68017578125, 'max_y': 833.6940307617188}	0 MB 20 MB 40 MB 60 MB 80 MB ICGC_MB110 CNS−Medullo Cancer type 16:275259−87888760 Position With other complex events Type 22 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 2 77 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 18 CN segments
77	1	Upper_Left	ICGC_MB131	8:22113923−128760776	13, 13	13	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	ICGC_MB131 CNS−Medullo Cancer type 3:38417904−38895251 Position After polyploidization Type 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 0; SV types t2tINV: 2; TRA: 6 39 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 8:22113923−128760776; Linked to chrs
77	2	Upper_Right	ICGC_MB145	17:17334828−78175336	7, 11	16	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_MB145 CNS−Medullo Cancer type 17:17334828−78175336 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 4; TRA: 2 61 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 16 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
77	3	Lower_Left	ICGC_MB160	8:41002272−123551081	9, 9	17	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 228.4719696044922, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB ICGC_MB160 CNS−Medullo Cancer type 8:41002272−123551081 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 16 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 17 CN segments
77	4	Lower_Right	ICGC_MB165	2:111074−18111365	13, 22	41	{'min_x': 308.0, 'min_y': 705.2749633789062, 'max_x': 518.580078125, 'max_y': 833.6940307617188}	0 MB 5 MB 10 MB 15 MB ICGC_MB165 CNS−Medullo Cancer type 2:111074−18111365 Position With other complex events Type 30 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 8; DUP: 8; h2hINV: 9; SV types t2tINV: 5; TRA: 0 98 SVs in sample 13, 22 Oscillating CN (2 and 3 states) 41 CN segments
78	1	Upper_Left	ICGC_MB165	5:14327−179565981	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_MB165 CNS−Medullo Cancer type 5:14327−179565981 Position Canonical without polyploidization Type 66 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 17; DUP: 17; h2hINV: 13; SV types t2tINV: 19; TRA: 0 98 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
78	2	Upper_Right	ICGC_MB224	17:27090584−78497663	7, 14	14	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_MB224 CNS−Medullo Cancer type 17:27090584−78497663 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 1 48 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
78	3	Lower_Left	ICGC_MB23	10:388457−53879148	8, 11	11	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 261.3322448730469, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB ICGC_MB23 CNS−Medullo Cancer type 10:388457−53879148 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 4 36 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments
78	4	Lower_Right	ICGC_MB34	5:292496−69696821	7, 9	55	{'min_x': 308.6600036621094, 'min_y': 705.2749633789062, 'max_x': 535.6201782226562, 'max_y': 833.6940307617188}	0 MB 20 MB 40 MB 60 MB 80 MB ICGC_MB34 CNS−Medullo Cancer type 5:292496−69696821 Position With other complex events Type 46 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 14; DUP: 9; h2hINV: 12; SV types t2tINV: 11; TRA: 2 242 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 55 CN segments
79	1	Upper_Left	ICGC_MB34	22:18004707−43092533	15, 15	35	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	ICGC_MB34 CNS−Medullo Cancer type 14:29090292−47295794 Position With other complex events Type 13 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 4 242 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 35 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. 22:18004707−43092533; Linked to chrs
79	2	Upper_Right	ICGC_MB34	X:15128807−127701065	7, 10	41	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_MB34 CNS−Medullo Cancer type X:15128807−127701065 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 6; SV types t2tINV: 5; TRA: 0 242 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 41 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
79	3	Lower_Left	ICGC_MB81	3:83993082−118079412	10, 21	48	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 229.22010803222656, 'max_y': 833.6940307617188}	90 MB 100 MB 110 MB ICGC_MB81 CNS−Medullo Cancer type 3:83993082−118079412 Position With other complex events Type 74 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 20; DUP: 21; h2hINV: 20; SV types t2tINV: 13; TRA: 0 91 SVs in sample 10, 21 Oscillating CN (2 and 3 states) 48 CN segments
79	4	Lower_Right	ICGC_MB83	20:305936−62568476	23, 23	23	{'min_x': 308.2900085449219, 'min_y': 705.2749633789062, 'max_x': 548.9404296875, 'max_y': 833.6940307617188}	0 MB 20 MB 40 MB 60 MB ICGC_MB83 CNS−Medullo Cancer type 20:305936−62568476 Position After polyploidization Type 47 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 11; DUP: 12; h2hINV: 13; SV types t2tINV: 11; TRA: 0 58 SVs in sample 23, 23 Oscillating CN (2 and 3 states) 23 CN segments
80	1	Upper_Left	ICGC_MB94	12:12616089−127105460	9, 21	26	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	ICGC_MB94 CNS−Medullo Cancer type 12:12616089−127105460 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 0 30 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 26 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
80	2	Upper_Right	70939245-41e0-4845-a473-5fef719b9828	11:67579787−119004447	11, 12	12	{'min_x': 330.07000732421875, 'min_y': 286.6499938964844, 'max_x': 536.6620483398438, 'max_y': 416.3340148925781}	70939245−41e0−4845−a473−5fef719b9828 CNS−Oligo Cancer type 11:67579787−119004447 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 8 62 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
80	3	Lower_Left	a5f851c5-6130-4ea1-9f86-be59331a92f7	12:40577459−111918430	11, 14	29	{'min_x': 41.20000076293945, 'min_y': 705.2749633789062, 'max_x': 272.13214111328125, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB a5f851c5−6130−4ea1−9f86−be59331a92f7 CNS−Oligo Cancer type 12:40577459−111918430 Position With other complex events Type 13 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 3 48 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 29 CN segments
80	4	Lower_Right	300fff5a-0f61-402d-b845-3938ba7b1294	4:94012474−136381345	8, 8	8	{'min_x': 324.75, 'min_y': 705.2749633789062, 'max_x': 543.3720092773438, 'max_y': 833.6940307617188}	100 MB 120 MB 140 MB 160 MB 180 MB 300fff5a−0f61−402d−b845−3938ba7b1294 ColoRect−AdenoCA Cancer type 4:94012474−136381345 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 4 51 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
81	1	Upper_Left	5116e3b4-2bac-40f5-8046-b9c1783faaa5	8:75252026−130197825	7, 8	78	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.3340148925781}	5116e3b4−2bac−40f5−8046−b9c1783faaa5 ColoRect−AdenoCA Cancer type 8:75252026−130197825 Position With other complex events Type 77 Interleaved intrachr. SVs 83 Total SVs (intrachr. + transl.) DEL: 25; DUP: 17; h2hINV: 19; SV types t2tINV: 16; TRA: 6 322 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 78 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
81	2	Upper_Right	5116e3b4-2bac-40f5-8046-b9c1783faaa5	11:4624293−78623113	18, 20	22	{'min_x': 329.7099914550781, 'min_y': 286.6499938964844, 'max_x': 537.0219116210938, 'max_y': 416.42401123046875}	5116e3b4−2bac−40f5−8046−b9c1783faaa5 ColoRect−AdenoCA Cancer type 10:3416561−47660152 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 12 322 SVs in sample 18, 20 Oscillating CN (2 and 3 states) 22 CN segments 0.69 FDR fragment joints 0 FDR chr. breakp. enrich. 11:4624293−78623113; Linked to chrs
81	3	Lower_Left	74a0264d-1d31-430d-9a88-e7334c8aa96c	11:36286027−55106614	9, 10	38	{'min_x': 38.86989974975586, 'min_y': 705.2749633789062, 'max_x': 268.860107421875, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 74a0264d−1d31−430d−9a88−e7334c8aa96c ColoRect−AdenoCA Cancer type 11:36286027−55106614 Position With other complex events Type 22 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 4; SV types t2tINV: 3; TRA: 0 184 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 38 CN segments
81	4	Lower_Right	7d8eab0a-e6c8-4449-9ebf-50c41db94a06	11:24587264−77217999	7, 7	7	{'min_x': 308.4200134277344, 'min_y': 705.2749633789062, 'max_x': 558.46240234375, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB 7d8eab0a−e6c8−4449−9ebf−50c41db94a06 ColoRect−AdenoCA Cancer type 11:24587264−77217999 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 8 170 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints
82	1	Upper_Left	84e34cf2-b3bb-4a1a-8fb7-6c2c604c4008	2:225114384−242999441	23, 25	25	{'min_x': 40.039798736572266, 'min_y': 286.6499938964844, 'max_x': 247.69195556640625, 'max_y': 416.3340148925781}	84e34cf2−b3bb−4a1a−8fb7−6c2c604c4008 ColoRect−AdenoCA Cancer type 2:225114384−242999441 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 96 SVs in sample 23, 25 Oscillating CN (2 and 3 states) 25 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
82	2	Upper_Right	84e34cf2-b3bb-4a1a-8fb7-6c2c604c4008	4:110377459−189112406	31, 31	31	{'min_x': 329.5400085449219, 'min_y': 286.6499938964844, 'max_x': 537.19189453125, 'max_y': 416.3340148925781}	84e34cf2−b3bb−4a1a−8fb7−6c2c604c4008 ColoRect−AdenoCA Cancer type 4:110377459−189112406 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 4; SV types t2tINV: 1; TRA: 14 96 SVs in sample 31, 31 Oscillating CN (2 and 3 states) 31 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
82	3	Lower_Left	857a5889-19e7-4208-8362-f1377c408037	10:170347−37518119	7, 20	20	{'min_x': 40.03010177612305, 'min_y': 705.2749633789062, 'max_x': 268.632080078125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 857a5889−19e7−4208−8362−f1377c408037 ColoRect−AdenoCA Cancer type 10:170347−37518119 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 7; h2hINV: 5; SV types t2tINV: 4; TRA: 0 47 SVs in sample 7, 20 Oscillating CN (2 and 3 states) 20 CN segments
82	4	Lower_Right	a512701f-88bb-4b05-8c94-fd285b9dd13e	10:4459777−93753340	14, 15	15	{'min_x': 307.17999267578125, 'min_y': 705.2749633789062, 'max_x': 537.6519165039062, 'max_y': 833.6940307617188}	0 MB 25 MB 50 MB 75 MB a512701f−88bb−4b05−8c94−fd285b9dd13e ColoRect−AdenoCA Cancer type 10:4459777−93753340 Position After polyploidization Type 4 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 0; TRA: 3 134 SVs in sample 14, 15 Oscillating CN (2 and 3 states) 15 CN segments
83	1	Upper_Left	d3b7ada6-5395-4212-a921-8e97c92b605d	17:29755964−52225944	10, 10	10	{'min_x': 38.539798736572266, 'min_y': 286.6499938964844, 'max_x': 249.1879425048828, 'max_y': 416.3340148925781}	d3b7ada6−5395−4212−a921−8e97c92b605d ColoRect−AdenoCA Cancer type 17:29755964−52225944 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 8 73 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
83	2	Upper_Right	d3b7ada6-5395-4212-a921-8e97c92b605d	18:5986794−35455161	7, 7	18	{'min_x': 328.0400085449219, 'min_y': 286.6499938964844, 'max_x': 538.6879272460938, 'max_y': 416.3340148925781}	d3b7ada6−5395−4212−a921−8e97c92b605d ColoRect−AdenoCA Cancer type 18:5986794−35455161 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 2 73 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
83	3	Lower_Left	dca004bf-9c14-45a1-b186-ab3759f6c7fe	6:221993−169360831	23, 36	87	{'min_x': 40.73979949951172, 'min_y': 705.2749633789062, 'max_x': 246.98410034179688, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB dca004bf−9c14−45a1−b186−ab3759f6c7fe ColoRect−AdenoCA Cancer type 6:221993−169360831 Position With other complex events Type 63 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 22; DUP: 15; h2hINV: 14; SV types t2tINV: 12; TRA: 0 153 SVs in sample 23, 36 Oscillating CN (2 and 3 states) 87 CN segments
83	4	Lower_Right	e8ec26bd-c88d-42b9-ac8a-ab121b8140f8	20:7138898−57297995	13, 19	80	{'min_x': 328.5400085449219, 'min_y': 705.2749633789062, 'max_x': 548.4699096679688, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB e8ec26bd−c88d−42b9−ac8a−ab121b8140f8 ColoRect−AdenoCA Cancer type 20:7138898−57297995 Position With other complex events Type 32 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 9; SV types t2tINV: 7; TRA: 0 94 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 80 CN segments
84	1	Upper_Left	f87c6dcc-1a9e-4df5-962c-1f946e2611f8	10:4835843−86898602	9, 19	32	{'min_x': 41.710201263427734, 'min_y': 286.6499938964844, 'max_x': 246.01596069335938, 'max_y': 416.3340148925781}	f87c6dcc−1a9e−4df5−962c−1f946e2611f8 ColoRect−AdenoCA Cancer type 10:4835843−86898602 Position With other complex events Type 20 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 2 116 SVs in sample 9, 19 Oscillating CN (2 and 3 states) 32 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
84	2	Upper_Right	1388bba1-02ba-40df-93e5-c3d58b7bbae0	1:32651575−117559110	53, 53	53	{'min_x': 328.2099914550781, 'min_y': 286.6499938964844, 'max_x': 538.5199584960938, 'max_y': 416.3340148925781}	1388bba1−02ba−40df−93e5−c3d58b7bbae0 ColoRect−AdenoCA Cancer type 1:32651575−117559110 Position Canonical without polyploidization Type 44 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 10; DUP: 16; h2hINV: 9; SV types t2tINV: 9; TRA: 0 306 SVs in sample 53, 53 Oscillating CN (2 and 3 states) 53 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
84	3	Lower_Left	1388bba1-02ba-40df-93e5-c3d58b7bbae0	12:361015−132561817	17, 49	129	{'min_x': 38.710201263427734, 'min_y': 705.2749633789062, 'max_x': 249.01995849609375, 'max_y': 833.6940307617188}	50 MB 100 MB 1388bba1−02ba−40df−93e5−c3d58b7bbae0 ColoRect−AdenoCA Cancer type 12:361015−132561817 Position With other complex events Type 179 Interleaved intrachr. SVs 179 Total SVs (intrachr. + transl.) DEL: 42; DUP: 44; h2hINV: 46; SV types t2tINV: 47; TRA: 0 306 SVs in sample 17, 49 Oscillating CN (2 and 3 states) 129 CN segments
84	4	Lower_Right	1388bba1-02ba-40df-93e5-c3d58b7bbae0	21:21231971−30536463	10, 10	24	{'min_x': 328.2099914550781, 'min_y': 705.2749633789062, 'max_x': 552.18017578125, 'max_y': 833.6940307617188}	15 MB 20 MB 25 MB 30 MB 1388bba1−02ba−40df−93e5−c3d58b7bbae0 ColoRect−AdenoCA Cancer type 21:21231971−30536463 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 7; SV types t2tINV: 5; TRA: 0 306 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 24 CN segments
85	1	Upper_Left	OCCAMS-AH-014	9:15450269−78965593	8, 9	29	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	OCCAMS−AH−014 Eso−AdenoCA Cancer type 9:15450269−78965593 Position With other complex events Type 14 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 7 299 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 29 CN segments 0.78 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
85	2	Upper_Right	OCCAMS-AH-046	17:3658212−53172475	8, 13	16	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−AH−046 Eso−AdenoCA Cancer type 17:3658212−53172475 Position With other complex events Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 1 145 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 16 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
85	3	Lower_Left	OCCAMS-AH-048	7:2901227−145317445	12, 12	89	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 229.22010803222656, 'max_y': 833.6940307617188}	50 MB 100 MB OCCAMS−AH−048 Eso−AdenoCA Cancer type 7:2901227−145317445 Position With other complex events Type 41 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 10; DUP: 12; h2hINV: 10; SV types t2tINV: 9; TRA: 0 142 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 89 CN segments
85	4	Lower_Right	OCCAMS-AH-063	8:30876019−41958223	8, 8	8	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB OCCAMS−AH−063 Eso−AdenoCA Cancer type 8:30876019−41958223 Position Before polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 101 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
86	1	Upper_Left	OCCAMS-AH-064	2:968502−127296039	7, 25	39	{'min_x': 61.849998474121094, 'min_y': 286.6499938964844, 'max_x': 225.87779235839844, 'max_y': 416.3340148925781}	OCCAMS−AH−064 Eso−AdenoCA Cancer type 2:968502−127296039 Position With other complex events Type 36 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 8; DUP: 11; h2hINV: 8; SV types t2tINV: 9; TRA: 3 448 SVs in sample 7, 25 Oscillating CN (2 and 3 states) 39 CN segments 0.91 FDR fragment joints 0.25 FDR chr. breakp. enrich. Linked to chrs
86	2	Upper_Right	OCCAMS-AH-064	3:1926043−196423191	7, 9	75	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−AH−064 Eso−AdenoCA Cancer type 3:1926043−196423191 Position With other complex events Type 13 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 4; TRA: 40 448 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 75 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
86	3	Lower_Left	OCCAMS-AH-064	13:27991549−115019710	10, 34	88	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 231.0820770263672, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB OCCAMS−AH−064 Eso−AdenoCA Cancer type 13:27991549−115019710 Position With other complex events Type 39 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 9; SV types t2tINV: 11; TRA: 1 448 SVs in sample 10, 34 Oscillating CN (2 and 3 states) 88 CN segments
86	4	Lower_Right	OCCAMS-AH-064	X:10521537−154343000	10, 15	91	{'min_x': 351.3500061035156, 'min_y': 705.2749633789062, 'max_x': 553.6118774414062, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB OCCAMS−AH−064 Eso−AdenoCA Cancer type X:10521537−154343000 Position With other complex events Type 36 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 10; SV types t2tINV: 10; TRA: 11 448 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 91 CN segments
87	1	Upper_Left	OCCAMS-AH-082	6:52224981−156272848	11, 14	62	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	OCCAMS−AH−082 Eso−AdenoCA Cancer type 6:52224981−156272848 Position With other complex events Type 31 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 6; SV types t2tINV: 8; TRA: 1 433 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 62 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
87	2	Upper_Right	OCCAMS-AH-085	9:33132354−139158900	9, 19	19	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−AH−085 Eso−AdenoCA Cancer type 9:33132354−139158900 Position With other complex events Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 9; SV types t2tINV: 2; TRA: 0 170 SVs in sample 9, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
87	3	Lower_Left	OCCAMS-AH-086	10:43601978−134914515	25, 30	113	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 225.87779235839844, 'max_y': 833.6940307617188}	50 MB 100 MB OCCAMS−AH−086 Eso−AdenoCA Cancer type 10:43601978−134914515 Position With other complex events Type 35 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 11; DUP: 7; h2hINV: 9; SV types t2tINV: 8; TRA: 30 619 SVs in sample 25, 30 Oscillating CN (2 and 3 states) 113 CN segments
87	4	Lower_Right	OCCAMS-AH-086	19:1174502−58337393	7, 12	103	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 524.8099365234375, 'max_y': 838.7838134765625}	10 MB 20 MB 30 MB 40 MB 50 MB OCCAMS−AH−086 Eso−AdenoCA Cancer type 19:1174502−58337393 Position With other complex events Type 40 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 10; SV types t2tINV: 10; TRA: 40 619 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 103 CN segments 0.99 FDR fragment joints
88	1	Upper_Left	OCCAMS-AH-088	7:53921918−151275079	15, 33	69	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	OCCAMS−AH−088 Eso−AdenoCA Cancer type 7:53921918−151275079 Position With other complex events Type 68 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 14; DUP: 15; h2hINV: 19; SV types t2tINV: 20; TRA: 2 167 SVs in sample 15, 33 Oscillating CN (2 and 3 states) 69 CN segments 0.75 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
88	2	Upper_Right	OCCAMS-AH-096	22:16884779−49630408	8, 21	25	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−AH−096 Eso−AdenoCA Cancer type 22:16884779−49630408 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 3; TRA: 6 326 SVs in sample 8, 21 Oscillating CN (2 and 3 states) 25 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
88	3	Lower_Left	OCCAMS-AH-108	17:614159−62917745	7, 7	102	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 258.14996337890625, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB OCCAMS−AH−108 Eso−AdenoCA Cancer type 17:614159−62917745 Position With other complex events Type 80 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 22; DUP: 19; h2hINV: 19; SV types t2tINV: 20; TRA: 0 162 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 102 CN segments
88	4	Lower_Right	OCCAMS-AH-112	1:1979872−212827045	21, 33	41	{'min_x': 307.55999755859375, 'min_y': 705.2749633789062, 'max_x': 516.3820190429688, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB 150 MB 200 MB OCCAMS−AH−112 Eso−AdenoCA Cancer type 1:1979872−212827045 Position With other complex events Type 14 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 10 221 SVs in sample 21, 33 Oscillating CN (2 and 3 states) 41 CN segments 0.78 FDR fragment joints
89	1	Upper_Left	OCCAMS-AH-112	2:23859234−191789699	11, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	OCCAMS−AH−112 Eso−AdenoCA Cancer type 2:23859234−191789699 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 3 221 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.98 FDR fragment joints 1 FDR chr. breakp. enrich. Linked to chrs
89	2	Upper_Right	OCCAMS-AH-112	12:8323902−14885237	10, 21	54	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5380249023438, 'max_y': 416.4242248535156}	OCCAMS−AH−112 Eso−AdenoCA Cancer type 4:5188482−185655429 Position With other complex events Type 16 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 1; SV types t2tINV: 6; TRA: 32 221 SVs in sample 10, 21 Oscillating CN (2 and 3 states) 54 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 1:1979872−212827044;10:23310943−61673311 12:8323902−14885237;5:110689915−118671115 Linked to chrs
89	3	Lower_Left	OCCAMS-AH-112	5:110689915−118671116	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 243.5019989013672, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB OCCAMS−AH−112 Eso−AdenoCA Cancer type 5:110689915−118671116 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 10 221 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
89	4	Lower_Right	OCCAMS-AH-112	9:2688258−130163538	11, 19	35	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 838.7838134765625}	50 MB 100 MB OCCAMS−AH−112 Eso−AdenoCA Cancer type 9:2688258−130163538 Position With other complex events Type 10 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 24 221 SVs in sample 11, 19 Oscillating CN (2 and 3 states) 35 CN segments 0.96 FDR fragment joints
90	1	Upper_Left	OCCAMS-AH-136	16:47562340−57689371	16, 16	16	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	OCCAMS−AH−136 Eso−AdenoCA Cancer type 16:47562340−57689371 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 2 67 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
90	2	Upper_Right	OCCAMS-AH-173	11:17492995−133541100	10, 37	66	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 416.3340148925781}	OCCAMS−AH−173 Eso−AdenoCA Cancer type 1:24204431−234619940 Position With other complex events Type 44 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 16; DUP: 8; h2hINV: 11; SV types t2tINV: 9; TRA: 7 410 SVs in sample 10, 37 Oscillating CN (2 and 3 states) 66 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:17492995−133541100;14:64173909−64406103 Linked to chrs
90	3	Lower_Left	OCCAMS-AH-173	8:14950710−146210675	9, 9	18	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	50 MB 100 MB OCCAMS−AH−173 Eso−AdenoCA Cancer type 8:14950710−146210675 Position With other complex events Type 5 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 9 410 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 18 CN segments
90	4	Lower_Right	OCCAMS-AH-196	18:13655503−77718608	8, 9	92	{'min_x': 344.07000732421875, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB OCCAMS−AH−196 Eso−AdenoCA Cancer type 18:13655503−77718608 Position With other complex events Type 82 Interleaved intrachr. SVs 90 Total SVs (intrachr. + transl.) DEL: 18; DUP: 25; h2hINV: 19; SV types t2tINV: 20; TRA: 8 216 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 92 CN segments
91	1	Upper_Left	OCCAMS-AH-197	11:60717275−95643409	9, 24	31	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	OCCAMS−AH−197 Eso−AdenoCA Cancer type 11:60717275−95643409 Position With other complex events Type 16 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 6; SV types t2tINV: 5; TRA: 1 269 SVs in sample 9, 24 Oscillating CN (2 and 3 states) 31 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
91	2	Upper_Right	OCCAMS-ED-003	3:77926901−140720659	9, 15	19	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−ED−003 Eso−AdenoCA Cancer type 3:77926901−140720659 Position With other complex events Type 4 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 4 117 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 19 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
91	3	Lower_Left	OCCAMS-ED-041	2:144209346−167223868	18, 18	18	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 265.7020568847656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB OCCAMS−ED−041 Eso−AdenoCA Cancer type 2:144209346−167223868 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 125 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments
91	4	Lower_Right	OCCAMS-GS-002	6:25217251−125203324	9, 23	28	{'min_x': 348.3299865722656, 'min_y': 705.2749633789062, 'max_x': 555.5618896484375, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB OCCAMS−GS−002 Eso−AdenoCA Cancer type 6:25217251−125203324 Position With other complex events Type 13 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 2 134 SVs in sample 9, 23 Oscillating CN (2 and 3 states) 28 CN segments
92	1	Upper_Left	OCCAMS-PS-014	3:10840533−149005314	7, 13	30	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	OCCAMS−PS−014 Eso−AdenoCA Cancer type 3:10840533−149005314 Position With other complex events Type 9 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 12 53 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 30 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. 9:3720535−31869664; Linked to chrs
92	2	Upper_Right	OCCAMS-PS-014	3:10840533−149005313	7, 15	15	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	OCCAMS−PS−014 Eso−AdenoCA Cancer type 9:3720535−31869665 Position With other complex events Type 4 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 12 53 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:10840533−149005313; Linked to chrs
92	3	Lower_Left	OCCAMS-RS-006	2:11537277−117535028	15, 15	15	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 246.64187622070312, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB OCCAMS−RS−006 Eso−AdenoCA Cancer type 2:11537277−117535028 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 19 198 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.91 FDR fragment joints
92	4	Lower_Right	OCCAMS-RS-007	4:124056−24705189	10, 17	37	{'min_x': 309.25, 'min_y': 705.2749633789062, 'max_x': 553.2123413085938, 'max_y': 833.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB OCCAMS−RS−007 Eso−AdenoCA Cancer type 4:124056−24705189 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 4; SV types t2tINV: 5; TRA: 0 242 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 37 CN segments
93	1	Upper_Left	OCCAMS-RS-008	18:28233723−70007646	8, 11	19	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	OCCAMS−RS−008 Eso−AdenoCA Cancer type 18:28233723−70007646 Position With other complex events Type 7 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 27 303 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 19 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 6:55525409−88702536; Linked to chrs
93	2	Upper_Right	OCCAMS-RS-008	1:200693009−220848035	7, 19	30	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	OCCAMS−RS−008 Eso−AdenoCA Cancer type 20:10454766−62655650 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 2 303 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 30 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 1:200693009−220848035; Linked to chrs
93	3	Lower_Left	OCCAMS-RS-024	4:15222955−60346330	8, 15	28	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 267.1902160644531, 'max_y': 838.7838134765625}	20 MB 30 MB 40 MB 50 MB 60 MB OCCAMS−RS−024 Eso−AdenoCA Cancer type 4:15222955−60346330 Position With other complex events Type 12 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 24 218 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 28 CN segments 0.91 FDR fragment joints
93	4	Lower_Right	OCCAMS-RS-024	5:61100033−179629173	8, 11	11	{'min_x': 315.760009765625, 'min_y': 705.2749633789062, 'max_x': 561.091796875, 'max_y': 838.7838134765625}	60 MB 90 MB 120 MB 150 MB 180 MB OCCAMS−RS−024 Eso−AdenoCA Cancer type 5:61100033−179629173 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 10 218 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.91 FDR fragment joints
94	1	Upper_Left	OCCAMS-RS-031	3:102654747−189241556	13, 13	20	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	OCCAMS−RS−031 Eso−AdenoCA Cancer type 3:102654747−189241556 Position After polyploidization Type 6 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 4; TRA: 5 156 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 20 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 4:8256829−162969785; Linked to chrs
94	2	Upper_Right	OCCAMS-RS-032	3:6793668−181259418	10, 24	25	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	OCCAMS−RS−032 Eso−AdenoCA Cancer type 9:15830088−125695294 Position With other complex events Type 10 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 12 159 SVs in sample 10, 24 Oscillating CN (2 and 3 states) 25 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. 3:6793668−181259418;8:32815344−128323683 Linked to chrs
94	3	Lower_Left	OCCAMS-RS-036	5:52934089−180192620	7, 11	37	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 232.0520477294922, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB OCCAMS−RS−036 Eso−AdenoCA Cancer type 5:52934089−180192620 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 6; SV types t2tINV: 5; TRA: 0 332 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 37 CN segments
94	4	Lower_Right	OCCAMS-RS-036	13:19096905−108942210	8, 11	41	{'min_x': 309.79998779296875, 'min_y': 705.2749633789062, 'max_x': 537.4420166015625, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 100 MB OCCAMS−RS−036 Eso−AdenoCA Cancer type 13:19096905−108942210 Position With other complex events Type 28 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 5; SV types t2tINV: 10; TRA: 8 332 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 41 CN segments
95	1	Upper_Left	OCCAMS-SH-003	9:7402627−123306880	31, 31	56	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.5441131591797, 'max_y': 416.3340148925781}	OCCAMS−SH−003 Eso−AdenoCA Cancer type 9:7402627−123306880 Position With other complex events Type 43 Interleaved intrachr. SVs 67 Total SVs (intrachr. + transl.) DEL: 12; DUP: 14; h2hINV: 8; SV types t2tINV: 9; TRA: 24 250 SVs in sample 31, 31 Oscillating CN (2 and 3 states) 56 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
95	2	Upper_Right	OCCAMS-SH-051	14:44423329−81442644	12, 13	50	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3778686523438, 'max_y': 416.42401123046875}	OCCAMS−SH−051 Eso−AdenoCA Cancer type 8:15493178−116198864 Position With other complex events Type 48 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 8; DUP: 13; h2hINV: 8; SV types t2tINV: 19; TRA: 5 450 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 50 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 14:44423329−81442644; Linked to chrs
95	3	Lower_Left	OCCAMS-SH-051	9:83628603−122095709	9, 13	18	{'min_x': 54.08980178833008, 'min_y': 705.2749633789062, 'max_x': 236.33212280273438, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 120 MB OCCAMS−SH−051 Eso−AdenoCA Cancer type 9:83628603−122095709 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 0 450 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 18 CN segments
95	4	Lower_Right	OCCAMS-SH-051	10:1449967−129457144	16, 63	63	{'min_x': 349.92999267578125, 'min_y': 705.2749633789062, 'max_x': 552.3720703125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB OCCAMS−SH−051 Eso−AdenoCA Cancer type 10:1449967−129457144 Position With other complex events Type 30 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 6; SV types t2tINV: 6; TRA: 18 450 SVs in sample 16, 63 Oscillating CN (2 and 3 states) 63 CN segments
96	1	Upper_Left	OCCAMS-SH-051	17:35498058−80272573	8, 13	34	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	OCCAMS−SH−051 Eso−AdenoCA Cancer type 17:35498058−80272573 Position With other complex events Type 17 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 3 450 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 34 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
96	2	Upper_Right	OCCAMS-SH-071	19:910192−23977386	11, 13	71	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.3340148925781}	OCCAMS−SH−071 Eso−AdenoCA Cancer type 19:910192−23977386 Position With other complex events Type 49 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 14; DUP: 6; h2hINV: 12; SV types t2tINV: 17; TRA: 0 284 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 71 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
96	3	Lower_Left	OCCAMS-ST-020	2:2097136−240675922	50, 78	78	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB OCCAMS−ST−020 Eso−AdenoCA Cancer type 2:2097136−240675922 Position Canonical without polyploidization Type 80 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 25; DUP: 19; h2hINV: 18; SV types t2tINV: 18; TRA: 0 165 SVs in sample 50, 78 Oscillating CN (2 and 3 states) 78 CN segments
96	4	Lower_Right	OCCAMS-ST-029	6:80712446−105721586	13, 20	20	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 529.802001953125, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB OCCAMS−ST−029 Eso−AdenoCA Cancer type 6:80712446−105721586 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 6; SV types t2tINV: 7; TRA: 0 286 SVs in sample 13, 20 Oscillating CN (2 and 3 states) 20 CN segments
97	1	Upper_Left	OCCAMS-ST-029	12:13909019−15158939	11, 11	73	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.5441131591797, 'max_y': 416.42401123046875}	OCCAMS−ST−029 Eso−AdenoCA Cancer type 9:18394399−139562954 Position With other complex events Type 49 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 13; DUP: 17; h2hINV: 8; SV types t2tINV: 11; TRA: 8 286 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 73 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 12:13909019−15158939; Linked to chrs
97	2	Upper_Right	OCCAMS-WG-002	5:146494000−172062115	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	OCCAMS−WG−002 Eso−AdenoCA Cancer type 5:146494000−172062115 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 138 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0.36 FDR chr. breakp. enrich. Linked to chrs
97	3	Lower_Left	OCCAMS-WG-019	8:11621919−129269031	7, 13	56	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	50 MB 100 MB OCCAMS−WG−019 Eso−AdenoCA Cancer type 8:11621919−129269031 Position With other complex events Type 20 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 5; SV types t2tINV: 7; TRA: 7 263 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 56 CN segments
97	4	Lower_Right	OCCAMS-ZZ-004	3:79151724−171586622	10, 12	38	{'min_x': 352.0799865722656, 'min_y': 705.2749633789062, 'max_x': 544.0123291015625, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB OCCAMS−ZZ−004 Eso−AdenoCA Cancer type 3:79151724−171586622 Position With other complex events Type 25 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 6; SV types t2tINV: 7; TRA: 1 323 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 38 CN segments
98	1	Upper_Left	OCCAMS-ZZ-004	13:22419265−109068331	8, 15	56	{'min_x': 61.849998474121094, 'min_y': 286.6499938964844, 'max_x': 225.87779235839844, 'max_y': 416.42401123046875}	OCCAMS−ZZ−004 Eso−AdenoCA Cancer type 13:22419265−109068331 Position With other complex events Type 32 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 4; DUP: 12; h2hINV: 8; SV types t2tINV: 8; TRA: 9 323 SVs in sample 8, 15 Oscillating CN (2 and 3 states) 56 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 10:364377−35292357; Linked to chrs
98	2	Upper_Right	OCCAMS-ZZ-016	3:35278145−141335185	7, 14	14	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	OCCAMS−ZZ−016 Eso−AdenoCA Cancer type 3:35278145−141335185 Position With other complex events Type 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 7 286 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
98	3	Lower_Left	OCCAMS-ZZ-019	5:54890695−171491811	18, 25	25	{'min_x': 43.460201263427734, 'min_y': 705.2749633789062, 'max_x': 252.9720916748047, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB OCCAMS−ZZ−019 Eso−AdenoCA Cancer type 5:54890695−171491811 Position Before polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 0 190 SVs in sample 18, 25 Oscillating CN (2 and 3 states) 25 CN segments
98	4	Lower_Right	3e5f451a-5882-4914-ae1a-95c898c2bcca	17:37011270−62375856	21, 21	21	{'min_x': 329.3699951171875, 'min_y': 705.2749633789062, 'max_x': 555.9100952148438, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 3e5f451a−5882−4914−ae1a−95c898c2bcca Head−SCC Cancer type 17:37011270−62375856 Position After polyploidization Type 4 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 17 362 SVs in sample 21, 21 Oscillating CN (2 and 3 states) 21 CN segments
99	1	Upper_Left	ad6c9d09-2c03-4786-a72d-dd2aa5f603d4	18:1261751−15359143	8, 32	37	{'min_x': 39.06990051269531, 'min_y': 286.6499938964844, 'max_x': 248.6599884033203, 'max_y': 416.3340148925781}	ad6c9d09−2c03−4786−a72d−dd2aa5f603d4 Head−SCC Cancer type 18:1261751−15359143 Position With other complex events Type 22 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 4; SV types t2tINV: 4; TRA: 1 360 SVs in sample 8, 32 Oscillating CN (2 and 3 states) 37 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
99	2	Upper_Right	cb99fb14-641c-4fb3-bf1d-17efb8cd982a	5:301373−56638638	13, 13	20	{'min_x': 330.3800048828125, 'min_y': 286.6499938964844, 'max_x': 536.3458251953125, 'max_y': 416.3340148925781}	cb99fb14−641c−4fb3−bf1d−17efb8cd982a Head−SCC Cancer type 5:301373−56638638 Position After polyploidization Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 1 96 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 20 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
99	3	Lower_Left	e303b8c4-6428-4134-bb9d-a95dc1d8e35e	1:1362882−85717387	15, 15	15	{'min_x': 38.36989974975586, 'min_y': 705.2749633789062, 'max_x': 249.3579559326172, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB e303b8c4−6428−4134−bb9d−a95dc1d8e35e Head−SCC Cancer type 1:1362882−85717387 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 1 224 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments
99	4	Lower_Right	2f1c4db6-88a7-4a5d-a5fe-94d85f569440	5:928958−174411985	82, 129	129	{'min_x': 308.6099853515625, 'min_y': 705.2749633789062, 'max_x': 536.48388671875, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB 2f1c4db6−88a7−4a5d−a5fe−94d85f569440 Kidney−ChRCC Cancer type 5:928958−174411985 Position After polyploidization Type 40 Interleaved intrachr. SVs 141 Total SVs (intrachr. + transl.) DEL: 9; DUP: 13; h2hINV: 8; SV types t2tINV: 10; TRA: 101 233 SVs in sample 82, 129 Oscillating CN (2 and 3 states) 129 CN segments
100	1	Upper_Left	2f1c4db6-88a7-4a5d-a5fe-94d85f569440	13:20416020−113987910	51, 138	138	{'min_x': 40.73979949951172, 'min_y': 286.6499938964844, 'max_x': 246.9839630126953, 'max_y': 416.3340148925781}	2f1c4db6−88a7−4a5d−a5fe−94d85f569440 Kidney−ChRCC Cancer type 13:20416020−113987910 Position With other complex events Type 58 Interleaved intrachr. SVs 160 Total SVs (intrachr. + transl.) DEL: 15; DUP: 12; h2hINV: 15; SV types t2tINV: 16; TRA: 102 233 SVs in sample 51, 138 Oscillating CN (2 and 3 states) 138 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
100	2	Upper_Right	70e306ee-9584-49d6-81a1-a49d837ab6aa	15:40179423−68153781	9, 22	64	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	70e306ee−9584−49d6−81a1−a49d837ab6aa Kidney−ChRCC Cancer type 3:27225774−76470709 Position With other complex events Type 44 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 10; DUP: 13; h2hINV: 12; SV types t2tINV: 9; TRA: 45 305 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 64 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. 15:40179423−68153781;8:48323075−117143869 Linked to chrs
100	3	Lower_Left	70e306ee-9584-49d6-81a1-a49d837ab6aa	15:40179423−68153782	10, 10	94	{'min_x': 38.86989974975586, 'min_y': 705.2749633789062, 'max_x': 248.8579559326172, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB 70e306ee−9584−49d6−81a1−a49d837ab6aa Kidney−ChRCC Cancer type 15:40179423−68153782 Position With other complex events Type 54 Interleaved intrachr. SVs 119 Total SVs (intrachr. + transl.) DEL: 13; DUP: 18; h2hINV: 12; SV types t2tINV: 11; TRA: 65 305 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 94 CN segments
100	4	Lower_Right	f2b58595-dec0-4194-ab33-7c7dc6c058a6	5:40655−32685928	7, 15	65	{'min_x': 309.1400146484375, 'min_y': 705.2749633789062, 'max_x': 539.4802856445312, 'max_y': 833.6940307617188}	0 MB 10 MB 20 MB 30 MB f2b58595−dec0−4194−ab33−7c7dc6c058a6 Kidney−ChRCC Cancer type 5:40655−32685928 Position With other complex events Type 56 Interleaved intrachr. SVs 61 Total SVs (intrachr. + transl.) DEL: 18; DUP: 12; h2hINV: 12; SV types t2tINV: 14; TRA: 5 81 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 65 CN segments
101	1	Upper_Left	659294b9-ded9-498a-bc00-c1d4d456aa4a	7:41484984−158377609	7, 21	110	{'min_x': 38.36989974975586, 'min_y': 286.6499938964844, 'max_x': 249.3579559326172, 'max_y': 416.3340148925781}	659294b9−ded9−498a−bc00−c1d4d456aa4a Kidney−RCC Cancer type 7:41484984−158377609 Position With other complex events Type 66 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 15; DUP: 18; h2hINV: 16; SV types t2tINV: 17; TRA: 0 72 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 110 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
101	2	Upper_Right	bbbce1ba-c739-43ba-b9cf-a4f746491ae3	5:86939720−123103947	8, 14	14	{'min_x': 329.2099914550781, 'min_y': 286.6499938964844, 'max_x': 537.5218505859375, 'max_y': 416.3340148925781}	bbbce1ba−c739−43ba−b9cf−a4f746491ae3 Kidney−RCC Cancer type 5:86939720−123103947 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 6 15 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
101	3	Lower_Left	db058eb4-9c5e-4226-92d1-de24aea83630	2:148510874−160670122	8, 8	8	{'min_x': 38.539798736572266, 'min_y': 705.2749633789062, 'max_x': 258.19189453125, 'max_y': 833.6940307617188}	152 MB 156 MB 160 MB db058eb4−9c5e−4226−92d1−de24aea83630 Kidney−RCC Cancer type 2:148510874−160670122 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 9 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
101	4	Lower_Right	4edd92e1-5da5-49a3-80e4-fa456aa425b8	7:85764754−138776191	14, 16	93	{'min_x': 325.9200134277344, 'min_y': 705.2749633789062, 'max_x': 537.830078125, 'max_y': 833.6940307617188}	90 MB 100 MB 110 MB 120 MB 130 MB 4edd92e1−5da5−49a3−80e4−fa456aa425b8 Kidney−RCC Cancer type 7:85764754−138776191 Position With other complex events Type 43 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 16; DUP: 9; h2hINV: 10; SV types t2tINV: 8; TRA: 2 78 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 93 CN segments
102	1	Upper_Left	C0005	5:120889469−128593853	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	C0005 Kidney−RCC Cancer type 5:120889469−128593853 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 17 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:62575892−70085334; Linked to chrs
102	2	Upper_Right	C0012	10:4199382−60236974	19, 31	34	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	C0012 Kidney−RCC Cancer type 10:4199382−60236974 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 49 SVs in sample 19, 31 Oscillating CN (2 and 3 states) 34 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
102	3	Lower_Left	C0014	3:78323577−84515937	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 247.1901397705078, 'max_y': 833.6940307617188}	80 MB 82 MB 84 MB C0014 Kidney−RCC Cancer type 3:78323577−84515937 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 0 17 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
102	4	Lower_Right	C0020	9:130216384−130739182	8, 8	8	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	130.4 MB 130.6 MB 130.8 MB C0020 Kidney−RCC Cancer type 9:130216384−130739182 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 3 32 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
103	1	Upper_Left	C0021	5:75100143−77822720	15, 15	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	C0021 Kidney−RCC Cancer type 3:54440509−59348361 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 4 16 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 5:75100143−77822720; Linked to chrs
103	2	Upper_Right	C0028	5:108336748−122172505	14, 14	14	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	C0028 Kidney−RCC Cancer type 5:108336748−122172505 Position After polyploidization Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 6 22 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:53741890−60601042; Linked to chrs
103	3	Lower_Left	C0038	11:70294810−133163692	30, 32	41	{'min_x': 53.60002899169922, 'min_y': 705.2749633789062, 'max_x': 259.29193115234375, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB 120 MB 130 MB C0038 Kidney−RCC Cancer type 11:70294810−133163692 Position Canonical without polyploidization Type 39 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 10; SV types t2tINV: 9; TRA: 18 77 SVs in sample 30, 32 Oscillating CN (2 and 3 states) 41 CN segments
103	4	Lower_Right	C0042	3:63359585−74750084	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 543.501953125, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB C0042 Kidney−RCC Cancer type 3:63359585−74750084 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 5 15 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
104	1	Upper_Left	C0048	2:158092242−161598269	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	C0048 Kidney−RCC Cancer type 2:158092242−161598269 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 6 30 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
104	2	Upper_Right	C0050	13:87973980−95150380	7, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	C0050 Kidney−RCC Cancer type 3:57083918−66979704 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 7 20 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 13:87973980−95150380; Linked to chrs
104	3	Lower_Left	C0073	2:203714228−211103949	7, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 236.43223571777344, 'max_y': 833.6940307617188}	206 MB 208 MB 210 MB C0073 Kidney−RCC Cancer type 2:203714228−211103949 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 34 90 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments
104	4	Lower_Right	C0077	5:96447966−99601957	7, 9	11	{'min_x': 307.2699890136719, 'min_y': 705.2749633789062, 'max_x': 561.3421020507812, 'max_y': 833.6940307617188}	0 MB 25 MB 50 MB 75 MB 100 MB C0077 Kidney−RCC Cancer type 5:96447966−99601957 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 4 19 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 11 CN segments
105	1	Upper_Left	C0085	3:80108501−85829127	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	C0085 Kidney−RCC Cancer type 3:80108501−85829127 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 6 17 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
105	2	Upper_Right	C0099	2:144120765−214902326	13, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	C0099 Kidney−RCC Cancer type 2:144120765−214902326 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 5 18 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 3:95657165−111808748; Linked to chrs
105	3	Lower_Left	1987b453-f97d-45c7-9c89-b9a33313d645	4:122039841−145149274	20, 20	20	{'min_x': 39.36989974975586, 'min_y': 705.2749633789062, 'max_x': 248.35995483398438, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 4:122039841−145149274 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 0 524 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments
105	4	Lower_Right	1987b453-f97d-45c7-9c89-b9a33313d645	14:25556654−90170623	7, 23	23	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 537.8599243164062, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 14:25556654−90170623 Position With other complex events Type 19 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 3; SV types t2tINV: 4; TRA: 10 524 SVs in sample 7, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.68 FDR fragment joints
106	1	Upper_Left	1987b453-f97d-45c7-9c89-b9a33313d645	20:20959449−62129527	9, 14	22	{'min_x': 39.36989974975586, 'min_y': 286.6499938964844, 'max_x': 248.35995483398438, 'max_y': 416.42401123046875}	1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 16:25250822−30860384 Position With other complex events Type 6 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 15 524 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 22 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 20:20959449−62129527; Linked to chrs
106	2	Upper_Right	3acf7438-fd65-442c-8a30-68b6714537f3	5:141997−63388893	7, 14	138	{'min_x': 330.5400085449219, 'min_y': 286.6499938964844, 'max_x': 536.1838989257812, 'max_y': 416.3340148925781}	3acf7438−fd65−442c−8a30−68b6714537f3 Liver−HCC Cancer type 5:141997−63388893 Position With other complex events Type 71 Interleaved intrachr. SVs 114 Total SVs (intrachr. + transl.) DEL: 23; DUP: 17; h2hINV: 17; SV types t2tINV: 14; TRA: 43 222 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 138 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
106	3	Lower_Left	457cca7c-a8b4-414e-a3c0-7fccf0ee2034	17:57017−81011331	7, 12	20	{'min_x': 40.539798736572266, 'min_y': 705.2749633789062, 'max_x': 266.080078125, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 457cca7c−a8b4−414e−a3c0−7fccf0ee2034 Liver−HCC Cancer type 17:57017−81011331 Position With other complex events Type 66 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 18; DUP: 13; h2hINV: 17; SV types t2tINV: 18; TRA: 0 137 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 20 CN segments
106	4	Lower_Right	457cca7c-a8b4-414e-a3c0-7fccf0ee2034	19:8778812−22442312	9, 19	19	{'min_x': 330.0400085449219, 'min_y': 705.2749633789062, 'max_x': 536.69189453125, 'max_y': 833.6940307617188}	12 MB 16 MB 20 MB 457cca7c−a8b4−414e−a3c0−7fccf0ee2034 Liver−HCC Cancer type 19:8778812−22442312 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 137 SVs in sample 9, 19 Oscillating CN (2 and 3 states) 19 CN segments
107	1	Upper_Left	56403463-1727-4c23-a709-de5f168c4073	4:74309555−190780625	13, 26	204	{'min_x': 39.86989974975586, 'min_y': 286.6499938964844, 'max_x': 247.85995483398438, 'max_y': 416.3340148925781}	56403463−1727−4c23−a709−de5f168c4073 Liver−HCC Cancer type 4:74309555−190780625 Position With other complex events Type 157 Interleaved intrachr. SVs 157 Total SVs (intrachr. + transl.) DEL: 31; DUP: 36; h2hINV: 45; SV types t2tINV: 45; TRA: 0 309 SVs in sample 13, 26 Oscillating CN (2 and 3 states) 204 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
107	2	Upper_Right	56403463-1727-4c23-a709-de5f168c4073	18:40499139−53757981	7, 7	7	{'min_x': 329.3699951171875, 'min_y': 286.6499938964844, 'max_x': 537.3599243164062, 'max_y': 416.3340148925781}	56403463−1727−4c23−a709−de5f168c4073 Liver−HCC Cancer type 18:40499139−53757981 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 309 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
107	3	Lower_Left	56a82a56-0241-4d3d-9de2-696b0c36df91	1:145474628−249083131	18, 19	19	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 271.9618835449219, 'max_y': 838.7838134765625}	100 MB 150 MB 200 MB 250 MB 56a82a56−0241−4d3d−9de2−696b0c36df91 Liver−HCC Cancer type 1:145474628−249083131 Position After polyploidization Type 13 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 11 109 SVs in sample 18, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.88 FDR fragment joints
107	4	Lower_Right	614c0ecf-6a84-4c86-8706-79be5bb00991	2:124760110−188573775	10, 18	21	{'min_x': 329.0400085449219, 'min_y': 705.2749633789062, 'max_x': 537.68994140625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 614c0ecf−6a84−4c86−8706−79be5bb00991 Liver−HCC Cancer type 2:124760110−188573775 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 1 171 SVs in sample 10, 18 Oscillating CN (2 and 3 states) 21 CN segments
108	1	Upper_Left	614c0ecf-6a84-4c86-8706-79be5bb00991	22:17018899−48999964	9, 18	18	{'min_x': 39.539798736572266, 'min_y': 286.6499938964844, 'max_x': 248.18995666503906, 'max_y': 416.3340148925781}	614c0ecf−6a84−4c86−8706−79be5bb00991 Liver−HCC Cancer type 22:17018899−48999964 Position With other complex events Type 25 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 8; SV types t2tINV: 5; TRA: 6 171 SVs in sample 9, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
108	2	Upper_Right	69d6881b-9e9a-407b-8b02-bad5fc2455bf	5:2046664−180200470	13, 35	50	{'min_x': 329.04998779296875, 'min_y': 286.6499938964844, 'max_x': 537.681884765625, 'max_y': 416.3340148925781}	69d6881b−9e9a−407b−8b02−bad5fc2455bf Liver−HCC Cancer type 5:2046664−180200470 Position With other complex events Type 88 Interleaved intrachr. SVs 88 Total SVs (intrachr. + transl.) DEL: 28; DUP: 17; h2hINV: 22; SV types t2tINV: 21; TRA: 0 102 SVs in sample 13, 35 Oscillating CN (2 and 3 states) 50 CN segments 0.63 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
108	3	Lower_Left	6c79f64b-63fe-46f5-bf7b-77208231b0f2	2:117574279−157367750	7, 11	11	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 245.64810180664062, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB 6c79f64b−63fe−46f5−bf7b−77208231b0f2 Liver−HCC Cancer type 2:117574279−157367750 Position After polyploidization Type 27 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 10; SV types t2tINV: 8; TRA: 12 125 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.59 FDR fragment joints
108	4	Lower_Right	6dcfc418-ab28-4365-95ea-c1ae254f2341	1:774798−196124730	11, 30	128	{'min_x': 308.6600036621094, 'min_y': 705.2749633789062, 'max_x': 536.8618774414062, 'max_y': 835.2338256835938}	0 MB 50 MB 100 MB 150 MB 200 MB 6dcfc418−ab28−4365−95ea−c1ae254f2341 Liver−HCC Cancer type 1:774798−196124730 Position With other complex events Type 35 Interleaved intrachr. SVs 93 Total SVs (intrachr. + transl.) DEL: 6; DUP: 11; h2hINV: 10; SV types t2tINV: 8; TRA: 58 572 SVs in sample 11, 30 Oscillating CN (2 and 3 states) 128 CN segments 0.72 FDR fragment joints 0 FDR chr. breakp. enrich.
109	1	Upper_Left	6dcfc418-ab28-4365-95ea-c1ae254f2341	18:9039200−46434123	11, 14	15	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 416.3340148925781}	6dcfc418−ab28−4365−95ea−c1ae254f2341 Liver−HCC Cancer type 14:70988852−75703457 Position After polyploidization Type 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 11 572 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 15 CN segments 0.84 FDR fragment joints 0.01 FDR chr. breakp. enrich. 18:9039200−46434123;9:71361828−139860148 Linked to chrs
109	2	Upper_Right	89791f8f-dc06-4a04-b166-afbfd6cf53de	3:333940−69546080	11, 11	13	{'min_x': 331.3800048828125, 'min_y': 286.6499938964844, 'max_x': 535.3478393554688, 'max_y': 416.3340148925781}	89791f8f−dc06−4a04−b166−afbfd6cf53de Liver−HCC Cancer type 3:333940−69546080 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 17 65 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 13 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
109	3	Lower_Left	b865dec4-f051-4fbe-9405-f832ff2010d7	5:90736−17223234	9, 21	21	{'min_x': 42.04999923706055, 'min_y': 705.2749633789062, 'max_x': 245.67796325683594, 'max_y': 833.6940307617188}	50 MB 100 MB b865dec4−f051−4fbe−9405−f832ff2010d7 Liver−HCC Cancer type 5:90736−17223234 Position With other complex events Type 12 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 10 245 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 21 CN segments
109	4	Lower_Right	bce25281-502e-4599-9679-32dc8462ffb1	1:4234113−243543953	19, 31	31	{'min_x': 329.7099914550781, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB bce25281−502e−4599−9679−32dc8462ffb1 Liver−HCC Cancer type 1:4234113−243543953 Position Before polyploidization Type 28 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 5; DUP: 10; h2hINV: 7; SV types t2tINV: 6; TRA: 14 154 SVs in sample 19, 31 Oscillating CN (2 and 3 states) 31 CN segments
110	1	Upper_Left	bfd20d71-18a5-4f01-8d56-84378ad92359	7:57254259−125189467	9, 9	18	{'min_x': 39.88010025024414, 'min_y': 286.6499938964844, 'max_x': 247.85195922851562, 'max_y': 416.42401123046875}	bfd20d71−18a5−4f01−8d56−84378ad92359 Liver−HCC Cancer type 2:97744377−180446202 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 4; SV types t2tINV: 1; TRA: 8 96 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 18 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 7:57254259−125189467; Linked to chrs
110	2	Upper_Right	d680df09-368e-42b5-b540-45c41ed31042	9:33778034−141035750	9, 10	10	{'min_x': 328.7099914550781, 'min_y': 286.6499938964844, 'max_x': 538.0198974609375, 'max_y': 416.3340148925781}	d680df09−368e−42b5−b540−45c41ed31042 Liver−HCC Cancer type 9:33778034−141035750 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 0 82 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
110	3	Lower_Left	ee63c44b-91f4-4004-8dea-192eab527036	10:12324933−114133790	7, 10	28	{'min_x': 39.539798736572266, 'min_y': 705.2749633789062, 'max_x': 248.18995666503906, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB ee63c44b−91f4−4004−8dea−192eab527036 Liver−HCC Cancer type 10:12324933−114133790 Position With other complex events Type 7 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 8 405 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 28 CN segments
110	4	Lower_Right	HX10	17:694982−12501666	12, 12	12	{'min_x': 341.7900085449219, 'min_y': 705.2749633789062, 'max_x': 561.3484497070312, 'max_y': 833.6940307617188}	2.5 MB 5 MB 7.5 MB 10 MB 12.5 MB HX10 Liver−HCC Cancer type 17:694982−12501666 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 0 51 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
111	1	Upper_Left	HX11	1:19776949−112077449	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	HX11 Liver−HCC Cancer type 1:19776949−112077449 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 0 42 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
111	2	Upper_Right	HX13	22:17088659−51192718	66, 66	75	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	HX13 Liver−HCC Cancer type 22:17088659−51192718 Position Canonical without polyploidization Type 50 Interleaved intrachr. SVs 50 Total SVs (intrachr. + transl.) DEL: 14; DUP: 13; h2hINV: 12; SV types t2tINV: 11; TRA: 0 70 SVs in sample 66, 66 Oscillating CN (2 and 3 states) 75 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
111	3	Lower_Left	HX23	7:145877960−154544153	13, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 256.42193603515625, 'max_y': 833.6940307617188}	148 MB 150 MB 152 MB 154 MB HX23 Liver−HCC Cancer type 7:145877960−154544153 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 48 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
111	4	Lower_Right	HX28	1:196470863−226612961	11, 11	11	{'min_x': 322.1700134277344, 'min_y': 705.2749633789062, 'max_x': 527.8522338867188, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB HX28 Liver−HCC Cancer type 1:196470863−226612961 Position After polyploidization Type 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 6 160 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
112	1	Upper_Left	HX28	1:196470863−226612960	15, 26	26	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	HX28 Liver−HCC Cancer type 2:3659186−184750659 Position With other complex events Type 8 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 4; SV types t2tINV: 1; TRA: 7 160 SVs in sample 15, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.59 FDR fragment joints 0.15 FDR chr. breakp. enrich. 1:196470863−226612960; Linked to chrs
112	2	Upper_Right	HX28	4:106905232−165763983	7, 7	12	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	HX28 Liver−HCC Cancer type 4:106905232−165763983 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 160 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 12 CN segments 0.84 FDR fragment joints 0.13 FDR chr. breakp. enrich. Linked to chrs
112	3	Lower_Left	HX28	X:10674156−36219064	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB HX28 Liver−HCC Cancer type X:10674156−36219064 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 160 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
112	4	Lower_Right	RK003	8:57075497−145572220	7, 10	11	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB RK003 Liver−HCC Cancer type 8:57075497−145572220 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 1 51 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 11 CN segments
113	1	Upper_Left	RK014	5:104702072−180283231	12, 12	17	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK014 Liver−HCC Cancer type 5:104702072−180283231 Position Before polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 0 56 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
113	2	Upper_Right	RK019	6:102249565−167532689	28, 31	74	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3778686523438, 'max_y': 416.42401123046875}	RK019 Liver−HCC Cancer type 6:102249565−167532689 Position With other complex events Type 32 Interleaved intrachr. SVs 126 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 7; SV types t2tINV: 8; TRA: 94 323 SVs in sample 28, 31 Oscillating CN (2 and 3 states) 74 CN segments 0.9 FDR fragment joints 0 FDR chr. breakp. enrich. 10:4609618−130110174; Linked to chrs
113	3	Lower_Left	RK019	12:64174368−133313418	60, 74	88	{'min_x': 60.18009948730469, 'min_y': 705.2749633789062, 'max_x': 227.54379272460938, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB RK019 Liver−HCC Cancer type 12:64174368−133313418 Position After polyploidization Type 44 Interleaved intrachr. SVs 133 Total SVs (intrachr. + transl.) DEL: 16; DUP: 8; h2hINV: 11; SV types t2tINV: 9; TRA: 89 323 SVs in sample 60, 74 Oscillating CN (2 and 3 states) 88 CN segments
113	4	Lower_Right	RK030	6:4750739−169684690	20, 20	38	{'min_x': 351.3500061035156, 'min_y': 705.2749633789062, 'max_x': 546.8619384765625, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB RK030 Liver−HCC Cancer type 6:4750739−169684690 Position With other complex events Type 30 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 7; SV types t2tINV: 7; TRA: 0 134 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 38 CN segments
114	1	Upper_Left	RK038	21:14694052−48076206	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	RK038 Liver−HCC Cancer type 21:14694052−48076206 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 0 99 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
114	2	Upper_Right	RK056	8:197777−146291756	7, 17	265	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	RK056 Liver−HCC Cancer type 8:197777−146291756 Position With other complex events Type 213 Interleaved intrachr. SVs 214 Total SVs (intrachr. + transl.) DEL: 53; DUP: 57; h2hINV: 48; SV types t2tINV: 55; TRA: 1 351 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 265 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
114	3	Lower_Left	RK062	4:104630720−185100401	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 256.2822265625, 'max_y': 833.6940307617188}	120 MB 140 MB 160 MB 180 MB RK062 Liver−HCC Cancer type 4:104630720−185100401 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 4 31 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
114	4	Lower_Right	RK067	1:44269676−245339193	10, 10	224	{'min_x': 319.9800109863281, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB RK067 Liver−HCC Cancer type 1:44269676−245339193 Position With other complex events Type 141 Interleaved intrachr. SVs 169 Total SVs (intrachr. + transl.) DEL: 30; DUP: 32; h2hINV: 45; SV types t2tINV: 34; TRA: 28 260 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 224 CN segments
115	1	Upper_Left	RK069	3:170788309−197801947	8, 12	57	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	RK069 Liver−HCC Cancer type 3:170788309−197801947 Position With other complex events Type 57 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 16; DUP: 12; h2hINV: 14; SV types t2tINV: 15; TRA: 1 81 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 57 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
115	2	Upper_Right	RK071	11:67544036−101188725	12, 12	21	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	RK071 Liver−HCC Cancer type 11:67544036−101188725 Position With other complex events Type 19 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 3; SV types t2tINV: 4; TRA: 7 288 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
115	3	Lower_Left	RK075	7:110056465−157254694	19, 32	32	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	120 MB 140 MB RK075 Liver−HCC Cancer type 7:110056465−157254694 Position With other complex events Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 10 122 SVs in sample 19, 32 Oscillating CN (2 and 3 states) 32 CN segments
115	4	Lower_Right	RK079	4:170703373−190415562	9, 9	17	{'min_x': 309.3599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB RK079 Liver−HCC Cancer type 4:170703373−190415562 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 5; SV types t2tINV: 5; TRA: 0 80 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 17 CN segments
116	1	Upper_Left	RK088	8:696677−24055234	13, 13	13	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK088 Liver−HCC Cancer type 8:696677−24055234 Position After polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 0 75 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
116	2	Upper_Right	RK091	2:149101886−209165492	17, 19	29	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	RK091 Liver−HCC Cancer type 2:149101886−209165492 Position With other complex events Type 5 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 50 427 SVs in sample 17, 19 Oscillating CN (2 and 3 states) 29 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 4:13542462−186127249; Linked to chrs
116	3	Lower_Left	RK091	4:13542462−186127250	31, 37	75	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 229.22010803222656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB RK091 Liver−HCC Cancer type 4:13542462−186127250 Position With other complex events Type 108 Interleaved intrachr. SVs 161 Total SVs (intrachr. + transl.) DEL: 29; DUP: 26; h2hINV: 23; SV types t2tINV: 30; TRA: 53 427 SVs in sample 31, 37 Oscillating CN (2 and 3 states) 75 CN segments
116	4	Lower_Right	RK091	5:50697540−118326639	7, 12	18	{'min_x': 339.2200012207031, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB RK091 Liver−HCC Cancer type 5:50697540−118326639 Position With other complex events Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 5; TRA: 8 427 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 18 CN segments
117	1	Upper_Left	RK091	10:59340268−108356079	8, 31	71	{'min_x': 32.019901275634766, 'min_y': 282.3299865722656, 'max_x': 255.70394897460938, 'max_y': 420.74383544921875}	RK091 Liver−HCC Cancer type 6:41192505−161744824 Position With other complex events Type 54 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 13; DUP: 16; h2hINV: 13; SV types t2tINV: 12; TRA: 54 427 SVs in sample 8, 31 Oscillating CN (2 and 3 states) 71 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 10:59340268−108356079;5:50697540−118326638 Linked to chrs 7:70340834−157389137;
117	2	Upper_Right	RK091	6:41192505−161744823	12, 20	20	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	RK091 Liver−HCC Cancer type 7:70340834−157389138 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 36 427 SVs in sample 12, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 6:41192505−161744823; Linked to chrs
117	3	Lower_Left	RK095	14:50525724−99068328	14, 24	45	{'min_x': 63.06019973754883, 'min_y': 705.2749633789062, 'max_x': 225.86016845703125, 'max_y': 833.6940307617188}	60 MB 70 MB 80 MB 90 MB RK095 Liver−HCC Cancer type 14:50525724−99068328 Position With other complex events Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 8; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 0 46 SVs in sample 14, 24 Oscillating CN (2 and 3 states) 45 CN segments
117	4	Lower_Right	RK098	4:46094650−65000200	9, 15	25	{'min_x': 325.55999755859375, 'min_y': 705.2749633789062, 'max_x': 530.9400634765625, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB RK098 Liver−HCC Cancer type 4:46094650−65000200 Position With other complex events Type 16 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 2; SV types t2tINV: 5; TRA: 2 145 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 25 CN segments
118	1	Upper_Left	RK098	8:61570001−124934583	11, 13	13	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	RK098 Liver−HCC Cancer type 8:61570001−124934583 Position After polyploidization Type 5 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 12 145 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 11:2705633−93356458; Linked to chrs
118	2	Upper_Right	RK099	4:31313801−55741627	14, 14	14	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	RK099 Liver−HCC Cancer type 4:31313801−55741627 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 0 56 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
118	3	Lower_Left	RK100	4:138117−57689386	7, 9	39	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 235.9720001220703, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB RK100 Liver−HCC Cancer type 4:138117−57689386 Position With other complex events Type 31 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 9; SV types t2tINV: 9; TRA: 0 104 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 39 CN segments
118	4	Lower_Right	RK101	9:4642656−38474066	9, 11	53	{'min_x': 309.17999267578125, 'min_y': 705.2749633789062, 'max_x': 517.0438842773438, 'max_y': 833.6940307617188}	0 MB 10 MB 20 MB 30 MB RK101 Liver−HCC Cancer type 9:4642656−38474066 Position With other complex events Type 40 Interleaved intrachr. SVs 56 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 12; SV types t2tINV: 11; TRA: 16 218 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 53 CN segments
119	1	Upper_Left	RK106	6:966582−129186137	8, 8	26	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK106 Liver−HCC Cancer type 6:966582−129186137 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 0 59 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 26 CN segments 0.9 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
119	2	Upper_Right	RK112	20:7912024−12423476	7, 8	8	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	RK112 Liver−HCC Cancer type 20:7912024−12423476 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 4 43 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
119	3	Lower_Left	RK119	5:59053606−179748409	12, 16	20	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 271.3919677734375, 'max_y': 833.6940307617188}	90 MB 120 MB 150 MB 180 MB RK119 Liver−HCC Cancer type 5:59053606−179748409 Position Canonical without polyploidization Type 36 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 8; DUP: 12; h2hINV: 8; SV types t2tINV: 8; TRA: 6 110 SVs in sample 12, 16 Oscillating CN (2 and 3 states) 20 CN segments
119	4	Lower_Right	RK130	11:98073900−131896731	10, 10	33	{'min_x': 351.3500061035156, 'min_y': 705.2749633789062, 'max_x': 519.8221435546875, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB RK130 Liver−HCC Cancer type 11:98073900−131896731 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 10; SV types t2tINV: 9; TRA: 0 68 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 33 CN segments
120	1	Upper_Left	RK163	4:55287724−78645421	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	RK163 Liver−HCC Cancer type 4:55287724−78645421 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 0 38 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
120	2	Upper_Right	RK167	1:1562933−71739261	8, 14	14	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	RK167 Liver−HCC Cancer type 1:1562933−71739261 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 5; SV types t2tINV: 3; TRA: 0 81 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
120	3	Lower_Left	RK169	6:67707659−110782332	8, 13	24	{'min_x': 47.81990051269531, 'min_y': 705.2749633789062, 'max_x': 264.1820373535156, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB 140 MB 160 MB RK169 Liver−HCC Cancer type 6:67707659−110782332 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 0 75 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 24 CN segments
120	4	Lower_Right	RK172	5:62205924−130667689	25, 43	64	{'min_x': 348.010009765625, 'min_y': 705.2749633789062, 'max_x': 551.2623291015625, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB 140 MB 160 MB RK172 Liver−HCC Cancer type 5:62205924−130667689 Position With other complex events Type 54 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 13; DUP: 18; h2hINV: 12; SV types t2tINV: 11; TRA: 1 168 SVs in sample 25, 43 Oscillating CN (2 and 3 states) 64 CN segments
121	1	Upper_Left	RK176	8:36542144−56972621	8, 9	17	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK176 Liver−HCC Cancer type 8:36542144−56972621 Position With other complex events Type 19 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 5; SV types t2tINV: 2; TRA: 12 94 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
121	2	Upper_Right	RK177	8:50712276−144686188	8, 9	22	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	RK177 Liver−HCC Cancer type 16:2729647−80636590 Position With other complex events Type 9 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 7 139 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. 8:50712276−144686188; Linked to chrs
121	3	Lower_Left	RK178	6:63544988−84372030	8, 11	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 267.3821716308594, 'max_y': 833.6940307617188}	75 MB 100 MB 125 MB 150 MB RK178 Liver−HCC Cancer type 6:63544988−84372030 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 63 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 13 CN segments
121	4	Lower_Right	RK198	20:41335728−54766828	8, 11	11	{'min_x': 308.0299987792969, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	35 MB 40 MB 45 MB 50 MB RK198 Liver−HCC Cancer type 20:41335728−54766828 Position After polyploidization Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 7 51 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments
122	1	Upper_Left	RK211	10:85728073−113319897	12, 13	13	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	RK211 Liver−HCC Cancer type 10:85728073−113319897 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 4 227 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.92 FDR fragment joints 0.35 FDR chr. breakp. enrich. 4:20275834−163873073; Linked to chrs
122	2	Upper_Right	RK224	5:56427433−179390593	8, 8	30	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	RK224 Liver−HCC Cancer type 5:56427433−179390593 Position With other complex events Type 13 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 2; TRA: 9 138 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 30 CN segments 0.77 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
122	3	Lower_Left	RK236	8:317288−65269814	11, 11	20	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	50 MB 100 MB RK236 Liver−HCC Cancer type 8:317288−65269814 Position With other complex events Type 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 7; SV types t2tINV: 5; TRA: 0 148 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 20 CN segments
122	4	Lower_Right	RK236	17:26612392−66246801	15, 34	43	{'min_x': 327.8500061035156, 'min_y': 705.2749633789062, 'max_x': 532.630126953125, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB RK236 Liver−HCC Cancer type 17:26612392−66246801 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 0 148 SVs in sample 15, 34 Oscillating CN (2 and 3 states) 43 CN segments
123	1	Upper_Left	RK237	1:12167222−154761279	7, 14	38	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK237 Liver−HCC Cancer type 1:12167222−154761279 Position With other complex events Type 29 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 6; SV types t2tINV: 8; TRA: 2 68 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 38 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
123	2	Upper_Right	RK254	7:58042074−122691771	9, 9	79	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	RK254 Liver−HCC Cancer type 7:58042074−122691771 Position With other complex events Type 57 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 15; DUP: 17; h2hINV: 12; SV types t2tINV: 13; TRA: 9 168 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 79 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
123	3	Lower_Left	RK256	1:1119435−15049596	12, 15	20	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 270.6219177246094, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB RK256 Liver−HCC Cancer type 1:1119435−15049596 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 0 91 SVs in sample 12, 15 Oscillating CN (2 and 3 states) 20 CN segments
123	4	Lower_Right	RK259	18:52328461−77268592	7, 12	12	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	60 MB 70 MB RK259 Liver−HCC Cancer type 18:52328461−77268592 Position With other complex events Type 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 2 45 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
124	1	Upper_Left	RK262	1:5685916−217171836	11, 18	18	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	RK262 Liver−HCC Cancer type 1:5685916−217171836 Position After polyploidization Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 1 76 SVs in sample 11, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.84 FDR fragment joints 0.04 FDR chr. breakp. enrich. Linked to chrs
124	2	Upper_Right	RK275	13:86378471−99546315	8, 8	14	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	RK275 Liver−HCC Cancer type 13:86378471−99546315 Position With other complex events Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 6; SV types t2tINV: 5; TRA: 0 69 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 14 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
124	3	Lower_Left	RK306	8:33832982−50702008	7, 14	14	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 259.3600158691406, 'max_y': 833.6940307617188}	40 MB 45 MB 50 MB RK306 Liver−HCC Cancer type 8:33832982−50702008 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 2 42 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments
124	4	Lower_Right	028e99e9-5b9a-4954-bb6e-6d4709a3cea8	12:21630873−71673041	9, 13	15	{'min_x': 306.70001220703125, 'min_y': 705.2749633789062, 'max_x': 538.5278930664062, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 60 MB 70 MB 028e99e9−5b9a−4954−bb6e−6d4709a3cea8 Lung−AdenoCA Cancer type 12:21630873−71673041 Position After polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 0 20 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 15 CN segments
125	1	Upper_Left	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	8:89155199−132576363	8, 8	59	{'min_x': 37.03010177612305, 'min_y': 282.3299865722656, 'max_x': 250.69595336914062, 'max_y': 420.74383544921875}	0d66bf6c−eed0−4726−bd5b−3bf6d610b4e0 Lung−AdenoCA Cancer type 12:61686111−128942893 Position With other complex events Type 10 Interleaved intrachr. SVs 81 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 71 414 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 59 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. 8:89155199−132576363;9:524316−133004750 Linked to chrs X:1621688−36004056;
125	2	Upper_Right	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	12:61686111−128942892	8, 16	56	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 420.74383544921875}	0d66bf6c−eed0−4726−bd5b−3bf6d610b4e0 Lung−AdenoCA Cancer type X:1621688−36004057 Position With other complex events Type 42 Interleaved intrachr. SVs 122 Total SVs (intrachr. + transl.) DEL: 11; DUP: 10; h2hINV: 10; SV types t2tINV: 11; TRA: 80 414 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 56 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 12:61686111−128942892;8:89155199−132576363 Linked to chrs 9:524316−133004750;
125	3	Lower_Left	0df573ee-28f0-4244-b434-09e6ca59fbf0	3:84403892−164988872	9, 15	33	{'min_x': 41.539798736572266, 'min_y': 705.2749633789062, 'max_x': 246.1859588623047, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 0df573ee−28f0−4244−b434−09e6ca59fbf0 Lung−AdenoCA Cancer type 3:84403892−164988872 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 2 350 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 33 CN segments
125	4	Lower_Right	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	X:14068417−40674197	11, 11	11	{'min_x': 315.55999755859375, 'min_y': 705.2749633789062, 'max_x': 552.6100463867188, 'max_y': 833.6940307617188}	15 MB 20 MB 25 MB 30 MB 35 MB 40 MB 2cd8ea73−cb3f−4b17−9b97−fa12eb03b85b Lung−AdenoCA Cancer type X:14068417−40674197 Position Canonical without polyploidization Type 31 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 10; SV types t2tINV: 10; TRA: 1 59 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
126	1	Upper_Left	35cb7841-9b09-465a-90c5-e3b8a9faad49	18:4223387−49884307	27, 40	40	{'min_x': 39.36989974975586, 'min_y': 286.6499938964844, 'max_x': 248.35995483398438, 'max_y': 416.3340148925781}	35cb7841−9b09−465a−90c5−e3b8a9faad49 Lung−AdenoCA Cancer type 18:4223387−49884307 Position Canonical without polyploidization Type 32 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 7; DUP: 11; h2hINV: 8; SV types t2tINV: 6; TRA: 0 208 SVs in sample 27, 40 Oscillating CN (2 and 3 states) 40 CN segments 0.7 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
126	2	Upper_Right	368e23f0-e573-4547-bf5a-14080baf737b	3:55114482−97697310	10, 16	35	{'min_x': 330.3699951171875, 'min_y': 286.6499938964844, 'max_x': 536.3539428710938, 'max_y': 416.3340148925781}	368e23f0−e573−4547−bf5a−14080baf737b Lung−AdenoCA Cancer type 3:55114482−97697310 Position With other complex events Type 27 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 9; h2hINV: 5; SV types t2tINV: 8; TRA: 0 170 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 35 CN segments 0.67 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
126	3	Lower_Left	397d3f69-1453-4057-b177-8723eec923d1	8:2155797−142175861	26, 29	256	{'min_x': 39.539798736572266, 'min_y': 705.2749633789062, 'max_x': 248.18995666503906, 'max_y': 833.6940307617188}	50 MB 100 MB 397d3f69−1453−4057−b177−8723eec923d1 Lung−AdenoCA Cancer type 8:2155797−142175861 Position With other complex events Type 331 Interleaved intrachr. SVs 331 Total SVs (intrachr. + transl.) DEL: 81; DUP: 83; h2hINV: 83; SV types t2tINV: 84; TRA: 0 356 SVs in sample 26, 29 Oscillating CN (2 and 3 states) 256 CN segments
126	4	Lower_Right	3d2aa654-1b5f-4eb4-a1c2-af31f5760069	2:70005417−214498426	8, 17	33	{'min_x': 330.3699951171875, 'min_y': 705.2749633789062, 'max_x': 543.832275390625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 3d2aa654−1b5f−4eb4−a1c2−af31f5760069 Lung−AdenoCA Cancer type 2:70005417−214498426 Position With other complex events Type 10 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 9 166 SVs in sample 8, 17 Oscillating CN (2 and 3 states) 33 CN segments
127	1	Upper_Left	61c655ec-52b5-453f-a6cc-b2aba445b027	19:3005321−54308857	10, 10	10	{'min_x': 39.36989974975586, 'min_y': 286.6499938964844, 'max_x': 248.35995483398438, 'max_y': 416.3340148925781}	61c655ec−52b5−453f−a6cc−b2aba445b027 Lung−AdenoCA Cancer type 19:3005321−54308857 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 0 44 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
127	2	Upper_Right	6dfd47d2-831a-4386-9051-f78199a16bb5	5:90154962−118543958	13, 13	13	{'min_x': 329.3800048828125, 'min_y': 286.6499938964844, 'max_x': 537.3519287109375, 'max_y': 416.3340148925781}	6dfd47d2−831a−4386−9051−f78199a16bb5 Lung−AdenoCA Cancer type 5:90154962−118543958 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 0; SV types t2tINV: 0; TRA: 1 113 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.48 FDR fragment joints 0.22 FDR chr. breakp. enrich. Linked to chrs
127	3	Lower_Left	6dfd47d2-831a-4386-9051-f78199a16bb5	15:24028054−98760287	10, 10	10	{'min_x': 39.88010025024414, 'min_y': 705.2749633789062, 'max_x': 247.85195922851562, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 6dfd47d2−831a−4386−9051−f78199a16bb5 Lung−AdenoCA Cancer type 15:24028054−98760287 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 4 113 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
127	4	Lower_Right	9b132e4f-7e35-4cc5-8711-43ad62b906d0	16:83384632−90071935	8, 8	8	{'min_x': 328.7200012207031, 'min_y': 705.2749633789062, 'max_x': 555.9801635742188, 'max_y': 833.6940307617188}	84 MB 86 MB 88 MB 90 MB 9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 16:83384632−90071935 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 209 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
128	1	Upper_Left	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	5:2066631−42135112	17, 23	23	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.3340148925781}	9f81c602−8afa−4588−b0b6−6e5a1a128d5a Lung−AdenoCA Cancer type 5:2066631−42135112 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 0 84 SVs in sample 17, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
128	2	Upper_Right	a1e65587-24c1-4b41-92a7-4e1f15fffd78	1:161178683−248860526	10, 11	21	{'min_x': 331.2099914550781, 'min_y': 286.6499938964844, 'max_x': 535.5159301757812, 'max_y': 416.3340148925781}	a1e65587−24c1−4b41−92a7−4e1f15fffd78 Lung−AdenoCA Cancer type 1:161178683−248860526 Position With other complex events Type 18 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 13 107 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
128	3	Lower_Left	a3de401d-91fe-49a2-bb07-81c1a06506e6	4:92565955−127635647	8, 8	13	{'min_x': 39.400001525878906, 'min_y': 705.2749633789062, 'max_x': 248.33006286621094, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB a3de401d−91fe−49a2−bb07−81c1a06506e6 Lung−AdenoCA Cancer type 4:92565955−127635647 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 3 94 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 13 CN segments
128	4	Lower_Right	a3de401d-91fe-49a2-bb07-81c1a06506e6	11:41318012−43840319	11, 11	11	{'min_x': 328.8999938964844, 'min_y': 705.2749633789062, 'max_x': 537.8300170898438, 'max_y': 833.6940307617188}	32 MB 36 MB 40 MB a3de401d−91fe−49a2−bb07−81c1a06506e6 Lung−AdenoCA Cancer type 11:41318012−43840319 Position After polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 2 94 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
129	1	Upper_Left	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	2:96640631−224440317	8, 8	8	{'min_x': 38.70000076293945, 'min_y': 286.6499938964844, 'max_x': 249.0279541015625, 'max_y': 416.3340148925781}	cc4bd56a−25c5−4c48−b583−ac3aeb778ca6 Lung−AdenoCA Cancer type 2:96640631−224440317 Position After polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 4; SV types t2tINV: 1; TRA: 1 237 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.48 FDR fragment joints 1 FDR chr. breakp. enrich. Linked to chrs
129	2	Upper_Right	d5326429-9805-47f9-97b0-fbda658e3f01	8:1104196−79784584	7, 10	45	{'min_x': 330.2099914550781, 'min_y': 286.6499938964844, 'max_x': 536.5138549804688, 'max_y': 416.3340148925781}	d5326429−9805−47f9−97b0−fbda658e3f01 Lung−AdenoCA Cancer type 8:1104196−79784584 Position With other complex events Type 29 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 7; SV types t2tINV: 10; TRA: 1 209 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 45 CN segments 0.7 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
129	3	Lower_Left	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	6:3073059−49773930	12, 18	18	{'min_x': 38.73979949951172, 'min_y': 705.2749633789062, 'max_x': 270.08001708984375, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB dbd5b0de−94c9−45dd−afb3−6820a7ecaca2 Lung−AdenoCA Cancer type 6:3073059−49773930 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 5 40 SVs in sample 12, 18 Oscillating CN (2 and 3 states) 18 CN segments
129	4	Lower_Right	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	1:145625856−163083972	7, 12	12	{'min_x': 315.3900146484375, 'min_y': 705.2749633789062, 'max_x': 538.3499145507812, 'max_y': 833.6940307617188}	150 MB 175 MB 200 MB 225 MB ebcba7f2−ce13−4bae−97cd−91a6b1dcd465 Lung−AdenoCA Cancer type 1:145625856−163083972 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 1; TRA: 0 52 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
130	1	Upper_Left	0398eae1-7216-4595-80a5-6b117d96e070	5:7830470−88829799	9, 10	45	{'min_x': 39.03010177612305, 'min_y': 286.6499938964844, 'max_x': 248.6979522705078, 'max_y': 416.3340148925781}	0398eae1−7216−4595−80a5−6b117d96e070 Lung−SCC Cancer type 5:7830470−88829799 Position With other complex events Type 28 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 5; SV types t2tINV: 6; TRA: 0 209 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 45 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
130	2	Upper_Right	1ee543d5-b8c0-4f79-8373-6bb6319f2ee2	5:8531769−45801499	8, 13	41	{'min_x': 329.5400085449219, 'min_y': 286.6499938964844, 'max_x': 537.19189453125, 'max_y': 416.3340148925781}	1ee543d5−b8c0−4f79−8373−6bb6319f2ee2 Lung−SCC Cancer type 5:8531769−45801499 Position With other complex events Type 36 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 11; SV types t2tINV: 8; TRA: 43 287 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 41 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
130	3	Lower_Left	1f6b2aca-7357-40d1-ba7a-99227d9900a2	18:21140095−63388413	11, 19	81	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 256.4799499511719, 'max_y': 838.7838134765625}	20 MB 40 MB 60 MB 1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 18:21140095−63388413 Position With other complex events Type 74 Interleaved intrachr. SVs 159 Total SVs (intrachr. + transl.) DEL: 15; DUP: 19; h2hINV: 20; SV types t2tINV: 20; TRA: 85 602 SVs in sample 11, 19 Oscillating CN (2 and 3 states) 81 CN segments 0.86 FDR fragment joints
130	4	Lower_Right	305f72a8-069b-410b-bbe4-4ecb761c748d	2:124378520−225481223	13, 15	15	{'min_x': 306.95001220703125, 'min_y': 705.2749633789062, 'max_x': 559.3119506835938, 'max_y': 833.6940307617188}	125 MB 150 MB 175 MB 200 MB 225 MB 305f72a8−069b−410b−bbe4−4ecb761c748d Lung−SCC Cancer type 2:124378520−225481223 Position Canonical without polyploidization Type 26 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 7; DUP: 10; h2hINV: 5; SV types t2tINV: 4; TRA: 4 92 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 15 CN segments
131	1	Upper_Left	376dfd27-68e8-4a1a-9c4f-5064279b2a9e	9:1296608−20464401	7, 7	15	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.3340148925781}	376dfd27−68e8−4a1a−9c4f−5064279b2a9e Lung−SCC Cancer type 9:1296608−20464401 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 3; TRA: 0 234 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 15 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
131	2	Upper_Right	395babb3-3f5d-4e71-a675-af4443f23028	9:21616519−136467696	7, 9	9	{'min_x': 330.2099914550781, 'min_y': 286.6499938964844, 'max_x': 536.5138549804688, 'max_y': 416.3340148925781}	395babb3−3f5d−4e71−a675−af4443f23028 Lung−SCC Cancer type 9:21616519−136467696 Position After polyploidization Type 12 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 2; SV types t2tINV: 2; TRA: 5 113 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
131	3	Lower_Left	3edf933a-be1a-46e8-bfb0-acdff30e64a0	12:22945549−94815954	16, 19	19	{'min_x': 41.210201263427734, 'min_y': 705.2749633789062, 'max_x': 246.51596069335938, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 3edf933a−be1a−46e8−bfb0−acdff30e64a0 Lung−SCC Cancer type 12:22945549−94815954 Position After polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 149 SVs in sample 16, 19 Oscillating CN (2 and 3 states) 19 CN segments
131	4	Lower_Right	422a46b2-a67c-4a7e-923f-9b651ced96f8	7:73026297−85512823	14, 14	14	{'min_x': 329.7099914550781, 'min_y': 705.2749633789062, 'max_x': 537.9920654296875, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 422a46b2−a67c−4a7e−923f−9b651ced96f8 Lung−SCC Cancer type 7:73026297−85512823 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 0; SV types t2tINV: 2; TRA: 2 76 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
132	1	Upper_Left	43abe847-4ba7-466e-8283-5d7b80b999a7	2:4435309−219331448	7, 9	92	{'min_x': 38.539798736572266, 'min_y': 286.6499938964844, 'max_x': 249.18795776367188, 'max_y': 416.3340148925781}	43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 2:4435309−219331448 Position With other complex events Type 63 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 13; DUP: 18; h2hINV: 15; SV types t2tINV: 17; TRA: 2 500 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 92 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
132	2	Upper_Right	43abe847-4ba7-466e-8283-5d7b80b999a7	3:96334427−197597663	7, 12	122	{'min_x': 328.0400085449219, 'min_y': 286.6499938964844, 'max_x': 538.6879272460938, 'max_y': 416.42401123046875}	43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 3:96334427−197597663 Position With other complex events Type 95 Interleaved intrachr. SVs 109 Total SVs (intrachr. + transl.) DEL: 13; DUP: 25; h2hINV: 30; SV types t2tINV: 27; TRA: 14 500 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 122 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 5:932078−55824518; Linked to chrs
132	3	Lower_Left	43abe847-4ba7-466e-8283-5d7b80b999a7	5:932078−55824519	7, 12	32	{'min_x': 38.539798736572266, 'min_y': 705.2749633789062, 'max_x': 260.2219543457031, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 5:932078−55824519 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 2 500 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 32 CN segments
132	4	Lower_Right	43abe847-4ba7-466e-8283-5d7b80b999a7	9:21846780−123901906	9, 13	59	{'min_x': 314.2099914550781, 'min_y': 705.2749633789062, 'max_x': 546.93212890625, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 9:21846780−123901906 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 500 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 59 CN segments
133	1	Upper_Left	4ca13c92-84b4-4edf-842a-b20b7e713415	8:24315943−122822158	7, 11	13	{'min_x': 39.36989974975586, 'min_y': 286.6499938964844, 'max_x': 248.35995483398438, 'max_y': 416.3340148925781}	4ca13c92−84b4−4edf−842a−b20b7e713415 Lung−SCC Cancer type 8:24315943−122822158 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 103 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 13 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
133	2	Upper_Right	7b982d5e-3a7d-40ac-bd25-6044c62879b6	18:5099437−27048292	8, 14	97	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	7b982d5e−3a7d−40ac−bd25−6044c62879b6 Lung−SCC Cancer type 2:16626479−125491838 Position With other complex events Type 70 Interleaved intrachr. SVs 110 Total SVs (intrachr. + transl.) DEL: 21; DUP: 20; h2hINV: 11; SV types t2tINV: 18; TRA: 40 349 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 97 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 18:5099437−27048292;3:30056583−192447181 Linked to chrs
133	3	Lower_Left	7b982d5e-3a7d-40ac-bd25-6044c62879b6	4:59343654−113670691	7, 8	17	{'min_x': 38.36989974975586, 'min_y': 705.2749633789062, 'max_x': 249.3579559326172, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 7b982d5e−3a7d−40ac−bd25−6044c62879b6 Lung−SCC Cancer type 4:59343654−113670691 Position With other complex events Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 2 349 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 17 CN segments
133	4	Lower_Right	7b982d5e-3a7d-40ac-bd25-6044c62879b6	7:12149298−158873626	26, 26	100	{'min_x': 327.8699951171875, 'min_y': 705.2749633789062, 'max_x': 562.1821899414062, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 7b982d5e−3a7d−40ac−bd25−6044c62879b6 Lung−SCC Cancer type 7:12149298−158873626 Position With other complex events Type 53 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 14; DUP: 12; h2hINV: 14; SV types t2tINV: 13; TRA: 27 349 SVs in sample 26, 26 Oscillating CN (2 and 3 states) 100 CN segments
134	1	Upper_Left	7d905f8f-3967-4ea8-96c8-17b1b03fbec3	20:49249923−49538223	8, 9	26	{'min_x': 40.710201263427734, 'min_y': 286.6499938964844, 'max_x': 247.0139617919922, 'max_y': 416.42401123046875}	7d905f8f−3967−4ea8−96c8−17b1b03fbec3 Lung−SCC Cancer type 2:79670598−142912803 Position With other complex events Type 39 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 12; DUP: 8; h2hINV: 8; SV types t2tINV: 11; TRA: 8 385 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 26 CN segments 0.81 FDR fragment joints 0 FDR chr. breakp. enrich. 20:49249923−49538223; Linked to chrs
134	2	Upper_Right	7d905f8f-3967-4ea8-96c8-17b1b03fbec3	16:1242659−24867894	11, 11	19	{'min_x': 330.2099914550781, 'min_y': 286.6499938964844, 'max_x': 536.513916015625, 'max_y': 416.3340148925781}	7d905f8f−3967−4ea8−96c8−17b1b03fbec3 Lung−SCC Cancer type 16:1242659−24867894 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 4 385 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 19 CN segments 0.74 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
134	3	Lower_Left	7d905f8f-3967-4ea8-96c8-17b1b03fbec3	18:3889958−60926976	7, 12	32	{'min_x': 40.710201263427734, 'min_y': 705.2749633789062, 'max_x': 247.0139617919922, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 7d905f8f−3967−4ea8−96c8−17b1b03fbec3 Lung−SCC Cancer type 18:3889958−60926976 Position With other complex events Type 18 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 6; SV types t2tINV: 6; TRA: 6 385 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 32 CN segments
134	4	Lower_Right	9af6ed4e-8cdc-4f49-84e9-ba1053b5b3ca	14:24946194−66674963	7, 17	21	{'min_x': 329.3800048828125, 'min_y': 705.2749633789062, 'max_x': 537.3519287109375, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB 9af6ed4e−8cdc−4f49−84e9−ba1053b5b3ca Lung−SCC Cancer type 14:24946194−66674963 Position With other complex events Type 15 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 10 428 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 21 CN segments
135	1	Upper_Left	adc853b1-b8bf-488c-a1e2-e95603459b55	1:82323412−119584894	8, 8	13	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	adc853b1−b8bf−488c−a1e2−e95603459b55 Lung−SCC Cancer type 1:82323412−119584894 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 2 176 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
135	2	Upper_Right	ce8612ab-3149-4a6a-b424-29c0c21c9b8b	19:5801908−24509732	11, 18	27	{'min_x': 328.20001220703125, 'min_y': 286.6499938964844, 'max_x': 538.5279541015625, 'max_y': 416.3340148925781}	ce8612ab−3149−4a6a−b424−29c0c21c9b8b Lung−SCC Cancer type 19:5801908−24509732 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 3; TRA: 0 213 SVs in sample 11, 18 Oscillating CN (2 and 3 states) 27 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
135	3	Lower_Left	d4bc755a-2585-4529-ae36-7e1d88bdecfe	3:102997353−197639661	7, 7	56	{'min_x': 39.23979949951172, 'min_y': 705.2749633789062, 'max_x': 248.4899444580078, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB d4bc755a−2585−4529−ae36−7e1d88bdecfe Lung−SCC Cancer type 3:102997353−197639661 Position With other complex events Type 39 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 8; DUP: 11; h2hINV: 9; SV types t2tINV: 11; TRA: 8 96 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 56 CN segments
135	4	Lower_Right	fd9ee494-65fe-4de4-adff-7952a059b17f	4:21261215−91243140	11, 17	17	{'min_x': 331.5799865722656, 'min_y': 705.2749633789062, 'max_x': 559.7020874023438, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB fd9ee494−65fe−4de4−adff−7952a059b17f Lung−SCC Cancer type 4:21261215−91243140 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 2; TRA: 3 273 SVs in sample 11, 17 Oscillating CN (2 and 3 states) 17 CN segments
136	1	Upper_Left	a8e2df1e-4042-42af-9231-3a00e83489f0	16:2075019−31393909	9, 9	36	{'min_x': 41.20000076293945, 'min_y': 286.6499938964844, 'max_x': 246.52395629882812, 'max_y': 416.3340148925781}	a8e2df1e−4042−42af−9231−3a00e83489f0 Lymph−BNHL Cancer type 16:2075019−31393909 Position With other complex events Type 28 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 9; DUP: 4; h2hINV: 7; SV types t2tINV: 8; TRA: 1 112 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 36 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
136	2	Upper_Right	f0a326d2-1f3e-4a5d-bca8-32aaccc52338	13:19719472−64497953	11, 11	11	{'min_x': 329.7099914550781, 'min_y': 286.6499938964844, 'max_x': 537.0219116210938, 'max_y': 416.3340148925781}	f0a326d2−1f3e−4a5d−bca8−32aaccc52338 Lymph−BNHL Cancer type 13:19719472−64497953 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 194 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0.78 FDR chr. breakp. enrich. Linked to chrs
136	3	Lower_Left	f0a326d2-1f3e-4a5d-bca8-32aaccc52338	18:24492930−66759172	13, 15	37	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 247.52195739746094, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB f0a326d2−1f3e−4a5d−bca8−32aaccc52338 Lymph−BNHL Cancer type 18:24492930−66759172 Position With other complex events Type 11 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 57 194 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 37 CN segments
136	4	Lower_Right	4108992	9:19438790−35406023	10, 10	10	{'min_x': 315.5899963378906, 'min_y': 705.2749633789062, 'max_x': 552.5903930664062, 'max_y': 833.6940307617188}	20 MB 25 MB 30 MB 35 MB 4108992 Lymph−BNHL Cancer type 9:19438790−35406023 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 8 244 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
137	1	Upper_Left	4108992	10:28967917−127614040	57, 76	76	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	4108992 Lymph−BNHL Cancer type 10:28967917−127614040 Position Canonical without polyploidization Type 76 Interleaved intrachr. SVs 171 Total SVs (intrachr. + transl.) DEL: 20; DUP: 13; h2hINV: 22; SV types t2tINV: 21; TRA: 95 244 SVs in sample 57, 76 Oscillating CN (2 and 3 states) 76 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
137	2	Upper_Right	4108992	10:28967917−127614039	30, 36	36	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	4108992 Lymph−BNHL Cancer type 11:26426720−124921346 Position Canonical without polyploidization Type 20 Interleaved intrachr. SVs 91 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 7; SV types t2tINV: 2; TRA: 71 244 SVs in sample 30, 36 Oscillating CN (2 and 3 states) 36 CN segments 0.63 FDR fragment joints 0 FDR chr. breakp. enrich. 10:28967917−127614039; Linked to chrs
137	3	Lower_Left	4111337	6:64848966−120732911	7, 9	27	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 255.11180114746094, 'max_y': 833.6940307617188}	80 MB 120 MB 160 MB 4111337 Lymph−BNHL Cancer type 6:64848966−120732911 Position With other complex events Type 21 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 5; SV types t2tINV: 5; TRA: 2 226 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 27 CN segments
137	4	Lower_Right	4111337	X:2879067−141829230	13, 32	66	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 555.2821655273438, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 4111337 Lymph−BNHL Cancer type X:2879067−141829230 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 0 226 SVs in sample 13, 32 Oscillating CN (2 and 3 states) 66 CN segments
138	1	Upper_Left	4120193	2:3501118−241999895	12, 13	27	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	4120193 Lymph−BNHL Cancer type 2:3501118−241999895 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 0 101 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 27 CN segments 0.59 FDR fragment joints 0.11 FDR chr. breakp. enrich. Linked to chrs
138	2	Upper_Right	4134434	5:99083900−158291676	27, 33	33	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	4134434 Lymph−BNHL Cancer type 1:72008571−200073394 Position Before polyploidization Type 13 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 3; SV types t2tINV: 5; TRA: 16 88 SVs in sample 27, 33 Oscillating CN (2 and 3 states) 33 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 5:99083900−158291676; Linked to chrs
138	3	Lower_Left	4139696	6:18142908−155212520	15, 15	15	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 4139696 Lymph−BNHL Cancer type 6:18142908−155212520 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 0 33 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments
138	4	Lower_Right	4144951	13:24997688−112761208	7, 7	14	{'min_x': 346.92999267578125, 'min_y': 705.2749633789062, 'max_x': 526.85205078125, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 4144951 Lymph−BNHL Cancer type 13:24997688−112761208 Position With other complex events Type 77 Interleaved intrachr. SVs 77 Total SVs (intrachr. + transl.) DEL: 18; DUP: 22; h2hINV: 18; SV types t2tINV: 19; TRA: 0 103 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 14 CN segments
139	1	Upper_Left	4145177	1:1727046−8960415	26, 26	26	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	4145177 Lymph−BNHL Cancer type 1:1727046−8960415 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 55 SVs in sample 26, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
139	2	Upper_Right	4147081	5:149829718−164575330	12, 12	12	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	4147081 Lymph−BNHL Cancer type 1:77588781−145118488 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 5; SV types t2tINV: 2; TRA: 12 107 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 5:149829718−164575330; Linked to chrs
139	3	Lower_Left	4147081	3:112007049−169759318	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	100 MB 150 MB 4147081 Lymph−BNHL Cancer type 3:112007049−169759318 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 5 107 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
139	4	Lower_Right	4147081	8:28532675−54463876	14, 14	14	{'min_x': 307.95001220703125, 'min_y': 705.2749633789062, 'max_x': 532.7199096679688, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB 4147081 Lymph−BNHL Cancer type 8:28532675−54463876 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 9 107 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
140	1	Upper_Left	4147968	12:47913057−127394426	12, 13	18	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	4147968 Lymph−BNHL Cancer type 12:47913057−127394426 Position Canonical without polyploidization Type 25 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 9; SV types t2tINV: 6; TRA: 5 140 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 18 CN segments 0.71 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
140	2	Upper_Right	4158726	9:20938863−81861601	16, 16	16	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	4158726 Lymph−BNHL Cancer type 18:49801362−72732256 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 21 47 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 9:20938863−81861601;13:29727063−43934816 Linked to chrs
140	3	Lower_Left	4177987	10:38964812−109297003	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 240.4020538330078, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 4177987 Lymph−BNHL Cancer type 10:38964812−109297003 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 3 15 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
140	4	Lower_Right	141	21:16368954−25156515	8, 8	8	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 528.090087890625, 'max_y': 833.6940307617188}	18 MB 20 MB 22 MB 24 MB 141 Lymph−CLL Cancer type 21:16368954−25156515 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 9 31 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
141	1	Upper_Left	AOCS-005	18:56378430−67139124	10, 17	48	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	AOCS−005 Ovary−AdenoCA Cancer type 18:56378430−67139124 Position With other complex events Type 27 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 8; SV types t2tINV: 4; TRA: 22 399 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 48 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
141	2	Upper_Right	AOCS-034	2:43382931−228657975	49, 66	66	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	AOCS−034 Ovary−AdenoCA Cancer type 4:77772−43781007 Position Canonical without polyploidization Type 43 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 6; DUP: 12; h2hINV: 12; SV types t2tINV: 13; TRA: 4 308 SVs in sample 49, 66 Oscillating CN (2 and 3 states) 66 CN segments 0.62 FDR fragment joints 0 FDR chr. breakp. enrich. 2:43382931−228657975;7:25135946−121567350 Linked to chrs
141	3	Lower_Left	AOCS-055	7:567398−57567811	12, 25	25	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 267.6822204589844, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB AOCS−055 Ovary−AdenoCA Cancer type 7:567398−57567811 Position With other complex events Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 1 362 SVs in sample 12, 25 Oscillating CN (2 and 3 states) 25 CN segments
141	4	Lower_Right	AOCS-056	8:35777050−145916683	7, 11	23	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB AOCS−056 Ovary−AdenoCA Cancer type 8:35777050−145916683 Position With other complex events Type 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 3 110 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 23 CN segments
142	1	Upper_Left	AOCS-058	21:31989442−43599046	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	AOCS−058 Ovary−AdenoCA Cancer type 4:19768980−47652511 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 4 243 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.64 FDR fragment joints 0.55 FDR chr. breakp. enrich. 21:31989442−43599046; Linked to chrs
142	2	Upper_Right	AOCS-059	19:7159079−17180659	7, 7	31	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	AOCS−059 Ovary−AdenoCA Cancer type 19:7159079−17180659 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 1 43 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 31 CN segments 0.71 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
142	3	Lower_Left	AOCS-064	X:43392645−129894760	8, 8	25	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	50 MB 100 MB AOCS−064 Ovary−AdenoCA Cancer type X:43392645−129894760 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 5; SV types t2tINV: 2; TRA: 1 402 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 25 CN segments
142	4	Lower_Right	AOCS-080	20:15018409−22766307	10, 13	13	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 520.1800537109375, 'max_y': 833.6940307617188}	10 MB 15 MB 20 MB AOCS−080 Ovary−AdenoCA Cancer type 20:15018409−22766307 Position After polyploidization Type 21 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 6; SV types t2tINV: 5; TRA: 1 207 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 13 CN segments
143	1	Upper_Left	AOCS-081	5:1326917−126150912	20, 21	27	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	AOCS−081 Ovary−AdenoCA Cancer type 5:1326917−126150912 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 150 SVs in sample 20, 21 Oscillating CN (2 and 3 states) 27 CN segments 0.94 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
143	2	Upper_Right	AOCS-084	1:37638433−46640509	8, 9	11	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	AOCS−084 Ovary−AdenoCA Cancer type 1:37638433−46640509 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 146 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
143	3	Lower_Left	AOCS-085	6:63724002−84893098	9, 9	9	{'min_x': 44.480098724365234, 'min_y': 705.2749633789062, 'max_x': 246.699951171875, 'max_y': 833.6940307617188}	40 MB 50 MB 60 MB 70 MB 80 MB AOCS−085 Ovary−AdenoCA Cancer type 6:63724002−84893098 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 4; SV types t2tINV: 2; TRA: 0 95 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
143	4	Lower_Right	AOCS-090	8:8519924−34671479	7, 16	18	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 838.7838134765625}	50 MB 100 MB AOCS−090 Ovary−AdenoCA Cancer type 8:8519924−34671479 Position With other complex events Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 4 334 SVs in sample 7, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.64 FDR fragment joints
144	1	Upper_Left	AOCS-090	13:20915954−32359355	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	AOCS−090 Ovary−AdenoCA Cancer type 13:20915954−32359355 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 2 334 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.95 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
144	2	Upper_Right	AOCS-093	2:125326527−209102159	70, 70	70	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	AOCS−093 Ovary−AdenoCA Cancer type 13:31521128−105978091 Position Canonical without polyploidization Type 49 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 12; DUP: 14; h2hINV: 13; SV types t2tINV: 10; TRA: 4 297 SVs in sample 70, 70 Oscillating CN (2 and 3 states) 70 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 2:125326527−209102159; Linked to chrs
144	3	Lower_Left	AOCS-096	13:56212396−69555802	11, 27	27	{'min_x': 35.5, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB AOCS−096 Ovary−AdenoCA Cancer type 13:56212396−69555802 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 197 SVs in sample 11, 27 Oscillating CN (2 and 3 states) 27 CN segments
144	4	Lower_Right	AOCS-097	15:20101979−89639810	10, 12	21	{'min_x': 307.1400146484375, 'min_y': 705.2749633789062, 'max_x': 526.4700317382812, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB AOCS−097 Ovary−AdenoCA Cancer type 15:20101979−89639810 Position With other complex events Type 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 5; SV types t2tINV: 6; TRA: 0 51 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 21 CN segments
145	1	Upper_Left	AOCS-108	3:7603269−193289152	7, 27	77	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	AOCS−108 Ovary−AdenoCA Cancer type 3:7603269−193289152 Position With other complex events Type 20 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 7 415 SVs in sample 7, 27 Oscillating CN (2 and 3 states) 77 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
145	2	Upper_Right	AOCS-111	19:28894477−56155201	11, 16	16	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	AOCS−111 Ovary−AdenoCA Cancer type 21:17237944−40394460 Position After polyploidization Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 3 106 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 19:28894477−56155201; Linked to chrs
145	3	Lower_Left	AOCS-113	1:208032015−248380796	9, 24	41	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 272.66192626953125, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB 250 MB AOCS−113 Ovary−AdenoCA Cancer type 1:208032015−248380796 Position With other complex events Type 36 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 14; DUP: 6; h2hINV: 9; SV types t2tINV: 7; TRA: 5 163 SVs in sample 9, 24 Oscillating CN (2 and 3 states) 41 CN segments
145	4	Lower_Right	AOCS-116	3:137813498−197700924	7, 10	42	{'min_x': 329.7900085449219, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB AOCS−116 Ovary−AdenoCA Cancer type 3:137813498−197700924 Position With other complex events Type 21 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 3 481 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 42 CN segments
146	1	Upper_Left	AOCS-117	2:22291212−238932055	7, 20	37	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 420.74383544921875}	AOCS−117 Ovary−AdenoCA Cancer type 8:42562155−137393245 Position With other complex events Type 10 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 1; SV types t2tINV: 0; TRA: 12 333 SVs in sample 7, 20 Oscillating CN (2 and 3 states) 37 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 2:22291212−238932055;20:34757165−60260320 Linked to chrs 3:202871−63948255;
146	2	Upper_Right	AOCS-117	20:34757165−60260321	10, 10	20	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	AOCS−117 Ovary−AdenoCA Cancer type 20:34757165−60260321 Position With other complex events Type 3 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 9 333 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 20 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
146	3	Lower_Left	AOCS-142	4:52826977−104671727	7, 8	52	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 260.482177734375, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB 125 MB AOCS−142 Ovary−AdenoCA Cancer type 4:52826977−104671727 Position With other complex events Type 22 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 10; SV types t2tINV: 6; TRA: 19 587 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 52 CN segments
146	4	Lower_Right	AOCS-153	11:6869185−128159617	7, 8	8	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 554.0421752929688, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−153 Ovary−AdenoCA Cancer type 11:6869185−128159617 Position After polyploidization Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 3; TRA: 4 194 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.59 FDR fragment joints
147	1	Upper_Left	AOCS-155	2:116979827−242917384	16, 21	40	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	AOCS−155 Ovary−AdenoCA Cancer type 2:116979827−242917384 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 0 268 SVs in sample 16, 21 Oscillating CN (2 and 3 states) 40 CN segments 0.78 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
147	2	Upper_Right	AOCS-159	12:24836900−124945298	12, 23	23	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	AOCS−159 Ovary−AdenoCA Cancer type 12:24836900−124945298 Position With other complex events Type 8 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 4; SV types t2tINV: 4; TRA: 5 259 SVs in sample 12, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.46 FDR fragment joints 0.4 FDR chr. breakp. enrich. 7:66581838−110075762; Linked to chrs
147	3	Lower_Left	AOCS-160	6:1616031−23308796	9, 22	37	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 268.7020568847656, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 120 MB AOCS−160 Ovary−AdenoCA Cancer type 6:1616031−23308796 Position With other complex events Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 3; SV types t2tINV: 5; TRA: 0 172 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 37 CN segments
147	4	Lower_Right	AOCS-162	18:1605416−20794812	7, 7	14	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB AOCS−162 Ovary−AdenoCA Cancer type 18:1605416−20794812 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 4; TRA: 1 172 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 14 CN segments
148	1	Upper_Left	AOCS-166	22:36538809−49089280	8, 16	18	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	AOCS−166 Ovary−AdenoCA Cancer type 22:36538809−49089280 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 1; SV types t2tINV: 2; TRA: 0 170 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
148	2	Upper_Right	AOCS-169	1:94394953−193703467	8, 10	32	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	AOCS−169 Ovary−AdenoCA Cancer type 1:94394953−193703467 Position With other complex events Type 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 13 413 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 32 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 4:67409369−77723303; Linked to chrs
148	3	Lower_Left	AOCS-169	9:12691740−121121973	8, 30	34	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	50 MB 100 MB AOCS−169 Ovary−AdenoCA Cancer type 9:12691740−121121973 Position With other complex events Type 3 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 7 413 SVs in sample 8, 30 Oscillating CN (2 and 3 states) 34 CN segments 0.64 FDR fragment joints
148	4	Lower_Right	0c1a2e7d-e7e4-481e-a012-ef214c444497	8:59542153−123021272	11, 11	18	{'min_x': 329.3699951171875, 'min_y': 705.2749633789062, 'max_x': 537.3599243164062, 'max_y': 833.6940307617188}	50 MB 100 MB 0c1a2e7d−e7e4−481e−a012−ef214c444497 Ovary−AdenoCA Cancer type 8:59542153−123021272 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 174 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 18 CN segments
149	1	Upper_Left	0c1a2e7d-e7e4-481e-a012-ef214c444497	18:4742587−29869159	15, 15	21	{'min_x': 39.86989974975586, 'min_y': 286.6499938964844, 'max_x': 247.85995483398438, 'max_y': 416.3340148925781}	0c1a2e7d−e7e4−481e−a012−ef214c444497 Ovary−AdenoCA Cancer type 18:4742587−29869159 Position After polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 174 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 21 CN segments 0.84 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
149	2	Upper_Right	30b8f4cd-9245-4496-a8a8-c3e59093bc0a	11:898947−50134754	9, 9	9	{'min_x': 329.0400085449219, 'min_y': 286.6499938964844, 'max_x': 537.68994140625, 'max_y': 416.3340148925781}	30b8f4cd−9245−4496−a8a8−c3e59093bc0a Ovary−AdenoCA Cancer type 11:898947−50134754 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 6; SV types t2tINV: 6; TRA: 0 206 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
149	3	Lower_Left	4b930a10-4b12-4428-84f9-3255b4a3bc4f	6:20732385−65386033	11, 18	18	{'min_x': 40.039798736572266, 'min_y': 705.2749633789062, 'max_x': 247.69195556640625, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 4b930a10−4b12−4428−84f9−3255b4a3bc4f Ovary−AdenoCA Cancer type 6:20732385−65386033 Position Before polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 1; TRA: 0 78 SVs in sample 11, 18 Oscillating CN (2 and 3 states) 18 CN segments
149	4	Lower_Right	4b930a10-4b12-4428-84f9-3255b4a3bc4f	19:10117072−19925765	7, 7	26	{'min_x': 306.17999267578125, 'min_y': 705.2749633789062, 'max_x': 548.0702514648438, 'max_y': 833.6940307617188}	10 MB 15 MB 20 MB 25 MB 30 MB 4b930a10−4b12−4428−84f9−3255b4a3bc4f Ovary−AdenoCA Cancer type 19:10117072−19925765 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 1 78 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 26 CN segments
150	1	Upper_Left	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	4:4561511−183003967	22, 35	35	{'min_x': 41.210201263427734, 'min_y': 286.6499938964844, 'max_x': 246.51596069335938, 'max_y': 416.3340148925781}	4c18d9cf−4af4−4a86−8b1c−f78795fbbd7e Ovary−AdenoCA Cancer type 4:4561511−183003967 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 3; SV types t2tINV: 5; TRA: 0 96 SVs in sample 22, 35 Oscillating CN (2 and 3 states) 35 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
150	2	Upper_Right	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	11:44797680−125468262	12, 12	12	{'min_x': 330.7099914550781, 'min_y': 286.6499938964844, 'max_x': 536.0159301757812, 'max_y': 416.3340148925781}	4c18d9cf−4af4−4a86−8b1c−f78795fbbd7e Ovary−AdenoCA Cancer type 11:44797680−125468262 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 96 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.95 FDR fragment joints 0.06 FDR chr. breakp. enrich. Linked to chrs
150	3	Lower_Left	5c127332-5ca0-45f1-a5ac-4876ad94e491	2:29255147−191672689	12, 15	65	{'min_x': 38.70000076293945, 'min_y': 705.2749633789062, 'max_x': 247.85995483398438, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB 5c127332−5ca0−45f1−a5ac−4876ad94e491 Ovary−AdenoCA Cancer type 2:29255147−191672689 Position With other complex events Type 10 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 20 318 SVs in sample 12, 15 Oscillating CN (2 and 3 states) 65 CN segments 0.83 FDR fragment joints
150	4	Lower_Right	62379be5-13f0-474b-94d3-6f944ec4ee96	20:1979378−25856531	29, 30	30	{'min_x': 329.7099914550781, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 62379be5−13f0−474b−94d3−6f944ec4ee96 Ovary−AdenoCA Cancer type 20:1979378−25856531 Position Canonical without polyploidization Type 33 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 10; DUP: 12; h2hINV: 6; SV types t2tINV: 5; TRA: 0 216 SVs in sample 29, 30 Oscillating CN (2 and 3 states) 30 CN segments
151	1	Upper_Left	700e91bb-d675-41b2-bbbd-935767c7b447	6:9405680−153296807	31, 33	37	{'min_x': 37.88010025024414, 'min_y': 286.6499938964844, 'max_x': 249.84796142578125, 'max_y': 416.42401123046875}	700e91bb−d675−41b2−bbbd−935767c7b447 Ovary−AdenoCA Cancer type 18:158944−67628538 Position Canonical without polyploidization Type 20 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 2 686 SVs in sample 31, 33 Oscillating CN (2 and 3 states) 37 CN segments 0.96 FDR fragment joints 0.04 FDR chr. breakp. enrich. 6:9405680−153296807; Linked to chrs
151	2	Upper_Right	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	11:56003935−131544055	11, 36	152	{'min_x': 328.3800048828125, 'min_y': 286.6499938964844, 'max_x': 538.3499145507812, 'max_y': 416.3340148925781}	7ca97692−0bf5−4bbd−81ce−10a051d04bd5 Ovary−AdenoCA Cancer type 11:56003935−131544055 Position With other complex events Type 63 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 16; DUP: 15; h2hINV: 16; SV types t2tINV: 16; TRA: 2 275 SVs in sample 11, 36 Oscillating CN (2 and 3 states) 152 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
151	3	Lower_Left	8a6d2ce3-cc57-451b-9b07-8263782aa23f	21:18052703−29183847	11, 15	15	{'min_x': 39.539798736572266, 'min_y': 705.2749633789062, 'max_x': 261.42999267578125, 'max_y': 833.6940307617188}	20 MB 25 MB 30 MB 35 MB 40 MB 45 MB 8a6d2ce3−cc57−451b−9b07−8263782aa23f Ovary−AdenoCA Cancer type 21:18052703−29183847 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 3 704 SVs in sample 11, 15 Oscillating CN (2 and 3 states) 15 CN segments
151	4	Lower_Right	ba68f2cf-9271-41fd-9655-1fac7681f588	8:29488947−40948299	9, 9	17	{'min_x': 317.7699890136719, 'min_y': 705.2749633789062, 'max_x': 539.370361328125, 'max_y': 833.6940307617188}	30 MB 32.5 MB 35 MB 37.5 MB 40 MB ba68f2cf−9271−41fd−9655−1fac7681f588 Ovary−AdenoCA Cancer type 8:29488947−40948299 Position With other complex events Type 5 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 8 204 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 17 CN segments
152	1	Upper_Left	c435627c-159d-4a6d-a819-30abac24bf4d	3:15395276−169948381	7, 14	117	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.42401123046875}	c435627c−159d−4a6d−a819−30abac24bf4d Ovary−AdenoCA Cancer type 8:8571303−145086772 Position With other complex events Type 67 Interleaved intrachr. SVs 77 Total SVs (intrachr. + transl.) DEL: 19; DUP: 18; h2hINV: 15; SV types t2tINV: 15; TRA: 10 283 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 117 CN segments 0.9 FDR fragment joints 0 FDR chr. breakp. enrich. 3:15395276−169948381; Linked to chrs
152	2	Upper_Right	c9e28934-8379-4511-817c-d787f2c4ca3a	1:22012754−22205189	7, 10	30	{'min_x': 328.20001220703125, 'min_y': 282.3299865722656, 'max_x': 538.5299682617188, 'max_y': 420.74383544921875}	c9e28934−8379−4511−817c−d787f2c4ca3a Ovary−AdenoCA Cancer type 17:48309481−79654739 Position With other complex events Type 5 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 2; TRA: 23 377 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 30 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 1:22012754−22205189;16:288679−70722743 Linked to chrs 2:18960070−230123603;
152	3	Lower_Left	e9483296-cb91-497a-b955-39a3c3289dac	11:78769716−119886055	7, 8	19	{'min_x': 38.86989974975586, 'min_y': 705.2749633789062, 'max_x': 248.8579559326172, 'max_y': 833.6940307617188}	50 MB 75 MB 100 MB e9483296−cb91−497a−b955−39a3c3289dac Ovary−AdenoCA Cancer type 11:78769716−119886055 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 3 126 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 19 CN segments
152	4	Lower_Right	f0c353fd-947c-41e2-b643-3ecc0d69796c	10:38043794−123678267	7, 8	8	{'min_x': 329.7099914550781, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB f0c353fd−947c−41e2−b643−3ecc0d69796c Ovary−AdenoCA Cancer type 10:38043794−123678267 Position After polyploidization Type 4 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 3 288 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments
153	1	Upper_Left	ICGC_0007	1:38813433−49397759	7, 13	45	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	ICGC_0007 Panc−AdenoCA Cancer type 1:38813433−49397759 Position With other complex events Type 28 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 8; SV types t2tINV: 9; TRA: 1 82 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 45 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
153	2	Upper_Right	ICGC_0007	17:47498985−79507305	12, 12	12	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0007 Panc−AdenoCA Cancer type 17:47498985−79507305 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 82 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.84 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
153	3	Lower_Left	ICGC_0007	20:1226919−53870564	13, 16	16	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 251.99984741210938, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB ICGC_0007 Panc−AdenoCA Cancer type 20:1226919−53870564 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 82 SVs in sample 13, 16 Oscillating CN (2 and 3 states) 16 CN segments
153	4	Lower_Right	ICGC_0020	6:36021238−98348848	9, 9	9	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 549.9821166992188, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB ICGC_0020 Panc−AdenoCA Cancer type 6:36021238−98348848 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 6 57 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
154	1	Upper_Left	ICGC_0020	11:2734690−58550648	12, 12	12	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0020 Panc−AdenoCA Cancer type 11:2734690−58550648 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 7 57 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
154	2	Upper_Right	ICGC_0021	19:28278241−58069967	13, 17	48	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3778686523438, 'max_y': 416.3340148925781}	ICGC_0021 Panc−AdenoCA Cancer type 19:28278241−58069967 Position With other complex events Type 33 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 7; DUP: 13; h2hINV: 7; SV types t2tINV: 6; TRA: 0 162 SVs in sample 13, 17 Oscillating CN (2 and 3 states) 48 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
154	3	Lower_Left	ICGC_0026	15:22891529−92856416	20, 20	20	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB ICGC_0026 Panc−AdenoCA Cancer type 15:22891529−92856416 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 1 66 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments
154	4	Lower_Right	ICGC_0031	7:89045625−146695947	10, 10	10	{'min_x': 311.260009765625, 'min_y': 705.2749633789062, 'max_x': 531.1520385742188, 'max_y': 833.6940307617188}	90 MB 100 MB 110 MB 120 MB 130 MB 140 MB ICGC_0031 Panc−AdenoCA Cancer type 7:89045625−146695947 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 5 27 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
155	1	Upper_Left	ICGC_0037	19:21564139−22548813	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0037 Panc−AdenoCA Cancer type 19:21564139−22548813 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 0 165 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
155	2	Upper_Right	ICGC_0052	21:16837999−44959353	9, 16	16	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_0052 Panc−AdenoCA Cancer type 21:16837999−44959353 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 4; SV types t2tINV: 5; TRA: 1 83 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
155	3	Lower_Left	ICGC_0055	9:31913973−97303304	9, 10	10	{'min_x': 46.58980178833008, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB ICGC_0055 Panc−AdenoCA Cancer type 9:31913973−97303304 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 23 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 10 CN segments
155	4	Lower_Right	ICGC_0067	9:73035221−139560353	13, 16	16	{'min_x': 331.6400146484375, 'min_y': 705.2749633789062, 'max_x': 561.9324340820312, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB 140 MB ICGC_0067 Panc−AdenoCA Cancer type 9:73035221−139560353 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 1 73 SVs in sample 13, 16 Oscillating CN (2 and 3 states) 16 CN segments
156	1	Upper_Left	ICGC_0067	14:82219284−100582142	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0067 Panc−AdenoCA Cancer type 14:82219284−100582142 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 73 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
156	2	Upper_Right	ICGC_0087	10:60725577−84090610	7, 9	9	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0087 Panc−AdenoCA Cancer type 10:60725577−84090610 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 1 79 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
156	3	Lower_Left	ICGC_0088	12:21367968−34833918	9, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB ICGC_0088 Panc−AdenoCA Cancer type 12:21367968−34833918 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 116 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 13 CN segments
156	4	Lower_Right	ICGC_0088	18:27451678−30477084	17, 17	17	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 544.2301025390625, 'max_y': 833.6940307617188}	24 MB 26 MB 28 MB 30 MB ICGC_0088 Panc−AdenoCA Cancer type 18:27451678−30477084 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 0 116 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
157	1	Upper_Left	ICGC_0108	7:2398212−48791277	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	ICGC_0108 Panc−AdenoCA Cancer type 7:2398212−48791277 Position After polyploidization Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 5; TRA: 1 130 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.59 FDR fragment joints 0.03 FDR chr. breakp. enrich. Linked to chrs
157	2	Upper_Right	ICGC_0109	5:55531264−177528041	22, 22	22	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0109 Panc−AdenoCA Cancer type 5:55531264−177528041 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 2 30 SVs in sample 22, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.78 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
157	3	Lower_Left	ICGC_0114	1:32132328−65796925	7, 7	43	{'min_x': 62.83980178833008, 'min_y': 705.2749633789062, 'max_x': 272.0020446777344, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 250 MB ICGC_0114 Panc−AdenoCA Cancer type 1:32132328−65796925 Position With other complex events Type 25 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 9; DUP: 8; h2hINV: 5; SV types t2tINV: 3; TRA: 1 195 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 43 CN segments
157	4	Lower_Right	ICGC_0114	2:28274298−38935751	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 533.6821899414062, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB ICGC_0114 Panc−AdenoCA Cancer type 2:28274298−38935751 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 1 195 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
158	1	Upper_Left	ICGC_0114	10:72984995−103221106	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0114 Panc−AdenoCA Cancer type 10:72984995−103221106 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 195 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.74 FDR fragment joints 0.55 FDR chr. breakp. enrich. Linked to chrs
158	2	Upper_Right	ICGC_0134	22:18019664−28052500	8, 18	18	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_0134 Panc−AdenoCA Cancer type 22:18019664−28052500 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 0 142 SVs in sample 8, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
158	3	Lower_Left	ICGC_0146	3:25423800−74920530	12, 12	12	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 246.0198211669922, 'max_y': 838.7838134765625}	30 MB 40 MB 50 MB 60 MB 70 MB ICGC_0146 Panc−AdenoCA Cancer type 3:25423800−74920530 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 18 105 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints
158	4	Lower_Right	ICGC_0146	10:3251990−120467283	32, 42	42	{'min_x': 326.5299987792969, 'min_y': 705.2749633789062, 'max_x': 559.4921875, 'max_y': 838.7838134765625}	30 MB 60 MB 90 MB 120 MB ICGC_0146 Panc−AdenoCA Cancer type 10:3251990−120467283 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 3; SV types t2tINV: 2; TRA: 26 105 SVs in sample 32, 42 Oscillating CN (2 and 3 states) 42 CN segments 0.59 FDR fragment joints
159	1	Upper_Left	ICGC_0146	11:44273470−122909222	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	ICGC_0146 Panc−AdenoCA Cancer type 11:44273470−122909222 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 3 105 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.91 FDR fragment joints 0.05 FDR chr. breakp. enrich. 5:13751277−82972678; Linked to chrs
159	2	Upper_Right	ICGC_0199	2:109779279−139790794	17, 17	17	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	ICGC_0199 Panc−AdenoCA Cancer type 2:109779279−139790794 Position After polyploidization Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 1 54 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
159	3	Lower_Left	ICGC_0205	8:466553−113346314	7, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB ICGC_0205 Panc−AdenoCA Cancer type 8:466553−113346314 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 3 127 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments
159	4	Lower_Right	ICGC_0214	1:196999875−239097447	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB ICGC_0214 Panc−AdenoCA Cancer type 1:196999875−239097447 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 254 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
160	1	Upper_Left	ICGC_0214	4:77735561−162014257	61, 69	69	{'min_x': 33.360198974609375, 'min_y': 282.3299865722656, 'max_x': 254.3639373779297, 'max_y': 416.3340148925781}	ICGC_0214 Panc−AdenoCA Cancer type 2:1473520−230672823 Position Canonical without polyploidization Type 142 Interleaved intrachr. SVs 147 Total SVs (intrachr. + transl.) DEL: 30; DUP: 44; h2hINV: 35; SV types t2tINV: 33; TRA: 5 254 SVs in sample 61, 69 Oscillating CN (2 and 3 states) 69 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 4:77735561−162014257;X:98103871−154466372 Linked to chrs
160	2	Upper_Right	ICGC_0214	1:196999875−239097446	7, 7	13	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	ICGC_0214 Panc−AdenoCA Cancer type 4:77735561−162014258 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 4 254 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.74 FDR fragment joints 0.56 FDR chr. breakp. enrich. 1:196999875−239097446; Linked to chrs
160	3	Lower_Left	ICGC_0217	21:14583619−47124626	8, 8	15	{'min_x': 56.389801025390625, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB ICGC_0217 Panc−AdenoCA Cancer type 21:14583619−47124626 Position With other complex events Type 16 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 4; SV types t2tINV: 3; TRA: 4 99 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 15 CN segments
160	4	Lower_Right	ICGC_0300	1:41444007−240774472	8, 13	59	{'min_x': 341.7900085449219, 'min_y': 705.2749633789062, 'max_x': 517.3521728515625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB ICGC_0300 Panc−AdenoCA Cancer type 1:41444007−240774472 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 0 68 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 59 CN segments
161	1	Upper_Left	ICGC_0303	17:28715899−50792664	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0303 Panc−AdenoCA Cancer type 17:28715899−50792664 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 0 132 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
161	2	Upper_Right	ICGC_0313	1:189423365−236063825	16, 22	22	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0313 Panc−AdenoCA Cancer type 1:189423365−236063825 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 7; SV types t2tINV: 6; TRA: 0 38 SVs in sample 16, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
161	3	Lower_Left	ICGC_0326	12:73647749−128290868	7, 7	14	{'min_x': 62.86009979248047, 'min_y': 705.2749633789062, 'max_x': 238.99183654785156, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB 120 MB ICGC_0326 Panc−AdenoCA Cancer type 12:73647749−128290868 Position With other complex events Type 24 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 4; SV types t2tINV: 8; TRA: 2 108 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 14 CN segments
161	4	Lower_Right	ICGC_0326	18:20681108−75019000	17, 24	24	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 537.1499633789062, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB ICGC_0326 Panc−AdenoCA Cancer type 18:20681108−75019000 Position Canonical without polyploidization Type 41 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 11; SV types t2tINV: 11; TRA: 6 108 SVs in sample 17, 24 Oscillating CN (2 and 3 states) 24 CN segments
162	1	Upper_Left	ICGC_0392	8:24086553−130006493	7, 15	54	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.42401123046875}	ICGC_0392 Panc−AdenoCA Cancer type 8:24086553−130006493 Position With other complex events Type 47 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 11; DUP: 11; h2hINV: 12; SV types t2tINV: 13; TRA: 5 205 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 54 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. 6:14848129−56658866; Linked to chrs
162	2	Upper_Right	ICGC_0392	12:25014211−58344707	7, 17	35	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.3340148925781}	ICGC_0392 Panc−AdenoCA Cancer type 12:25014211−58344707 Position With other complex events Type 42 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 10; DUP: 6; h2hINV: 14; SV types t2tINV: 12; TRA: 2 205 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 35 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
162	3	Lower_Left	ICGC_0392	17:19427565−80415097	7, 7	42	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 267.3901672363281, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB ICGC_0392 Panc−AdenoCA Cancer type 17:19427565−80415097 Position With other complex events Type 18 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 5; SV types t2tINV: 3; TRA: 7 205 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 42 CN segments
162	4	Lower_Right	ICGC_0393	13:24905703−113852941	8, 10	55	{'min_x': 346.6400146484375, 'min_y': 705.2749633789062, 'max_x': 524.4722290039062, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB ICGC_0393 Panc−AdenoCA Cancer type 13:24905703−113852941 Position With other complex events Type 24 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 6; SV types t2tINV: 8; TRA: 39 158 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 55 CN segments
163	1	Upper_Left	ICGC_0412	18:3408603−25505804	9, 16	16	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	ICGC_0412 Panc−AdenoCA Cancer type 18:3408603−25505804 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 34 SVs in sample 9, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
163	2	Upper_Right	ICGC_0419	2:33811228−80725292	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0419 Panc−AdenoCA Cancer type 2:33811228−80725292 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 5; SV types t2tINV: 5; TRA: 0 132 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.99 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
163	3	Lower_Left	ICGC_0419	21:15770299−47546356	15, 26	26	{'min_x': 48.70000076293945, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB ICGC_0419 Panc−AdenoCA Cancer type 21:15770299−47546356 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 8; DUP: 4; h2hINV: 5; SV types t2tINV: 6; TRA: 0 132 SVs in sample 15, 26 Oscillating CN (2 and 3 states) 26 CN segments
163	4	Lower_Right	ICGC_0420	12:27339007−85847160	10, 19	19	{'min_x': 317.9800109863281, 'min_y': 705.2749633789062, 'max_x': 535.4000244140625, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB 80 MB ICGC_0420 Panc−AdenoCA Cancer type 12:27339007−85847160 Position With other complex events Type 31 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 8; SV types t2tINV: 8; TRA: 1 90 SVs in sample 10, 19 Oscillating CN (2 and 3 states) 19 CN segments
164	1	Upper_Left	ICGC_0486	2:95882672−200533578	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0486 Panc−AdenoCA Cancer type 2:95882672−200533578 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 112 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.64 FDR fragment joints 0.13 FDR chr. breakp. enrich. Linked to chrs
164	2	Upper_Right	ICGC_0502	3:1045935−2770954	9, 12	12	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0502 Panc−AdenoCA Cancer type 3:1045935−2770954 Position Canonical without polyploidization Type 38 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 9; DUP: 14; h2hINV: 6; SV types t2tINV: 9; TRA: 1 120 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
164	3	Lower_Left	ICGC_0521	5:51314841−160442765	10, 16	16	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 270.25213623046875, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB ICGC_0521 Panc−AdenoCA Cancer type 5:51314841−160442765 Position Before polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 1 107 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 16 CN segments
164	4	Lower_Right	ICGC_0521	9:40335567−125502754	21, 21	21	{'min_x': 315.44000244140625, 'min_y': 705.2749633789062, 'max_x': 559.2921752929688, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB ICGC_0521 Panc−AdenoCA Cancer type 9:40335567−125502754 Position Before polyploidization Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 4 107 SVs in sample 21, 21 Oscillating CN (2 and 3 states) 21 CN segments
165	1	Upper_Left	ICGC_0526	13:42400145−51281145	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	ICGC_0526 Panc−AdenoCA Cancer type 12:77174515−81375488 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 0; TRA: 12 127 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 13:42400145−51281145; Linked to chrs
165	2	Upper_Right	ICGC_0526	12:77174515−81375487	13, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	ICGC_0526 Panc−AdenoCA Cancer type 13:42400145−51281146 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 5; SV types t2tINV: 2; TRA: 12 127 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 12:77174515−81375487; Linked to chrs
165	3	Lower_Left	ICGC_0526	16:4628924−90122371	14, 16	16	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB ICGC_0526 Panc−AdenoCA Cancer type 16:4628924−90122371 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 7; TRA: 0 127 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
165	4	Lower_Right	ICGC_0535	6:25273614−62346185	8, 11	11	{'min_x': 331.0400085449219, 'min_y': 705.2749633789062, 'max_x': 545.1620483398438, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB ICGC_0535 Panc−AdenoCA Cancer type 6:25273614−62346185 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 102 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 11 CN segments
166	1	Upper_Left	ICGC_0535	12:80590486−121388006	11, 17	17	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ICGC_0535 Panc−AdenoCA Cancer type 12:80590486−121388006 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 1 102 SVs in sample 11, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.77 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
166	2	Upper_Right	ICGC_0536	2:167051773−233617455	10, 15	15	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ICGC_0536 Panc−AdenoCA Cancer type 2:167051773−233617455 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 1 59 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
166	3	Lower_Left	PCSI_0015	7:56204033−125643006	8, 10	36	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 272.6919250488281, 'max_y': 838.7838134765625}	40 MB 80 MB 120 MB 160 MB PCSI_0015 Panc−AdenoCA Cancer type 7:56204033−125643006 Position With other complex events Type 9 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 23 541 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 36 CN segments 0.97 FDR fragment joints
166	4	Lower_Right	PCSI_0015	8:100785898−143451880	9, 34	49	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 838.7838134765625}	50 MB 100 MB PCSI_0015 Panc−AdenoCA Cancer type 8:100785898−143451880 Position With other complex events Type 15 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 15 541 SVs in sample 9, 34 Oscillating CN (2 and 3 states) 49 CN segments 0.59 FDR fragment joints
167	1	Upper_Left	PCSI_0015	7:56204033−125643005	8, 42	44	{'min_x': 32.019901275634766, 'min_y': 278.0099792480469, 'max_x': 255.7040252685547, 'max_y': 416.4242248535156}	PCSI_0015 Panc−AdenoCA Cancer type 12:1762415−132632652 Position With other complex events Type 5 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 31 541 SVs in sample 8, 42 Oscillating CN (2 and 3 states) 44 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 1:3415964−191894580;2:154803413−189497987 7:56204033−125643005;8:100785898−143451879 Linked to chrs
167	2	Upper_Right	PCSI_0023	15:28070426−73690087	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	PCSI_0023 Panc−AdenoCA Cancer type 15:28070426−73690087 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 0 114 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
167	3	Lower_Left	PCSI_0048	3:3120897−83846277	13, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB PCSI_0048 Panc−AdenoCA Cancer type 3:3120897−83846277 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 119 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
167	4	Lower_Right	PCSI_0072	18:3860804−37436169	7, 10	26	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 541.540283203125, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB PCSI_0072 Panc−AdenoCA Cancer type 18:3860804−37436169 Position With other complex events Type 26 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 7; SV types t2tINV: 4; TRA: 1 88 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 26 CN segments
168	1	Upper_Left	PCSI_0080	15:46323229−67503083	8, 8	38	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.54379272460938, 'max_y': 416.3340148925781}	PCSI_0080 Panc−AdenoCA Cancer type 15:46323229−67503083 Position With other complex events Type 39 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 10; SV types t2tINV: 9; TRA: 0 138 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 38 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
168	2	Upper_Right	PCSI_0081	22:17339868−50561700	7, 14	63	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.3340148925781}	PCSI_0081 Panc−AdenoCA Cancer type 22:17339868−50561700 Position With other complex events Type 34 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 5; DUP: 10; h2hINV: 10; SV types t2tINV: 9; TRA: 0 195 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 63 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
168	3	Lower_Left	PCSI_0082	8:6295682−40937004	8, 9	16	{'min_x': 42.650001525878906, 'min_y': 705.2749633789062, 'max_x': 262.46014404296875, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB PCSI_0082 Panc−AdenoCA Cancer type 8:6295682−40937004 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 0 160 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 16 CN segments
168	4	Lower_Right	PCSI_0082	16:7095949−87854086	32, 32	41	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 536.7698364257812, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB PCSI_0082 Panc−AdenoCA Cancer type 16:7095949−87854086 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 6; SV types t2tINV: 8; TRA: 0 160 SVs in sample 32, 32 Oscillating CN (2 and 3 states) 41 CN segments
169	1	Upper_Left	PCSI_0101	14:20883702−106705000	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	PCSI_0101 Panc−AdenoCA Cancer type 7:111513717−152373524 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 2 202 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.92 FDR fragment joints 0.52 FDR chr. breakp. enrich. 14:20883702−106705000; Linked to chrs
169	2	Upper_Right	PCSI_0101	7:111513717−152373523	18, 34	60	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	PCSI_0101 Panc−AdenoCA Cancer type 14:20883702−106705001 Position With other complex events Type 32 Interleaved intrachr. SVs 88 Total SVs (intrachr. + transl.) DEL: 9; DUP: 5; h2hINV: 8; SV types t2tINV: 10; TRA: 56 202 SVs in sample 18, 34 Oscillating CN (2 and 3 states) 60 CN segments 0.7 FDR fragment joints 0 FDR chr. breakp. enrich. 7:111513717−152373523; Linked to chrs
169	3	Lower_Left	PCSI_0101	15:20557095−102195722	41, 41	41	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 264.70208740234375, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB PCSI_0101 Panc−AdenoCA Cancer type 15:20557095−102195722 Position Canonical without polyploidization Type 53 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 16; DUP: 11; h2hINV: 12; SV types t2tINV: 14; TRA: 55 202 SVs in sample 41, 41 Oscillating CN (2 and 3 states) 41 CN segments
169	4	Lower_Right	PCSI_0104	1:72694825−237333439	14, 19	19	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB PCSI_0104 Panc−AdenoCA Cancer type 1:72694825−237333439 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 3 107 SVs in sample 14, 19 Oscillating CN (2 and 3 states) 19 CN segments
170	1	Upper_Left	PCSI_0111	1:224736774−247023067	7, 8	17	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0111 Panc−AdenoCA Cancer type 1:224736774−247023067 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 260 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 17 CN segments 0.97 FDR fragment joints 0.19 FDR chr. breakp. enrich. Linked to chrs
170	2	Upper_Right	PCSI_0111	6:104571922−165438063	11, 23	23	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	PCSI_0111 Panc−AdenoCA Cancer type 3:35128015−182834759 Position With other complex events Type 4 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 11 260 SVs in sample 11, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.59 FDR fragment joints 0.51 FDR chr. breakp. enrich. 6:104571922−165438063; Linked to chrs
170	3	Lower_Left	PCSI_0111	11:66329047−111791324	8, 13	40	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 256.8418884277344, 'max_y': 833.6940307617188}	80 MB 100 MB 120 MB PCSI_0111 Panc−AdenoCA Cancer type 11:66329047−111791324 Position With other complex events Type 33 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 11; SV types t2tINV: 8; TRA: 2 260 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 40 CN segments
170	4	Lower_Right	PCSI_0145	14:32259593−106721663	7, 11	71	{'min_x': 350.5400085449219, 'min_y': 705.2749633789062, 'max_x': 541.5023193359375, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB PCSI_0145 Panc−AdenoCA Cancer type 14:32259593−106721663 Position With other complex events Type 30 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 7; SV types t2tINV: 8; TRA: 5 550 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 71 CN segments
171	1	Upper_Left	PCSI_0173	2:156697897−174544813	10, 10	10	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0173 Panc−AdenoCA Cancer type 2:156697897−174544813 Position After polyploidization Type 9 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 8 140 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
171	2	Upper_Right	PCSI_0174	11:4497415−80861714	7, 17	29	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	PCSI_0174 Panc−AdenoCA Cancer type 11:4497415−80861714 Position With other complex events Type 26 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 6; SV types t2tINV: 7; TRA: 0 110 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 29 CN segments 0.99 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
171	3	Lower_Left	PCSI_0217	10:997409−23898134	7, 12	23	{'min_x': 60.849998474121094, 'min_y': 705.2749633789062, 'max_x': 261.6219482421875, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB PCSI_0217 Panc−AdenoCA Cancer type 10:997409−23898134 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 0 152 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 23 CN segments
171	4	Lower_Right	PCSI_0217	12:41107420−120160634	22, 27	27	{'min_x': 322.29998779296875, 'min_y': 705.2749633789062, 'max_x': 514.661865234375, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB PCSI_0217 Panc−AdenoCA Cancer type 12:41107420−120160634 Position Before polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 0 152 SVs in sample 22, 27 Oscillating CN (2 and 3 states) 27 CN segments
172	1	Upper_Left	PCSI_0226	12:6793815−132449370	13, 19	29	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0226 Panc−AdenoCA Cancer type 12:6793815−132449370 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 9; SV types t2tINV: 5; TRA: 0 144 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 29 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
172	2	Upper_Right	PCSI_0230	7:38154775−158410033	13, 32	52	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.3340148925781}	PCSI_0230 Panc−AdenoCA Cancer type 7:38154775−158410033 Position With other complex events Type 48 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 14; SV types t2tINV: 14; TRA: 4 235 SVs in sample 13, 32 Oscillating CN (2 and 3 states) 52 CN segments 0.76 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
172	3	Lower_Left	PCSI_0230	15:23887647−81786260	13, 21	21	{'min_x': 38.70000076293945, 'min_y': 705.2749633789062, 'max_x': 261.840087890625, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB PCSI_0230 Panc−AdenoCA Cancer type 15:23887647−81786260 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 5; TRA: 51 235 SVs in sample 13, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints
172	4	Lower_Right	PCSI_0230	21:24156719−42334957	8, 12	12	{'min_x': 318.19000244140625, 'min_y': 705.2749633789062, 'max_x': 528.820068359375, 'max_y': 833.6940307617188}	25 MB 30 MB 35 MB 40 MB PCSI_0230 Panc−AdenoCA Cancer type 21:24156719−42334957 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 50 235 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 12 CN segments
173	1	Upper_Left	PCSI_0239	4:33126224−179897669	17, 45	45	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.54379272460938, 'max_y': 416.42401123046875}	PCSI_0239 Panc−AdenoCA Cancer type 13:19829855−23893773 Position With other complex events Type 37 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 11; SV types t2tINV: 10; TRA: 2 111 SVs in sample 17, 45 Oscillating CN (2 and 3 states) 45 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 4:33126224−179897669; Linked to chrs
173	2	Upper_Right	PCSI_0261	4:67443335−187140838	9, 20	58	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0442504882812, 'max_y': 416.42401123046875}	PCSI_0261 Panc−AdenoCA Cancer type 4:67443335−187140838 Position With other complex events Type 41 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 12; DUP: 14; h2hINV: 9; SV types t2tINV: 6; TRA: 6 382 SVs in sample 9, 20 Oscillating CN (2 and 3 states) 58 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 9:9041105−26051500; Linked to chrs
173	3	Lower_Left	PCSI_0261	18:8939813−74242436	15, 18	33	{'min_x': 56.38010025024414, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB PCSI_0261 Panc−AdenoCA Cancer type 18:8939813−74242436 Position With other complex events Type 13 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 5; SV types t2tINV: 3; TRA: 2 382 SVs in sample 15, 18 Oscillating CN (2 and 3 states) 33 CN segments
173	4	Lower_Right	PCSI_0274	12:47428310−76942994	7, 10	10	{'min_x': 339.0899963378906, 'min_y': 705.2749633789062, 'max_x': 558.2222290039062, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 120 MB PCSI_0274 Panc−AdenoCA Cancer type 12:47428310−76942994 Position After polyploidization Type 6 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 13 202 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments
174	1	Upper_Left	PCSI_0279	19:31472618−51366174	9, 13	35	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0279 Panc−AdenoCA Cancer type 19:31472618−51366174 Position With other complex events Type 20 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 1 57 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 35 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
174	2	Upper_Right	PCSI_0280	11:489225−45714066	8, 14	79	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0442504882812, 'max_y': 416.3340148925781}	PCSI_0280 Panc−AdenoCA Cancer type 11:489225−45714066 Position With other complex events Type 49 Interleaved intrachr. SVs 50 Total SVs (intrachr. + transl.) DEL: 16; DUP: 15; h2hINV: 8; SV types t2tINV: 10; TRA: 1 96 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 79 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
174	3	Lower_Left	PCSI_0281	22:23142389−50230074	7, 17	18	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 266.99993896484375, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB PCSI_0281 Panc−AdenoCA Cancer type 22:23142389−50230074 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 0 85 SVs in sample 7, 17 Oscillating CN (2 and 3 states) 18 CN segments
174	4	Lower_Right	PCSI_0284	2:125112849−242849922	18, 45	46	{'min_x': 339.20001220703125, 'min_y': 705.2749633789062, 'max_x': 516.1821899414062, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB PCSI_0284 Panc−AdenoCA Cancer type 2:125112849−242849922 Position With other complex events Type 30 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 7; SV types t2tINV: 7; TRA: 2 238 SVs in sample 18, 45 Oscillating CN (2 and 3 states) 46 CN segments
175	1	Upper_Left	PCSI_0284	20:48853377−57995207	7, 13	13	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0284 Panc−AdenoCA Cancer type 20:48853377−57995207 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 1 238 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
175	2	Upper_Right	PCSI_0287	6:26445451−161795623	47, 47	47	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	PCSI_0287 Panc−AdenoCA Cancer type 6:26445451−161795623 Position Canonical without polyploidization Type 41 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 12; DUP: 7; h2hINV: 12; SV types t2tINV: 10; TRA: 0 152 SVs in sample 47, 47 Oscillating CN (2 and 3 states) 47 CN segments 0.73 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
175	3	Lower_Left	PCSI_0287	9:12263449−31719162	7, 7	7	{'min_x': 45.81990051269531, 'min_y': 705.2749633789062, 'max_x': 269.5401306152344, 'max_y': 833.6940307617188}	15 MB 20 MB 25 MB 30 MB 35 MB PCSI_0287 Panc−AdenoCA Cancer type 9:12263449−31719162 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 152 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
175	4	Lower_Right	PCSI_0297	9:3612495−91279620	20, 20	20	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB PCSI_0297 Panc−AdenoCA Cancer type 9:3612495−91279620 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 22 181 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments
176	1	Upper_Left	PCSI_0297	12:49890146−51896557	12, 12	12	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	PCSI_0297 Panc−AdenoCA Cancer type 12:49890146−51896557 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 1; SV types t2tINV: 1; TRA: 8 181 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.21 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
176	2	Upper_Right	PCSI_0297	17:16438476−80055892	8, 10	73	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	PCSI_0297 Panc−AdenoCA Cancer type 17:16438476−80055892 Position With other complex events Type 42 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 11; DUP: 12; h2hINV: 10; SV types t2tINV: 9; TRA: 1 181 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 73 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
176	3	Lower_Left	PCSI_0300	19:29270995−48823894	7, 7	21	{'min_x': 38.18980026245117, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB PCSI_0300 Panc−AdenoCA Cancer type 19:29270995−48823894 Position With other complex events Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 6 208 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 21 CN segments
176	4	Lower_Right	PCSI_0303	18:18793459−48361192	14, 16	16	{'min_x': 316.8999938964844, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB PCSI_0303 Panc−AdenoCA Cancer type 18:18793459−48361192 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 6 28 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
177	1	Upper_Left	PCSI_0305	2:147370933−187071951	12, 16	21	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0305 Panc−AdenoCA Cancer type 2:147370933−187071951 Position With other complex events Type 13 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 6; TRA: 4 166 SVs in sample 12, 16 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
177	2	Upper_Right	PCSI_0307	6:64529563−136604930	18, 18	18	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	PCSI_0307 Panc−AdenoCA Cancer type 6:64529563−136604930 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 43 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
177	3	Lower_Left	PCSI_0324	5:43481679−126819152	10, 10	10	{'min_x': 51.110198974609375, 'min_y': 705.2749633789062, 'max_x': 267.35211181640625, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB PCSI_0324 Panc−AdenoCA Cancer type 5:43481679−126819152 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 14 204 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
177	4	Lower_Right	PCSI_0325	7:2311735−70487292	7, 14	59	{'min_x': 351.3500061035156, 'min_y': 705.2749633789062, 'max_x': 515.3779296875, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB PCSI_0325 Panc−AdenoCA Cancer type 7:2311735−70487292 Position With other complex events Type 26 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 10; SV types t2tINV: 7; TRA: 23 207 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 59 CN segments
178	1	Upper_Left	PCSI_0338	1:51308307−249192722	8, 9	40	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0338 Panc−AdenoCA Cancer type 1:51308307−249192722 Position With other complex events Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 8; DUP: 4; h2hINV: 5; SV types t2tINV: 3; TRA: 0 225 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 40 CN segments 0.63 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
178	2	Upper_Right	PCSI_0340	18:149060−29571306	10, 19	37	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	PCSI_0340 Panc−AdenoCA Cancer type 18:149060−29571306 Position With other complex events Type 48 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 11; DUP: 13; h2hINV: 14; SV types t2tINV: 10; TRA: 1 237 SVs in sample 10, 19 Oscillating CN (2 and 3 states) 37 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
178	3	Lower_Left	PCSI_0345	8:51309933−137292850	9, 9	9	{'min_x': 46.23979949951172, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB PCSI_0345 Panc−AdenoCA Cancer type 8:51309933−137292850 Position Canonical without polyploidization Type 29 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 6; SV types t2tINV: 8; TRA: 11 92 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
178	4	Lower_Right	PCSI_0350	18:31950397−68899945	7, 13	25	{'min_x': 349.67999267578125, 'min_y': 705.2749633789062, 'max_x': 517.0438842773438, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB PCSI_0350 Panc−AdenoCA Cancer type 18:31950397−68899945 Position With other complex events Type 40 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 9; DUP: 12; h2hINV: 10; SV types t2tINV: 9; TRA: 0 100 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 25 CN segments
179	1	Upper_Left	PCSI_0350	22:19346879−47234372	10, 16	16	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	PCSI_0350 Panc−AdenoCA Cancer type 22:19346879−47234372 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 3 100 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
179	2	Upper_Right	PCSI_0351	4:40669996−189308624	12, 12	12	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	PCSI_0351 Panc−AdenoCA Cancer type 4:40669996−189308624 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 75 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.74 FDR fragment joints 0.12 FDR chr. breakp. enrich. Linked to chrs
179	3	Lower_Left	PCSI_0352	14:20953269−101623829	11, 36	36	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 266.2618408203125, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB 100 MB PCSI_0352 Panc−AdenoCA Cancer type 14:20953269−101623829 Position With other complex events Type 13 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 6; SV types t2tINV: 4; TRA: 17 72 SVs in sample 11, 36 Oscillating CN (2 and 3 states) 36 CN segments 0.59 FDR fragment joints
179	4	Lower_Right	PCSI_0354	18:4121150−73576993	10, 10	10	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB PCSI_0354 Panc−AdenoCA Cancer type 18:4121150−73576993 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 4 73 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
180	1	Upper_Left	PCSI_0356	17:22238087−79107549	31, 32	32	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	PCSI_0356 Panc−AdenoCA Cancer type 8:40478806−140298863 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 6; SV types t2tINV: 4; TRA: 31 228 SVs in sample 31, 32 Oscillating CN (2 and 3 states) 32 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. 17:22238087−79107549; Linked to chrs
180	2	Upper_Right	PCSI_0356	11:323191−36726710	24, 48	63	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3778686523438, 'max_y': 416.3340148925781}	PCSI_0356 Panc−AdenoCA Cancer type 11:323191−36726710 Position With other complex events Type 34 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 8; DUP: 12; h2hINV: 9; SV types t2tINV: 5; TRA: 0 228 SVs in sample 24, 48 Oscillating CN (2 and 3 states) 63 CN segments 0.6 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
180	3	Lower_Left	PCSI_0356	17:22238087−79107550	11, 14	27	{'min_x': 50.419898986816406, 'min_y': 705.2749633789062, 'max_x': 232.17991638183594, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB PCSI_0356 Panc−AdenoCA Cancer type 17:22238087−79107550 Position With other complex events Type 25 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 5; SV types t2tINV: 8; TRA: 33 228 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 27 CN segments
180	4	Lower_Right	PCSI_0392	12:7998293−127887019	9, 11	11	{'min_x': 340.20001220703125, 'min_y': 705.2749633789062, 'max_x': 554.8521118164062, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB PCSI_0392 Panc−AdenoCA Cancer type 12:7998293−127887019 Position After polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 1 160 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments
181	1	Upper_Left	PCSI_0403	12:388638−75487543	21, 34	41	{'min_x': 60.18009948730469, 'min_y': 286.6499938964844, 'max_x': 227.5441131591797, 'max_y': 416.3340148925781}	PCSI_0403 Panc−AdenoCA Cancer type 12:388638−75487543 Position With other complex events Type 59 Interleaved intrachr. SVs 61 Total SVs (intrachr. + transl.) DEL: 17; DUP: 14; h2hINV: 9; SV types t2tINV: 19; TRA: 2 115 SVs in sample 21, 34 Oscillating CN (2 and 3 states) 41 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
181	2	Upper_Right	PCSI_0403	17:25733074−70173103	11, 14	14	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	PCSI_0403 Panc−AdenoCA Cancer type 17:25733074−70173103 Position Canonical without polyploidization Type 25 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 7; SV types t2tINV: 3; TRA: 2 115 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
181	3	Lower_Left	PCSI_0451	8:47674760−136141807	8, 10	15	{'min_x': 50.13010025024414, 'min_y': 705.2749633789062, 'max_x': 228.8020782470703, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB PCSI_0451 Panc−AdenoCA Cancer type 8:47674760−136141807 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 5; SV types t2tINV: 2; TRA: 1 56 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 15 CN segments
181	4	Lower_Right	PCSI_0458	2:2888790−157310482	9, 23	26	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 555.8421020507812, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB PCSI_0458 Panc−AdenoCA Cancer type 2:2888790−157310482 Position With other complex events Type 17 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 8; h2hINV: 4; SV types t2tINV: 4; TRA: 4 83 SVs in sample 9, 23 Oscillating CN (2 and 3 states) 26 CN segments
182	1	Upper_Left	PCSI_0472	10:28947349−34511968	13, 18	18	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	PCSI_0472 Panc−AdenoCA Cancer type 10:28947349−34511968 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 238 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
182	2	Upper_Right	PCSI_0473	6:36130410−92771456	7, 11	21	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	PCSI_0473 Panc−AdenoCA Cancer type 6:36130410−92771456 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 61 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
182	3	Lower_Left	PCSI_0477	2:45422−204621489	7, 9	16	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 236.0321044921875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB PCSI_0477 Panc−AdenoCA Cancer type 2:45422−204621489 Position With other complex events Type 3 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 8 323 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 16 CN segments
182	4	Lower_Right	PCSI_0477	3:2293198−187254007	10, 10	23	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB PCSI_0477 Panc−AdenoCA Cancer type 3:2293198−187254007 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 6 323 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 23 CN segments
183	1	Upper_Left	PCSI_0477	17:21709058−72004070	8, 14	17	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	PCSI_0477 Panc−AdenoCA Cancer type 17:21709058−72004070 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 3 323 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 17 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
183	2	Upper_Right	PCSI_0527	12:16004740−48600593	7, 7	20	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	PCSI_0527 Panc−AdenoCA Cancer type 12:16004740−48600593 Position With other complex events Type 17 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 3; SV types t2tINV: 5; TRA: 5 53 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 20 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
183	3	Lower_Left	PCSI_0572	2:21945480−110876001	8, 13	24	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 242.68215942382812, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB PCSI_0572 Panc−AdenoCA Cancer type 2:21945480−110876001 Position With other complex events Type 9 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 0; SV types t2tINV: 0; TRA: 15 86 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 24 CN segments
183	4	Lower_Right	ICGC_0431	10:4904254−111891388	17, 17	17	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 838.7838134765625}	30 MB 60 MB 90 MB ICGC_0431 Panc−Endocrine Cancer type 10:4904254−111891388 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 29 68 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.59 FDR fragment joints
184	1	Upper_Left	ICGC_0455	1:188073080−236635572	10, 19	19	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	ICGC_0455 Panc−Endocrine Cancer type 1:188073080−236635572 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 1 72 SVs in sample 10, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
184	2	Upper_Right	ICGC_0498	11:21255252−90295432	41, 41	41	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	ICGC_0498 Panc−Endocrine Cancer type 1:8214142−231450770 Position Canonical without polyploidization Type 30 Interleaved intrachr. SVs 96 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 5; SV types t2tINV: 5; TRA: 66 148 SVs in sample 41, 41 Oscillating CN (2 and 3 states) 41 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:21255252−90295432; Linked to chrs
184	3	Lower_Left	ICGC_0498	11:21255252−90295433	26, 26	26	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 236.7698516845703, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB ICGC_0498 Panc−Endocrine Cancer type 11:21255252−90295433 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 37 148 SVs in sample 26, 26 Oscillating CN (2 and 3 states) 26 CN segments
184	4	Lower_Right	ITNET-1266	11:67900950−116481177	17, 17	17	{'min_x': 317.45001220703125, 'min_y': 705.2749633789062, 'max_x': 529.6220092773438, 'max_y': 833.6940307617188}	70 MB 80 MB 90 MB 100 MB 110 MB ITNET−1266 Panc−Endocrine Cancer type 11:67900950−116481177 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 3; TRA: 3 30 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
185	1	Upper_Left	ITNET-0087	8:15876266−129305739	16, 16	25	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	ITNET−0087 Panc−Endocrine Cancer type 8:15876266−129305739 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 5; SV types t2tINV: 6; TRA: 2 28 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 25 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
185	2	Upper_Right	ITNET-0118	15:35208509−67092577	15, 15	15	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	ITNET−0118 Panc−Endocrine Cancer type 15:35208509−67092577 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 19 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
185	3	Lower_Left	ITNET-0152	22:17924903−47818249	30, 30	30	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	30 MB 40 MB ITNET−0152 Panc−Endocrine Cancer type 22:17924903−47818249 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 99 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 5; SV types t2tINV: 2; TRA: 83 227 SVs in sample 30, 30 Oscillating CN (2 and 3 states) 30 CN segments
185	4	Lower_Right	ITNET-0152	X:808303−155214868	122, 122	122	{'min_x': 308.2200012207031, 'min_y': 705.2749633789062, 'max_x': 552.6119384765625, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB ITNET−0152 Panc−Endocrine Cancer type X:808303−155214868 Position Canonical without polyploidization Type 109 Interleaved intrachr. SVs 196 Total SVs (intrachr. + transl.) DEL: 29; DUP: 26; h2hINV: 27; SV types t2tINV: 27; TRA: 87 227 SVs in sample 122, 122 Oscillating CN (2 and 3 states) 122 CN segments
186	1	Upper_Left	ITNET-0968	1:95538888−234231402	15, 15	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	ITNET−0968 Panc−Endocrine Cancer type 18:12732238−76910328 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 16 42 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 1:95538888−234231402; Linked to chrs
186	2	Upper_Right	EOPC-011	3:36958690−96921576	14, 14	14	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 416.3340148925781}	EOPC−011 Prost−AdenoCA Cancer type 6:145595779−168829760 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 0; SV types t2tINV: 0; TRA: 8 27 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 3:36958690−96921576;10:21109565−51786602 Linked to chrs
186	3	Lower_Left	EOPC-018	2:193357450−199873274	12, 12	12	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	196 MB 200 MB 204 MB EOPC−018 Prost−AdenoCA Cancer type 2:193357450−199873274 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 3 16 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
186	4	Lower_Right	EOPC-021	1:5717619−90237612	12, 12	12	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 551.7322998046875, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB EOPC−021 Prost−AdenoCA Cancer type 1:5717619−90237612 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 13 52 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
187	1	Upper_Left	EOPC-021	2:55039051−149412025	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	EOPC−021 Prost−AdenoCA Cancer type 2:55039051−149412025 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 12 52 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 1:5717619−90237611; Linked to chrs
187	2	Upper_Right	EOPC-029	11:96486263−98959029	19, 19	19	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	EOPC−029 Prost−AdenoCA Cancer type 11:96486263−98959029 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 16 90 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
187	3	Lower_Left	EOPC-030	11:70358348−117056058	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 236.04197692871094, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB EOPC−030 Prost−AdenoCA Cancer type 11:70358348−117056058 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 5; SV types t2tINV: 5; TRA: 17 116 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
187	4	Lower_Right	EOPC-030	15:45489848−50514324	8, 8	8	{'min_x': 328.2799987792969, 'min_y': 705.2749633789062, 'max_x': 532.949951171875, 'max_y': 833.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB EOPC−030 Prost−AdenoCA Cancer type 15:45489848−50514324 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 17 116 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
188	1	Upper_Left	EOPC-05	12:20367968−117498112	13, 13	13	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	EOPC−05 Prost−AdenoCA Cancer type 12:20367968−117498112 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 9 35 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
188	2	Upper_Right	EOPC-06	11:3698754−86989800	16, 16	16	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	EOPC−06 Prost−AdenoCA Cancer type 11:3698754−86989800 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 4; SV types t2tINV: 2; TRA: 0 62 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
188	3	Lower_Left	EOPC-06	19:4983858−52796956	8, 8	8	{'min_x': 40.580101013183594, 'min_y': 705.2749633789062, 'max_x': 241.0498809814453, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB EOPC−06 Prost−AdenoCA Cancer type 19:4983858−52796956 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 6 62 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
188	4	Lower_Right	CPCG0001	6:73106289−128515137	10, 10	10	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB CPCG0001 Prost−AdenoCA Cancer type 6:73106289−128515137 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 5 183 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
189	1	Upper_Left	CPCG0020	5:85713705−111436997	8, 19	19	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CPCG0020 Prost−AdenoCA Cancer type 5:85713705−111436997 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 3 57 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
189	2	Upper_Right	CPCG0040	4:66000602−188117670	13, 19	19	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0040 Prost−AdenoCA Cancer type 4:66000602−188117670 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 4 86 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
189	3	Lower_Left	CPCG0047	5:58141508−132747188	8, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB CPCG0047 Prost−AdenoCA Cancer type 5:58141508−132747188 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 3 74 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 13 CN segments
189	4	Lower_Right	CPCG0047	17:7344436−80003025	10, 10	10	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 558.4501953125, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB CPCG0047 Prost−AdenoCA Cancer type 17:7344436−80003025 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 7 74 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
190	1	Upper_Left	CPCG0078	3:102500885−131983072	9, 9	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	CPCG0078 Prost−AdenoCA Cancer type 7:87564783−152327924 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 2; TRA: 4 75 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 15 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. 3:102500885−131983072; Linked to chrs
190	2	Upper_Right	CPCG0087	10:65582868−91714710	10, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0087 Prost−AdenoCA Cancer type 10:65582868−91714710 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 4 96 SVs in sample 10, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
190	3	Lower_Left	CPCG0095	19:35792212−49163182	9, 9	9	{'min_x': 37.83980178833008, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	30 MB 35 MB 40 MB 45 MB CPCG0095 Prost−AdenoCA Cancer type 19:35792212−49163182 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 66 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
190	4	Lower_Right	CPCG0098	6:80395987−95133658	16, 16	16	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 528.3019409179688, 'max_y': 833.6940307617188}	90 MB 100 MB 110 MB CPCG0098 Prost−AdenoCA Cancer type 6:80395987−95133658 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 0 100 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
191	1	Upper_Left	CPCG0098	X:26243883−91967097	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0098 Prost−AdenoCA Cancer type X:26243883−91967097 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 100 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
191	2	Upper_Right	CPCG0099	5:49962437−111461751	10, 23	23	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CPCG0099 Prost−AdenoCA Cancer type 5:49962437−111461751 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 116 SVs in sample 10, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
191	3	Lower_Left	CPCG0123	2:32918330−74219519	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB 150 MB CPCG0123 Prost−AdenoCA Cancer type 2:32918330−74219519 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 144 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
191	4	Lower_Right	CPCG0123	8:22894046−144595974	7, 7	7	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 100 MB CPCG0123 Prost−AdenoCA Cancer type 8:22894046−144595974 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 4; SV types t2tINV: 4; TRA: 0 144 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
192	1	Upper_Left	CPCG0123	10:75239971−97413753	9, 9	9	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 416.3340148925781}	CPCG0123 Prost−AdenoCA Cancer type 17:27075680−55017524 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 11 144 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 10:75239971−97413753;4:40113263−89954085 Linked to chrs
192	2	Upper_Right	CPCG0124	10:48369342−119949557	13, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0124 Prost−AdenoCA Cancer type 13:29235366−111679206 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 7 121 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 10:48369342−119949557; Linked to chrs
192	3	Lower_Left	CPCG0128	2:57746139−137270112	12, 19	19	{'min_x': 52.56019973754883, 'min_y': 705.2749633789062, 'max_x': 236.08212280273438, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 120 MB CPCG0128 Prost−AdenoCA Cancer type 2:57746139−137270112 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 0 84 SVs in sample 12, 19 Oscillating CN (2 and 3 states) 19 CN segments
192	4	Lower_Right	CPCG0128	7:106208873−123387813	20, 20	20	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	110 MB 115 MB 120 MB CPCG0128 Prost−AdenoCA Cancer type 7:106208873−123387813 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 2 84 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments
193	1	Upper_Left	CPCG0154	12:41871673−107239693	11, 19	19	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CPCG0154 Prost−AdenoCA Cancer type 12:41871673−107239693 Position With other complex events Type 7 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 4; TRA: 17 79 SVs in sample 11, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
193	2	Upper_Right	CPCG0158	7:38307844−131180183	7, 7	16	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CPCG0158 Prost−AdenoCA Cancer type 7:38307844−131180183 Position With other complex events Type 5 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 8 114 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
193	3	Lower_Left	CPCG0158	20:26127345−62406063	11, 28	52	{'min_x': 42.610198974609375, 'min_y': 705.2749633789062, 'max_x': 253.66006469726562, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 60 MB CPCG0158 Prost−AdenoCA Cancer type 20:26127345−62406063 Position With other complex events Type 35 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 5; DUP: 11; h2hINV: 10; SV types t2tINV: 9; TRA: 6 114 SVs in sample 11, 28 Oscillating CN (2 and 3 states) 52 CN segments
193	4	Lower_Right	CPCG0166	1:64280405−222074952	14, 16	16	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 536.2821044921875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CPCG0166 Prost−AdenoCA Cancer type 1:64280405−222074952 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 15 126 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
194	1	Upper_Left	CPCG0183	5:61391468−82150238	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0183 Prost−AdenoCA Cancer type 5:61391468−82150238 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 124 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
194	2	Upper_Right	CPCG0183	16:63407336−87039387	14, 14	14	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0183 Prost−AdenoCA Cancer type 16:63407336−87039387 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 1 124 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.48 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
194	3	Lower_Left	CPCG0184	7:28022973−144475086	7, 9	19	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 268.02197265625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0184 Prost−AdenoCA Cancer type 7:28022973−144475086 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 2 77 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 19 CN segments
194	4	Lower_Right	CPCG0185	10:11812464−112681665	7, 11	22	{'min_x': 349.0899963378906, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB CPCG0185 Prost−AdenoCA Cancer type 10:11812464−112681665 Position With other complex events Type 8 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 8 72 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 22 CN segments
195	1	Upper_Left	CPCG0191	12:51747202−124872407	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	CPCG0191 Prost−AdenoCA Cancer type 8:4682515−119746552 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 0; SV types t2tINV: 4; TRA: 8 121 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.55 FDR fragment joints 0 FDR chr. breakp. enrich. 12:51747202−124872407; Linked to chrs
195	2	Upper_Right	CPCG0199	3:162683867−169237872	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0199 Prost−AdenoCA Cancer type 3:162683867−169237872 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 109 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.98 FDR fragment joints 0.18 FDR chr. breakp. enrich. Linked to chrs
195	3	Lower_Left	CPCG0199	5:30217746−163056821	16, 16	16	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 261.05194091796875, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CPCG0199 Prost−AdenoCA Cancer type 5:30217746−163056821 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 5; TRA: 2 109 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
195	4	Lower_Right	CPCG0199	7:7799682−14177776	8, 8	8	{'min_x': 326.95001220703125, 'min_y': 705.2749633789062, 'max_x': 524.1801147460938, 'max_y': 833.6940307617188}	10 MB 15 MB 20 MB 25 MB 30 MB CPCG0199 Prost−AdenoCA Cancer type 7:7799682−14177776 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 3; SV types t2tINV: 1; TRA: 0 109 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
196	1	Upper_Left	CPCG0199	12:40811810−113578120	22, 22	22	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0199 Prost−AdenoCA Cancer type 12:40811810−113578120 Position Canonical without polyploidization Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 7; SV types t2tINV: 7; TRA: 0 109 SVs in sample 22, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
196	2	Upper_Right	CPCG0201	5:19275862−166331721	26, 29	46	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3779296875, 'max_y': 416.3340148925781}	CPCG0201 Prost−AdenoCA Cancer type 5:19275862−166331721 Position With other complex events Type 36 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 11; SV types t2tINV: 12; TRA: 3 350 SVs in sample 26, 29 Oscillating CN (2 and 3 states) 46 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
196	3	Lower_Left	CPCG0201	6:64935112−158946645	18, 24	24	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 267.9321594238281, 'max_y': 838.7838134765625}	80 MB 100 MB 120 MB 140 MB 160 MB CPCG0201 Prost−AdenoCA Cancer type 6:64935112−158946645 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 11 350 SVs in sample 18, 24 Oscillating CN (2 and 3 states) 24 CN segments 0.84 FDR fragment joints
196	4	Lower_Right	CPCG0201	9:6256612−23184831	37, 37	37	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	10 MB 15 MB 20 MB CPCG0201 Prost−AdenoCA Cancer type 9:6256612−23184831 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 8; SV types t2tINV: 7; TRA: 10 350 SVs in sample 37, 37 Oscillating CN (2 and 3 states) 37 CN segments
197	1	Upper_Left	CPCG0201	13:78597547−81366968	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0201 Prost−AdenoCA Cancer type 13:78597547−81366968 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 7 350 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
197	2	Upper_Right	CPCG0206	5:7327241−94584506	11, 17	17	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0206 Prost−AdenoCA Cancer type 5:7327241−94584506 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 6; SV types t2tINV: 2; TRA: 7 173 SVs in sample 11, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
197	3	Lower_Left	CPCG0208	5:54711398−151747029	23, 23	23	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 267.17193603515625, 'max_y': 833.6940307617188}	75 MB 100 MB 125 MB 150 MB CPCG0208 Prost−AdenoCA Cancer type 5:54711398−151747029 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 6; TRA: 16 90 SVs in sample 23, 23 Oscillating CN (2 and 3 states) 23 CN segments
197	4	Lower_Right	CPCG0208	8:6075645−42724629	8, 8	8	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB CPCG0208 Prost−AdenoCA Cancer type 8:6075645−42724629 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 4 90 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
198	1	Upper_Left	CPCG0211	3:37350014−175530480	7, 10	20	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CPCG0211 Prost−AdenoCA Cancer type 2:15850928−179041463 Position With other complex events Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 9 106 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 20 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 3:37350014−175530480; Linked to chrs
198	2	Upper_Right	CPCG0211	14:23310029−91217856	11, 13	18	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0211 Prost−AdenoCA Cancer type 14:23310029−91217856 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 4 106 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 18 CN segments 0.92 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
198	3	Lower_Left	CPCG0217	12:11281216−18305829	14, 14	14	{'min_x': 37.28010177612305, 'min_y': 705.2749633789062, 'max_x': 261.179931640625, 'max_y': 833.6940307617188}	10 MB 12 MB 14 MB 16 MB 18 MB CPCG0217 Prost−AdenoCA Cancer type 12:11281216−18305829 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 30 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
198	4	Lower_Right	CPCG0232	1:33333284−160926638	23, 34	50	{'min_x': 319.8599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB CPCG0232 Prost−AdenoCA Cancer type 1:33333284−160926638 Position With other complex events Type 14 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 24 235 SVs in sample 23, 34 Oscillating CN (2 and 3 states) 50 CN segments 0.64 FDR fragment joints
199	1	Upper_Left	CPCG0232	5:54443227−122107536	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0232 Prost−AdenoCA Cancer type 5:54443227−122107536 Position Canonical without polyploidization Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 6; SV types t2tINV: 4; TRA: 0 235 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.8 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
199	2	Upper_Right	CPCG0232	18:54357319−68058750	9, 9	9	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0232 Prost−AdenoCA Cancer type 18:54357319−68058750 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 2 235 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.91 FDR fragment joints 0.35 FDR chr. breakp. enrich. 3:70605253−72494754; Linked to chrs
199	3	Lower_Left	CPCG0233	3:7634513−179524544	8, 17	92	{'min_x': 60.18009948730469, 'min_y': 705.2749633789062, 'max_x': 227.54379272460938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0233 Prost−AdenoCA Cancer type 3:7634513−179524544 Position With other complex events Type 39 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 11; SV types t2tINV: 10; TRA: 2 348 SVs in sample 8, 17 Oscillating CN (2 and 3 states) 92 CN segments
199	4	Lower_Right	CPCG0233	4:59417131−151727783	29, 29	50	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 550.7122192382812, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CPCG0233 Prost−AdenoCA Cancer type 4:59417131−151727783 Position With other complex events Type 18 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 4; SV types t2tINV: 6; TRA: 16 348 SVs in sample 29, 29 Oscillating CN (2 and 3 states) 50 CN segments
200	1	Upper_Left	CPCG0233	6:81224216−133441817	12, 26	26	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CPCG0233 Prost−AdenoCA Cancer type 6:81224216−133441817 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 0 348 SVs in sample 12, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.64 FDR fragment joints 0.8 FDR chr. breakp. enrich. Linked to chrs
200	2	Upper_Right	CPCG0233	8:91134186−115039929	10, 10	10	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0233 Prost−AdenoCA Cancer type 8:91134186−115039929 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 348 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.84 FDR fragment joints 0.08 FDR chr. breakp. enrich. Linked to chrs
200	3	Lower_Left	CPCG0233	21:18298400−22568498	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 238.2400665283203, 'max_y': 833.6940307617188}	19 MB 20 MB 21 MB 22 MB CPCG0233 Prost−AdenoCA Cancer type 21:18298400−22568498 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 4 348 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
200	4	Lower_Right	CPCG0236	1:170266116−192996844	14, 14	14	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 550.1119995117188, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB CPCG0236 Prost−AdenoCA Cancer type 1:170266116−192996844 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 0 237 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
201	1	Upper_Left	CPCG0236	4:12833922−68421773	7, 11	19	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CPCG0236 Prost−AdenoCA Cancer type 4:12833922−68421773 Position With other complex events Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 1 237 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 19 CN segments 0.9 FDR fragment joints 0.06 FDR chr. breakp. enrich. Linked to chrs
201	2	Upper_Right	CPCG0236	5:97010270−106309341	7, 7	7	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0236 Prost−AdenoCA Cancer type 5:97010270−106309341 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 237 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
201	3	Lower_Left	CPCG0236	10:46962433−85287848	21, 21	36	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 231.4799346923828, 'max_y': 838.7838134765625}	50 MB 60 MB 70 MB 80 MB CPCG0236 Prost−AdenoCA Cancer type 10:46962433−85287848 Position With other complex events Type 28 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 9; DUP: 5; h2hINV: 7; SV types t2tINV: 7; TRA: 25 237 SVs in sample 21, 21 Oscillating CN (2 and 3 states) 36 CN segments 0.84 FDR fragment joints
201	4	Lower_Right	CPCG0238	1:25248495−156885998	14, 17	17	{'min_x': 339.0299987792969, 'min_y': 705.2749633789062, 'max_x': 552.391845703125, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CPCG0238 Prost−AdenoCA Cancer type 1:25248495−156885998 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 4; TRA: 1 132 SVs in sample 14, 17 Oscillating CN (2 and 3 states) 17 CN segments
202	1	Upper_Left	CPCG0238	13:33264435−83241801	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0238 Prost−AdenoCA Cancer type 13:33264435−83241801 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 2 132 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
202	2	Upper_Right	CPCG0241	3:53132905−194929595	23, 25	25	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0241 Prost−AdenoCA Cancer type 2:9693687−239470346 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 7; SV types t2tINV: 5; TRA: 24 206 SVs in sample 23, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.72 FDR fragment joints 0 FDR chr. breakp. enrich. 3:53132905−194929595; Linked to chrs
202	3	Lower_Left	CPCG0241	3:53132905−194929596	15, 21	29	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	100 MB 150 MB CPCG0241 Prost−AdenoCA Cancer type 3:53132905−194929596 Position With other complex events Type 24 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 5; SV types t2tINV: 9; TRA: 50 206 SVs in sample 15, 21 Oscillating CN (2 and 3 states) 29 CN segments 0.64 FDR fragment joints
202	4	Lower_Right	CPCG0241	13:63794744−71333917	8, 8	8	{'min_x': 342.3699951171875, 'min_y': 705.2749633789062, 'max_x': 533.22216796875, 'max_y': 833.6940307617188}	70 MB 80 MB 90 MB 100 MB CPCG0241 Prost−AdenoCA Cancer type 13:63794744−71333917 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 206 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
203	1	Upper_Left	CPCG0242	19:14507324−55917568	11, 26	66	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CPCG0242 Prost−AdenoCA Cancer type 8:8188079−96079992 Position With other complex events Type 23 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 3; SV types t2tINV: 5; TRA: 21 217 SVs in sample 11, 26 Oscillating CN (2 and 3 states) 66 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 19:14507324−55917568; Linked to chrs
203	2	Upper_Right	CPCG0246	12:8702882−45773773	11, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0246 Prost−AdenoCA Cancer type 12:8702882−45773773 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 4; SV types t2tINV: 6; TRA: 0 25 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
203	3	Lower_Left	CPCG0248	12:23143579−30936876	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 270.8299865722656, 'max_y': 833.6940307617188}	25 MB 27 MB 29 MB 31 MB CPCG0248 Prost−AdenoCA Cancer type 12:23143579−30936876 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 4 110 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
203	4	Lower_Right	CPCG0249	2:52137503−222453077	15, 21	28	{'min_x': 343.1199951171875, 'min_y': 705.2749633789062, 'max_x': 529.18212890625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CPCG0249 Prost−AdenoCA Cancer type 2:52137503−222453077 Position With other complex events Type 49 Interleaved intrachr. SVs 50 Total SVs (intrachr. + transl.) DEL: 18; DUP: 5; h2hINV: 14; SV types t2tINV: 12; TRA: 1 458 SVs in sample 15, 21 Oscillating CN (2 and 3 states) 28 CN segments
204	1	Upper_Left	CPCG0249	8:12585867−142127031	20, 21	78	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.42401123046875}	CPCG0249 Prost−AdenoCA Cancer type 5:24023055−168167900 Position With other complex events Type 99 Interleaved intrachr. SVs 103 Total SVs (intrachr. + transl.) DEL: 22; DUP: 24; h2hINV: 29; SV types t2tINV: 24; TRA: 4 458 SVs in sample 20, 21 Oscillating CN (2 and 3 states) 78 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 8:12585867−142127031; Linked to chrs
204	2	Upper_Right	CPCG0249	13:82314051−113900733	15, 32	32	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	CPCG0249 Prost−AdenoCA Cancer type 11:6102762−104228614 Position With other complex events Type 33 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 9; SV types t2tINV: 11; TRA: 5 458 SVs in sample 15, 32 Oscillating CN (2 and 3 states) 32 CN segments 0.69 FDR fragment joints 0 FDR chr. breakp. enrich. 13:82314051−113900733; Linked to chrs
204	3	Lower_Left	CPCG0256	10:753210−118664596	9, 15	26	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB CPCG0256 Prost−AdenoCA Cancer type 10:753210−118664596 Position With other complex events Type 8 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 5 64 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 26 CN segments
204	4	Lower_Right	CPCG0258	3:119241441−156069152	8, 8	8	{'min_x': 310.5, 'min_y': 705.2749633789062, 'max_x': 549.4420166015625, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 120 MB 150 MB CPCG0258 Prost−AdenoCA Cancer type 3:119241441−156069152 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 45 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
205	1	Upper_Left	CPCG0263	11:121125846−122406012	10, 12	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	CPCG0263 Prost−AdenoCA Cancer type 8:50690802−90644745 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 7 67 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 15 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 11:121125846−122406012; Linked to chrs
205	2	Upper_Right	CPCG0267	1:204042528−237113743	11, 11	14	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0267 Prost−AdenoCA Cancer type 1:204042528−237113743 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 10 63 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 3:10350196−84771996; Linked to chrs
205	3	Lower_Left	CPCG0267	3:10350196−84771997	7, 8	8	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0267 Prost−AdenoCA Cancer type 3:10350196−84771997 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 11 63 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments
205	4	Lower_Right	CPCG0268	1:156391329−161122378	10, 20	20	{'min_x': 334.82000732421875, 'min_y': 705.2749633789062, 'max_x': 558.1920776367188, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CPCG0268 Prost−AdenoCA Cancer type 1:156391329−161122378 Position With other complex events Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 6; SV types t2tINV: 6; TRA: 0 135 SVs in sample 10, 20 Oscillating CN (2 and 3 states) 20 CN segments
206	1	Upper_Left	CPCG0268	5:86850288−103636603	8, 13	13	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0268 Prost−AdenoCA Cancer type 5:86850288−103636603 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 1 135 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
206	2	Upper_Right	CPCG0324	2:138429668−155586709	9, 9	9	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0324 Prost−AdenoCA Cancer type 2:138429668−155586709 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 0 81 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0.09 FDR chr. breakp. enrich. Linked to chrs
206	3	Lower_Left	CPCG0331	3:5905087−156509264	9, 21	27	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 236.2418670654297, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0331 Prost−AdenoCA Cancer type 3:5905087−156509264 Position With other complex events Type 25 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 6; SV types t2tINV: 8; TRA: 10 123 SVs in sample 9, 21 Oscillating CN (2 and 3 states) 27 CN segments
206	4	Lower_Right	CPCG0331	10:26837814−93718569	9, 14	14	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB CPCG0331 Prost−AdenoCA Cancer type 10:26837814−93718569 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 10 123 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 14 CN segments
207	1	Upper_Left	CPCG0336	8:63930625−78804766	11, 16	16	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0336 Prost−AdenoCA Cancer type 8:63930625−78804766 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 68 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
207	2	Upper_Right	CPCG0340	5:53204904−155545927	9, 22	24	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CPCG0340 Prost−AdenoCA Cancer type 5:53204904−155545927 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 9; DUP: 8; h2hINV: 6; SV types t2tINV: 6; TRA: 0 139 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 24 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
207	3	Lower_Left	CPCG0340	6:18322627−152548190	22, 22	22	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 266.5219421386719, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0340 Prost−AdenoCA Cancer type 6:18322627−152548190 Position Canonical without polyploidization Type 28 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 6; SV types t2tINV: 7; TRA: 11 139 SVs in sample 22, 22 Oscillating CN (2 and 3 states) 22 CN segments
207	4	Lower_Right	CPCG0342	10:46999321−113799131	7, 12	12	{'min_x': 352.3900146484375, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB CPCG0342 Prost−AdenoCA Cancer type 10:46999321−113799131 Position With other complex events Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 2 72 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments
208	1	Upper_Left	CPCG0350	18:4244316−74665299	14, 16	16	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	CPCG0350 Prost−AdenoCA Cancer type 8:20040649−42029377 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 1; SV types t2tINV: 1; TRA: 45 202 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.21 FDR fragment joints 0 FDR chr. breakp. enrich. 18:4244316−74665299; Linked to chrs
208	2	Upper_Right	CPCG0350	8:20040649−42029376	14, 18	18	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	CPCG0350 Prost−AdenoCA Cancer type 11:32402370−134754988 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 41 202 SVs in sample 14, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 8:20040649−42029376;18:4244316−74665299 Linked to chrs
208	3	Lower_Left	CPCG0350	18:4244316−74665300	19, 19	19	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB CPCG0350 Prost−AdenoCA Cancer type 18:4244316−74665300 Position Canonical without polyploidization Type 22 Interleaved intrachr. SVs 75 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 5; SV types t2tINV: 5; TRA: 53 202 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments
208	4	Lower_Right	CPCG0354	12:12779174−126256048	19, 19	19	{'min_x': 332.3299865722656, 'min_y': 705.2749633789062, 'max_x': 557.85205078125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CPCG0354 Prost−AdenoCA Cancer type 12:12779174−126256048 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 9 113 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments
209	1	Upper_Left	CPCG0354	17:6755315−80126854	8, 8	8	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0354 Prost−AdenoCA Cancer type 17:6755315−80126854 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 1; SV types t2tINV: 0; TRA: 13 113 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.38 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
209	2	Upper_Right	CPCG0360	12:11938733−90103272	8, 14	30	{'min_x': 349.67999267578125, 'min_y': 286.6499938964844, 'max_x': 517.0438842773438, 'max_y': 416.3340148925781}	CPCG0360 Prost−AdenoCA Cancer type 12:11938733−90103272 Position With other complex events Type 49 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 13; DUP: 9; h2hINV: 13; SV types t2tINV: 14; TRA: 0 171 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 30 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
209	3	Lower_Left	CPCG0362	13:20078680−98039016	8, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB CPCG0362 Prost−AdenoCA Cancer type 13:20078680−98039016 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 3 48 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 9 CN segments
209	4	Lower_Right	CPCG0364	6:1360399−168764390	14, 14	38	{'min_x': 307.54998779296875, 'min_y': 705.2749633789062, 'max_x': 548.3220825195312, 'max_y': 833.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB CPCG0364 Prost−AdenoCA Cancer type 6:1360399−168764390 Position With other complex events Type 18 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 4; SV types t2tINV: 4; TRA: 13 78 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 38 CN segments
210	1	Upper_Left	CPCG0366	6:167735883−169038472	7, 7	7	{'min_x': 30.360200881958008, 'min_y': 282.3299865722656, 'max_x': 257.36993408203125, 'max_y': 416.3340148925781}	CPCG0366 Prost−AdenoCA Cancer type 1:150909043−205693972 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 0; SV types t2tINV: 1; TRA: 9 213 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.84 FDR fragment joints 0.62 FDR chr. breakp. enrich. 6:167735883−169038472;13:20995521−107382175 Linked to chrs
210	2	Upper_Right	CPCG0366	6:167735883−169038472	7, 8	44	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.42401123046875}	CPCG0366 Prost−AdenoCA Cancer type 2:22493101−230456464 Position With other complex events Type 62 Interleaved intrachr. SVs 117 Total SVs (intrachr. + transl.) DEL: 12; DUP: 16; h2hINV: 16; SV types t2tINV: 18; TRA: 55 213 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 44 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. 6:167735883−169038472; Linked to chrs
210	3	Lower_Left	CPCG0369	6:128987682−166522109	9, 12	12	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 259.25213623046875, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB CPCG0369 Prost−AdenoCA Cancer type 6:128987682−166522109 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 0 131 SVs in sample 9, 12 Oscillating CN (2 and 3 states) 12 CN segments
210	4	Lower_Right	CPCG0372	1:10695500−119824570	7, 7	7	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 524.9418334960938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB CPCG0372 Prost−AdenoCA Cancer type 1:10695500−119824570 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 6 86 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
211	1	Upper_Left	CPCG0372	20:20333170−56648940	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0372 Prost−AdenoCA Cancer type 20:20333170−56648940 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 86 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
211	2	Upper_Right	CPCG0375	2:103449140−146851707	9, 9	9	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0375 Prost−AdenoCA Cancer type 2:103449140−146851707 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 88 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.84 FDR fragment joints 0.58 FDR chr. breakp. enrich. Linked to chrs
211	3	Lower_Left	CPCG0375	7:14565219−18687976	9, 9	9	{'min_x': 42.31990051269531, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	15 MB 16 MB 17 MB 18 MB CPCG0375 Prost−AdenoCA Cancer type 7:14565219−18687976 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 0 88 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
211	4	Lower_Right	CPCG0375	12:39777632−83554265	17, 17	17	{'min_x': 342.0199890136719, 'min_y': 705.2749633789062, 'max_x': 547.4902954101562, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB CPCG0375 Prost−AdenoCA Cancer type 12:39777632−83554265 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 0 88 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
212	1	Upper_Left	CPCG0388	2:117339084−155136678	10, 15	15	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0388 Prost−AdenoCA Cancer type 2:117339084−155136678 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 212 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.71 FDR fragment joints 0.9 FDR chr. breakp. enrich. Linked to chrs
212	2	Upper_Right	CPCG0388	5:22412327−101716388	16, 27	32	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CPCG0388 Prost−AdenoCA Cancer type 5:22412327−101716388 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 0 212 SVs in sample 16, 27 Oscillating CN (2 and 3 states) 32 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
212	3	Lower_Left	CPCG0388	12:7695125−132397887	27, 27	27	{'min_x': 50.0, 'min_y': 705.2749633789062, 'max_x': 257.2219543457031, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CPCG0388 Prost−AdenoCA Cancer type 12:7695125−132397887 Position Canonical without polyploidization Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 6; SV types t2tINV: 6; TRA: 0 212 SVs in sample 27, 27 Oscillating CN (2 and 3 states) 27 CN segments
212	4	Lower_Right	CPCG0392	5:44374104−175313675	25, 69	69	{'min_x': 317.3999938964844, 'min_y': 705.2749633789062, 'max_x': 559.8521118164062, 'max_y': 838.7838134765625}	50 MB 75 MB 100 MB 125 MB 150 MB 175 MB CPCG0392 Prost−AdenoCA Cancer type 5:44374104−175313675 Position With other complex events Type 43 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 6; DUP: 11; h2hINV: 13; SV types t2tINV: 13; TRA: 27 198 SVs in sample 25, 69 Oscillating CN (2 and 3 states) 69 CN segments 0.59 FDR fragment joints
213	1	Upper_Left	CPCG0392	17:40076564−53795248	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0392 Prost−AdenoCA Cancer type 17:40076564−53795248 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 11 198 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
213	2	Upper_Right	CPCG0404	8:131182988−138911084	43, 43	43	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0404 Prost−AdenoCA Cancer type 3:98011541−158330216 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 7 176 SVs in sample 43, 43 Oscillating CN (2 and 3 states) 43 CN segments 0.63 FDR fragment joints 0 FDR chr. breakp. enrich. 8:131182988−138911084; Linked to chrs
213	3	Lower_Left	CPCG0404	4:10877187−133253578	30, 30	30	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB CPCG0404 Prost−AdenoCA Cancer type 4:10877187−133253578 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 7; SV types t2tINV: 8; TRA: 2 176 SVs in sample 30, 30 Oscillating CN (2 and 3 states) 30 CN segments
213	4	Lower_Right	CPCG0404	5:12953930−128804942	9, 14	19	{'min_x': 331.239990234375, 'min_y': 705.2749633789062, 'max_x': 550.662109375, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CPCG0404 Prost−AdenoCA Cancer type 5:12953930−128804942 Position With other complex events Type 21 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 6 176 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 19 CN segments
214	1	Upper_Left	CPCG0407	4:127348851−137036859	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0407 Prost−AdenoCA Cancer type 4:127348851−137036859 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 0 72 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
214	2	Upper_Right	CPCG0409	8:75912919−113963126	28, 28	28	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	CPCG0409 Prost−AdenoCA Cancer type 3:9353418−184040107 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 11 106 SVs in sample 28, 28 Oscillating CN (2 and 3 states) 28 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 8:75912919−113963126; Linked to chrs
214	3	Lower_Left	CPCG0409	8:75912919−113963127	18, 18	18	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	50 MB 100 MB CPCG0409 Prost−AdenoCA Cancer type 8:75912919−113963127 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 0; TRA: 9 106 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments
214	4	Lower_Right	CPCG0409	12:9962423−104916091	13, 13	13	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 548.282470703125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB CPCG0409 Prost−AdenoCA Cancer type 12:9962423−104916091 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 2 106 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
215	1	Upper_Left	CPCG0412	11:30685891−119565687	16, 19	19	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	CPCG0412 Prost−AdenoCA Cancer type 11:30685891−119565687 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 1 55 SVs in sample 16, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.67 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
215	2	Upper_Right	CPCG0413	5:28572732−82901949	23, 27	27	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CPCG0413 Prost−AdenoCA Cancer type 5:28572732−82901949 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 5; TRA: 0 55 SVs in sample 23, 27 Oscillating CN (2 and 3 states) 27 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
215	3	Lower_Left	0065_CRUK_PC_0065	1:75879779−120025710	11, 11	11	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 833.6940307617188}	100 MB 125 MB 150 MB 0065_CRUK_PC_0065 Prost−AdenoCA Cancer type 1:75879779−120025710 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 36 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments
215	4	Lower_Right	0065_CRUK_PC_0065	3:27203160−193771532	10, 10	10	{'min_x': 340.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 0065_CRUK_PC_0065 Prost−AdenoCA Cancer type 3:27203160−193771532 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 1; TRA: 0 36 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
216	1	Upper_Left	0067_CRUK_PC_0067	3:21978772−168757004	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	0067_CRUK_PC_0067 Prost−AdenoCA Cancer type 3:21978772−168757004 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 83 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.91 FDR fragment joints 0.04 FDR chr. breakp. enrich. Linked to chrs
216	2	Upper_Right	0067_CRUK_PC_0067	13:67945892−69823504	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	0067_CRUK_PC_0067 Prost−AdenoCA Cancer type 8:64237001−88665512 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 0; TRA: 12 83 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 13:67945892−69823504; Linked to chrs
216	3	Lower_Left	0067_CRUK_PC_0067	9:26921758−30071295	9, 9	9	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 263.7402038574219, 'max_y': 833.6940307617188}	28 MB 29 MB 30 MB 0067_CRUK_PC_0067 Prost−AdenoCA Cancer type 9:26921758−30071295 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 83 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
216	4	Lower_Right	0072_CRUK_PC_0072	1:67986816−86784290	20, 20	20	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB 0072_CRUK_PC_0072 Prost−AdenoCA Cancer type 1:67986816−86784290 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 4; SV types t2tINV: 4; TRA: 19 165 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments
217	1	Upper_Left	0072_CRUK_PC_0072	13:34142528−82507263	10, 10	10	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	0072_CRUK_PC_0072 Prost−AdenoCA Cancer type 8:12443102−41913983 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 4 165 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.84 FDR fragment joints 0.11 FDR chr. breakp. enrich. 13:34142528−82507263; Linked to chrs
217	2	Upper_Right	0072_CRUK_PC_0072	10:27291487−93614346	13, 13	13	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	0072_CRUK_PC_0072 Prost−AdenoCA Cancer type 10:27291487−93614346 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 12 165 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
217	3	Lower_Left	0072_CRUK_PC_0072	12:38382189−133229840	17, 17	17	{'min_x': 37.03010177612305, 'min_y': 705.2749633789062, 'max_x': 232.99598693847656, 'max_y': 838.7838134765625}	50 MB 100 MB 0072_CRUK_PC_0072 Prost−AdenoCA Cancer type 12:38382189−133229840 Position Canonical without polyploidization Type 4 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 29 165 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.64 FDR fragment joints
217	4	Lower_Right	0077_CRUK_PC_0077	1:148930966−248810132	53, 56	78	{'min_x': 339.2799987792969, 'min_y': 705.2749633789062, 'max_x': 561.9821166992188, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB 250 MB 0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 1:148930966−248810132 Position With other complex events Type 45 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 12; DUP: 10; h2hINV: 11; SV types t2tINV: 12; TRA: 0 198 SVs in sample 53, 56 Oscillating CN (2 and 3 states) 78 CN segments
218	1	Upper_Left	0077_CRUK_PC_0077	5:46053227−172902120	16, 28	28	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 4:32778170−136168076 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 4 198 SVs in sample 16, 28 Oscillating CN (2 and 3 states) 28 CN segments 0.59 FDR fragment joints 0.12 FDR chr. breakp. enrich. 5:46053227−172902120; Linked to chrs
218	2	Upper_Right	0077_CRUK_PC_0077	2:34203351−199138380	16, 22	22	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 5:46053227−172902121 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 0; TRA: 10 198 SVs in sample 16, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 2:34203351−199138380;4:32778170−136168075 Linked to chrs
218	3	Lower_Left	0077_CRUK_PC_0077	6:697961−127720347	9, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 265.9619445800781, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 6:697961−127720347 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 3 198 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 13 CN segments
218	4	Lower_Right	0077_CRUK_PC_0077	12:10457601−23828590	7, 7	7	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	15 MB 20 MB 0077_CRUK_PC_0077 Prost−AdenoCA Cancer type 12:10457601−23828590 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 2 198 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
219	1	Upper_Left	0082_CRUK_PC_0082	10:59502181−102770425	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	0082_CRUK_PC_0082 Prost−AdenoCA Cancer type 6:2865588−18891521 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 14 128 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 10:59502181−102770425; Linked to chrs
219	2	Upper_Right	0082_CRUK_PC_0082	10:59502181−102770426	16, 24	24	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	0082_CRUK_PC_0082 Prost−AdenoCA Cancer type 10:59502181−102770426 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 7; SV types t2tINV: 6; TRA: 5 128 SVs in sample 16, 24 Oscillating CN (2 and 3 states) 24 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
219	3	Lower_Left	0089_CRUK_PC_0089	6:81197888−127781306	18, 18	18	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 256.12200927734375, 'max_y': 833.6940307617188}	100 MB 120 MB 140 MB 0089_CRUK_PC_0089 Prost−AdenoCA Cancer type 6:81197888−127781306 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 0 52 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments
219	4	Lower_Right	0089_CRUK_PC_0089	13:19665581−31750172	8, 12	17	{'min_x': 313.75, 'min_y': 705.2749633789062, 'max_x': 521.3402099609375, 'max_y': 833.6940307617188}	20 MB 22.5 MB 25 MB 27.5 MB 30 MB 0089_CRUK_PC_0089 Prost−AdenoCA Cancer type 13:19665581−31750172 Position With other complex events Type 5 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 4 52 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 17 CN segments
220	1	Upper_Left	0090_CRUK_PC_0090	4:67524856−158414913	14, 14	22	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	0090_CRUK_PC_0090 Prost−AdenoCA Cancer type 4:67524856−158414913 Position Canonical without polyploidization Type 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 7; SV types t2tINV: 8; TRA: 0 194 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 22 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
220	2	Upper_Right	0090_CRUK_PC_0090	12:4134323−74087961	12, 13	24	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	0090_CRUK_PC_0090 Prost−AdenoCA Cancer type 12:4134323−74087961 Position With other complex events Type 31 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 8; SV types t2tINV: 8; TRA: 1 194 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 24 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
220	3	Lower_Left	0091_CRUK_PC_0091	5:654406−92191496	21, 23	23	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 260.7919006347656, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 5:654406−92191496 Position Before polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 5; TRA: 0 308 SVs in sample 21, 23 Oscillating CN (2 and 3 states) 23 CN segments
220	4	Lower_Right	0091_CRUK_PC_0091	11:3944706−132738959	15, 15	15	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 833.6940307617188}	50 MB 100 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 11:3944706−132738959 Position Before polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 308 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments
221	1	Upper_Left	0091_CRUK_PC_0091	13:61651222−91504851	8, 8	8	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 12:4404224−14760891 Position Before polyploidization Type 4 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 5 308 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 1 FDR fragment joints 0.67 FDR chr. breakp. enrich. 13:61651222−91504851; Linked to chrs
221	2	Upper_Right	0091_CRUK_PC_0091	13:61651222−91504852	25, 34	34	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 13:61651222−91504852 Position Before polyploidization Type 23 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 7; SV types t2tINV: 6; TRA: 7 308 SVs in sample 25, 34 Oscillating CN (2 and 3 states) 34 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. 12:4404224−14760890; Linked to chrs
221	3	Lower_Left	A12-0020_CRUK_PC_0020	3:7099331−154439230	17, 17	17	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 263.9519958496094, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB A12−0020_CRUK_PC_0020 Prost−AdenoCA Cancer type 3:7099331−154439230 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 3 189 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 17 CN segments
221	4	Lower_Right	A21-0096_CRUK_PC_0096	4:102585699−128146094	28, 28	28	{'min_x': 307.05999755859375, 'min_y': 705.2749633789062, 'max_x': 551.2418212890625, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB 150 MB 180 MB A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type 4:102585699−128146094 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 5; SV types t2tINV: 4; TRA: 12 496 SVs in sample 28, 28 Oscillating CN (2 and 3 states) 28 CN segments
222	1	Upper_Left	A21-0096_CRUK_PC_0096	6:110920236−118495780	11, 13	13	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type 6:110920236−118495780 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 5; SV types t2tINV: 5; TRA: 11 496 SVs in sample 11, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 8:38045408−103847168; Linked to chrs
222	2	Upper_Right	A21-0096_CRUK_PC_0096	10:9280803−129008364	10, 16	16	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type 7:47819326−108795651 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 27 496 SVs in sample 10, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.59 FDR fragment joints 0.02 FDR chr. breakp. enrich. 10:9280803−129008364; Linked to chrs
222	3	Lower_Left	A21-0096_CRUK_PC_0096	8:38045408−103847169	14, 19	87	{'min_x': 41.71989822387695, 'min_y': 705.2749633789062, 'max_x': 262.8020935058594, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type 8:38045408−103847169 Position With other complex events Type 27 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 9; SV types t2tINV: 9; TRA: 22 496 SVs in sample 14, 19 Oscillating CN (2 and 3 states) 87 CN segments
222	4	Lower_Right	A21-0096_CRUK_PC_0096	10:9280803−129008365	39, 55	55	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 838.7838134765625}	50 MB 100 MB A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type 10:9280803−129008365 Position Canonical without polyploidization Type 44 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 13; SV types t2tINV: 13; TRA: 30 496 SVs in sample 39, 55 Oscillating CN (2 and 3 states) 55 CN segments 0.73 FDR fragment joints
223	1	Upper_Left	A24-0021_CRUK_PC_0021	1:39903182−157347896	10, 15	57	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 416.3340148925781}	A24−0021_CRUK_PC_0021 Prost−AdenoCA Cancer type 2:104733057−222529357 Position With other complex events Type 67 Interleaved intrachr. SVs 92 Total SVs (intrachr. + transl.) DEL: 16; DUP: 20; h2hINV: 12; SV types t2tINV: 19; TRA: 25 313 SVs in sample 10, 15 Oscillating CN (2 and 3 states) 57 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 1:39903182−157347896;16:1786815−72144385 Linked to chrs
223	2	Upper_Right	A24-0021_CRUK_PC_0021	11:14837827−64851797	7, 13	26	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	A24−0021_CRUK_PC_0021 Prost−AdenoCA Cancer type 3:12152327−178682467 Position With other complex events Type 11 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 20 313 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 26 CN segments 0.71 FDR fragment joints 0 FDR chr. breakp. enrich. 11:14837827−64851797;6:78541847−151587658 Linked to chrs
223	3	Lower_Left	A24-0021_CRUK_PC_0021	6:78541847−151587659	13, 13	13	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 262.1617431640625, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB A24−0021_CRUK_PC_0021 Prost−AdenoCA Cancer type 6:78541847−151587659 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 3; SV types t2tINV: 1; TRA: 14 313 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
223	4	Lower_Right	A34-0022_CRUK_PC_0022	8:18259748−136762151	11, 16	67	{'min_x': 309.07000732421875, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB A34−0022_CRUK_PC_0022 Prost−AdenoCA Cancer type 8:18259748−136762151 Position With other complex events Type 51 Interleaved intrachr. SVs 93 Total SVs (intrachr. + transl.) DEL: 13; DUP: 12; h2hINV: 13; SV types t2tINV: 13; TRA: 42 461 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 67 CN segments 1 FDR fragment joints
224	1	Upper_Left	A34-0022_CRUK_PC_0022	10:82501407−92221074	23, 23	23	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	A34−0022_CRUK_PC_0022 Prost−AdenoCA Cancer type 10:82501407−92221074 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 5; SV types t2tINV: 5; TRA: 0 461 SVs in sample 23, 23 Oscillating CN (2 and 3 states) 23 CN segments 0.99 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
224	2	Upper_Right	3acd8328-76f7-4f43-9660-394b95748c3d	1:21235981−246814200	11, 11	16	{'min_x': 329.7099914550781, 'min_y': 286.6499938964844, 'max_x': 537.0219116210938, 'max_y': 416.42401123046875}	3acd8328−76f7−4f43−9660−394b95748c3d Prost−AdenoCA Cancer type 1:21235981−246814200 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 1; TRA: 5 88 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 16 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. 5:54730905−58095208; Linked to chrs
224	3	Lower_Left	3acd8328-76f7-4f43-9660-394b95748c3d	8:9194649−67046989	9, 9	9	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 247.52195739746094, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 60 MB 3acd8328−76f7−4f43−9660−394b95748c3d Prost−AdenoCA Cancer type 8:9194649−67046989 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 13 88 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
224	4	Lower_Right	3acd8328-76f7-4f43-9660-394b95748c3d	17:10827228−11022986	12, 12	12	{'min_x': 329.4599914550781, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 833.6940307617188}	10.85 MB 10.9 MB 10.95 MB 11 MB 3acd8328−76f7−4f43−9660−394b95748c3d Prost−AdenoCA Cancer type 17:10827228−11022986 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 13 88 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
225	1	Upper_Left	4fe004e5-49f9-4336-a690-6ebad512c813	8:64418681−134574191	11, 16	16	{'min_x': 40.400001525878906, 'min_y': 286.6499938964844, 'max_x': 247.331787109375, 'max_y': 416.3340148925781}	4fe004e5−49f9−4336−a690−6ebad512c813 Prost−AdenoCA Cancer type 8:64418681−134574191 Position Canonical without polyploidization Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 6; SV types t2tINV: 7; TRA: 0 126 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
225	2	Upper_Right	4fe004e5-49f9-4336-a690-6ebad512c813	18:4417928−70232682	8, 14	14	{'min_x': 329.8999938964844, 'min_y': 286.6499938964844, 'max_x': 536.831787109375, 'max_y': 416.3340148925781}	4fe004e5−49f9−4336−a690−6ebad512c813 Prost−AdenoCA Cancer type 18:4417928−70232682 Position With other complex events Type 17 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 7 126 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
225	3	Lower_Left	5dd69c3e-9a3d-450c-9f10-10b4d6daeeba	1:50713589−191622424	15, 15	15	{'min_x': 38.91019821166992, 'min_y': 705.2749633789062, 'max_x': 248.8201446533203, 'max_y': 833.6940307617188}	100 MB 150 MB 5dd69c3e−9a3d−450c−9f10−10b4d6daeeba Prost−AdenoCA Cancer type 1:50713589−191622424 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 9; SV types t2tINV: 4; TRA: 0 39 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 15 CN segments
225	4	Lower_Right	5dd69c3e-9a3d-450c-9f10-10b4d6daeeba	6:62617511−70840186	9, 9	9	{'min_x': 318.2200012207031, 'min_y': 705.2749633789062, 'max_x': 538.3201293945312, 'max_y': 833.6940307617188}	63 MB 65 MB 67 MB 69 MB 5dd69c3e−9a3d−450c−9f10−10b4d6daeeba Prost−AdenoCA Cancer type 6:62617511−70840186 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 0 39 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
226	1	Upper_Left	73f875cb-bcfc-43ba-ab97-4e94caf836d4	2:82362285−156575950	10, 10	10	{'min_x': 40.539798736572266, 'min_y': 286.6499938964844, 'max_x': 247.1839599609375, 'max_y': 416.3340148925781}	73f875cb−bcfc−43ba−ab97−4e94caf836d4 Prost−AdenoCA Cancer type 2:82362285−156575950 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 144 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.84 FDR fragment joints 0.77 FDR chr. breakp. enrich. Linked to chrs
226	2	Upper_Right	73f875cb-bcfc-43ba-ab97-4e94caf836d4	7:8238638−153576066	14, 14	35	{'min_x': 330.0400085449219, 'min_y': 286.6499938964844, 'max_x': 536.6838989257812, 'max_y': 416.3340148925781}	73f875cb−bcfc−43ba−ab97−4e94caf836d4 Prost−AdenoCA Cancer type 7:8238638−153576066 Position With other complex events Type 25 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 11; DUP: 6; h2hINV: 5; SV types t2tINV: 3; TRA: 0 144 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 35 CN segments 0.58 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
226	3	Lower_Left	c039014f-821c-43d6-9d3c-914f9c8d98fa	2:50901965−229972547	15, 36	36	{'min_x': 40.86989974975586, 'min_y': 705.2749633789062, 'max_x': 246.8539581298828, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 2:50901965−229972547 Position With other complex events Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 7; SV types t2tINV: 8; TRA: 0 222 SVs in sample 15, 36 Oscillating CN (2 and 3 states) 36 CN segments
226	4	Lower_Right	c039014f-821c-43d6-9d3c-914f9c8d98fa	5:30074933−152675583	21, 32	32	{'min_x': 312.1099853515625, 'min_y': 705.2749633789062, 'max_x': 555.4719848632812, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 120 MB 150 MB c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 5:30074933−152675583 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 2 222 SVs in sample 21, 32 Oscillating CN (2 and 3 states) 32 CN segments
227	1	Upper_Left	c039014f-821c-43d6-9d3c-914f9c8d98fa	11:29320290−106781286	7, 10	21	{'min_x': 40.86989974975586, 'min_y': 286.6499938964844, 'max_x': 246.8539581298828, 'max_y': 416.42401123046875}	c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 7:84753907−128099139 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 4 222 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:29320290−106781286; Linked to chrs
227	2	Upper_Right	c039014f-821c-43d6-9d3c-914f9c8d98fa	8:49431428−59807696	19, 19	19	{'min_x': 330.3699951171875, 'min_y': 286.6499938964844, 'max_x': 536.3538818359375, 'max_y': 416.3340148925781}	c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 8:49431428−59807696 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 0 222 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 19 CN segments 0.99 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
227	3	Lower_Left	c039014f-821c-43d6-9d3c-914f9c8d98fa	21:16364103−29777341	12, 12	12	{'min_x': 40.86989974975586, 'min_y': 705.2749633789062, 'max_x': 246.8539581298828, 'max_y': 833.6940307617188}	20 MB 25 MB c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 21:16364103−29777341 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 1 222 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 12 CN segments
227	4	Lower_Right	da5b0169-e4f4-4674-b348-220af03ff4b5	2:140924944−217210101	8, 12	12	{'min_x': 308.54998779296875, 'min_y': 705.2749633789062, 'max_x': 536.7720947265625, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB da5b0169−e4f4−4674−b348−220af03ff4b5 Prost−AdenoCA Cancer type 2:140924944−217210101 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 29 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 12 CN segments
228	1	Upper_Left	f6381367-142c-45d0-92b3-c1727d1813ce	6:87766263−107431907	7, 7	7	{'min_x': 39.539798736572266, 'min_y': 286.6499938964844, 'max_x': 248.18994140625, 'max_y': 416.3340148925781}	f6381367−142c−45d0−92b3−c1727d1813ce Prost−AdenoCA Cancer type 6:87766263−107431907 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 0; SV types t2tINV: 3; TRA: 2 133 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0.26 FDR chr. breakp. enrich. Linked to chrs
228	2	Upper_Right	MELA-0001	4:18741843−110768809	7, 13	68	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0001 Skin−Melanoma Cancer type 4:18741843−110768809 Position With other complex events Type 16 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 6; SV types t2tINV: 5; TRA: 28 460 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 68 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
228	3	Lower_Left	MELA-0001	11:57335469−97526275	7, 9	95	{'min_x': 58.51020050048828, 'min_y': 705.2749633789062, 'max_x': 229.22010803222656, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB MELA−0001 Skin−Melanoma Cancer type 11:57335469−97526275 Position With other complex events Type 56 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 10; DUP: 15; h2hINV: 19; SV types t2tINV: 12; TRA: 23 460 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 95 CN segments
228	4	Lower_Right	MELA-0002	5:759044−45795365	10, 12	122	{'min_x': 308.4100036621094, 'min_y': 705.2749633789062, 'max_x': 530.2321166992188, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB 150 MB MELA−0002 Skin−Melanoma Cancer type 5:759044−45795365 Position With other complex events Type 71 Interleaved intrachr. SVs 135 Total SVs (intrachr. + transl.) DEL: 13; DUP: 26; h2hINV: 15; SV types t2tINV: 17; TRA: 64 748 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 122 CN segments 0.57 FDR fragment joints
229	1	Upper_Left	MELA-0002	11:48612434−104669301	10, 14	137	{'min_x': 32.019901275634766, 'min_y': 278.0099792480469, 'max_x': 255.70394897460938, 'max_y': 416.4242248535156}	MELA−0002 Skin−Melanoma Cancer type 7:1508469−101805272 Position With other complex events Type 73 Interleaved intrachr. SVs 113 Total SVs (intrachr. + transl.) DEL: 12; DUP: 15; h2hINV: 22; SV types t2tINV: 24; TRA: 40 748 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 137 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:48612434−104669301;2:11161529−144813239 22:17741148−36618399;3:69823911−79435314 Linked to chrs
229	2	Upper_Right	MELA-0002	5:759044−45795364	7, 10	113	{'min_x': 329.8599853515625, 'min_y': 282.3299865722656, 'max_x': 536.8639526367188, 'max_y': 416.3340148925781}	MELA−0002 Skin−Melanoma Cancer type 11:48612434−104669302 Position With other complex events Type 34 Interleaved intrachr. SVs 83 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 8; SV types t2tINV: 9; TRA: 49 748 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 113 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 5:759044−45795364;7:1508469−101805271 Linked to chrs
229	3	Lower_Left	MELA-0002	18:19034698−74083616	7, 10	21	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB MELA−0002 Skin−Melanoma Cancer type 18:19034698−74083616 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 4 748 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 21 CN segments
229	4	Lower_Right	MELA-0003	5:1296136−45874996	11, 27	52	{'min_x': 307.739990234375, 'min_y': 705.2749633789062, 'max_x': 522.9420776367188, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB MELA−0003 Skin−Melanoma Cancer type 5:1296136−45874996 Position With other complex events Type 33 Interleaved intrachr. SVs 109 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 6; SV types t2tINV: 10; TRA: 76 1187 SVs in sample 11, 27 Oscillating CN (2 and 3 states) 52 CN segments
230	1	Upper_Left	MELA-0003	9:24544471−36364603	7, 7	7	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	MELA−0003 Skin−Melanoma Cancer type 9:24544471−36364603 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 1187 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
230	2	Upper_Right	MELA-0003	1:15885881−58152235	11, 24	377	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	MELA−0003 Skin−Melanoma Cancer type 12:43076099−128657837 Position With other complex events Type 536 Interleaved intrachr. SVs 881 Total SVs (intrachr. + transl.) DEL: 150; DUP: 120; h2hINV: 130; SV types t2tINV: 136; TRA: 345 1187 SVs in sample 11, 24 Oscillating CN (2 and 3 states) 377 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 1:15885881−58152235;4:41842565−58016946 Linked to chrs
230	3	Lower_Left	MELA-0007	8:3242350−72370952	8, 19	59	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 226.24020385742188, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB MELA−0007 Skin−Melanoma Cancer type 8:3242350−72370952 Position With other complex events Type 29 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 8; SV types t2tINV: 7; TRA: 10 377 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 59 CN segments
230	4	Lower_Right	MELA-0007	9:9654286−66858139	7, 10	156	{'min_x': 308.8800048828125, 'min_y': 705.2749633789062, 'max_x': 530.7999877929688, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB 60 MB MELA−0007 Skin−Melanoma Cancer type 9:9654286−66858139 Position With other complex events Type 80 Interleaved intrachr. SVs 202 Total SVs (intrachr. + transl.) DEL: 17; DUP: 25; h2hINV: 17; SV types t2tINV: 21; TRA: 122 377 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 156 CN segments
231	1	Upper_Left	MELA-0007	5:265764−28190998	11, 21	21	{'min_x': 42.03010177612305, 'min_y': 282.3299865722656, 'max_x': 245.6979522705078, 'max_y': 416.3340148925781}	MELA−0007 Skin−Melanoma Cancer type 12:20581752−32372625 Position With other complex events Type 6 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 11 377 SVs in sample 11, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 5:265764−28190998;9:9654286−66858138 Linked to chrs
231	2	Upper_Right	MELA-0009	11:41485920−112489308	9, 14	18	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	MELA−0009 Skin−Melanoma Cancer type 20:50318897−61655152 Position With other complex events Type 5 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 12 351 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 18 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 11:41485920−112489308; Linked to chrs
231	3	Lower_Left	MELA-0009	22:31415162−49131333	7, 7	7	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	30 MB 40 MB MELA−0009 Skin−Melanoma Cancer type 22:31415162−49131333 Position After polyploidization Type 9 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 8 351 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
231	4	Lower_Right	MELA-0012	7:32236661−117391259	7, 15	97	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 838.7838134765625}	40 MB 80 MB 120 MB MELA−0012 Skin−Melanoma Cancer type 7:32236661−117391259 Position With other complex events Type 70 Interleaved intrachr. SVs 96 Total SVs (intrachr. + transl.) DEL: 18; DUP: 15; h2hINV: 16; SV types t2tINV: 21; TRA: 26 508 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 97 CN segments 0.83 FDR fragment joints
232	1	Upper_Left	MELA-0012	11:60665556−76908359	13, 18	28	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	MELA−0012 Skin−Melanoma Cancer type 12:62098962−89622897 Position With other complex events Type 12 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 3 508 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 28 CN segments 0.91 FDR fragment joints 0.97 FDR chr. breakp. enrich. 11:60665556−76908359; Linked to chrs
232	2	Upper_Right	MELA-0012	13:22438944−77491950	10, 10	10	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.42401123046875}	MELA−0012 Skin−Melanoma Cancer type 13:22438944−77491950 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 6 508 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.84 FDR fragment joints 0.77 FDR chr. breakp. enrich. 8:508734−74087760; Linked to chrs
232	3	Lower_Left	MELA-0012	X:22327741−154060135	11, 34	34	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 263.7919006347656, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB MELA−0012 Skin−Melanoma Cancer type X:22327741−154060135 Position With other complex events Type 16 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 6 508 SVs in sample 11, 34 Oscillating CN (2 and 3 states) 34 CN segments
232	4	Lower_Right	MELA-0043	6:146452116−170788391	14, 14	14	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 544.6719360351562, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB MELA−0043 Skin−Melanoma Cancer type 6:146452116−170788391 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 1 106 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments
233	1	Upper_Left	MELA-0043	7:5229877−53502420	7, 10	16	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	MELA−0043 Skin−Melanoma Cancer type 7:5229877−53502420 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 0 106 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 16 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
233	2	Upper_Right	MELA-0048	7:858862−151538983	8, 8	316	{'min_x': 348.010009765625, 'min_y': 286.6499938964844, 'max_x': 518.72021484375, 'max_y': 416.3340148925781}	MELA−0048 Skin−Melanoma Cancer type 7:858862−151538983 Position With other complex events Type 121 Interleaved intrachr. SVs 279 Total SVs (intrachr. + transl.) DEL: 34; DUP: 25; h2hINV: 29; SV types t2tINV: 33; TRA: 158 444 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 316 CN segments 0.72 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
233	3	Lower_Left	MELA-0052	11:59180890−101076970	7, 9	29	{'min_x': 60.18009948730469, 'min_y': 705.2749633789062, 'max_x': 264.971923828125, 'max_y': 833.6940307617188}	70 MB 80 MB 90 MB 100 MB MELA−0052 Skin−Melanoma Cancer type 11:59180890−101076970 Position With other complex events Type 40 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 12; SV types t2tINV: 8; TRA: 0 91 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 29 CN segments
233	4	Lower_Right	MELA-0055	1:9644166−63480813	9, 9	14	{'min_x': 350.9700012207031, 'min_y': 705.2749633789062, 'max_x': 520.8822631835938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB MELA−0055 Skin−Melanoma Cancer type 1:9644166−63480813 Position After polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 2 38 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 14 CN segments
234	1	Upper_Left	MELA-0056	2:134717568−156505138	12, 13	17	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	MELA−0056 Skin−Melanoma Cancer type 2:134717568−156505138 Position Before polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 0 224 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 17 CN segments 0.98 FDR fragment joints 0.17 FDR chr. breakp. enrich. Linked to chrs
234	2	Upper_Right	MELA-0056	11:61794852−122148653	11, 16	25	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0056 Skin−Melanoma Cancer type 11:61794852−122148653 Position With other complex events Type 12 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 3; TRA: 8 224 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 25 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
234	3	Lower_Left	MELA-0060	14:21034990−55876063	10, 10	39	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 235.1800079345703, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB MELA−0060 Skin−Melanoma Cancer type 14:21034990−55876063 Position With other complex events Type 14 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 5; SV types t2tINV: 5; TRA: 5 213 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 39 CN segments
234	4	Lower_Right	MELA-0066	17:6966673−74491773	7, 21	160	{'min_x': 348.010009765625, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB MELA−0066 Skin−Melanoma Cancer type 17:6966673−74491773 Position With other complex events Type 211 Interleaved intrachr. SVs 235 Total SVs (intrachr. + transl.) DEL: 54; DUP: 57; h2hINV: 48; SV types t2tINV: 52; TRA: 24 355 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 160 CN segments
235	1	Upper_Left	MELA-0067	6:26830084−55474034	8, 11	22	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	MELA−0067 Skin−Melanoma Cancer type 6:26830084−55474034 Position With other complex events Type 22 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 5; SV types t2tINV: 7; TRA: 0 676 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 22 CN segments 0.93 FDR fragment joints 0.15 FDR chr. breakp. enrich. Linked to chrs
235	2	Upper_Right	MELA-0067	11:58806330−124114051	8, 10	64	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	MELA−0067 Skin−Melanoma Cancer type 7:129744428−147453672 Position With other complex events Type 13 Interleaved intrachr. SVs 149 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 4; SV types t2tINV: 3; TRA: 136 676 SVs in sample 8, 10 Oscillating CN (2 and 3 states) 64 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 11:58806330−124114051; Linked to chrs
235	3	Lower_Left	MELA-0067	11:58806330−124114052	11, 11	344	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 272.74200439453125, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB MELA−0067 Skin−Melanoma Cancer type 11:58806330−124114052 Position With other complex events Type 405 Interleaved intrachr. SVs 547 Total SVs (intrachr. + transl.) DEL: 96; DUP: 109; h2hINV: 104; SV types t2tINV: 96; TRA: 142 676 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 344 CN segments 0.83 FDR fragment joints
235	4	Lower_Right	MELA-0067	20:18728454−50145269	7, 15	15	{'min_x': 324.3699951171875, 'min_y': 705.2749633789062, 'max_x': 557.4302368164062, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB MELA−0067 Skin−Melanoma Cancer type 20:18728454−50145269 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 1 676 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 15 CN segments
236	1	Upper_Left	MELA-0070	20:37323724−59336021	15, 15	30	{'min_x': 40.360198974609375, 'min_y': 282.3299865722656, 'max_x': 247.36395263671875, 'max_y': 416.3340148925781}	MELA−0070 Skin−Melanoma Cancer type 5:703450−42018198 Position With other complex events Type 3 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 19 450 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 30 CN segments 0.91 FDR fragment joints 0.34 FDR chr. breakp. enrich. 20:37323724−59336021;9:447092−9513408 Linked to chrs
236	2	Upper_Right	MELA-0070	17:38259169−65526579	9, 10	34	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.42401123046875}	MELA−0070 Skin−Melanoma Cancer type 16:69653875−83050346 Position With other complex events Type 5 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 47 450 SVs in sample 9, 10 Oscillating CN (2 and 3 states) 34 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 17:38259169−65526579; Linked to chrs
236	3	Lower_Left	MELA-0070	17:38259169−65526580	9, 13	30	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	50 MB 60 MB 70 MB MELA−0070 Skin−Melanoma Cancer type 17:38259169−65526580 Position With other complex events Type 7 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 37 450 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 30 CN segments 0.74 FDR fragment joints
236	4	Lower_Right	MELA-0070	20:37323724−59336022	10, 11	21	{'min_x': 321.20001220703125, 'min_y': 705.2749633789062, 'max_x': 519.790283203125, 'max_y': 838.7838134765625}	35 MB 40 MB 45 MB 50 MB 55 MB MELA−0070 Skin−Melanoma Cancer type 20:37323724−59336022 Position With other complex events Type 4 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 12 450 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.64 FDR fragment joints
237	1	Upper_Left	MELA-0075	10:72902980−90393121	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	MELA−0075 Skin−Melanoma Cancer type 10:72902980−90393121 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 0 42 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
237	2	Upper_Right	MELA-0076	14:24748061−58748685	10, 24	24	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0076 Skin−Melanoma Cancer type 14:24748061−58748685 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 5; SV types t2tINV: 6; TRA: 0 59 SVs in sample 10, 24 Oscillating CN (2 and 3 states) 24 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
237	3	Lower_Left	MELA-0160	9:80306032−139519485	13, 15	43	{'min_x': 61.849998474121094, 'min_y': 705.2749633789062, 'max_x': 225.87779235839844, 'max_y': 833.6940307617188}	50 MB 100 MB MELA−0160 Skin−Melanoma Cancer type 9:80306032−139519485 Position With other complex events Type 34 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 13; DUP: 7; h2hINV: 5; SV types t2tINV: 9; TRA: 4 96 SVs in sample 13, 15 Oscillating CN (2 and 3 states) 43 CN segments
237	4	Lower_Right	MELA-0167	5:1403933−109603948	7, 10	31	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 539.9220581054688, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB MELA−0167 Skin−Melanoma Cancer type 5:1403933−109603948 Position With other complex events Type 14 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 38 339 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 31 CN segments 0.59 FDR fragment joints
238	1	Upper_Left	MELA-0167	11:14788852−130055978	7, 12	188	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.3340148925781}	MELA−0167 Skin−Melanoma Cancer type 11:14788852−130055978 Position With other complex events Type 137 Interleaved intrachr. SVs 167 Total SVs (intrachr. + transl.) DEL: 44; DUP: 25; h2hINV: 34; SV types t2tINV: 34; TRA: 30 339 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 188 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
238	2	Upper_Right	MELA-0169	6:70072538−100661050	10, 20	20	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0169 Skin−Melanoma Cancer type 6:70072538−100661050 Position With other complex events Type 5 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 8 95 SVs in sample 10, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
238	3	Lower_Left	MELA-0170	4:5123431−49258772	7, 8	19	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 263.9219665527344, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB MELA−0170 Skin−Melanoma Cancer type 4:5123431−49258772 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 1 83 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 19 CN segments
238	4	Lower_Right	MELA-0174	3:8169851−171292232	7, 7	7	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 544.43212890625, 'max_y': 833.6940307617188}	40 MB 80 MB 120 MB 160 MB MELA−0174 Skin−Melanoma Cancer type 3:8169851−171292232 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 0; SV types t2tINV: 1; TRA: 13 249 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
239	1	Upper_Left	MELA-0174	5:120366559−126309299	14, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.42401123046875}	MELA−0174 Skin−Melanoma Cancer type 9:2192834−27453601 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 12 249 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 5:120366559−126309299; Linked to chrs
239	2	Upper_Right	MELA-0180	11:67275408−80004995	7, 8	8	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	MELA−0180 Skin−Melanoma Cancer type 11:67275408−80004995 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 6; SV types t2tINV: 3; TRA: 0 82 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
239	3	Lower_Left	MELA-0184	9:474983−8830179	8, 11	62	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 228.69007873535156, 'max_y': 833.6940307617188}	5 MB 10 MB 15 MB 20 MB MELA−0184 Skin−Melanoma Cancer type 9:474983−8830179 Position With other complex events Type 13 Interleaved intrachr. SVs 115 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 102 394 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 62 CN segments
239	4	Lower_Right	MELA-0184	17:47916−22130644	8, 11	251	{'min_x': 309.2900085449219, 'min_y': 705.2749633789062, 'max_x': 518.72021484375, 'max_y': 833.6940307617188}	0 MB 20 MB 40 MB 60 MB MELA−0184 Skin−Melanoma Cancer type 17:47916−22130644 Position With other complex events Type 190 Interleaved intrachr. SVs 308 Total SVs (intrachr. + transl.) DEL: 49; DUP: 44; h2hINV: 49; SV types t2tINV: 48; TRA: 118 394 SVs in sample 8, 11 Oscillating CN (2 and 3 states) 251 CN segments
240	1	Upper_Left	MELA-0185	10:17445989−38881097	9, 11	18	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	MELA−0185 Skin−Melanoma Cancer type 10:17445989−38881097 Position With other complex events Type 6 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 12 60 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 18 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 9:18382271−35495731; Linked to chrs
240	2	Upper_Right	MELA-0193	6:548107−82083993	8, 17	59	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0193 Skin−Melanoma Cancer type 6:548107−82083993 Position With other complex events Type 26 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 6; SV types t2tINV: 5; TRA: 20 264 SVs in sample 8, 17 Oscillating CN (2 and 3 states) 59 CN segments 0.79 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
240	3	Lower_Left	MELA-0193	11:4690426−90534996	10, 12	75	{'min_x': 63.519901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB MELA−0193 Skin−Melanoma Cancer type 11:4690426−90534996 Position With other complex events Type 19 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 9; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 27 264 SVs in sample 10, 12 Oscillating CN (2 and 3 states) 75 CN segments
240	4	Lower_Right	MELA-0200	9:13186614−35103688	8, 8	14	{'min_x': 348.3500061035156, 'min_y': 705.2749633789062, 'max_x': 553.21240234375, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB MELA−0200 Skin−Melanoma Cancer type 9:13186614−35103688 Position With other complex events Type 19 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 4; SV types t2tINV: 4; TRA: 4 55 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 14 CN segments
241	1	Upper_Left	MELA-0203	6:44528437−168230895	11, 14	14	{'min_x': 54.730098724365234, 'min_y': 286.6499938964844, 'max_x': 232.99598693847656, 'max_y': 416.3340148925781}	MELA−0203 Skin−Melanoma Cancer type 6:44528437−168230895 Position Canonical without polyploidization Type 21 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 2 44 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 14 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
241	2	Upper_Right	MELA-0223	22:25575062−40335606	11, 11	11	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	MELA−0223 Skin−Melanoma Cancer type 22:25575062−40335606 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 7 104 SVs in sample 11, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
241	3	Lower_Left	MELA-0226	7:123055563−158071677	17, 42	42	{'min_x': 55.139801025390625, 'min_y': 705.2749633789062, 'max_x': 235.23208618164062, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB 140 MB MELA−0226 Skin−Melanoma Cancer type 7:123055563−158071677 Position With other complex events Type 32 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 5; DUP: 10; h2hINV: 10; SV types t2tINV: 7; TRA: 11 152 SVs in sample 17, 42 Oscillating CN (2 and 3 states) 42 CN segments
241	4	Lower_Right	MELA-0229	3:39682784−62393971	7, 11	11	{'min_x': 344.2300109863281, 'min_y': 705.2749633789062, 'max_x': 522.4959716796875, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB MELA−0229 Skin−Melanoma Cancer type 3:39682784−62393971 Position Canonical without polyploidization Type 41 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 10; DUP: 13; h2hINV: 11; SV types t2tINV: 7; TRA: 6 155 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 11 CN segments
242	1	Upper_Left	MELA-0230	4:28707038−182542170	7, 13	347	{'min_x': 58.51020050048828, 'min_y': 286.6499938964844, 'max_x': 229.22010803222656, 'max_y': 416.42401123046875}	MELA−0230 Skin−Melanoma Cancer type 4:28707038−182542170 Position With other complex events Type 242 Interleaved intrachr. SVs 316 Total SVs (intrachr. + transl.) DEL: 66; DUP: 56; h2hINV: 66; SV types t2tINV: 54; TRA: 74 441 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 347 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 8:35775519−80798641; Linked to chrs
242	2	Upper_Right	MELA-0230	4:28707038−182542169	14, 20	46	{'min_x': 351.3500061035156, 'min_y': 286.6499938964844, 'max_x': 515.3779296875, 'max_y': 416.42401123046875}	MELA−0230 Skin−Melanoma Cancer type 8:35775519−80798642 Position With other complex events Type 23 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 10; SV types t2tINV: 5; TRA: 40 441 SVs in sample 14, 20 Oscillating CN (2 and 3 states) 46 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 4:28707038−182542169; Linked to chrs
242	3	Lower_Left	MELA-0231	1:49615754−106759581	10, 11	77	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 271.6219482421875, 'max_y': 835.2338256835938}	50 MB 100 MB 150 MB 200 MB 250 MB MELA−0231 Skin−Melanoma Cancer type 1:49615754−106759581 Position With other complex events Type 43 Interleaved intrachr. SVs 100 Total SVs (intrachr. + transl.) DEL: 10; DUP: 13; h2hINV: 11; SV types t2tINV: 9; TRA: 57 1234 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 77 CN segments 0.89 FDR fragment joints 0 FDR chr. breakp. enrich.
242	4	Lower_Right	MELA-0231	2:5310579−242675572	7, 19	198	{'min_x': 309.4200134277344, 'min_y': 705.2749633789062, 'max_x': 519.8220825195312, 'max_y': 830.9138793945312}	0 MB 50 MB 100 MB 150 MB 200 MB MELA−0231 Skin−Melanoma Cancer type 2:5310579−242675572 Position With other complex events Type 57 Interleaved intrachr. SVs 198 Total SVs (intrachr. + transl.) DEL: 16; DUP: 11; h2hINV: 13; SV types t2tINV: 17; TRA: 141 1234 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 198 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich.
243	1	Upper_Left	MELA-0231	10:19180867−131722345	8, 12	150	{'min_x': 30.360200881958008, 'min_y': 269.3699645996094, 'max_x': 257.36993408203125, 'max_y': 416.424072265625}	MELA−0231 Skin−Melanoma Cancer type 5:4413255−157081452 Position With other complex events Type 80 Interleaved intrachr. SVs 146 Total SVs (intrachr. + transl.) DEL: 20; DUP: 15; h2hINV: 21; SV types t2tINV: 24; TRA: 66 1234 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 150 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 10:19180867−131722345;11:85905386−127883070 14:27456610−34055767;2:5310579−242675571 20:5565486−62296241;4:58934408−183626933 Linked to chrs
243	2	Upper_Right	MELA-0231	1:49615754−106759580	8, 9	117	{'min_x': 321.5199890136719, 'min_y': 273.6899719238281, 'max_x': 545.2039794921875, 'max_y': 420.74407958984375}	MELA−0231 Skin−Melanoma Cancer type 6:76285221−169646112 Position With other complex events Type 37 Interleaved intrachr. SVs 133 Total SVs (intrachr. + transl.) DEL: 10; DUP: 10; h2hINV: 6; SV types t2tINV: 11; TRA: 96 1234 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 117 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 1:49615754−106759580;11:85905386−127883070 2:5310579−242675571;20:5565486−62296241 Linked to chrs 4:58934408−183626933;7:712296−54531287
243	3	Lower_Left	MELA-0231	9:396152−20238662	8, 9	29	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 224.2118377685547, 'max_y': 838.7838134765625}	50 MB 100 MB MELA−0231 Skin−Melanoma Cancer type 9:396152−20238662 Position With other complex events Type 9 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 18 1234 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 29 CN segments 0.59 FDR fragment joints
243	4	Lower_Right	MELA-0231	11:85905386−127883071	7, 11	43	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 513.7119140625, 'max_y': 830.1439819335938}	50 MB 100 MB MELA−0231 Skin−Melanoma Cancer type 11:85905386−127883071 Position With other complex events Type 7 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 28 1234 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 43 CN segments 0.64 FDR fragment joints
244	1	Upper_Left	MELA-0231	12:4111597−34617370	7, 7	27	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	MELA−0231 Skin−Melanoma Cancer type 12:4111597−34617370 Position With other complex events Type 9 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 6 1234 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 27 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. 9:396152−20238661; Linked to chrs
244	2	Upper_Right	MELA-0231	X:114145722−144057315	9, 14	24	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	MELA−0231 Skin−Melanoma Cancer type X:114145722−144057315 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 1 1234 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 24 CN segments 0.84 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
244	3	Lower_Left	MELA-0234	11:83286872−101298726	8, 8	8	{'min_x': 44.900001525878906, 'min_y': 705.2749633789062, 'max_x': 264.12200927734375, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB MELA−0234 Skin−Melanoma Cancer type 11:83286872−101298726 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 0 128 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments
244	4	Lower_Right	MELA-0239	1:36546861−105343304	42, 42	63	{'min_x': 319.05999755859375, 'min_y': 705.2749633789062, 'max_x': 542.4821166992188, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB MELA−0239 Skin−Melanoma Cancer type 1:36546861−105343304 Position Canonical without polyploidization Type 48 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 13; DUP: 14; h2hINV: 11; SV types t2tINV: 10; TRA: 0 93 SVs in sample 42, 42 Oscillating CN (2 and 3 states) 63 CN segments
245	1	Upper_Left	01ad975d-c2ed-4e4d-bd3b-c9512fc9073c	17:34042841−67932342	14, 14	14	{'min_x': 38.88010025024414, 'min_y': 286.6499938964844, 'max_x': 248.84996032714844, 'max_y': 416.3340148925781}	01ad975d−c2ed−4e4d−bd3b−c9512fc9073c Skin−Melanoma Cancer type 17:34042841−67932342 Position Before polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 0 50 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
245	2	Upper_Right	1404791b-86bf-4dfd-85b4-c8ff356f109c	11:33008500−79611121	11, 29	53	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5379638671875, 'max_y': 416.4242248535156}	1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 6:503244−53879504 Position With other complex events Type 30 Interleaved intrachr. SVs 124 Total SVs (intrachr. + transl.) DEL: 4; DUP: 9; h2hINV: 7; SV types t2tINV: 10; TRA: 94 573 SVs in sample 11, 29 Oscillating CN (2 and 3 states) 53 CN segments 0.63 FDR fragment joints 0 FDR chr. breakp. enrich. 11:33008500−79611121;19:32205724−58908288 22:29353674−50585361;7:306183−65693058 Linked to chrs
245	3	Lower_Left	1404791b-86bf-4dfd-85b4-c8ff356f109c	11:33008500−79611122	13, 19	58	{'min_x': 38.70000076293945, 'min_y': 705.2749633789062, 'max_x': 270.97198486328125, 'max_y': 838.7838134765625}	50 MB 70 MB 90 MB 110 MB 1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 11:33008500−79611122 Position With other complex events Type 6 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 1; SV types t2tINV: 4; TRA: 77 573 SVs in sample 13, 19 Oscillating CN (2 and 3 states) 58 CN segments 0.59 FDR fragment joints
245	4	Lower_Right	1404791b-86bf-4dfd-85b4-c8ff356f109c	17:26903274−78531573	7, 18	37	{'min_x': 315.7699890136719, 'min_y': 705.2749633789062, 'max_x': 535.3478393554688, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 17:26903274−78531573 Position With other complex events Type 26 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 9; DUP: 6; h2hINV: 7; SV types t2tINV: 4; TRA: 19 573 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 37 CN segments
246	1	Upper_Left	210726bd-db19-48ae-9a3d-e6ac44480e85	5:1296282−31464643	7, 7	24	{'min_x': 38.539798736572266, 'min_y': 286.6499938964844, 'max_x': 249.18795776367188, 'max_y': 416.3340148925781}	210726bd−db19−48ae−9a3d−e6ac44480e85 Skin−Melanoma Cancer type 5:1296282−31464643 Position With other complex events Type 24 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 7; SV types t2tINV: 7; TRA: 1 108 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 24 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
246	2	Upper_Right	210726bd-db19-48ae-9a3d-e6ac44480e85	12:44527293−127533801	8, 16	16	{'min_x': 328.0400085449219, 'min_y': 286.6499938964844, 'max_x': 538.6878662109375, 'max_y': 416.3340148925781}	210726bd−db19−48ae−9a3d−e6ac44480e85 Skin−Melanoma Cancer type 12:44527293−127533801 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 3 108 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
246	3	Lower_Left	3582fb74-f43d-4fcd-8f22-bb1506fcff1c	5:52969272−84413143	13, 23	23	{'min_x': 43.21989822387695, 'min_y': 705.2749633789062, 'max_x': 244.51197814941406, 'max_y': 833.6940307617188}	60 MB 70 MB 80 MB 3582fb74−f43d−4fcd−8f22−bb1506fcff1c Skin−Melanoma Cancer type 5:52969272−84413143 Position With other complex events Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 1 179 SVs in sample 13, 23 Oscillating CN (2 and 3 states) 23 CN segments
246	4	Lower_Right	3582fb74-f43d-4fcd-8f22-bb1506fcff1c	11:68283918−109705790	7, 11	40	{'min_x': 322.9599914550781, 'min_y': 705.2749633789062, 'max_x': 562.0020141601562, 'max_y': 833.6940307617188}	70 MB 80 MB 90 MB 100 MB 110 MB 3582fb74−f43d−4fcd−8f22−bb1506fcff1c Skin−Melanoma Cancer type 11:68283918−109705790 Position With other complex events Type 7 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 33 179 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 40 CN segments
247	1	Upper_Left	3fea3f02-2db3-44e0-984e-c61130d92c9b	9:34192125−138885872	15, 37	50	{'min_x': 40.06990051269531, 'min_y': 286.6499938964844, 'max_x': 247.6617889404297, 'max_y': 416.3340148925781}	3fea3f02−2db3−44e0−984e−c61130d92c9b Skin−Melanoma Cancer type 9:34192125−138885872 Position With other complex events Type 28 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 10; SV types t2tINV: 8; TRA: 2 262 SVs in sample 15, 37 Oscillating CN (2 and 3 states) 50 CN segments 0.62 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
247	2	Upper_Right	40e17bf8-6c19-4e5e-b60d-ad54f504a970	22:29683567−49998523	21, 46	46	{'min_x': 329.5400085449219, 'min_y': 286.6499938964844, 'max_x': 537.19189453125, 'max_y': 416.42401123046875}	40e17bf8−6c19−4e5e−b60d−ad54f504a970 Skin−Melanoma Cancer type 9:32139979−140579391 Position With other complex events Type 21 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 5; SV types t2tINV: 3; TRA: 4 140 SVs in sample 21, 46 Oscillating CN (2 and 3 states) 46 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 22:29683567−49998523; Linked to chrs
247	3	Lower_Left	40e17bf8-6c19-4e5e-b60d-ad54f504a970	22:29683567−49998524	16, 16	16	{'min_x': 40.039798736572266, 'min_y': 705.2749633789062, 'max_x': 261.71978759765625, 'max_y': 833.6940307617188}	30 MB 35 MB 40 MB 45 MB 50 MB 40e17bf8−6c19−4e5e−b60d−ad54f504a970 Skin−Melanoma Cancer type 22:29683567−49998524 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 4 140 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
247	4	Lower_Right	5bc515c8-7727-4d69-98e9-31bbcb748550	1:145684513−247510948	11, 43	77	{'min_x': 328.0400085449219, 'min_y': 705.2749633789062, 'max_x': 538.6879272460938, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB 5bc515c8−7727−4d69−98e9−31bbcb748550 Skin−Melanoma Cancer type 1:145684513−247510948 Position With other complex events Type 36 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 8; SV types t2tINV: 8; TRA: 0 178 SVs in sample 11, 43 Oscillating CN (2 and 3 states) 77 CN segments
248	1	Upper_Left	5bc515c8-7727-4d69-98e9-31bbcb748550	1:145684513−247510947	9, 15	74	{'min_x': 38.539798736572266, 'min_y': 286.6499938964844, 'max_x': 249.18795776367188, 'max_y': 416.42401123046875}	5bc515c8−7727−4d69−98e9−31bbcb748550 Skin−Melanoma Cancer type 15:45003571−101242417 Position With other complex events Type 50 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 19; DUP: 11; h2hINV: 10; SV types t2tINV: 10; TRA: 18 178 SVs in sample 9, 15 Oscillating CN (2 and 3 states) 74 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145684513−247510947; Linked to chrs
248	2	Upper_Right	5f6df69c-4ebf-4811-8b28-ad393dfbe1a3	2:15930327−35023335	20, 20	20	{'min_x': 324.8599853515625, 'min_y': 282.3299865722656, 'max_x': 541.8719482421875, 'max_y': 420.74383544921875}	5f6df69c−4ebf−4811−8b28−ad393dfbe1a3 Skin−Melanoma Cancer type 18:69402625−77693227 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 10 160 SVs in sample 20, 20 Oscillating CN (2 and 3 states) 20 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 2:15930327−35023335;3:81208042−140376908 Linked to chrs 6:80713179−118504283;
248	3	Lower_Left	5f6df69c-4ebf-4811-8b28-ad393dfbe1a3	20:40210929−55897885	14, 16	16	{'min_x': 39.91019821166992, 'min_y': 705.2749633789062, 'max_x': 267.5901794433594, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 60 MB 5f6df69c−4ebf−4811−8b28−ad393dfbe1a3 Skin−Melanoma Cancer type 20:40210929−55897885 Position After polyploidization Type 12 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 2 160 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
248	4	Lower_Right	68f75ab5-9d77-40c5-a8ce-f56016bbe9e4	19:969992−20616012	11, 14	211	{'min_x': 329.5400085449219, 'min_y': 705.2749633789062, 'max_x': 551.22998046875, 'max_y': 833.6940307617188}	5 MB 10 MB 15 MB 20 MB 68f75ab5−9d77−40c5−a8ce−f56016bbe9e4 Skin−Melanoma Cancer type 19:969992−20616012 Position With other complex events Type 269 Interleaved intrachr. SVs 271 Total SVs (intrachr. + transl.) DEL: 79; DUP: 69; h2hINV: 58; SV types t2tINV: 63; TRA: 2 305 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 211 CN segments
249	1	Upper_Left	76cc1d42-acec-46b3-9663-5e4de2550353	2:182474699−242863436	42, 47	47	{'min_x': 38.86989974975586, 'min_y': 286.6499938964844, 'max_x': 248.8579559326172, 'max_y': 416.3340148925781}	76cc1d42−acec−46b3−9663−5e4de2550353 Skin−Melanoma Cancer type 2:182474699−242863436 Position Canonical without polyploidization Type 27 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 8; SV types t2tINV: 6; TRA: 1 245 SVs in sample 42, 47 Oscillating CN (2 and 3 states) 47 CN segments 0.96 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
249	2	Upper_Right	76cc1d42-acec-46b3-9663-5e4de2550353	4:176289985−190678345	18, 18	18	{'min_x': 328.3699951171875, 'min_y': 286.6499938964844, 'max_x': 538.35791015625, 'max_y': 416.3340148925781}	76cc1d42−acec−46b3−9663−5e4de2550353 Skin−Melanoma Cancer type 4:176289985−190678345 Position After polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 245 SVs in sample 18, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.97 FDR fragment joints 1 FDR chr. breakp. enrich. Linked to chrs
249	3	Lower_Left	76cc1d42-acec-46b3-9663-5e4de2550353	5:253936−44452670	7, 25	67	{'min_x': 38.86989974975586, 'min_y': 705.2749633789062, 'max_x': 248.8579559326172, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 76cc1d42−acec−46b3−9663−5e4de2550353 Skin−Melanoma Cancer type 5:253936−44452670 Position With other complex events Type 52 Interleaved intrachr. SVs 86 Total SVs (intrachr. + transl.) DEL: 11; DUP: 14; h2hINV: 13; SV types t2tINV: 14; TRA: 34 245 SVs in sample 7, 25 Oscillating CN (2 and 3 states) 67 CN segments
249	4	Lower_Right	7b92fcd4-f9be-4b97-94a2-b2e8348aeaba	X:118264440−146947067	7, 14	20	{'min_x': 319.5, 'min_y': 705.2749633789062, 'max_x': 537.5219116210938, 'max_y': 833.6940307617188}	120 MB 130 MB 140 MB 7b92fcd4−f9be−4b97−94a2−b2e8348aeaba Skin−Melanoma Cancer type X:118264440−146947067 Position With other complex events Type 12 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 0; h2hINV: 3; SV types t2tINV: 4; TRA: 4 137 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 20 CN segments
250	1	Upper_Left	7ce09a09-074e-4f38-bed7-98ab34347fbe	11:5892683−117914382	10, 19	91	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 416.3340148925781}	7ce09a09−074e−4f38−bed7−98ab34347fbe Skin−Melanoma Cancer type 1:149816333−248002432 Position With other complex events Type 52 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 13; DUP: 15; h2hINV: 12; SV types t2tINV: 12; TRA: 18 201 SVs in sample 10, 19 Oscillating CN (2 and 3 states) 91 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 11:5892683−117914382;7:61559135−158613295 Linked to chrs
250	2	Upper_Right	7ce09a09-074e-4f38-bed7-98ab34347fbe	1:149816333−248002431	10, 11	49	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 420.74383544921875}	7ce09a09−074e−4f38−bed7−98ab34347fbe Skin−Melanoma Cancer type 7:61559135−158613296 Position With other complex events Type 26 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 8; SV types t2tINV: 8; TRA: 31 201 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 49 CN segments 0.71 FDR fragment joints 0 FDR chr. breakp. enrich. 1:149816333−248002431;11:5892683−117914382 Linked to chrs 3:120763840−170508367;
250	3	Lower_Left	7ce09a09-074e-4f38-bed7-98ab34347fbe	11:5892683−117914383	8, 24	30	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 263.9619445800781, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB 7ce09a09−074e−4f38−bed7−98ab34347fbe Skin−Melanoma Cancer type 11:5892683−117914383 Position With other complex events Type 5 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 0; TRA: 10 201 SVs in sample 8, 24 Oscillating CN (2 and 3 states) 30 CN segments 0.59 FDR fragment joints
250	4	Lower_Right	800d3a17-269f-4d97-94ff-8585f20038d8	2:32129440−88367600	8, 14	23	{'min_x': 330.6000061035156, 'min_y': 705.2749633789062, 'max_x': 546.8720703125, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 2:32129440−88367600 Position With other complex events Type 17 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 5; SV types t2tINV: 4; TRA: 17 337 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 23 CN segments
251	1	Upper_Left	800d3a17-269f-4d97-94ff-8585f20038d8	15:60170393−102151414	8, 17	76	{'min_x': 37.03010177612305, 'min_y': 282.3299865722656, 'max_x': 250.69595336914062, 'max_y': 416.3340148925781}	800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 3:69695493−193847204 Position With other complex events Type 29 Interleaved intrachr. SVs 67 Total SVs (intrachr. + transl.) DEL: 4; DUP: 10; h2hINV: 5; SV types t2tINV: 10; TRA: 38 337 SVs in sample 8, 17 Oscillating CN (2 and 3 states) 76 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 15:60170393−102151414;7:112828−25746189 Linked to chrs
251	2	Upper_Right	800d3a17-269f-4d97-94ff-8585f20038d8	4:58983388−104017952	8, 9	29	{'min_x': 331.0400085449219, 'min_y': 286.6499938964844, 'max_x': 535.6859130859375, 'max_y': 416.3340148925781}	800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 4:58983388−104017952 Position With other complex events Type 15 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 3 337 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 29 CN segments 0.64 FDR fragment joints 0.36 FDR chr. breakp. enrich. Linked to chrs
251	3	Lower_Left	800d3a17-269f-4d97-94ff-8585f20038d8	7:112828−25746190	8, 9	56	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 246.1859588623047, 'max_y': 838.7838134765625}	50 MB 100 MB 800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 7:112828−25746190 Position With other complex events Type 15 Interleaved intrachr. SVs 62 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 47 337 SVs in sample 8, 9 Oscillating CN (2 and 3 states) 56 CN segments 0.9 FDR fragment joints
251	4	Lower_Right	800d3a17-269f-4d97-94ff-8585f20038d8	11:14627440−19120746	11, 29	48	{'min_x': 326.8500061035156, 'min_y': 705.2749633789062, 'max_x': 535.6859130859375, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 11:14627440−19120746 Position With other complex events Type 44 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 8; DUP: 14; h2hINV: 10; SV types t2tINV: 12; TRA: 9 337 SVs in sample 11, 29 Oscillating CN (2 and 3 states) 48 CN segments
252	1	Upper_Left	800d3a17-269f-4d97-94ff-8585f20038d8	11:14627440−19120745	7, 7	80	{'min_x': 33.68980026245117, 'min_y': 282.3299865722656, 'max_x': 254.03794860839844, 'max_y': 420.74383544921875}	800d3a17−269f−4d97−94ff−8585f20038d8 Skin−Melanoma Cancer type 15:60170393−102151415 Position With other complex events Type 23 Interleaved intrachr. SVs 81 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 6; SV types t2tINV: 7; TRA: 58 337 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 80 CN segments 0.67 FDR fragment joints 0 FDR chr. breakp. enrich. 11:14627440−19120745;3:69695493−193847203 Linked to chrs 7:112828−25746189;
252	2	Upper_Right	81cedb9e-ee43-476b-9ed9-8d0fdb346065	6:89466188−158235277	15, 21	21	{'min_x': 328.3800048828125, 'min_y': 286.6499938964844, 'max_x': 538.349853515625, 'max_y': 416.3340148925781}	81cedb9e−ee43−476b−9ed9−8d0fdb346065 Skin−Melanoma Cancer type 6:89466188−158235277 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 57 SVs in sample 15, 21 Oscillating CN (2 and 3 states) 21 CN segments 0.98 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
252	3	Lower_Left	85400bf1-23e0-4e0f-8df7-f0d108641aee	1:7068840−120031293	12, 19	42	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 270.84185791015625, 'max_y': 838.7838134765625}	30 MB 60 MB 90 MB 120 MB 85400bf1−23e0−4e0f−8df7−f0d108641aee Skin−Melanoma Cancer type 1:7068840−120031293 Position With other complex events Type 77 Interleaved intrachr. SVs 102 Total SVs (intrachr. + transl.) DEL: 20; DUP: 21; h2hINV: 18; SV types t2tINV: 18; TRA: 25 219 SVs in sample 12, 19 Oscillating CN (2 and 3 states) 42 CN segments 0.97 FDR fragment joints
252	4	Lower_Right	85400bf1-23e0-4e0f-8df7-f0d108641aee	8:19835544−144243959	9, 18	43	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 535.6858520507812, 'max_y': 838.7838134765625}	50 MB 100 MB 85400bf1−23e0−4e0f−8df7−f0d108641aee Skin−Melanoma Cancer type 8:19835544−144243959 Position With other complex events Type 55 Interleaved intrachr. SVs 90 Total SVs (intrachr. + transl.) DEL: 16; DUP: 12; h2hINV: 15; SV types t2tINV: 12; TRA: 35 219 SVs in sample 9, 18 Oscillating CN (2 and 3 states) 43 CN segments 0.86 FDR fragment joints
253	1	Upper_Left	85400bf1-23e0-4e0f-8df7-f0d108641aee	1:7068840−120031292	8, 8	8	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 416.3340148925781}	85400bf1−23e0−4e0f−8df7−f0d108641aee Skin−Melanoma Cancer type 9:72055003−138463855 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 33 219 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 1:7068840−120031292;8:19835544−144243958 Linked to chrs
253	2	Upper_Right	8c54fcfd-999f-43c5-b31f-26d006f5fff3	12:12308231−133162422	7, 13	99	{'min_x': 333.7200012207031, 'min_y': 286.6499938964844, 'max_x': 533.0038452148438, 'max_y': 416.42401123046875}	8c54fcfd−999f−43c5−b31f−26d006f5fff3 Skin−Melanoma Cancer type 12:12308231−133162422 Position With other complex events Type 97 Interleaved intrachr. SVs 134 Total SVs (intrachr. + transl.) DEL: 23; DUP: 27; h2hINV: 21; SV types t2tINV: 26; TRA: 37 351 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 99 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. 8:27003357−144300867; Linked to chrs
253	3	Lower_Left	97d9dfc9-c937-48b4-b453-df081950419f	6:30956994−44170027	8, 16	16	{'min_x': 40.539798736572266, 'min_y': 705.2749633789062, 'max_x': 247.1839599609375, 'max_y': 833.6940307617188}	35 MB 40 MB 97d9dfc9−c937−48b4−b453−df081950419f Skin−Melanoma Cancer type 6:30956994−44170027 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 0 38 SVs in sample 8, 16 Oscillating CN (2 and 3 states) 16 CN segments
253	4	Lower_Right	a01a350d-64be-4af3-91c3-7d681c3db11d	1:150504464−246161534	17, 60	65	{'min_x': 304.32000732421875, 'min_y': 705.2749633789062, 'max_x': 538.18994140625, 'max_y': 833.6940307617188}	150 MB 175 MB 200 MB 225 MB a01a350d−64be−4af3−91c3−7d681c3db11d Skin−Melanoma Cancer type 1:150504464−246161534 Position With other complex events Type 47 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 11; DUP: 8; h2hINV: 13; SV types t2tINV: 15; TRA: 1 78 SVs in sample 17, 60 Oscillating CN (2 and 3 states) 65 CN segments
254	1	Upper_Left	b85b14d7-3b5a-4800-af12-622ec03b9fe5	3:47423861−128885161	10, 20	145	{'min_x': 39.91019821166992, 'min_y': 286.6499938964844, 'max_x': 247.82211303710938, 'max_y': 416.42401123046875}	b85b14d7−3b5a−4800−af12−622ec03b9fe5 Skin−Melanoma Cancer type 18:274892−77288441 Position With other complex events Type 232 Interleaved intrachr. SVs 254 Total SVs (intrachr. + transl.) DEL: 56; DUP: 58; h2hINV: 58; SV types t2tINV: 60; TRA: 22 633 SVs in sample 10, 20 Oscillating CN (2 and 3 states) 145 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 3:47423861−128885161; Linked to chrs
254	2	Upper_Right	be73fde2-d843-426b-9306-a02d3f2a754b	7:10477885−62019633	13, 13	32	{'min_x': 329.2099914550781, 'min_y': 286.6499938964844, 'max_x': 537.5219116210938, 'max_y': 416.3340148925781}	be73fde2−d843−426b−9306−a02d3f2a754b Skin−Melanoma Cancer type 7:10477885−62019633 Position With other complex events Type 10 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 11 50 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 32 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
254	3	Lower_Left	c2948fe9-5798-43bc-a743-511e94e417f8	1:150445691−247569477	21, 37	97	{'min_x': 40.56990051269531, 'min_y': 705.2749633789062, 'max_x': 247.16192626953125, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB c2948fe9−5798−43bc−a743−511e94e417f8 Skin−Melanoma Cancer type 1:150445691−247569477 Position With other complex events Type 56 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 15; DUP: 16; h2hINV: 13; SV types t2tINV: 12; TRA: 2 236 SVs in sample 21, 37 Oscillating CN (2 and 3 states) 97 CN segments
254	4	Lower_Right	c2948fe9-5798-43bc-a743-511e94e417f8	7:83569717−150614810	9, 9	9	{'min_x': 330.07000732421875, 'min_y': 705.2749633789062, 'max_x': 559.4219360351562, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB c2948fe9−5798−43bc−a743−511e94e417f8 Skin−Melanoma Cancer type 7:83569717−150614810 Position After polyploidization Type 57 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 14; DUP: 13; h2hINV: 11; SV types t2tINV: 19; TRA: 0 236 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
255	1	Upper_Left	d8eac750-9daf-4465-b672-9e31fd369057	21:15944010−48061613	17, 26	26	{'min_x': 40.039798736572266, 'min_y': 286.6499938964844, 'max_x': 247.69195556640625, 'max_y': 416.3340148925781}	d8eac750−9daf−4465−b672−9e31fd369057 Skin−Melanoma Cancer type 21:15944010−48061613 Position After polyploidization Type 72 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 21; DUP: 15; h2hINV: 19; SV types t2tINV: 17; TRA: 1 266 SVs in sample 17, 26 Oscillating CN (2 and 3 states) 26 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
255	2	Upper_Right	e36c9411-773b-4a8e-9b43-895b3cb044c7	13:33553524−110451695	22, 22	22	{'min_x': 328.20001220703125, 'min_y': 286.6499938964844, 'max_x': 538.5279541015625, 'max_y': 416.3340148925781}	e36c9411−773b−4a8e−9b43−895b3cb044c7 Skin−Melanoma Cancer type 13:33553524−110451695 Position Canonical without polyploidization Type 72 Interleaved intrachr. SVs 105 Total SVs (intrachr. + transl.) DEL: 19; DUP: 19; h2hINV: 16; SV types t2tINV: 18; TRA: 33 167 SVs in sample 22, 22 Oscillating CN (2 and 3 states) 22 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
255	3	Lower_Left	12bfd446-2ee5-4664-a492-c023d134f60f	9:434615−126676283	9, 34	54	{'min_x': 40.86989974975586, 'min_y': 705.2749633789062, 'max_x': 267.8419189453125, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 12bfd446−2ee5−4664−a492−c023d134f60f SoftTissue−Leiomyo Cancer type 9:434615−126676283 Position With other complex events Type 37 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 10; SV types t2tINV: 10; TRA: 4 247 SVs in sample 9, 34 Oscillating CN (2 and 3 states) 54 CN segments
255	4	Lower_Right	12bfd446-2ee5-4664-a492-c023d134f60f	12:49689929−126602595	7, 7	7	{'min_x': 310.5199890136719, 'min_y': 705.2749633789062, 'max_x': 536.3538818359375, 'max_y': 833.6940307617188}	50 MB 70 MB 90 MB 110 MB 12bfd446−2ee5−4664−a492−c023d134f60f SoftTissue−Leiomyo Cancer type 12:49689929−126602595 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 2 247 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
256	1	Upper_Left	257dc623-41e1-4fa3-859c-c787db10bd60	1:69086265−109086561	16, 18	21	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 1:69086265−109086561 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 356 SVs in sample 16, 18 Oscillating CN (2 and 3 states) 21 CN segments 0.88 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
256	2	Upper_Right	257dc623-41e1-4fa3-859c-c787db10bd60	4:18377040−178289697	7, 13	56	{'min_x': 328.7099914550781, 'min_y': 286.6499938964844, 'max_x': 538.0199584960938, 'max_y': 416.42401123046875}	257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 2:47029935−227773557 Position With other complex events Type 22 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 8; SV types t2tINV: 6; TRA: 41 356 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 56 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 4:18377040−178289697; Linked to chrs
256	3	Lower_Left	257dc623-41e1-4fa3-859c-c787db10bd60	4:18377040−178289698	13, 25	46	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 248.51995849609375, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 4:18377040−178289698 Position With other complex events Type 27 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 6; SV types t2tINV: 6; TRA: 18 356 SVs in sample 13, 25 Oscillating CN (2 and 3 states) 46 CN segments 0.96 FDR fragment joints
256	4	Lower_Right	257dc623-41e1-4fa3-859c-c787db10bd60	6:5887196−52586986	7, 11	52	{'min_x': 308.69000244140625, 'min_y': 705.2749633789062, 'max_x': 549.7523803710938, 'max_y': 833.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB 257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 6:5887196−52586986 Position With other complex events Type 27 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 9; DUP: 6; h2hINV: 7; SV types t2tINV: 5; TRA: 3 356 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 52 CN segments
257	1	Upper_Left	257dc623-41e1-4fa3-859c-c787db10bd60	7:72402131−155562912	10, 17	17	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 7:72402131−155562912 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 7; SV types t2tINV: 3; TRA: 0 356 SVs in sample 10, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.59 FDR fragment joints 0.31 FDR chr. breakp. enrich. Linked to chrs
257	2	Upper_Right	257dc623-41e1-4fa3-859c-c787db10bd60	4:18377040−178289697	7, 9	15	{'min_x': 328.7099914550781, 'min_y': 286.6499938964844, 'max_x': 538.0199584960938, 'max_y': 416.42401123046875}	257dc623−41e1−4fa3−859c−c787db10bd60 SoftTissue−Leiomyo Cancer type 9:11837191−29559822 Position With other complex events Type 6 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 10 356 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 15 CN segments 0.91 FDR fragment joints 0.27 FDR chr. breakp. enrich. 4:18377040−178289697; Linked to chrs
257	3	Lower_Left	5a64f7e9-3833-4a3c-962b-13eb3e305c69	2:3363332−238409727	32, 39	39	{'min_x': 39.70000076293945, 'min_y': 705.2749633789062, 'max_x': 248.0299530029297, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB 5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 2:3363332−238409727 Position Canonical without polyploidization Type 23 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 5; SV types t2tINV: 5; TRA: 20 339 SVs in sample 32, 39 Oscillating CN (2 and 3 states) 39 CN segments
257	4	Lower_Right	5a64f7e9-3833-4a3c-962b-13eb3e305c69	3:95733851−125309240	14, 16	16	{'min_x': 309.1000061035156, 'min_y': 705.2749633789062, 'max_x': 537.5299072265625, 'max_y': 833.6940307617188}	0 MB 50 MB 100 MB 150 MB 5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 3:95733851−125309240 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 5; TRA: 0 339 SVs in sample 14, 16 Oscillating CN (2 and 3 states) 16 CN segments
258	1	Upper_Left	5a64f7e9-3833-4a3c-962b-13eb3e305c69	9:1710868−35411917	32, 34	44	{'min_x': 39.70000076293945, 'min_y': 286.6499938964844, 'max_x': 248.0299530029297, 'max_y': 416.3340148925781}	5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 9:1710868−35411917 Position Canonical without polyploidization Type 31 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 8; SV types t2tINV: 10; TRA: 2 339 SVs in sample 32, 34 Oscillating CN (2 and 3 states) 44 CN segments 0.73 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
258	2	Upper_Right	5a64f7e9-3833-4a3c-962b-13eb3e305c69	12:107038045−133376551	10, 24	87	{'min_x': 329.20001220703125, 'min_y': 286.6499938964844, 'max_x': 537.5299072265625, 'max_y': 416.3340148925781}	5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 12:107038045−133376551 Position With other complex events Type 80 Interleaved intrachr. SVs 81 Total SVs (intrachr. + transl.) DEL: 22; DUP: 17; h2hINV: 21; SV types t2tINV: 20; TRA: 1 339 SVs in sample 10, 24 Oscillating CN (2 and 3 states) 87 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
258	3	Lower_Left	5a64f7e9-3833-4a3c-962b-13eb3e305c69	16:3616081−84764407	10, 10	10	{'min_x': 39.70000076293945, 'min_y': 705.2749633789062, 'max_x': 255.6599884033203, 'max_y': 833.6940307617188}	20 MB 40 MB 60 MB 80 MB 5a64f7e9−3833−4a3c−962b−13eb3e305c69 SoftTissue−Leiomyo Cancer type 16:3616081−84764407 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 2 339 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
258	4	Lower_Right	7f9031da-124a-4a38-83e6-878a50e58c24	21:14637168−34593655	16, 16	16	{'min_x': 311.67999267578125, 'min_y': 705.2749633789062, 'max_x': 537.3599243164062, 'max_y': 833.6940307617188}	15 MB 20 MB 25 MB 30 MB 7f9031da−124a−4a38−83e6−878a50e58c24 SoftTissue−Leiomyo Cancer type 21:14637168−34593655 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 5 229 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments
259	1	Upper_Left	8654c2b5-27d7-43c5-9a39-7fdefd7a0324	3:12932880−76585300	9, 22	29	{'min_x': 40.039798736572266, 'min_y': 286.6499938964844, 'max_x': 247.69195556640625, 'max_y': 416.42401123046875}	8654c2b5−27d7−43c5−9a39−7fdefd7a0324 SoftTissue−Leiomyo Cancer type 9:1318657−44240245 Position With other complex events Type 17 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 6; TRA: 3 38 SVs in sample 9, 22 Oscillating CN (2 and 3 states) 29 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 3:12932880−76585300; Linked to chrs
259	2	Upper_Right	9c9b53e5-cdbe-4510-a839-4a3b5039681b	18:25133083−67867957	7, 15	41	{'min_x': 328.0400085449219, 'min_y': 286.6499938964844, 'max_x': 538.6879272460938, 'max_y': 416.42401123046875}	9c9b53e5−cdbe−4510−a839−4a3b5039681b SoftTissue−Leiomyo Cancer type 3:9549122−195919822 Position With other complex events Type 18 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 8; DUP: 3; h2hINV: 1; SV types t2tINV: 6; TRA: 6 240 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 41 CN segments 0.48 FDR fragment joints 0.01 FDR chr. breakp. enrich. 18:25133083−67867957; Linked to chrs
259	3	Lower_Left	9c9b53e5-cdbe-4510-a839-4a3b5039681b	13:62209862−72754123	7, 7	7	{'min_x': 38.539798736572266, 'min_y': 705.2749633789062, 'max_x': 261.3219299316406, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 9c9b53e5−cdbe−4510−a839−4a3b5039681b SoftTissue−Leiomyo Cancer type 13:62209862−72754123 Position After polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 240 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments
259	4	Lower_Right	9c9b53e5-cdbe-4510-a839-4a3b5039681b	21:10931511−44826284	12, 15	34	{'min_x': 328.0400085449219, 'min_y': 705.2749633789062, 'max_x': 538.6879272460938, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 9c9b53e5−cdbe−4510−a839−4a3b5039681b SoftTissue−Leiomyo Cancer type 21:10931511−44826284 Position With other complex events Type 13 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 5 240 SVs in sample 12, 15 Oscillating CN (2 and 3 states) 34 CN segments
260	1	Upper_Left	c20682a1-f340-430d-99f9-077fe093ed19	10:32651421−125302235	11, 16	44	{'min_x': 41.06990051269531, 'min_y': 286.6499938964844, 'max_x': 246.65390014648438, 'max_y': 416.3340148925781}	c20682a1−f340−430d−99f9−077fe093ed19 SoftTissue−Leiomyo Cancer type 10:32651421−125302235 Position With other complex events Type 21 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 3; SV types t2tINV: 5; TRA: 1 215 SVs in sample 11, 16 Oscillating CN (2 and 3 states) 44 CN segments 0.72 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
260	2	Upper_Right	ea3a524b-6ee3-4904-8924-29fcaa20985c	2:9263222−242771261	7, 14	14	{'min_x': 329.3699951171875, 'min_y': 286.6499938964844, 'max_x': 537.3599243164062, 'max_y': 416.42401123046875}	ea3a524b−6ee3−4904−8924−29fcaa20985c SoftTissue−Leiomyo Cancer type 1:2466876−6163124 Position With other complex events Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 2; TRA: 9 318 SVs in sample 7, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.64 FDR fragment joints 1 FDR chr. breakp. enrich. 2:9263222−242771261; Linked to chrs
260	3	Lower_Left	ea3a524b-6ee3-4904-8924-29fcaa20985c	2:9263222−242771262	12, 19	103	{'min_x': 39.86989974975586, 'min_y': 705.2749633789062, 'max_x': 247.85995483398438, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 200 MB ea3a524b−6ee3−4904−8924−29fcaa20985c SoftTissue−Leiomyo Cancer type 2:9263222−242771262 Position With other complex events Type 22 Interleaved intrachr. SVs 126 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 6; SV types t2tINV: 3; TRA: 104 318 SVs in sample 12, 19 Oscillating CN (2 and 3 states) 103 CN segments 0.73 FDR fragment joints
260	4	Lower_Right	ea3a524b-6ee3-4904-8924-29fcaa20985c	18:275901−68359363	17, 18	72	{'min_x': 308.489990234375, 'min_y': 705.2749633789062, 'max_x': 537.3599243164062, 'max_y': 838.7838134765625}	0 MB 20 MB 40 MB 60 MB ea3a524b−6ee3−4904−8924−29fcaa20985c SoftTissue−Leiomyo Cancer type 18:275901−68359363 Position With other complex events Type 13 Interleaved intrachr. SVs 78 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 2; SV types t2tINV: 5; TRA: 65 318 SVs in sample 17, 18 Oscillating CN (2 and 3 states) 72 CN segments 0.64 FDR fragment joints
261	1	Upper_Left	ea3a524b-6ee3-4904-8924-29fcaa20985c	2:9263222−242771261	14, 23	61	{'min_x': 38.70000076293945, 'min_y': 282.3299865722656, 'max_x': 249.0299530029297, 'max_y': 416.3340148925781}	ea3a524b−6ee3−4904−8924−29fcaa20985c SoftTissue−Leiomyo Cancer type 21:14714130−47619466 Position With other complex events Type 6 Interleaved intrachr. SVs 61 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 55 318 SVs in sample 14, 23 Oscillating CN (2 and 3 states) 61 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 2:9263222−242771261;18:275901−68359362 Linked to chrs
261	2	Upper_Right	2905cbd1-719b-46d9-b8af-8fe4927bc473	11:12674170−130091311	7, 7	138	{'min_x': 321.5199890136719, 'min_y': 269.3699645996094, 'max_x': 545.2039794921875, 'max_y': 416.424072265625}	2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 1:145389851−238867163 Position With other complex events Type 45 Interleaved intrachr. SVs 207 Total SVs (intrachr. + transl.) DEL: 18; DUP: 9; h2hINV: 10; SV types t2tINV: 8; TRA: 162 1958 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 138 CN segments 0.57 FDR fragment joints 0 FDR chr. breakp. enrich. 11:12674170−130091311;12:8404400−101121300 18:19701585−65299989;19:10607945−56113175 2:103504725−236615449;5:893523−179304806 Linked to chrs
261	3	Lower_Left	2905cbd1-719b-46d9-b8af-8fe4927bc473	3:158182221−193942170	17, 17	33	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 247.99183654785156, 'max_y': 838.7838134765625}	80 MB 120 MB 160 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 3:158182221−193942170 Position With other complex events Type 25 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 4; SV types t2tINV: 6; TRA: 7 1958 SVs in sample 17, 17 Oscillating CN (2 and 3 states) 33 CN segments 0.78 FDR fragment joints
261	4	Lower_Right	2905cbd1-719b-46d9-b8af-8fe4927bc473	11:12674170−130091312	7, 9	72	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 551.0223388671875, 'max_y': 835.2338256835938}	25 MB 50 MB 75 MB 100 MB 125 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 11:12674170−130091312 Position With other complex events Type 8 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 66 1958 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 72 CN segments 0.84 FDR fragment joints 0.64 FDR chr. breakp. enrich.
262	1	Upper_Left	2905cbd1-719b-46d9-b8af-8fe4927bc473	1:145389851−238867162	7, 9	292	{'min_x': 30.360200881958008, 'min_y': 269.3699645996094, 'max_x': 257.36993408203125, 'max_y': 416.424072265625}	2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 12:8404400−101121301 Position With other complex events Type 243 Interleaved intrachr. SVs 725 Total SVs (intrachr. + transl.) DEL: 63; DUP: 64; h2hINV: 56; SV types t2tINV: 60; TRA: 482 1958 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 292 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;11:12674170−130091311 16:83655547−88637357;2:103504725−236615449 20:48743238−54339929;3:158182221−193942169 Linked to chrs
262	2	Upper_Right	2cacd9d0-8414-4f17-8259-c9d838597f39	12:17335568−78414574	16, 22	68	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	2cacd9d0−8414−4f17−8259−c9d838597f39 SoftTissue−Liposarc Cancer type 1:180979548−248890604 Position With other complex events Type 32 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 9; DUP: 10; h2hINV: 6; SV types t2tINV: 7; TRA: 14 531 SVs in sample 16, 22 Oscillating CN (2 and 3 states) 68 CN segments 0.82 FDR fragment joints 0 FDR chr. breakp. enrich. 12:17335568−78414574;4:7659968−47714737 Linked to chrs
262	3	Lower_Left	2cacd9d0-8414-4f17-8259-c9d838597f39	12:17335568−78414575	7, 7	266	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 263.4618225097656, 'max_y': 838.7838134765625}	50 MB 75 MB 100 MB 125 MB 2cacd9d0−8414−4f17−8259−c9d838597f39 SoftTissue−Liposarc Cancer type 12:17335568−78414575 Position With other complex events Type 119 Interleaved intrachr. SVs 288 Total SVs (intrachr. + transl.) DEL: 31; DUP: 29; h2hINV: 28; SV types t2tINV: 31; TRA: 169 531 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 266 CN segments 0.98 FDR fragment joints
262	4	Lower_Right	2cacd9d0-8414-4f17-8259-c9d838597f39	17:27172002−57726288	9, 9	9	{'min_x': 328.8399963378906, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB 2cacd9d0−8414−4f17−8259−c9d838597f39 SoftTissue−Liposarc Cancer type 17:27172002−57726288 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 7 531 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 9 CN segments
263	1	Upper_Left	2cacd9d0-8414-4f17-8259-c9d838597f39	19:596348−34678229	23, 40	40	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.3340148925781}	2cacd9d0−8414−4f17−8259−c9d838597f39 SoftTissue−Liposarc Cancer type 19:596348−34678229 Position With other complex events Type 43 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 8; DUP: 16; h2hINV: 11; SV types t2tINV: 8; TRA: 2 531 SVs in sample 23, 40 Oscillating CN (2 and 3 states) 40 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
263	2	Upper_Right	2ff6aede-7bcd-440b-99ab-7a023faf658e	1:16936361−248844598	39, 74	251	{'min_x': 330.7099914550781, 'min_y': 286.6499938964844, 'max_x': 536.015869140625, 'max_y': 416.42401123046875}	2ff6aede−7bcd−440b−99ab−7a023faf658e SoftTissue−Liposarc Cancer type 1:16936361−248844598 Position With other complex events Type 163 Interleaved intrachr. SVs 259 Total SVs (intrachr. + transl.) DEL: 38; DUP: 40; h2hINV: 44; SV types t2tINV: 41; TRA: 96 1218 SVs in sample 39, 74 Oscillating CN (2 and 3 states) 251 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 5:86635−168032759; Linked to chrs
263	3	Lower_Left	2ff6aede-7bcd-440b-99ab-7a023faf658e	5:86635−168032760	88, 88	181	{'min_x': 41.210201263427734, 'min_y': 705.2749633789062, 'max_x': 246.51596069335938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 2ff6aede−7bcd−440b−99ab−7a023faf658e SoftTissue−Liposarc Cancer type 5:86635−168032760 Position With other complex events Type 417 Interleaved intrachr. SVs 528 Total SVs (intrachr. + transl.) DEL: 110; DUP: 102; h2hINV: 98; SV types t2tINV: 107; TRA: 111 1218 SVs in sample 88, 88 Oscillating CN (2 and 3 states) 181 CN segments
263	4	Lower_Right	2ff6aede-7bcd-440b-99ab-7a023faf658e	12:41458405−132968720	5, 7	261	{'min_x': 330.7099914550781, 'min_y': 705.2749633789062, 'max_x': 536.015869140625, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB 120 MB 2ff6aede−7bcd−440b−99ab−7a023faf658e SoftTissue−Liposarc Cancer type 12:41458405−132968720 Position With other complex events Type 294 Interleaved intrachr. SVs 430 Total SVs (intrachr. + transl.) DEL: 62; DUP: 85; h2hINV: 76; SV types t2tINV: 71; TRA: 136 1218 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 261 CN segments
264	1	Upper_Left	2ff6aede-7bcd-440b-99ab-7a023faf658e	13:21166372−114867952	25, 25	25	{'min_x': 41.210201263427734, 'min_y': 286.6499938964844, 'max_x': 246.51596069335938, 'max_y': 416.42401123046875}	2ff6aede−7bcd−440b−99ab−7a023faf658e SoftTissue−Liposarc Cancer type 13:21166372−114867952 Position Canonical without polyploidization Type 19 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 30 1218 SVs in sample 25, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.84 FDR fragment joints 0.51 FDR chr. breakp. enrich. 5:86635−168032759; Linked to chrs
264	2	Upper_Right	3505f91d-bc66-4732-84b6-18c5b32ca6b8	4:64107549−135664103	17, 25	175	{'min_x': 321.5199890136719, 'min_y': 278.0099792480469, 'max_x': 545.2039794921875, 'max_y': 416.4242248535156}	3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 1:147269177−248454297 Position With other complex events Type 59 Interleaved intrachr. SVs 204 Total SVs (intrachr. + transl.) DEL: 13; DUP: 13; h2hINV: 15; SV types t2tINV: 18; TRA: 145 1246 SVs in sample 17, 25 Oscillating CN (2 and 3 states) 175 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. 12:4488859−131646236;2:2725830−47762583 4:64107549−135664103;5:111534825−180595775 Linked to chrs
264	3	Lower_Left	3505f91d-bc66-4732-84b6-18c5b32ca6b8	2:2725830−47762584	8, 12	122	{'min_x': 31.689800262451172, 'min_y': 705.2749633789062, 'max_x': 248.51995849609375, 'max_y': 834.4639282226562}	50 MB 100 MB 150 MB 200 MB 3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 2:2725830−47762584 Position With other complex events Type 36 Interleaved intrachr. SVs 155 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 11; SV types t2tINV: 6; TRA: 119 1246 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 122 CN segments 0.74 FDR fragment joints
264	4	Lower_Right	3505f91d-bc66-4732-84b6-18c5b32ca6b8	5:111534825−180595776	15, 15	135	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 538.0198974609375, 'max_y': 834.4639282226562}	50 MB 100 MB 150 MB 3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 5:111534825−180595776 Position With other complex events Type 22 Interleaved intrachr. SVs 127 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 6; SV types t2tINV: 7; TRA: 105 1246 SVs in sample 15, 15 Oscillating CN (2 and 3 states) 135 CN segments 0.86 FDR fragment joints
265	1	Upper_Left	3505f91d-bc66-4732-84b6-18c5b32ca6b8	7:61912885−158960074	15, 19	126	{'min_x': 39.210201263427734, 'min_y': 286.6499938964844, 'max_x': 248.51995849609375, 'max_y': 416.3340148925781}	3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 7:61912885−158960074 Position With other complex events Type 57 Interleaved intrachr. SVs 126 Total SVs (intrachr. + transl.) DEL: 10; DUP: 19; h2hINV: 15; SV types t2tINV: 13; TRA: 69 1246 SVs in sample 15, 19 Oscillating CN (2 and 3 states) 126 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
265	2	Upper_Right	3505f91d-bc66-4732-84b6-18c5b32ca6b8	1:147269177−248454296	15, 32	45	{'min_x': 321.5199890136719, 'min_y': 282.3299865722656, 'max_x': 545.2039794921875, 'max_y': 420.74383544921875}	3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 11:1215903−134523511 Position With other complex events Type 10 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 29 1246 SVs in sample 15, 32 Oscillating CN (2 and 3 states) 45 CN segments 0.96 FDR fragment joints 0.91 FDR chr. breakp. enrich. 1:147269177−248454296;12:4488859−131646236 Linked to chrs 6:57953521−119636360;
265	3	Lower_Left	3505f91d-bc66-4732-84b6-18c5b32ca6b8	12:4488859−131646237	7, 7	384	{'min_x': 30.360200881958008, 'min_y': 705.2749633789062, 'max_x': 258.8419494628906, 'max_y': 830.1439819335938}	25 MB 50 MB 75 MB 100 MB 125 MB 3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 12:4488859−131646237 Position With other complex events Type 146 Interleaved intrachr. SVs 391 Total SVs (intrachr. + transl.) DEL: 31; DUP: 35; h2hINV: 37; SV types t2tINV: 43; TRA: 245 1246 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 384 CN segments 0.64 FDR fragment joints
265	4	Lower_Right	3505f91d-bc66-4732-84b6-18c5b32ca6b8	X:77058127−154924953	7, 7	147	{'min_x': 320.29998779296875, 'min_y': 705.2749633789062, 'max_x': 538.0198974609375, 'max_y': 834.4639282226562}	80 MB 100 MB 120 MB 140 MB 3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type X:77058127−154924953 Position With other complex events Type 35 Interleaved intrachr. SVs 205 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 5; SV types t2tINV: 11; TRA: 170 1246 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 147 CN segments 0.64 FDR fragment joints
266	1	Upper_Left	6b189eff-b919-49d6-8775-dbf32c9ccbba	14:95901595−105399402	6, 8	196	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.5139617919922, 'max_y': 416.42401123046875}	6b189eff−b919−49d6−8775−dbf32c9ccbba SoftTissue−Liposarc Cancer type 5:82214−43509706 Position With other complex events Type 74 Interleaved intrachr. SVs 315 Total SVs (intrachr. + transl.) DEL: 21; DUP: 23; h2hINV: 15; SV types t2tINV: 15; TRA: 241 890 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 196 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 14:95901595−105399402; Linked to chrs
266	2	Upper_Right	6b189eff-b919-49d6-8775-dbf32c9ccbba	5:82214−43509705	4, 4	291	{'min_x': 328.20001220703125, 'min_y': 282.3299865722656, 'max_x': 538.5299682617188, 'max_y': 416.3340148925781}	6b189eff−b919−49d6−8775−dbf32c9ccbba SoftTissue−Liposarc Cancer type 12:48350328−127948831 Position With other complex events Type 400 Interleaved intrachr. SVs 708 Total SVs (intrachr. + transl.) DEL: 102; DUP: 98; h2hINV: 95; SV types t2tINV: 105; TRA: 308 890 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 291 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. 5:82214−43509705;14:95901595−105399402 Linked to chrs
266	3	Lower_Left	73d2e8ef-4e10-416a-845b-f48374e48ecb	1:145112810−172403220	7, 7	440	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 247.52195739746094, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 1:145112810−172403220 Position With other complex events Type 256 Interleaved intrachr. SVs 432 Total SVs (intrachr. + transl.) DEL: 73; DUP: 65; h2hINV: 56; SV types t2tINV: 62; TRA: 176 1088 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 440 CN segments
266	4	Lower_Right	73d2e8ef-4e10-416a-845b-f48374e48ecb	3:3279482−196670440	14, 24	153	{'min_x': 309.3299865722656, 'min_y': 705.2749633789062, 'max_x': 537.0219116210938, 'max_y': 830.1439819335938}	0 MB 50 MB 100 MB 150 MB 73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 3:3279482−196670440 Position With other complex events Type 58 Interleaved intrachr. SVs 170 Total SVs (intrachr. + transl.) DEL: 16; DUP: 15; h2hINV: 14; SV types t2tINV: 13; TRA: 112 1088 SVs in sample 14, 24 Oscillating CN (2 and 3 states) 153 CN segments 0.97 FDR fragment joints
267	1	Upper_Left	73d2e8ef-4e10-416a-845b-f48374e48ecb	4:121551106−185803467	25, 25	25	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.3340148925781}	73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 4:121551106−185803467 Position After polyploidization Type 27 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 9; DUP: 3; h2hINV: 7; SV types t2tINV: 8; TRA: 3 1088 SVs in sample 25, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
267	2	Upper_Right	73d2e8ef-4e10-416a-845b-f48374e48ecb	12:57518989−72095051	9, 20	158	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5379638671875, 'max_y': 416.4242248535156}	73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 5:703397−41841709 Position With other complex events Type 53 Interleaved intrachr. SVs 170 Total SVs (intrachr. + transl.) DEL: 10; DUP: 12; h2hINV: 18; SV types t2tINV: 13; TRA: 117 1088 SVs in sample 9, 20 Oscillating CN (2 and 3 states) 158 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 12:57518989−72095051;17:38121352−80696807 22:32381273−48585046;3:3279482−196670439 Linked to chrs
267	3	Lower_Left	73d2e8ef-4e10-416a-845b-f48374e48ecb	7:113482279−131109557	5, 6	167	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 266.77203369140625, 'max_y': 833.6940307617188}	80 MB 90 MB 100 MB 110 MB 120 MB 130 MB 73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 7:113482279−131109557 Position With other complex events Type 47 Interleaved intrachr. SVs 215 Total SVs (intrachr. + transl.) DEL: 12; DUP: 8; h2hINV: 14; SV types t2tINV: 13; TRA: 168 1088 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 167 CN segments
267	4	Lower_Right	73d2e8ef-4e10-416a-845b-f48374e48ecb	8:13601211−30077763	10, 10	40	{'min_x': 323.19000244140625, 'min_y': 705.2749633789062, 'max_x': 562.5720825195312, 'max_y': 834.4639282226562}	30 MB 60 MB 90 MB 120 MB 73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 8:13601211−30077763 Position With other complex events Type 7 Interleaved intrachr. SVs 60 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 0; TRA: 53 1088 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 40 CN segments 0.59 FDR fragment joints
268	1	Upper_Left	73d2e8ef-4e10-416a-845b-f48374e48ecb	17:38121352−80696807	19, 22	37	{'min_x': 33.68980026245117, 'min_y': 278.0099792480469, 'max_x': 254.03794860839844, 'max_y': 416.4242248535156}	73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 12:57518989−72095052 Position With other complex events Type 25 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 5; SV types t2tINV: 7; TRA: 49 1088 SVs in sample 19, 22 Oscillating CN (2 and 3 states) 37 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. 17:38121352−80696807;22:32381273−48585046 3:3279482−196670439;5:703397−41841708 Linked to chrs
268	2	Upper_Right	73d2e8ef-4e10-416a-845b-f48374e48ecb	3:3279482−196670439	7, 7	25	{'min_x': 329.7099914550781, 'min_y': 282.3299865722656, 'max_x': 537.0219116210938, 'max_y': 420.74383544921875}	73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 14:29873311−73266124 Position With other complex events Type 9 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 23 1088 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 25 CN segments 0.83 FDR fragment joints 0 FDR chr. breakp. enrich. 3:3279482−196670439;5:703397−41841708 Linked to chrs 8:13601211−30077762;
268	3	Lower_Left	73d2e8ef-4e10-416a-845b-f48374e48ecb	X:22888722−42758155	12, 13	13	{'min_x': 40.210201263427734, 'min_y': 705.2749633789062, 'max_x': 264.52191162109375, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type X:22888722−42758155 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 0 1088 SVs in sample 12, 13 Oscillating CN (2 and 3 states) 13 CN segments
268	4	Lower_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	1:157434186−248437131	9, 13	240	{'min_x': 319.8599853515625, 'min_y': 705.2749633789062, 'max_x': 562.2523193359375, 'max_y': 835.2338256835938}	100 MB 150 MB 200 MB 250 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 1:157434186−248437131 Position With other complex events Type 179 Interleaved intrachr. SVs 598 Total SVs (intrachr. + transl.) DEL: 52; DUP: 35; h2hINV: 44; SV types t2tINV: 48; TRA: 419 2036 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 240 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich.
269	1	Upper_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	2:117676635−243016298	14, 14	18	{'min_x': 39.54999923706055, 'min_y': 286.6499938964844, 'max_x': 248.1819610595703, 'max_y': 416.42401123046875}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 2:117676635−243016298 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 4 2036 SVs in sample 14, 14 Oscillating CN (2 and 3 states) 18 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. 8:80454829−117232183; Linked to chrs
269	2	Upper_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	6:1095728−156611835	12, 12	32	{'min_x': 326.20001220703125, 'min_y': 278.0099792480469, 'max_x': 540.5319213867188, 'max_y': 416.4242248535156}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 3:8155512−83721537 Position With other complex events Type 29 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 8; SV types t2tINV: 8; TRA: 26 2036 SVs in sample 12, 12 Oscillating CN (2 and 3 states) 32 CN segments 0.86 FDR fragment joints 0.73 FDR chr. breakp. enrich. 11:20106252−97980851;16:261147−88704040 6:1095728−156611835;X:70422197−98898337 Linked to chrs
269	3	Lower_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	5:13726553−174060331	7, 12	97	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 248.1819610595703, 'max_y': 838.7838134765625}	50 MB 100 MB 150 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 5:13726553−174060331 Position With other complex events Type 25 Interleaved intrachr. SVs 105 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 4; SV types t2tINV: 8; TRA: 80 2036 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 97 CN segments 0.64 FDR fragment joints
269	4	Lower_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	6:1095728−156611836	20, 29	135	{'min_x': 307.79998779296875, 'min_y': 705.2749633789062, 'max_x': 537.681884765625, 'max_y': 830.1439819335938}	0 MB 40 MB 80 MB 120 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 6:1095728−156611836 Position With other complex events Type 93 Interleaved intrachr. SVs 148 Total SVs (intrachr. + transl.) DEL: 23; DUP: 26; h2hINV: 19; SV types t2tINV: 25; TRA: 55 2036 SVs in sample 20, 29 Oscillating CN (2 and 3 states) 135 CN segments 0.82 FDR fragment joints
270	1	Upper_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	16:261147−88704040	10, 11	21	{'min_x': 39.54999923706055, 'min_y': 282.3299865722656, 'max_x': 248.1819610595703, 'max_y': 416.3340148925781}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 7:9379433−133023159 Position With other complex events Type 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 5 2036 SVs in sample 10, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.74 FDR fragment joints 0 FDR chr. breakp. enrich. 16:261147−88704040;9:1604237−38289691 Linked to chrs
270	2	Upper_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	8:80454829−117232184	7, 10	10	{'min_x': 329.04998779296875, 'min_y': 286.6499938964844, 'max_x': 537.681884765625, 'max_y': 416.3340148925781}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 8:80454829−117232184 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 4; TRA: 0 2036 SVs in sample 7, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
270	3	Lower_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	9:1604237−38289692	7, 15	68	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 248.1819610595703, 'max_y': 830.1439819335938}	10 MB 20 MB 30 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 9:1604237−38289692 Position With other complex events Type 12 Interleaved intrachr. SVs 76 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 2; SV types t2tINV: 0; TRA: 64 2036 SVs in sample 7, 15 Oscillating CN (2 and 3 states) 68 CN segments 0.48 FDR fragment joints
270	4	Lower_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	11:20106252−97980852	23, 39	62	{'min_x': 324.8599853515625, 'min_y': 705.2749633789062, 'max_x': 549.152099609375, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 11:20106252−97980852 Position With other complex events Type 26 Interleaved intrachr. SVs 67 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 7; SV types t2tINV: 7; TRA: 41 2036 SVs in sample 23, 39 Oscillating CN (2 and 3 states) 62 CN segments 0.95 FDR fragment joints
271	1	Upper_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	13:56101373−108997400	11, 14	461	{'min_x': 32.019901275634766, 'min_y': 265.0499572753906, 'max_x': 255.7040252685547, 'max_y': 420.743896484375}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 12:27498321−130397265 Position With other complex events Type 409 Interleaved intrachr. SVs 913 Total SVs (intrachr. + transl.) DEL: 97; DUP: 106; h2hINV: 101; SV types t2tINV: 105; TRA: 504 2036 SVs in sample 11, 14 Oscillating CN (2 and 3 states) 461 CN segments 0.94 FDR fragment joints 0 FDR chr. breakp. enrich. 10:3043555−124930156;11:20106252−97980851 13:56101373−108997400;15:22917198−97545745 16:261147−88704040;20:37676020−59930521 Linked to chrs 3:8155512−83721536;5:13726553−174060330
271	2	Upper_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	12:27498321−130397264	12, 28	63	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5379638671875, 'max_y': 416.4242248535156}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 13:56101373−108997401 Position With other complex events Type 33 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 9; SV types t2tINV: 10; TRA: 22 2036 SVs in sample 12, 28 Oscillating CN (2 and 3 states) 63 CN segments 0.89 FDR fragment joints 1 FDR chr. breakp. enrich. 12:27498321−130397264;19:5386099−49674391 4:637238−140609576;6:1095728−156611835 Linked to chrs
271	3	Lower_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	14:21880534−104480456	7, 19	70	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 253.54193115234375, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB 100 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 14:21880534−104480456 Position With other complex events Type 20 Interleaved intrachr. SVs 86 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 5; SV types t2tINV: 4; TRA: 66 2036 SVs in sample 7, 19 Oscillating CN (2 and 3 states) 70 CN segments 0.83 FDR fragment joints
271	4	Lower_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	15:22917198−97545746	10, 14	69	{'min_x': 328.20001220703125, 'min_y': 705.2749633789062, 'max_x': 537.681884765625, 'max_y': 838.7838134765625}	40 MB 60 MB 80 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 15:22917198−97545746 Position With other complex events Type 35 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 10; DUP: 8; h2hINV: 9; SV types t2tINV: 8; TRA: 23 2036 SVs in sample 10, 14 Oscillating CN (2 and 3 states) 69 CN segments 0.97 FDR fragment joints
272	1	Upper_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	12:27498321−130397264	11, 12	98	{'min_x': 32.019901275634766, 'min_y': 269.3699645996094, 'max_x': 255.70394897460938, 'max_y': 416.424072265625}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 16:261147−88704041 Position With other complex events Type 19 Interleaved intrachr. SVs 118 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 3; SV types t2tINV: 7; TRA: 99 2036 SVs in sample 11, 12 Oscillating CN (2 and 3 states) 98 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 12:27498321−130397264;15:22917198−97545745 19:5386099−49674391;6:1095728−156611835 7:9379433−133023158;8:80454829−117232183 Linked to chrs
272	2	Upper_Right	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	10:3043555−124930156	19, 19	46	{'min_x': 323.19000244140625, 'min_y': 278.0099792480469, 'max_x': 543.5379638671875, 'max_y': 416.4242248535156}	854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type 19:5386099−49674392 Position With other complex events Type 10 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 31 2036 SVs in sample 19, 19 Oscillating CN (2 and 3 states) 46 CN segments 0.96 FDR fragment joints 0.03 FDR chr. breakp. enrich. 10:3043555−124930156;15:22917198−97545745 16:261147−88704040;9:1604237−38289691 Linked to chrs
272	3	Lower_Left	854e42bc-95b2-4b77-a4b2-ffbd6c28b281	X:70422197−98898338	7, 13	28	{'min_x': 32.019901275634766, 'min_y': 705.2749633789062, 'max_x': 248.1819610595703, 'max_y': 834.4639282226562}	40 MB 80 MB 120 MB 854e42bc−95b2−4b77−a4b2−ffbd6c28b281 SoftTissue−Liposarc Cancer type X:70422197−98898338 Position With other complex events Type 23 Interleaved intrachr. SVs 94 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 8; SV types t2tINV: 4; TRA: 71 2036 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 28 CN segments 0.59 FDR fragment joints
272	4	Lower_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	4:88570552−123136247	9, 13	46	{'min_x': 309.0899963378906, 'min_y': 705.2749633789062, 'max_x': 535.515869140625, 'max_y': 838.7838134765625}	0 MB 50 MB 100 MB 150 MB 8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 4:88570552−123136247 Position With other complex events Type 24 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 5; SV types t2tINV: 6; TRA: 33 782 SVs in sample 9, 13 Oscillating CN (2 and 3 states) 46 CN segments 0.97 FDR fragment joints
273	1	Upper_Left	8f3f6f7c-4b50-467e-a6e8-d836735913f6	8:65806479−108515176	11, 19	29	{'min_x': 41.710201263427734, 'min_y': 286.6499938964844, 'max_x': 246.01596069335938, 'max_y': 416.42401123046875}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 5:71550993−162747485 Position With other complex events Type 25 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 6; SV types t2tINV: 9; TRA: 19 782 SVs in sample 11, 19 Oscillating CN (2 and 3 states) 29 CN segments 0.64 FDR fragment joints 0.87 FDR chr. breakp. enrich. 8:65806479−108515176; Linked to chrs
273	2	Upper_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	12:1089811−133349178	8, 20	88	{'min_x': 323.19000244140625, 'min_y': 282.3299865722656, 'max_x': 543.5379638671875, 'max_y': 416.3340148925781}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 6:9401122−151337809 Position With other complex events Type 20 Interleaved intrachr. SVs 91 Total SVs (intrachr. + transl.) DEL: 9; DUP: 3; h2hINV: 3; SV types t2tINV: 5; TRA: 71 782 SVs in sample 8, 20 Oscillating CN (2 and 3 states) 88 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. 12:1089811−133349178;4:88570552−123136246 Linked to chrs
273	3	Lower_Left	8f3f6f7c-4b50-467e-a6e8-d836735913f6	8:65806479−108515177	7, 9	15	{'min_x': 41.710201263427734, 'min_y': 705.2749633789062, 'max_x': 250.17198181152344, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 8:65806479−108515177 Position With other complex events Type 7 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 22 782 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 15 CN segments
273	4	Lower_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	9:13132039−27112660	11, 18	22	{'min_x': 330.9800109863281, 'min_y': 705.2749633789062, 'max_x': 551.2021484375, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB 8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 9:13132039−27112660 Position With other complex events Type 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 7 782 SVs in sample 11, 18 Oscillating CN (2 and 3 states) 22 CN segments
274	1	Upper_Left	8f3f6f7c-4b50-467e-a6e8-d836735913f6	11:14830528−20532173	6, 7	580	{'min_x': 35.360198974609375, 'min_y': 282.3299865722656, 'max_x': 252.3719482421875, 'max_y': 420.74383544921875}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 12:1089811−133349179 Position With other complex events Type 334 Interleaved intrachr. SVs 459 Total SVs (intrachr. + transl.) DEL: 84; DUP: 84; h2hINV: 85; SV types t2tINV: 81; TRA: 125 782 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 580 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 11:14830528−20532173;6:9401122−151337808 Linked to chrs 9:13132039−27112659;
274	2	Upper_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	13:100098950−108510778	7, 12	12	{'min_x': 331.2099914550781, 'min_y': 286.6499938964844, 'max_x': 535.515869140625, 'max_y': 416.3340148925781}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 13:100098950−108510778 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 0 782 SVs in sample 7, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.84 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
274	3	Lower_Left	9517413b-b5b8-4130-8ba1-d86d44abe2ec	12:18468583−117642876	4, 4	101	{'min_x': 38.210201263427734, 'min_y': 705.2749633789062, 'max_x': 249.51795959472656, 'max_y': 833.6940307617188}	40 MB 60 MB 80 MB 100 MB 9517413b−b5b8−4130−8ba1−d86d44abe2ec SoftTissue−Liposarc Cancer type 12:18468583−117642876 Position With other complex events Type 167 Interleaved intrachr. SVs 330 Total SVs (intrachr. + transl.) DEL: 39; DUP: 45; h2hINV: 36; SV types t2tINV: 47; TRA: 163 498 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 101 CN segments
274	4	Lower_Right	b5f27002-4277-418d-90b0-cc5a2742692e	1:175909202−201271527	7, 7	15	{'min_x': 329.0400085449219, 'min_y': 705.2749633789062, 'max_x': 537.6898803710938, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 200 MB b5f27002−4277−418d−90b0−cc5a2742692e SoftTissue−Liposarc Cancer type 1:175909202−201271527 Position With other complex events Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 2 895 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 15 CN segments
275	1	Upper_Left	cd73a55f-03c1-4da0-9fa7-1ae4a263664e	12:39672405−132182028	7, 21	115	{'min_x': 40.36989974975586, 'min_y': 286.6499938964844, 'max_x': 247.36195373535156, 'max_y': 416.42401123046875}	cd73a55f−03c1−4da0−9fa7−1ae4a263664e SoftTissue−Liposarc Cancer type 5:40979−180658104 Position With other complex events Type 48 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 16; DUP: 9; h2hINV: 11; SV types t2tINV: 12; TRA: 6 595 SVs in sample 7, 21 Oscillating CN (2 and 3 states) 115 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 12:39672405−132182028; Linked to chrs
275	2	Upper_Right	cd73a55f-03c1-4da0-9fa7-1ae4a263664e	12:39672405−132182028	7, 18	49	{'min_x': 329.8699951171875, 'min_y': 286.6499938964844, 'max_x': 536.8618774414062, 'max_y': 416.42401123046875}	cd73a55f−03c1−4da0−9fa7−1ae4a263664e SoftTissue−Liposarc Cancer type 8:30791212−101358676 Position With other complex events Type 35 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 8; SV types t2tINV: 11; TRA: 8 595 SVs in sample 7, 18 Oscillating CN (2 and 3 states) 49 CN segments 0.72 FDR fragment joints 0.01 FDR chr. breakp. enrich. 12:39672405−132182028; Linked to chrs
275	3	Lower_Left	cd73a55f-03c1-4da0-9fa7-1ae4a263664e	12:39672405−132182029	8, 8	516	{'min_x': 33.68980026245117, 'min_y': 705.2749633789062, 'max_x': 247.36195373535156, 'max_y': 834.4639282226562}	60 MB 80 MB 100 MB 120 MB cd73a55f−03c1−4da0−9fa7−1ae4a263664e SoftTissue−Liposarc Cancer type 12:39672405−132182029 Position With other complex events Type 376 Interleaved intrachr. SVs 394 Total SVs (intrachr. + transl.) DEL: 90; DUP: 86; h2hINV: 99; SV types t2tINV: 101; TRA: 18 595 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 516 CN segments 0.73 FDR fragment joints
275	4	Lower_Right	cd73a55f-03c1-4da0-9fa7-1ae4a263664e	19:4529269−35019475	17, 34	34	{'min_x': 319.8599853515625, 'min_y': 705.2749633789062, 'max_x': 536.8618774414062, 'max_y': 838.7838134765625}	10 MB 20 MB 30 MB cd73a55f−03c1−4da0−9fa7−1ae4a263664e SoftTissue−Liposarc Cancer type 19:4529269−35019475 Position With other complex events Type 21 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 6; SV types t2tINV: 8; TRA: 6 595 SVs in sample 17, 34 Oscillating CN (2 and 3 states) 34 CN segments 0.63 FDR fragment joints
276	1	Upper_Left	e786de34-4c21-460f-89ab-008de4347049	6:39847295−158859759	7, 13	15	{'min_x': 39.539798736572266, 'min_y': 286.6499938964844, 'max_x': 248.18995666503906, 'max_y': 416.42401123046875}	e786de34−4c21−460f−89ab−008de4347049 SoftTissue−Liposarc Cancer type 4:25848307−38595195 Position With other complex events Type 7 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 0; SV types t2tINV: 4; TRA: 24 872 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 15 CN segments 0.48 FDR fragment joints 0.07 FDR chr. breakp. enrich. 6:39847295−158859759; Linked to chrs
276	2	Upper_Right	e786de34-4c21-460f-89ab-008de4347049	6:39847295−158859760	5, 6	213	{'min_x': 329.0400085449219, 'min_y': 286.6499938964844, 'max_x': 537.6898803710938, 'max_y': 416.42401123046875}	e786de34−4c21−460f−89ab−008de4347049 SoftTissue−Liposarc Cancer type 6:39847295−158859760 Position With other complex events Type 197 Interleaved intrachr. SVs 494 Total SVs (intrachr. + transl.) DEL: 55; DUP: 48; h2hINV: 48; SV types t2tINV: 46; TRA: 297 872 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 213 CN segments 0.86 FDR fragment joints 0 FDR chr. breakp. enrich. 4:25848307−38595194; Linked to chrs
276	3	Lower_Left	e786de34-4c21-460f-89ab-008de4347049	12:48431354−77284404	3, 4	171	{'min_x': 35.360198974609375, 'min_y': 705.2749633789062, 'max_x': 248.18995666503906, 'max_y': 838.7838134765625}	60 MB 70 MB e786de34−4c21−460f−89ab−008de4347049 SoftTissue−Liposarc Cancer type 12:48431354−77284404 Position With other complex events Type 155 Interleaved intrachr. SVs 448 Total SVs (intrachr. + transl.) DEL: 34; DUP: 42; h2hINV: 45; SV types t2tINV: 34; TRA: 293 872 SVs in sample 3, 4 Oscillating CN (2 and 3 states) 171 CN segments 0.64 FDR fragment joints
276	4	Lower_Right	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	3:94442780−174075990	7, 13	50	{'min_x': 321.6400146484375, 'min_y': 705.2749633789062, 'max_x': 535.6859130859375, 'max_y': 838.7838134765625}	100 MB 120 MB 140 MB 160 MB e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 3:94442780−174075990 Position With other complex events Type 14 Interleaved intrachr. SVs 69 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 55 696 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 50 CN segments 0.88 FDR fragment joints
277	1	Upper_Left	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	3:94442780−174075989	8, 8	103	{'min_x': 37.03010177612305, 'min_y': 282.3299865722656, 'max_x': 250.69595336914062, 'max_y': 420.74383544921875}	e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 11:993833−37433476 Position With other complex events Type 55 Interleaved intrachr. SVs 138 Total SVs (intrachr. + transl.) DEL: 17; DUP: 6; h2hINV: 15; SV types t2tINV: 17; TRA: 83 696 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 103 CN segments 0.48 FDR fragment joints 0 FDR chr. breakp. enrich. 3:94442780−174075989;5:1295334−20553338 Linked to chrs 6:42555034−48239598;
277	2	Upper_Right	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	3:94442780−174075989	4, 8	174	{'min_x': 324.8599853515625, 'min_y': 278.0099792480469, 'max_x': 541.871826171875, 'max_y': 416.4242248535156}	e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 12:8061289−120789609 Position With other complex events Type 195 Interleaved intrachr. SVs 354 Total SVs (intrachr. + transl.) DEL: 46; DUP: 42; h2hINV: 49; SV types t2tINV: 58; TRA: 159 696 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 174 CN segments 0.62 FDR fragment joints 0 FDR chr. breakp. enrich. 11:993833−37433475;21:35308379−35766982 3:94442780−174075989;6:42555034−48239598 Linked to chrs
277	3	Lower_Left	ea0e5ae7-1f15-4504-aea3-efd1f6733304	1:145025792−241989428	5, 6	228	{'min_x': 41.20000076293945, 'min_y': 705.2749633789062, 'max_x': 246.52395629882812, 'max_y': 833.6940307617188}	100 MB 150 MB 200 MB ea0e5ae7−1f15−4504−aea3−efd1f6733304 SoftTissue−Liposarc Cancer type 1:145025792−241989428 Position With other complex events Type 66 Interleaved intrachr. SVs 182 Total SVs (intrachr. + transl.) DEL: 14; DUP: 16; h2hINV: 16; SV types t2tINV: 20; TRA: 116 595 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 228 CN segments
277	4	Lower_Right	ea0e5ae7-1f15-4504-aea3-efd1f6733304	11:132789−38263176	8, 25	268	{'min_x': 309.1700134277344, 'min_y': 705.2749633789062, 'max_x': 536.02392578125, 'max_y': 833.6940307617188}	0 MB 30 MB 60 MB 90 MB ea0e5ae7−1f15−4504−aea3−efd1f6733304 SoftTissue−Liposarc Cancer type 11:132789−38263176 Position With other complex events Type 134 Interleaved intrachr. SVs 184 Total SVs (intrachr. + transl.) DEL: 39; DUP: 33; h2hINV: 34; SV types t2tINV: 28; TRA: 50 595 SVs in sample 8, 25 Oscillating CN (2 and 3 states) 268 CN segments
278	1	Upper_Left	ea0e5ae7-1f15-4504-aea3-efd1f6733304	12:8047626−76351792	6, 7	250	{'min_x': 41.20000076293945, 'min_y': 286.6499938964844, 'max_x': 246.52395629882812, 'max_y': 416.3340148925781}	ea0e5ae7−1f15−4504−aea3−efd1f6733304 SoftTissue−Liposarc Cancer type 12:8047626−76351792 Position With other complex events Type 81 Interleaved intrachr. SVs 202 Total SVs (intrachr. + transl.) DEL: 20; DUP: 21; h2hINV: 18; SV types t2tINV: 22; TRA: 121 595 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 250 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
278	2	Upper_Right	ea0e5ae7-1f15-4504-aea3-efd1f6733304	18:915255−52915207	32, 52	52	{'min_x': 330.70001220703125, 'min_y': 286.6499938964844, 'max_x': 536.02392578125, 'max_y': 416.3340148925781}	ea0e5ae7−1f15−4504−aea3−efd1f6733304 SoftTissue−Liposarc Cancer type 18:915255−52915207 Position After polyploidization Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 5; SV types t2tINV: 5; TRA: 0 595 SVs in sample 32, 52 Oscillating CN (2 and 3 states) 52 CN segments 0.94 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
278	3	Lower_Left	f75d2589-fd7b-49a1-a1c8-0b4726b81f3c	12:43926078−100997188	7, 8	441	{'min_x': 40.539798736572266, 'min_y': 705.2749633789062, 'max_x': 266.87200927734375, 'max_y': 833.6940307617188}	60 MB 80 MB 100 MB f75d2589−fd7b−49a1−a1c8−0b4726b81f3c SoftTissue−Liposarc Cancer type 12:43926078−100997188 Position With other complex events Type 336 Interleaved intrachr. SVs 484 Total SVs (intrachr. + transl.) DEL: 88; DUP: 80; h2hINV: 91; SV types t2tINV: 77; TRA: 148 562 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 441 CN segments
278	4	Lower_Right	f75d2589-fd7b-49a1-a1c8-0b4726b81f3c	19:1283296−50665825	7, 13	65	{'min_x': 330.0400085449219, 'min_y': 705.2749633789062, 'max_x': 555.3499145507812, 'max_y': 833.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB f75d2589−fd7b−49a1−a1c8−0b4726b81f3c SoftTissue−Liposarc Cancer type 19:1283296−50665825 Position With other complex events Type 37 Interleaved intrachr. SVs 135 Total SVs (intrachr. + transl.) DEL: 9; DUP: 10; h2hINV: 8; SV types t2tINV: 10; TRA: 98 562 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 65 CN segments
279	1	Upper_Left	CGP_donor_GC00015	10:1196201−77760857	7, 7	16	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.3340148925781}	CGP_donor_GC00015 Stomach−AdenoCA Cancer type 10:1196201−77760857 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 2 170 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.84 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
279	2	Upper_Right	CGP_donor_GC00017	12:7028514−133278608	50, 50	50	{'min_x': 344.2300109863281, 'min_y': 286.6499938964844, 'max_x': 522.4959716796875, 'max_y': 416.3340148925781}	CGP_donor_GC00017 Stomach−AdenoCA Cancer type 12:7028514−133278608 Position Canonical without polyploidization Type 30 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 9; SV types t2tINV: 8; TRA: 9 115 SVs in sample 50, 50 Oscillating CN (2 and 3 states) 50 CN segments 0.91 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
279	3	Lower_Left	CGP_donor_GC00017	22:22068632−50649237	9, 14	14	{'min_x': 54.730098724365234, 'min_y': 705.2749633789062, 'max_x': 263.7198181152344, 'max_y': 833.6940307617188}	30 MB 40 MB 50 MB CGP_donor_GC00017 Stomach−AdenoCA Cancer type 22:22068632−50649237 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 4; SV types t2tINV: 4; TRA: 5 115 SVs in sample 9, 14 Oscillating CN (2 and 3 states) 14 CN segments
279	4	Lower_Right	CGP_donor_GC00029	4:125902490−167111168	7, 9	14	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 545.8521728515625, 'max_y': 833.6940307617188}	80 MB 120 MB 160 MB CGP_donor_GC00029 Stomach−AdenoCA Cancer type 4:125902490−167111168 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 1; TRA: 2 246 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 14 CN segments
280	1	Upper_Left	CGP_donor_GC00029	8:112366160−131135554	7, 7	29	{'min_x': 63.519901275634766, 'min_y': 286.6499938964844, 'max_x': 224.2118377685547, 'max_y': 416.42401123046875}	CGP_donor_GC00029 Stomach−AdenoCA Cancer type 5:54358154−138271539 Position With other complex events Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 6; SV types t2tINV: 4; TRA: 2 246 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 29 CN segments 0.78 FDR fragment joints 0 FDR chr. breakp. enrich. 8:112366160−131135554; Linked to chrs
280	2	Upper_Right	CGP_donor_GC00047	13:20671166−113982594	7, 11	17	{'min_x': 353.0199890136719, 'min_y': 286.6499938964844, 'max_x': 513.7119140625, 'max_y': 416.3340148925781}	CGP_donor_GC00047 Stomach−AdenoCA Cancer type 13:20671166−113982594 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 6 187 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 17 CN segments 0.95 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
280	3	Lower_Left	CGP_donor_GC00054	11:7783797−85700498	7, 7	52	{'min_x': 59.639801025390625, 'min_y': 705.2749633789062, 'max_x': 264.5118103027344, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_GC00054 Stomach−AdenoCA Cancer type 11:7783797−85700498 Position With other complex events Type 9 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 7 550 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 52 CN segments
280	4	Lower_Right	CGP_donor_GC00054	12:18101997−94069586	7, 20	24	{'min_x': 353.0199890136719, 'min_y': 705.2749633789062, 'max_x': 539.0222778320312, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB CGP_donor_GC00054 Stomach−AdenoCA Cancer type 12:18101997−94069586 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 2 550 SVs in sample 7, 20 Oscillating CN (2 and 3 states) 24 CN segments
281	1	Upper_Left	647dc54f-a51b-40ea-9d97-c93598c2af71	1:119235280−239786526	9, 11	11	{'min_x': 40.210201263427734, 'min_y': 286.6499938964844, 'max_x': 247.52195739746094, 'max_y': 416.42401123046875}	647dc54f−a51b−40ea−9d97−c93598c2af71 Stomach−AdenoCA Cancer type 1:119235280−239786526 Position After polyploidization Type 4 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 7 294 SVs in sample 9, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 11:2708193−95973109; Linked to chrs
281	2	Upper_Right	87c217d4-66f4-46ca-8244-7856ce658fd3	10:85982825−129728054	7, 7	7	{'min_x': 329.8699951171875, 'min_y': 286.6499938964844, 'max_x': 536.8619384765625, 'max_y': 416.3340148925781}	87c217d4−66f4−46ca−8244−7856ce658fd3 Stomach−AdenoCA Cancer type 10:85982825−129728054 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 1 85 SVs in sample 7, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.97 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
281	3	Lower_Left	8b5746f9-dbee-40bd-9141-1081960cf286	11:12725196−43348618	13, 13	13	{'min_x': 39.88010025024414, 'min_y': 705.2749633789062, 'max_x': 247.85195922851562, 'max_y': 833.6940307617188}	30 MB 60 MB 90 MB 8b5746f9−dbee−40bd−9141−1081960cf286 Stomach−AdenoCA Cancer type 11:12725196−43348618 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 0 363 SVs in sample 13, 13 Oscillating CN (2 and 3 states) 13 CN segments
281	4	Lower_Right	8cb0144b-be6b-40a1-86a2-708f96d9b615	20:42226186−62284371	9, 9	40	{'min_x': 319.55999755859375, 'min_y': 705.2749633789062, 'max_x': 544.9798583984375, 'max_y': 833.6940307617188}	20 MB 30 MB 40 MB 50 MB 60 MB 8cb0144b−be6b−40a1−86a2−708f96d9b615 Stomach−AdenoCA Cancer type 20:42226186−62284371 Position With other complex events Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 8 507 SVs in sample 9, 9 Oscillating CN (2 and 3 states) 40 CN segments
282	1	Upper_Left	8d3e3d09-bc61-4d5e-b8d6-5aee6cb488ae	18:25148058−76030080	7, 9	9	{'min_x': 38.210201263427734, 'min_y': 286.6499938964844, 'max_x': 249.51795959472656, 'max_y': 416.3340148925781}	8d3e3d09−bc61−4d5e−b8d6−5aee6cb488ae Stomach−AdenoCA Cancer type 18:25148058−76030080 Position Canonical without polyploidization Type 5 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 2 42 SVs in sample 7, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.92 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
282	2	Upper_Right	b8a1c8c7-3945-4d84-8f58-3a1a1eb10730	9:74822475−138742365	7, 13	80	{'min_x': 329.0400085449219, 'min_y': 286.6499938964844, 'max_x': 537.68994140625, 'max_y': 416.42401123046875}	b8a1c8c7−3945−4d84−8f58−3a1a1eb10730 Stomach−AdenoCA Cancer type 6:39514580−170510916 Position With other complex events Type 56 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 17; DUP: 16; h2hINV: 10; SV types t2tINV: 13; TRA: 10 298 SVs in sample 7, 13 Oscillating CN (2 and 3 states) 80 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. 9:74822475−138742365; Linked to chrs
282	3	Lower_Left	b8a1c8c7-3945-4d84-8f58-3a1a1eb10730	9:74822475−138742366	10, 10	10	{'min_x': 39.539798736572266, 'min_y': 705.2749633789062, 'max_x': 248.18994140625, 'max_y': 833.6940307617188}	60 MB 90 MB 120 MB b8a1c8c7−3945−4d84−8f58−3a1a1eb10730 Stomach−AdenoCA Cancer type 9:74822475−138742366 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 2 298 SVs in sample 10, 10 Oscillating CN (2 and 3 states) 10 CN segments
282	4	Lower_Right	e37cae9e-0656-4b89-b326-739a5cc859e0	12:38025321−70035232	7, 8	61	{'min_x': 328.5299987792969, 'min_y': 705.2749633789062, 'max_x': 554.2219848632812, 'max_y': 833.6940307617188}	25 MB 50 MB 75 MB 100 MB 125 MB e37cae9e−0656−4b89−b326−739a5cc859e0 Stomach−AdenoCA Cancer type 12:38025321−70035232 Position With other complex events Type 49 Interleaved intrachr. SVs 67 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 16; SV types t2tINV: 17; TRA: 18 303 SVs in sample 7, 8 Oscillating CN (2 and 3 states) 61 CN segments
283	1	Upper_Left	085ffcdc-8600-42e2-852a-506465f716a2	10:43499619−48588565	16, 16	16	{'min_x': 41.20000076293945, 'min_y': 286.6499938964844, 'max_x': 246.52395629882812, 'max_y': 416.3340148925781}	085ffcdc−8600−42e2−852a−506465f716a2 Thy−AdenoCA Cancer type 10:43499619−48588565 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 0 22 SVs in sample 16, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.59 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
283	2	Upper_Right	24118b8f-59fe-482a-aed3-7b1bde1571b7	1:8226155−101008006	8, 12	19	{'min_x': 326.5299987792969, 'min_y': 282.3299865722656, 'max_x': 540.1959838867188, 'max_y': 416.3340148925781}	24118b8f−59fe−482a−aed3−7b1bde1571b7 Uterus−AdenoCA Cancer type 10:45492675−89934330 Position With other complex events Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 6 152 SVs in sample 8, 12 Oscillating CN (2 and 3 states) 19 CN segments 0.64 FDR fragment joints 0.02 FDR chr. breakp. enrich. 1:8226155−101008006;18:3979871−48656506 Linked to chrs
283	3	Lower_Left	8d9e4917-334b-4c76-aee1-1e22be772db0	22:19039995−39045748	8, 19	21	{'min_x': 37.58980178833008, 'min_y': 705.2749633789062, 'max_x': 250.95993041992188, 'max_y': 833.6940307617188}	20 MB 25 MB 30 MB 35 MB 40 MB 8d9e4917−334b−4c76−aee1−1e22be772db0 Uterus−AdenoCA Cancer type 22:19039995−39045748 Position With other complex events Type 5 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 0; SV types t2tINV: 1; TRA: 6 422 SVs in sample 8, 19 Oscillating CN (2 and 3 states) 21 CN segments
283	4	Lower_Right	944a102f-3475-45aa-9e30-4b92d1449f00	3:104698386−197525118	8, 14	40	{'min_x': 329.8699951171875, 'min_y': 705.2749633789062, 'max_x': 536.8618774414062, 'max_y': 833.6940307617188}	50 MB 100 MB 150 MB 944a102f−3475−45aa−9e30−4b92d1449f00 Uterus−AdenoCA Cancer type 3:104698386−197525118 Position With other complex events Type 33 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 6; SV types t2tINV: 11; TRA: 10 189 SVs in sample 8, 14 Oscillating CN (2 and 3 states) 40 CN segments
284	1	Upper_Left	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	17:35162507−78407459	8, 13	39	{'min_x': 42.080101013183594, 'min_y': 286.6499938964844, 'max_x': 245.64794921875, 'max_y': 416.3340148925781}	af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 17:35162507−78407459 Position With other complex events Type 13 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 3 315 SVs in sample 8, 13 Oscillating CN (2 and 3 states) 39 CN segments 0.64 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
284	2	Upper_Right	b60f22ac-a659-4f33-b01d-820e86a9a5c9	12:4347137−85863796	7, 11	19	{'min_x': 329.7099914550781, 'min_y': 286.6499938964844, 'max_x': 537.0219116210938, 'max_y': 416.3340148925781}	b60f22ac−a659−4f33−b01d−820e86a9a5c9 Uterus−AdenoCA Cancer type 12:4347137−85863796 Position With other complex events Type 12 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 3; SV types t2tINV: 0; TRA: 5 353 SVs in sample 7, 11 Oscillating CN (2 and 3 states) 19 CN segments 0.59 FDR fragment joints 0.09 FDR chr. breakp. enrich. Linked to chrs
284	3	Lower_Left	bad34c92-1e64-4187-a0b4-061105fd13ba	6:42773558−154331741	13, 18	42	{'min_x': 39.210201263427734, 'min_y': 705.2749633789062, 'max_x': 256.0322265625, 'max_y': 833.6940307617188}	80 MB 120 MB 160 MB bad34c92−1e64−4187−a0b4−061105fd13ba Uterus−AdenoCA Cancer type 6:42773558−154331741 Position With other complex events Type 16 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 2; SV types t2tINV: 6; TRA: 8 315 SVs in sample 13, 18 Oscillating CN (2 and 3 states) 42 CN segments
284	4	Lower_Right	c350b53b-3c27-4b9e-8b57-d7b6a1205a1f	11:59618659−129738667	8, 8	8	{'min_x': 321.5199890136719, 'min_y': 705.2749633789062, 'max_x': 550.3019409179688, 'max_y': 838.7838134765625}	25 MB 50 MB 75 MB 100 MB 125 MB c350b53b−3c27−4b9e−8b57−d7b6a1205a1f Uterus−AdenoCA Cancer type 11:59618659−129738667 Position Canonical without polyploidization Type 3 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 0; SV types t2tINV: 0; TRA: 6 278 SVs in sample 8, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.59 FDR fragment joints
